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Abstract 
Luminescent metal complexes have seen great success in many applications from bio-
sensing to display technology and lighting. A range of different Pt, Pd and Ir complexes 
featuring multidentate ligands have been synthesised in this work with the aim of 
incorporation into organic light emitting diodes (OLEDs).  
Chapter 2 focuses on Pt complexes containing bidentate 1,2,4-triazole ligands. Homoleptic 
complexes exhibit red emission that is concentration-dependent, showing excimeric 
emission at higher concentrations. Impressive quantum yield (φ) values ranging from 21 to 
48 % have been obtained in degassed solution. Consequently, both solution-processed and 
vacuum thermally evaporated devices of these complexes were fabricated and a maximum 
EQE of 14.9 % was obtained for a thermally evaporated device.   
Chapter 3 describes the synthesis and photophysical properties of IrIII complexes featuring 
tridentate N^C^N ligands in combination with 1,2,4-triazole ligands of bidentate and 
tridentate denticity. Some isoelectronic PtIV analogues were also synthesised for 
comparison. The PtIV complexes display superior photophysical properties in comparison to 
the Ir complexes. Indeed, the Pt complex containing dipyridylbenzene (dpyb) as the N^C^N 
ligand in combination with a bidentate 1,2,4-triazole ligand has a φ of 5.9 % and a lifetime 
of 3.1 µs. On increasing the denticity of the triazole ligand from bidentate to tridentate in a 
bis-tridentate Pt complex, an improved φ of 28 % and a lifetime of 11 µs were obtained. 
In Chapter 4, Pt and Pd analogues containing C^N^N^C ligands were synthesised and 
probed for their excimeric emission. Increased complex rigidity was observed for these 
compounds due to the incorporation of tetradentate ligands about the metal centre. The Pt 
compounds generally displayed more impressive photophysical properties compared to 
their Pd analogues, but a Pd complex containing a thiophene tetradentate ligand was 
incorporated into a solution-processed OLED to give a respectable EQE of 3.17 %.   
Finally, in Chapter 5 the foundations for future work to achieve highly efficient NIR OLEDs 
were laid via the synthesis of dinuclear complexes containing Pt(N^C^N) units rigidly linked 
by a xanthene core in a face-to-face conformation. These complexes displayed visible and 
NIR emission with high efficiencies in both solution (φ = 5-35 %) and in films (φ up to 57 %). 
The NIR emission emanates from excimer-like excited states in each case, probably 
involving a varying mixture of face-to-face intra- and intermolecular interactions.   
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1. General Introduction 
The role of  transition metals such as PtII and IrIII in luminescent complexes for applications 
such as OLEDs1,2,3,4,5, photodynamic therapy (PDT) agents6,7,8,9,10 and sensors11,12,13,14 has 
gained significant standing in the past few years. Perhaps the most widely recognised 
luminescent Ir complex is Ir(ppy)3, where ppy is 2-phenylpyridine, which was discovered to 
have excellent photoluminescent properties in dilute solution.15 Pt compounds have been 
rather less well studied but offer a range of intriguing properties owing to their d8 electron 
configuration which can result in square planar geometries. This can allow for structural 
distortion, as well as intermolecular interactions which can impact upon the subsequent 
luminescence properties of PtII complexes, opening up a vast array of exciting structure-
property relationships.  
1.1 Luminescence in metal complexes 
1.1.1 What is luminescence?  
Luminescence describes the excitation and subsequent relaxation of electrons in molecules 
back to the ground state to give out radiation in the form of light. The two main classes of 
photoluminescence are fluorescence and phosphorescence.  
Fluorescence occurs when an excited state of a molecule returns rapidly to the ground 
state with emission of a photon via a spin-allowed transition i.e. ΔS = 0. This could for 
example be the transition from the first excited singlet state to the ground state (S1→S0).  
Fluorescence usually occurs when higher vibrational excited states of either S1 or S2 are 
populated followed by internal conversion (IC) and subsequent rapid relaxation to the 
lowest vibrational level of S1. This process of IC is non-radiative and usually takes place in 
10-12 s or less.10 Emission may occur to a higher vibrational level of the electronic ground 
state, which then quickly reaches thermal equilibrium.  
Phosphorescence, on the other hand, is the emission of light via a non-spin-allowed 
transition, i.e. ΔS ≠ 0. In organic molecules for example, transitions from the triplet excited 
state to the ground state are formally spin-forbidden. Consequently, emission rate 
constants are low and radiative lifetimes are typically on the order of milliseconds to 
seconds.  
A Jablonski diagram, first proposed in 1935 by Alexander Jablonksi, is used to represent the 
radiative and non-radiative processes through absorption and emission via either 
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fluorescence or phosphorescence.16 A typical Jablonski diagram is shown in Figure 1.1. The 
ground, first and second electronic singlet states are depicted by S0, S1 and S2, respectively. 
At each electronic energy level, the fluorophores can exist in several vibrational energy 
levels. Transitions between states are depicted as vertical lines to illustrate the 
instantaneous nature of light absorption, dashed lines are used to represent non-radiative 
processes such as IC, inter-system crossing (ISC) and vibrational relaxation.   
 
Figure 1.1: A Jablonksi diagram showing the vibrational levels for absorption, non-radiative 
decay and luminescence via either fluorescence or phosphorescence.  
The molecular orbitals in metal complexes are described loosely as metal-centred or ligand-
centred. There are four main electronic transitions to describe the excited state: metal-
centred (MC), ligand-to-metal charge transfer (LMCT), metal-to ligand charge transfer 
(MLCT) and ligand-centred (LC) (Fig. 1.2). The relative energies of the orbitals within the 
complex and hence the energies of the transitions will depend greatly on the identity of the 
metal, its oxidation state and the identity of the ligands. Density functional theory (DFT) is 
often employed to calculate the energies of the highest occupied molecular orbital (HOMO) 
and lowest unoccupied molecular orbital (LUMO) levels within complexes to determine the 
energies of each transition, in addition to predicting the contribution of each ligand and 
metal to these transitions.    
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Figure 1.2: Diagrams showing the energy levels of molecular orbitals between which the 
excitations occur for an arbitrary metal complex (left) and the relative energies of these 
resulting transitions on an energy level diagram in which the ground state is represented as 
having E=0 (right). 
1.1.2 The efficiency of luminescence in metal complexes 
The efficiency of luminescence is quantified by the quantum yield, φlum, or the ratio 
between the number of photons absorbed versus those emitted in a molecule. This can also 
be referred to as the photoluminescence quantum yield (PLQY). The assumption that the 
emissive state is formed with unitary efficiency leads to the PLQY being determined by 
equation 1. Luminescence in metal complexes is favoured by a high radiative rate constant, 
kr, of the emissive state and by a low rate of non-radiative decay, knr, which are also defined 
below (equations 2 and 3). The luminescence lifetime, τ, is defined as the reciprocal of the 
experimentally determined rate constant of decay. 
 
                                                                (1)  
                  𝑘𝑟 =  𝜑𝜏
−1             (2) 
                                                            𝑘𝑛𝑟 = 𝑘𝑟(𝜑
−1 − 1)           (3) 
Suppression of knr is key to achieving efficient phosphorescence and there are two main 
strategies to achieve this.  
1. Decreasing the degree of structural distortion in the excited state relative to the 
ground state. 
2. Destabilisation of potentially deactivating MC excited states. 
𝜑𝑙𝑢𝑚 =  
𝑘𝑟
𝑘𝑟 + 𝑘𝑛𝑟
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PtII complexes with d8 electron configuration normally adopt a square planar arrangement. 
This geometry offers the greatest stabilization according to the ligand field theory, since the 
highest energy orbital dx2-y2 remains unoccupied. However, this vacant coordination site 
renders the excited state more flexible and prone to reorganisation which can promote knr.  
The Huang-Rhys factor S quantifies the structural distortion of a molecule in going from its 
ground to excited state.17 When S=0 there is no structural distortion and a sharp single peak 
is observed in the emission spectrum corresponding to the 0-0 transition. With increasing 
structural distortion, a vibronic progression is observed in the emission spectrum (Fig. 1.3). 
The relative intensities of the 0-0 transition and the first vibronic peak 1-0 are given by the 
equation below.  
𝑆 =
𝐼1−0
𝐼0−0
          (4) 
 
 
 
Figure 1.3: Correlations between the structural distortion of the triplet excited state with 
respect to the ground state and the emission spectrum. Reproduced from Li et al. by 
permission of the Royal Society of Chemistry. 18  
Another approach to reduce knr comes from increasing the energy of the MC 3d-d states to 
well above that of the emitting triplet excited state. These MC d-d states contain 
antibonding orbitals and serve to decrease the Pt-L bonding character which allows non-
radiative decay via severe distortion in the excited state. The use of strong field ligands such 
as C-deprotonated cyclometallated ligands can help to achieve this.  
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1.1.3 Effect of cyclometallation on excited states 
Cyclometallation involves the binding of a polydentate ligand to a metal via a covalent 
metal–carbon bond, whilst other bonds to the metal from heteroatoms such as nitrogen 
can be classed as being of a more coordinate nature. There is a net deprotonation of the 
aromatic C–H upon binding, hence cyclometallating ligands are anionic. Examples include 
the bidentate 2-phenylpyridine (ppyH) and tridentate 1,3-di(2-pyridyl)benzene (dpybH). 
The C— ligating ion is a very strong σ-donor whereas the pyridyl group is a good π-acceptor. 
As a result, these ligands offer the metal ion a very strong ligand-field. They cause large d 
orbital splitting and raise the dx2-y2 orbitals to higher energy than the anti-bonding ligand π* 
orbital(s).19 This minimises the undesirable non-radiative d-d transition and improves the 
phosphorescence quantum efficiency. The involvement of the metal in the electronic 
transitions is essential in promoting the formally forbidden phosphorescent emission where 
the excited states are classified as having MLCT character.20 Usually in cyclometallating 
complexes, however, the ligand and metal are heavily mixed in the HOMO hence they are 
assigned a more mixed MLCT/LLCT character.  
 
Figure 1.4: Increasing rigidity across complexes of bidentate,21 tridentate20 and 
tetradentate22 ligands (left to right) and their corresponding φ values. 
Generally, an increase in complex rigidity might be expected to arise from an increase in the 
number of binding sites in the cyclometallating ligand from bidentate to tetradentate (Fig. 
1.4). This increase in rigidity helps to inhibit non-radiative decay such as vibrational 
deactivation and promote efficient luminescence. For example, rigidity usually increases in 
the order of bidentate < tridentate < tetradentate complexes. Hence, there are many 
examples of cyclometallated tetradentate ligands in different transition metal complexes 
which are currently under investigation for use within OLEDs owing to their impressive 
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photophysical properties, a result of strongly rigidified complex structures with high energy 
d-d states.22, 23, 24,25,26 
On the contrary, investigation into many bis-cyclometallated platinum complexes with 
bidentate ligands has shown that their potential for application in OLED devices is rather 
limited owing to their poor photophysical characteristics and inadequate thermal 
stability.21,27 The complex cis-Pt(ppy)2 was found to be nearly non-emissive at room 
temperature (RT) whilst Pt(thpy)2 (Hthpy = 2-(2-thienyl)pyridine) was emissive at RT yet was 
unstable toward sublimation and consequently unsuitable for the vapour deposition 
process used in OLED manufacture. 
The lack of RT phosphorescence and thermal stability for these bis-bidentate complexes is 
at least partially attributed to the lack of rigidity and D2d distortion.28,29,30 The design of a 
more rigid complex structure could help to improve the emission efficiency and for this 
reason tri- and tetradentate ligands are potentially highly attractive.  
1.2 Inter- and intramolecular interactions in PtII complexes 
As mentioned previously, one of the ways in which PtII complexes differ from those of other 
metals such as IrIII is that they are normally 4-coordinate square-planar as opposed to 6-
coordinate octahedral. Aside from the structural distortion which can negatively impact 
upon the luminescence of the compound, this geometry can also introduce the possibility 
of interactions between complexes which often play an important role in their 
photophysical behaviour. These interactions may involve π-π stacking between ligands, π-d 
interactions between one filled 5dz2 Pt orbital and a π orbital on the ligand, d-d interactions 
between 5dz2 orbitals on the metal, or a combination of these. 
In terms of PtPt interactions, for complexes containing only one metal centre 
(mononuclear PtII complexes) interactions are present between individual molecules and so 
are classed as intermolecular interactions. In complexes containing two or more distinct PtII 
units that are covalently bound (multinuclear PtII complexes), some interactions can 
potentially also occur between the units within the molecule and are classed as 
intramolecular. For complexes containing two metals of the same type, the term dinuclear 
is used, whilst if two different metal sites are present, these complexes are classed as 
bimetallic.  
These interactions can occur in the ground state, leading to dimers or aggregates, or in the 
excited state, leading to excimers, or both. Aggregates and excimers may display different 
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emission properties. They are typically red-shifted from those of the isolated monomers, 
due to the stabilisation that arises when two PtII units are brought into close contact. 
The face-to-face interaction between two PtII atoms splits the occupied 5dz2 and 
unoccupied 6pz atomic orbitals to give filled dσ and dσ* and unfilled pσ and pσ* molecular 
orbitals.31 Configuration interaction with MOs of the same symmetry formed by overlap of 
the vacant 6pz orbitals results in stabilisation of the 5dz2 MOs, decreasing the total energy 
leading to a red-shift in energy (Fig. 1.5).32  
 
Figure 1.5: a) MO diagram showing the occupation of the 5dz2 orbitals without considering 
the configuration interaction and b) stabilisation of the 5dz2 orbitals due to the 
configuration interaction. Reproduced from Puttock et al. by permission of Elsevier.32 
When aromatic ligands are involved, they provide additional π and π* orbitals which allow 
electronic transitions of MMLCT (metal-metal to ligand charge transfer) character. These 
transitions are seen to have a smaller HOMO-LUMO gap and hence can explain why the 
absorption and emission are typically red-shifted. Moreover, it also gives the possibility of 
π→π* transitions which could also account for the lower energy emission (Fig. 1.6).   
 
Figure 1.6: MO diagram to show the involvement of aromatic ligands with π orbitals. 
Reproduced from Puttock et al. by permission of Elsevier.32 
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1.3 Organic light emitting diodes (OLEDs) 
As alluded to earlier, one of the main applications in which luminescent PtII complexes have 
been used is OLEDs. OLEDs have become of increasing interest since the first report of such 
a device in 1987 by Tang and Van Slyke.33 They have potential applications as a new 
generation of display and lighting technology. The energy efficiency of traditional light 
bulbs and lighting devices is very low. Lighting accounts on average for over 20 % of the 
world’s electricity consumption, giving rise to high carbon emissions.34  OLEDs are much 
more energy efficient than traditional light sources such as incandescent bulbs and could 
consequently reduce the world’s carbon emissions significantly. Moreover, for display 
technologies, they do not require a backlight, give higher colour purity and offer improved 
viewing angles in comparison to LED TVs.35,36  
 
Figure 1.7: Simplified schematic of a single-layer OLED. 
OLEDs can be in single-layer or multi-layer devices. In a single-layer device, OLEDs contain 
two electrodes with a single emitting layer (EML) sandwiched in between (Fig. 1.7). The 
EML is usually made up of an organic material such as a polymer e.g. poly(p-
phenylenevinylene) or a small molecule such as tris(8-hydroxyquinolinato)aluminium 
(Alq3).37,38,39 A voltage is applied across the device making the anode positive with respect 
to the cathode. A current of electrons flows through the device from cathode to anode and 
electrons are injected into the LUMO of the organic layer at the cathode and withdrawn 
from the HOMO at the anode. The resulting holes and electrons that are formed can 
recombine through electrostatic forces to form an exciton. The decay of this exciton results 
in a relaxation of the energy levels, accompanied by emission of radiation via 
electroluminescence whose frequency depends on the HOMO-LUMO gap of the material 
(Fig. 1.8).  
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Figure 1.8: Schematic representation of electroluminescence where G.S represents the 
ground state. 
These excitons can emit from either the singlet or triplet state. Statistically, in 
electroluminescence the triplet to singlet exciton formation is 3:1, irrespective of spin orbit 
coupling (SOC) and the rate of intersystem crossing (kISC). Electroluminescence thus differs 
from photoluminescence, where the amount of triplet excited state formation in a 
molecule can be anything from 0 to 100 % according to the magnitude of kISC versus other 
processes open to the singlet state (i.e. non-radiative decay etc.). 
Transitions from triplet excited states to the singlet ground state are formally spin-
forbidden, therefore only the singlet states, about 25 % of total excitons generated in the 
OLED during electroluminescence, can be harvested with the use of a fluorescent emitter 
(excluding thermally activated delayed fluorescence (TADF) emitters). Phosphorescent 
emitters such as PtII complexes, on the other hand, can harness both singlet and triplet 
excitons and theoretically maximise the internal quantum efficiency (IQE) of devices to 100 
% when incorporated into an EML.11 RT phosphorescence emitted from many transition 
metal complexes is attributed to the large SOC constants of these metals, which enables an 
efficient singlet-triplet ISC and promotes the rate constant of phosphorescence (kp).  
Exciton-quenching processes close to the electrodes or non-radiative recombination of 
charges at the electrodes can occur and reduce the efficiency of devices. To combat this, 
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other layers are introduced to form a multi-layer device. In these devices incorporation of 
hole- and electron-transport and blocking layers facilitate charge injection and enhanced 
recombination of electrons and holes in the EML to improve the efficiency of devices.40,41,42 
1.3.1 Efficiencies 
The efficiency of an OLED is defined by both the internal and external quantum efficiencies, 
IQE and EQE respectively. The IQE (ηint) can theoretically reach up to 100 % and is defined 
as the ratio of the total number of photons produced within the device to the number of 
electrons injected.43 Similarly, but with a subtle key difference, the EQE (ηext) is defined as 
the ratio of the number of photons emitted by the OLED into the viewing direction, or the 
viewing direction efficiency (ηC), to the number of electrons injected. The two parameters 
can thus be connected by the equation given below:44 
𝜂𝑒𝑥𝑡(𝜆) = 𝜂𝑖𝑛𝑡(𝜆)𝜂𝐶    (5) 
The luminous efficiency measured in cd/A is a key term used to describe the efficiency of an 
OLED for display applications. It is very similar to ηext but differs as the incident photons 
from the device are weighted according to the photopic response from the eye i.e. how 
sensitive the eye is to certain colours, whilst ηext counts all photons as equal. The luminous 
efficiency is given by the following equation: 
𝜂𝐿 =
𝐴𝐿
𝐼𝑂𝐿𝐸𝐷
     (6) 
where L is the luminance of the OLED in cd/m2 and A is the device active area (not always 
equal to the area of light emission, owing again to the photopic response factor).  
The luminous power efficiency or luminosity (ηp) is measured in lm/W. It is defined as the 
ratio of the luminous power emitted in the forward direction (LP) to the total electrical 
power required to drive the OLED at a given voltage. The equation below shows the 
relationship between these variables: 
 
𝜂𝑃 =
𝐿𝑃
𝐼𝑂𝐿𝐸𝐷𝑉
     (7) 
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1.3.2 Processing methods 
The processing methods for OLED fabrication have developed significantly over the past 
few years and range from physical vapour deposition methods to condensed phase 
techniques.45 The processing methods are tailored to the type of device structure i.e. multi-
layer/single-layer devices and to the types of polymer/small molecules within these layers. 
The two main processing techniques that will be discussed in this thesis are limited to 
vacuum thermal evaporation (VTE) and solution-processing, but many other techniques 
including inkjet printing and organic vapour phase deposition are also currently employed 
in many commercial OLED fabrications.46  
VTE involves heating the compounds for deposition under vacuum to temperatures ranging 
from 100 to 500 °C in crucibles (Fig. 1.9). This induces evaporation of the compounds onto 
substrates. The material must pass through a shadow mask which protects the substrate 
and allows one third of all pixels to be deposited before it moves and allows deposition of 
the next set of pixels. VTE enables the formation of homogeneous layers, promoting ease of 
multi-layer device fabrication. The main drawback with this technique is the high cost of 
vacuum equipment and the shadow masks which are heavy, hard to clean and sometimes 
hard to obtain precise alignment for the deposition of pixels.  
 
Figure 1.9: Schematic of VTE in OLED fabrication. 
Solution-processing utilises volatile solvents such as chlorobenzene to apply the material to 
a substrate. The solvent evaporates and leaves behind a thin film of material via techniques 
such as spin-coating.  Solution-processing is becoming more widely used but is still limited 
by the lower control over film quality and more complicated route to multi-layer devices in 
comparison to VTE.  
12 
 
1.3.3 OLED development 
The development and efficiency of OLEDs has increased significantly over the years for both 
purely organic and heavy metal-doped devices. TADF molecules were first put to use in 
OLEDs by Adachi et al. in 2012.47 They removed the maximum barrier for 𝜂𝑖𝑛𝑡 of 25 % for 
purely organic devices via reverse intersystem crossing (RISC) from the lowest energy triplet 
excited state to the lowest energy singlet excited state which enables utilisation of 100 % of 
excitons. This has led to a surge of research in the area with multiple papers reporting high 
EQEs of over 30 % for purely organic TADF molecule-containing devices.48,49,50 
Consequently, there has been a remarkable effort to improve the efficiency of heavy metal- 
based devices and a push to achieve purer colour emission for deep blue51,52 and red 
colours53,54, as well as huge efforts towards efficient white organic light emitting diodes 
(WOLEDs)55,56,57 which could dramatically reduce the energy consumption for lighting 
worldwide. 
Of particular interest in this thesis is the advancement of red and near-infrared (NIR) 
emission in PtII complexes. This has many potential applications including bio-imaging58,59,60, 
since skin transparency is at its highest at these wavelengths61, and OLED lighting where 
highly efficient OLEDs in the NIR region are currently scarce. This lack of efficient red and 
NIR emitters mainly stems from the consequences of the energy gap law (EGL) which 
describes how the deactivation pathway between the lowest lying singlet (S1) or triplet (T1) 
states and the ground state (S0) can occur by coupling between the zero vibration level of 
the S1 (or T1) state and the higher vibration levels of the S0 state.62,63 The smaller the energy 
gap, the larger this non-radiative process is and consequently red and NIR emission are 
particularly vulnerable when it comes to poorer efficiencies. One way of achieving deep red 
and NIR emission is via the formation of Pt excimers as alluded to earlier, and this will be 
covered in greater detail in the chapters that follow.   
A large area of interest to improve efficiency in phosphorescent OLEDs of all emission 
colours has been in orientation of the emitting dipole64,65 to surpass the theoretical limit of 
25-30 % EQE. The design criteria for horizontally oriented molecules parallel to the 
substrate has two main points66,67: 
1) the molecule should be linear  
2) the molecule must have bulky terminal units to suppress intermolecular interactions 
other than crystallisation 
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It has subsequently been found that highly oriented emitting dipoles (parallel to the 
substrate) in purely crystalline layers of Pt and Ir complexes can lead to high EQEs of up to 
45 %. 68,69,70 Many other research efforts are taking place to improve the design of OLEDs to 
make them more commercially accessible and the investigation of heavy metal complexes 
is at the forefront of this research.  
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2. Pt complexes featuring bidentate 
triazole and tetrazole ligands 
2.1 Introduction 
2.1.1 Synthesis of triazole and tetrazole ligands 
Azole ligands are increasingly popular in luminescent metal complexes.71,72,73,74 They can be 
combined with a heterocycle such as pyridine to give ligands with synergistic strong σ-
donating and π-accepting character.75 Triazoles and tetrazoles are the main focus of this 
section.  
 
Figure 2.1: 1,2,3-triazole, 1,2,4-triazole and tetrazole structures. 
Triazoles are defined as any five-membered ring containing three nitrogen atoms and can 
exist as either 1,2,3-triazoles or 1,2,4-triazoles as shown in Fig. 2.1. They were first 
discussed by Bladin in 189576 and have since made significant contributions in 
agriculture77,78,79, medicine80,81,82 and, as will be discussed, photoactive devices. In tetrazoles 
there are four nitrogen atoms in the five-membered ring. They have similar attributes to 
triazoles but are more prone to instability as they are more electron rich and can generate 
two moles of N2 per molecule. This can subsequently limit their usage in many applications.  
1,2,3-Triazoles are typically accessed via either the Huisgen azide-alkyne 1,3-dipolar 
cycloaddition83 or the copper-catalysed azide-alkyne cycloaddition (CuAAC) (Scheme 2.1).84 
The CuAAC method is favourable as it utilises click chemistry first pioneered by Sharpless in 
200185 which makes these types of ligands easily accessible with high purity. The 1,2,3-
triazole ligands can exist in two main forms: regular and inverse (Fig. 2.2). The regular form 
is more common and allows coordination to a metal centre via the more electron rich N3 
atom whereas the inverse form is more synthetically challenging and 1,2,3-triazoles 
coordinate through the less electron rich N2 position.86  
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Scheme 2.1: Copper-catalysed azide-alkyne cycloaddition synthesis. 
1,2,4-Triazoles substituted at the 3 and 5 positions are of particular interest due to the 
functionality that can be incorporated into the ring which can aid in solubility and influence 
the luminescent properties of the subsequent complexes that are formed. They can be 
synthesised via a variety of different methods.87 During their first years of synthesis, fusion 
of an aromatic cyanide with an acid hydrazide benzenesulfonate or p-toluenesulfonate at 
200-250 °C was a popular method.88 This was succeeded by distillation of an acid hydrazide 
with an acid amide, known as the Pellizzari reaction.89 Now more modern methods of 
synthesis are used which include oxidative cyclization of amidines with nitriles or 
acylhydrazines.90 One example is from De Cola et. al.91 shown in Scheme 2.2 where 
formation of the 1,2,4-triazole takes place in three main steps: 
1. initial reaction of 2-pyridinecarbonitrile with hydrazine monohydrate 
2. attack of the resulting amidrazone on an acyl chloride  
3. condensation reaction in ethylene glycol at 185 °C to form the triazole  
 
Scheme 2.2: Three-step synthesis of 1,2,4-triazoles adapted from De Cola et al. 
Tetrazoles are commonly synthesised via the 1,3-dipolar cycloaddition of a carbonitrile with 
sodium azide (NaN3) in the presence of ammonium chloride (NH4Cl) as a buffer (Scheme 
2.3).92 This is another example of click chemistry and is followed in this project. 
 
Scheme 2.3: Tetrazole synthesis via 1,3-dipolar cycloaddition. 
2.1.2 Binding modes of bidentate triazole and tetrazole ligands in complexes 
Both classes of triazole, and the tetrazoles, can be combined with pyridine to form 
bidentate ligands for metals such as PtII. Depending upon the coordination mode, these 
ligands can be analogous to the archetypal bipyridine (bpy) ligand via binding through both 
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neutral N atoms or they can bind via a neutral N atom on the pyridine and a deprotonated 
N atom on the triazole/tetrazole to form a pseudo-cyclometallating ligand like the 
archetypal phenyl pyridine (ppy) (Fig. 2.2).  
 
Figure 2.2: Different modes of coordination in 1,2,3-triazole, 1,2,4-triazole and tetrazole 
complexes where blue indicates neutral coordination and red indicates anionic/potentially 
anionic coordination. 
Many examples of bidentate luminescent azolate complexes have been synthesised in the 
past few decades and this review will focus primarily on triazole and tetrazole PtII 
complexes, together with some examples that combine these ligands with IrIII.  
2.1.3 Pt complexes containing bidentate cyclometallating ligands 
2.1.3.1 Pt(N^C)2 complexes  
Firstly, it is important to set the scene with the development and current standing of 
cyclometallated Pt(N^C)2 complexes containing bidentate ligands which can be used as a 
platform for comparison with triazole and tetrazole pseudocyclometallating analogues that 
will be discussed. Homoleptic complexes, namely cis-[Pt(ppy)2], cis-[Pt(thpy)2] and cis-
[Pt(bhq)2], (where ppy= 2-phenylpyridine, thypy= 2-(2-thienyl)pyridine and bhq= 
benzo(h)quinoline), were first prepared over 20 years ago (Fig. 2.3).21,27 It was only cis-
[Pt(thpy)2] that showed any RT emission, giving an impressive PLQY of 36 % whilst the 
others were virtually non-emissive at RT and only displayed emission at 77 K with lifetimes 
on the µs timescale.  
17 
 
 
Figure 2.3: Structures of cis-[Pt(ppy)2] (1), cis-[Pt(thpy)2] (2) and cis-[Pt(bhq)2] (3). 
2.1.3.2 Pt[(N^C)(HC^N)(Cl)] Complexes. 
Complexes containing chloride ligands are expected to be only weakly emissive at RT due to 
their low ligand field strength. This was demonstrated through the photophysical 
properties of [Pt(ppy)Cl2]– investigated by Kvam et al. which showed no emission at RT but 
highly structured emission at 77 K with a quantum yield of 0.9 and lifetime of 15.2 μs in 
MeOH/H2O (1:1).93 It was found that the weak-field splitting of the chloride ligand causes a 
small energy gap between the lowest emitting 3MLCT state and the upper lying d-d states, 
which can be thermally populated at RT, and thus quenches the emission. Through the 
attempted synthesis of many other homoleptic Pt(N^C)2 complexes, came heteroleptic 
complexes with the general structure Pt[(N^C)(HC^N)(Cl)].94 These complexes contain one 
cyclometallating unit, a terminal chloride and neutral N donor ligand.  
The structures and luminescence spectra of complexes 4-7 of the form Pt[(N^C)(HC^N)(Cl)] 
are shown below (Fig. 2.4). Complex 4 emission was studied in detail in an earlier paper and 
was seen to give emission in solution with λmax of 489, 523 and 555 nm. Lifetimes in toluene 
solution at 298 K and at 77 K were 640 ns and 11 μs respectively.95 On comparing 
complexes 4-7 there was an obvious red-shift in the λmax of emission from 6 > 7 > 5 >  4. 
Emission from 6 and 7, which contain electron-donating groups and extended conjugation, 
was red-shifted significantly in comparison to that from complexes 4 and 5 which contained 
no substitution or electron-withdrawing substituents on the phenyl rings.  
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Figure 2.4: Structures of complexes 4-7 and their normalised absorbance and luminescence 
in DCM. Reproduced from Cho et al. by permission of Elsevier.95 
2.1.3.3 [Pt(N^C)L]+ Complexes 
Kvam also investigated the photophysical properties of charged heteroleptic complexes;  
[Pt(ppy)(en)]+ (8), [Pt(ppy)(bpy)]+ (9) and [Pt(phen)(bpy)]+ (10).93 These complexes contain a 
cyclometallating unit and a neutral ligand of the form N^N which results in an overall 
positive charge on the complex. These complexes were found to be emissive at RT where 8, 
9 and 10 had lifetimes and quantum yields of 1.7, 4.0 and 3.5 μs and 5.8, 1.7 and 1.3 % 
respectively in dimethylformamide (DMF) solution. The combination of strong σ-donating 
cyclometallating ligands with strong-field bpy and ethylenediamine (en) ligands in these 
complexes helps to increase the energy gap between MLCT and MC states, giving efficient 
emission.  
2.1.4 Pt complexes containing bidentate azole ligands  
The photophysical properties of the Pt complexes containing bidentate azole ligands that 
are discussed in the following sections are summarised in Table 2.1 at the end of the 
introductory section of this chapter.  
2.1.4.1      1,2,3-Triazole complexes 
Despite an increasing amount of research interest on 1,2,3-triazole-containing complexes of 
transition metals including Ir, Re and Os,96,97,98 there is very little literature on the 
photophysical properties of Pt complexes containing 1,2,3-triazoles as bidentate ligands. 
Kilpin et al. synthesised regular and inverse Pt and Pd 1,2,3-triazole complexes 11-14 with 
chloride ancillary ligands (Fig. 2.5). The only electronic spectroscopic data provided was the 
UV-Vis absorption of the regular complexes 11 and 12 which showed LC π-π* transitions at 
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279 nm for the Pd complex and 294 nm for the Pt complex.  MLCT transitions were 
observed at 376 and 330 nm for the Pd and Pt complexes respectively.99 
  
Figure 2.5: Absorption spectra of regular 1,2,3-triazole complexes 11 and 12 and the 
corresponding ligand in DMF solution. Reproduced from Kilpin et al. by permission of 
Elsevier.99 
As previously alluded to, work on luminescent Ir complexes containing 1,2,3-triazoles has 
been more prevalent. Felici et al. synthesised a series of luminescent ionic iridium 
complexes of the form [Ir(X)(Y)(Z)]Cl where X, Y and Z represent different bidentate              
1-substituted-4-phenyl-1H-1,2,3-triazole cyclometallating ligands (Fig. 2.6).100 Quantum 
yields ranged from 7.1 to 25 % and lifetimes ranged from 18 to 34 ns in degassed solutions. 
The broad emission was assigned as an MLCT excited state of the HOMO-LUMO transition. 
The figure below shows complex 15 where X = 1-methyl-4-phenyl-1H-1,2,3-triazole, Y =       
1-adamantyl-4-phenyl-1H-1,2,3-triazole and Z = 1-adamantyl-4-pyridyl-1H-1,2,3-triazole 
and it displayed a PLQY of 11 % in acetonitrile (MeCN).  
 
 
Figure 2.6: UV-Vis absorption spectrum (solid), RT emission spectrum (dotted) in MeCN of 
15 and 77 K emission spectrum (dashed) in glassy butyronitrile matrix (λexc= 335 nm) where 
ada = adamantyl. Reproduced from Felici et al. by permission of MDPI.100  
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2.1.4.2      1,2,4-triazole complexes  
Interestingly, there are also relatively few examples of PtII complexes containing bidentate 
1,2,4-triazole ligands that are strongly luminescent in solution and there are fewer 
examples of these 1,2,4-triazole-containing complexes that have been incorporated into 
devices.101 Examples of some PtII complexes containing bidentate 1,2,4-triazole ligands 
were prepared by Chang et al. in 2006 (Fig. 2.7).102  The luminescence spectra of 16 and 17 
were measured in a degassed tetrahydrofuran (THF) solution at RT; however, the emission 
was extremely weak with PLQYs lower than 10-3 and phosphorescence lifetimes of <10 ns. It 
was postulated this was due to self-quenching because of the strong tendency for PtPt 
units to aggregate. Due to the poor solubility of these compounds, concentration-
dependent studies could not be performed to elucidate this further, but in vacuum-
deposited thin films, moderate to highly intense luminescence was obtained with λmax 
values of 564 and 544 nm for complexes 16 and 17 respectively.  
 
Figure 2.7: Structure of PtII 1,2,4-triazole complexes 16 and 17. 
Indeed, even changing the binding mode of the ligand does not seem to improve the 
solution-state properties of these 1,2,4-triazole PtII bidentate complexes. For example, 
Strassner et al. have recently returned to their investigations on the ‘Enders triazole’,  
previously reported by Enders et al. in 2003.103 This compound contains a 1,2,4-triazole 
ligand which binds through the carbon, as opposed to any of the available nitrogens, as an 
N-heterocyclic carbene (NHC).  The Pt complexes 18 and 19 shown in Figure 2.8 display no 
observable emission in degassed DCM, but when doped at 2 wt. % into a PMMA film give 
highly efficient sky blue emission with quantum yields of over 80 %.104 These are rare 
examples of a 1,2,4-triazole binding as a C^C— ligand and, as of yet, there is no data 
referring to the electroluminescent performance of these complexes.  
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Figure 2.8: Synthesis of complexes 18 and 19 using the Enders triazole ligand, i) Ag2O, DMF, 
40 °C; ii) Pt(COD)Cl2, DMF, 3 h at RT, 21 h at 125 °C; and iii) KOtBu, -diketone, DMF, 21 h at 
RT, 6 h at 100 °C. 
In 2009 Li et al.105 reported the PtII bis[3,5-bis(2-pyridyl)-1,2,4-triazolato] complex (20) 
which remains as one of the few strongly luminescent and soluble examples of a 1,2,4-
triazole Pt complex containing bidentate ligands that is suitable for OLED incorporation in 
the literature to date (Fig 2.9). It was synthesised by refluxing two equivalents of 3,5-bis(2-
pyridyl)-1,2,4-triazole with one equivalent of cis-bis(benzonitrile)PtCl2 in pyridine/acetone 
under nitrogen for three days. The crystal structure of the complex showed columnar stacks 
stabilized via strong intermolecular interactions with PtPt distances of 3.289 Å. These 
short distances could help to explain the formation of excimers which were present in both 
the photoluminescence (PL) and electroluminescence (EL) spectra. The amount of excimer 
formation was dependent upon either the concentration of the thin film or the dopant 
concentration within the EML of the OLED. OLEDs were fabricated by sequential thermal 
evaporation with the device structure of: glass / ITO / NPB (40 nm) / x % 20 : CBP (25 nm) / 
TPBI (30 nm) / Mg:Ag, 1:10 (200 nm) (Table 2.1). Doping levels of x = 5–10 % gave optimal 
EL efficiency and white colour coordinates resulting from simultaneous monomer and 
excimer emissions. The peak power and luminous efficiencies obtained were 9.8 lm/W and 
14 cd/A, respectively, whilst the peak EQE was 6.6 %.   
 
 
Figure 2.9: Molecular structure of 20 and the columnar stacks formed, stabilised by strong 
intermolecular interactions. Reproduced from Li et al. by permission of Elsevier.105  
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As implied earlier, there are also examples of Ir complexes with azole ligands giving 
different properties to those offered by Pt. A detailed study into IrIII complexes containing 
(4′-substituted-2′-pyridyl)-1,2,4-triazole ligands has been conducted by Park et al. to obtain 
highly desirable deep blue emission.106 The synthesis of the 1,2,4-triazole ligands was 
achieved by a [2 + 3] cycloaddition reaction of substituted 2-pyridylnitriles where R=CH3 
and OCH3 with trifluoroacetic acid hydrazide (Scheme 2.4). Subsequent reactions to afford 
complexes 21 and 22 (Fig. 2.10) included formation of the Ir chloro-bridged dimer which 
was then cleaved with the appropriate triazole ligand.  
 
Scheme 2.4: Synthesis of selected 1,2,4-triazole ligands used in the synthesis of complexes 
21 and 22.  
 
 
 
 
Figure 2.10: Emission of complexes 21 and 22. Reprinted with permission from Park et al.106 
Copyright 2013 American Chemical Society.   
Depending upon the R groups on both the N^C ligand and the triazole ligand, the emission 
maxima ranged from 448 to 464 nm with quantum yields of between 0.20 and 0.42 either 
in DCM solution or thin film (5 wt. % in PMMA). Electron-donating substituents on the 
pyridine of the triazole ligand and electron-withdrawing substituents on the difluorophenyl 
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of the N^C ligand proved to give the bluest emission and complex 22 was thus chosen to be 
tested in an OLED device (λmax of 448 nm, PLQY= 42 %). This device gave commission 
internationale de l’Eclairage (CIE) coordinates of (0.15, 0.18) which is extremely close to the 
‘perfect’ deep blue coordinates of (0.15, 0.15) and thus shows the potential of 1,2,4-triazole 
Ir complexes for colour purity in deep blue OLEDs. 
Despite some impressive photophysical properties in the solid-state for some PtII complexes 
containing bidentate triazole complexes, solubility issues and poor luminescence efficiency 
in the solution-state has led to these complexes taking a back seat in terms of OLED 
fabrication. The current leaders in the field for bidentate PtII azole complexes as potential 
OLED dopants are in fact those containing pyrazole ligands. These are seen to show 
impressive PL and EL properties, a few of which are outlined here.  
2.1.4.3 Pyrazole complexes 
Kim et al. optimised the orientation of the molecular dipole in OLEDs containing the Pt 
pyrazole complexes 23-25 (based on the work by Chang et al. in 2006102) to give very high 
EQE values (Fig. 2.11).107 The maximum EQE obtained was 38.8 % for complex 23 which was 
incorporated as a neat film for the EML of an OLED.  
 
Figure 2.11: Structures of Pt pyrazole complexes 23, 24, and 25.  
Interestingly, the PL intensities of these complexes in solution were very low, showing 
largely monomer emission at 10-5 M concentrations, however, when measured in a neat 
thin film, the emission was purely excimeric and gave PLQYs of 96, 43 and 56 % for 23, 24 
and 25 respectively. The emitting dipole orientation of the crystal emitting layers was also 
found to be largely affected by the position of the CF3-substituted pyrazolate units in these 
Pt complexes and complex 23 gave the best arrangement for molecular orientation.  
As mentioned earlier, devices with deep-red emission are highly sought after for their 
biological applications, but the number of highly efficient devices remains relatively low. 
New research pushes these boundaries every day where, for example, Ly et al. synthesised 
three new homoleptic 2-pyrazinyl pyrazolate PtII complexes in 2016 (26-28, Fig. 2.12).108 
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They have very similar structures to the ones made by Kim’s group but incorporate pyrazine 
groups to replace pyridine moieties, giving impressive results.  
 
Figure 2.12: Structures of homoleptic 2-pyrazinyl pyrazolate PtII complexes 26, 27 and 28.   
Quantum yields of the complexes ranged from 55 to 82 % with complex 26 displaying the 
most impressive EQE of 24 % in the device emitting at 740 nm in the NIR. This impressive 
device performance was attributed to the high thin-film PLQY of 81 %, as well as the 
horizontal orientation of the emission dipoles. Indeed, it surpassed any other NIR OLED 
efficiency prior to it, the closest of which had an EQE of 14.5 % with emission at 700 nm 
based upon a tridentate Pt(NCN)Cl complex synthesised by our group in 2008.109 
2.1.4.4 Tetrazole complexes  
The number of tetrazole complexes in OLEDs is significantly fewer than many other azole 
complexes due to their instability stemming from the extremely electron rich heterocycle 
containing four nitrogen atoms. They do, however, show some promising photophysical 
attributes. For instance, MaGee et al. investigated PtII complexes with 2-pyridyltetrazolate 
and ortho-xylene-linked bis(NHC)cyclophane (cyph) ligands (29 and 30, Fig. 2.13).110 
Complex 29 was synthesised by reaction of Pt(cyph)Cl2 with the 2-pyridyltetrazole ligand in 
DMSO with triethylamine (NEt3) base and subsequent anion exchange with potassium 
hexafluorophosphate (KPF6) in water. Complex 30 was then afforded by reaction of 29 with 
a solution of methyl triflate in dichloromethane (DCM) at −50 °C. Complex 29 displayed a 
quantum yield of 14 % and had deep blue emission with λmax of 436 nm whilst complex 30 
had slightly red-shifted emission at 448 nm and a reduced quantum yield of 2 %.  
 
Figure 2.13: Structures of Pt tetrazole complexes 29, 30, 31 and 32. 
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These compounds were not incorporated into devices, but efforts have been made by 
Brulatti et al. to include similar 2-pyridyl tetrazolate PtII complexes, 31 and 32 (Fig. 2.13), 
into VTE OLEDs.111 Synthesis of these complexes was conducted by cleavage of the 
corresponding [Pt(N^C)(µ-Cl)]2 dimer with the 2-pyridyltetrazole ligand in methoxyethanol 
at reflux for 10 hours. The effect of complex concentration in the device was probed and 
showed that higher concentrations of the complex dopant in 4,4’,4”-tris(N-
carbazolyl)triphenylamine (TCTA) films gave red excimeric emission whilst at low 
concentrations blue-green emission was observed for the monomer, and this was reflected 
in their CIE coordinates (Fig. 2.14 and 2.15).  The neat films that were studied were 
polycrystalline, in comparison to the amorphous films which resulted at lower weight 
concentrations of the Pt emitter in TCTA. The best performing device was found to have    
15 wt. % of 31 in the TCTA host giving an EQE of 10 %. For Pt complexes containing 
bidentate tetrazole ligands this is the highest recorded EQE in the literature (see Table 2.1 
for device information).   
  
  
Figure 2.14: Top: Solid-state PL spectra of (a) 31 and (b) 32 and bottom: EL spectra of (a) 31 
and (b) 32 with different dopant concentrations in the TCTA host. Reproduced from Brulatti 
et al. by permission of the Royal Society of Chemistry.111 
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Figure 2.15: CIE coordinates for complex 31 in different devices demonstrating effective 
colour tuning abilities. Reproduced from Brulatti et al. by permission of the Royal Society of 
Chemistry.111 
Although the focus of this work is on complexes containing bidentate triazole and tetrazole 
ligands, one cannot ignore the huge development in highly rigidified tridentate and 
tetradentate complexes with impressive photophysical properties that in many, but not all, 
cases outperform bidentate analogues, and these will be discussed in the chapters that 
follow.  
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Table 2.1: PL and EL data of Pt azole complexes containing bidentate ligands. All EL data given is for the maximum values obtained. Please refer to 
the list of abbreviations for the device architecture column.  
Complex no. 
& reference 
Device Architecture PL performance EL performance 
λmax (nm) 
[soln/film] 
PLQY (%) 
[soln/film] 
Lifetime (ns) 
[soln/film] 
λmax(nm) 
[mono/exc] 
CE 
(cd A-1) 
PE 
(lm W-1) 
Brightness 
(cd m-2) 
EQE 
(%) 
Triazole 
16 102 - [482, 512, 540 
/ 564] 
[2/16] [400/400] - - - - - 
17 102 - [-/544] [-/33] [-/300] - - - - - 
18 104 - [-/470] [-/82] [-/7200] - - - - - 
19 104 - [-/467] [-/87] [-/8500] - - - - - 
20 105 ITO / NPB (40 nm) / 10 wt. % 20 : CBP (25 nm) / TPBI (30 nm) / 
Mg:Ag, 1:10 (200 nm) 
- - - [480/575] 14 9.8 6130 6.6 
22 106 ITO / NPB (500 nm) / TAPC (350 nm)  / CDBP (100nm) / CDBP: 10 
wt. % 22 (500 nm) / Me2Si(TAZ)2 (600 nm) / LiF : Al 
[448/448] [42-/] [3600/-] - 7 - 4 - 
Pyrazole 
23 107 
ITO (100 nm) / TAPC (80 nm) / TCTA (10 nm)/ 23/24 (30 nm) / 
BmPyPb (15 nm) / BmPyPb: 1 wt. % Rb2CO3 (40 nm) / Al (100 
nm). 
[407/625] 
 
[- / 96] [- /380] [-/625] 62 53.8 - 38.8 
24 107 [403/622] 
 
[- / 43] [- /480] [-/622] 22.4 8.4 - 15.7 
25 107 ITO (100nm) / mCP: 5wt. % ReO3 (60 nm) / mCP (10 nm) / 25 (30 
nm) / B3PymPm (15 nm) / B3PYMPM: 1 wt. % Rb2CO3 (40 nm) / 
Al (100 nm). 
[423/620] 
 
[- / 56] [- /490] [-/620] 36.3 18.2 - 22.6 
26 108 
ITO (100 nm)/ HATCN (10 nm)/ NPB (50 nm)/ mCP (15 nm)/ 
26/27/28 (20 nm) / TPBi (60 nm) / Liq (2 nm) / Al (100 nm). 
[ -/ 740] [ - / 81] [- /310] [-/740] - - - 24 
27 108 [ -/ 703] [ - /55] [- /370] [-/683] - - - 21 
28 108 [ -/ 673] [ - /82] [- /310] [-/669] - - - 24 
Tetrazole 
31111 
ITO (20 nm) / TPD:PC (60 nm) / TCTA (10 nm )/ 31/32 (30 nm) / 
TAZ (10 nm) / LiF (0.5 nm )/ Al (100 nm). 
[480/675] [ - /30] [- /700] [-/675] - - - 2 
32111 [460/678] [- /75] [- /500] [-/655] - - - 8 
31111 ITO (20 nm) / TPD:PC (60 nm) / TCTA (10 nm) / TCTA : 15 wt. % 
31 (30 nm) / TAZ (10 nm) / LiF (0.5 nm) / Al (100 nm). 
- - - [-/600] - - - 10 
28 
 
2.2 Objectives 
As can be seen from the literature review, there are a number of PtII azole complexes 
containing bidentate ligands which show potential application in OLED devices. However, 
specifically for triazole and tetrazole complexes, there are only limited examples showing 
the necessary attributes for OLED incorporation. This is due to several factors, but it has 
been identified that the main problems facing these types of complexes are associated with 
solubility and aggregation. It is also apparent that efficient deep blue and deep red/NIR 
emission are both highly sought after for many applications, although they remain a 
challenge to achieve.  
Consequently, we aim to: 
• Synthesise luminescent PtII complexes featuring bidentate 1,2,4-triazole and 
tetrazole ligands with high performance in both solution and solid-state 
photoluminescence. 
• Tune the emission of these types of complexes to push for deep red/NIR emission 
via intermolecular interactions. 
• Test these complexes for their electroluminescence behaviour in OLED devices. 
To achieve these aims we have synthesised two main types of 1,2,4-triazole complex: 
1. Homoleptic complexes containing two of the same bidentate ligand bound to a PtII 
centre. 
2. Heteroleptic complexes which contained only one 1,2,4-triazole ligand bound to a 
PtII centre but with another ligand, including bipyridine (bpy), phenanthroline 
(phen), thienylpyridine (thpy) and phenylquinoline (pquin), to complete the 
coordination sphere.  
In addition to this, we investigated some homoleptic PtII complexes containing bidentate 
tetrazole ligands of a similar nature for comparison.  
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2.3 Results and discussion: Triazole complexes 
2.3.1 Homoleptic 1,2,4-Triazole complexes  
2.3.1.1 Synthesis  
Three groups of 1,2,4-triazole ligands were synthesised containing:  
1. no functionality on the pyridine ring HL1-4,  
2. a quinoline ring in place of the pyridine HL5-6,   
3. functionality at the 4-position on the pyridine HL7-10.  
Scheme 2.5: Synthesis of 1,2,4-triazole intermediates and resulting ligands HL1-6. 
The synthesis of HL1-6 took place in a 3-step process adapted from De Cola’s group91 shown 
in Scheme 2.5:  
1. Formation of intermediate 1 (I1x) via reaction of the carbonitrile with hydrazine 
monohydrate. 
2. Formation of intermediate 2 (I2x) via reaction of I1x with the appropriate acyl 
chloride. 
3. Formation of 1,2,4-triazole ligands (HL1-6) via the condensation reaction of I2x.  
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Respectable yields were achieved at each step and final-step yields ranged between 43 and 
94 %. The triazole with R=NO2 was also synthesised, but this gave a low yield as the ligand 
did not lead to a soluble complex so it is not discussed any further. Purification was 
achieved with water washes and recrystallization in hot EtOH for HL5-6.  
HL7-10 were synthesised in a similar manner to HL1-6 with a prior Suzuki cross-coupling to 
incorporate functionality at the 4-position on the pyridine ring in the formation of 
precursors (P1-4, Scheme 2.6). The Suzuki step proceeded in good yields for all variants (50-
90 %) and the presence of the aryl group at the 4-position did not hinder the subsequent 
steps, hence all the derivatives were obtained in good yield and with high purity. 
 
Scheme 2.6: Synthesis of 1,2,4-triazole precursors, intermediates and ligands HL7-10. 
Crystals suitable for X-ray diffraction analysis were obtained for HL1 and HL2 by slow 
evaporation from DCM solution (Figs. 2.16 and 2.17). HL1 is close to linear with a torsion 
angle of 9.137 ° between the pyridyl ring and the triazole ring. HL1 is arranged in dimers 
connected through hydrogen-bonding between the pyridine N and the triazole N—H. These 
dimers stack in an anti-parallel fashion which may arise from the tBu groups that provide 
steric hindrance to parallel stacking. Similarly, HL2 displays a structure close to linearity with 
a torsion angle between the pyridyl ring and the triazole ring of 7.572 °. Moreover, a similar 
packing arrangement is adopted in HL2 with hydrogen bonding connecting the independent 
molecules, but in this case the OMe groups orient themselves facing towards each other.  
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Figure 2.16: Molecular structure and crystal packing of HL1.   
 
Figure 2.17: Molecular structure and crystal packing of HL2.   
Crystals suitable for X-ray diffraction were also obtained for HL6 by slow evaporation from 
DCM solution (Fig. 2.18). The crystal structure revealed parallel sheets of dimers stacking in 
a staggered conformation alongside antiparallel stacked staggered sheets. The dimers in 
parallel sheets were connected though hydrogen bonding between the N—H and N atoms 
on opposite triazole rings. Interplanar distances in the parallel sheets were ca. 3.7 Å.  
32 
 
 
 
Figure 2.18: Molecular structure and crystal packing of HL6.   
Homoleptic PtII complexes of the form PtL1-42 were synthesised by reaction of the proligands 
HL1-4 with potassium tetrachloroplatinate(II) (K2PtCl4) in EtOH/H2O (3:1) under reflux for 18 
hours (Scheme 2.7). The conditions are somewhat milder than those typically used for 
cyclometallation with platinum where higher boiling point solvents such as acetic acid 
(AcOH) at reflux are commonly used.112,113,114  
The complexes were purified by recrystallization from hot DMF and yields varied from 17 to 
67 %. Complexation was also attempted for HL5-6 and evidence of some product formation 
was observed by mass spectrometry (MS), but the products could not be successfully 
isolated due to low yields with a lot of starting material left over. This may perhaps be due 
to the steric hindrance of the 2 bulky quinoline ligands coming into contact with each other, 
disfavouring complexation.  
 
Scheme 2.7: Synthesis of homoleptic 1,2,4-triazole complexes PtL1-42. 
All complexes other than PtL12 suffered from poor solubility in common organic solvents. It 
was found that the addition of trifluoroacetic acid (TFA) helped to solubilise PtL2-42 in CDCl3 
for NMR analysis, presumably by protonation of the “exterior” N atom which is discussed 
later on.  
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Figure 2.19: 400 MHz 298K 1H NMR spectrum in CDCl3 showing comparison between HL1 
(top) and PtL12 (bottom). 
The complexes were analysed by 1H NMR and Figure 2.19 shows the comparison of the free 
ligand HL1 and the corresponding homoleptic complex PtL12. The downfield shift of H6 to 
higher ppm was indicative of complexation and this was accompanied by upfield shifts of 
the other signals.   
Crystals suitable for X-ray diffraction were obtained for complexes PtL12 and PtL22 by hot 
recrystallization in DMF (Figs. 2.20 and 2.21).  In all cases the triazole rings are trans to each 
other. This contrasts with bis-cyclometallated Pt complexes which normally have a cis 
relation between the pyridine N atoms and the C— atoms owing to the strong trans 
influence of the σ-donating C— atoms which makes them unfavourable to be placed 
opposite one another.115 This suggests the N— trans effect in these complexes is less 
important. Indeed, it is evident that the Pt1—N2 (triazole) distances are only slightly 
smaller than the Pt1—N1 (pyridine) distances in each complex (Tables 2.2 and 2.3).  
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Figure 2.20: Molecular structure and crystal packing of PtL12. 
Table 2.2: Selected bond lengths and angles for PtL12 . 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
2.033(4) 
1.992(4) 
N11-Pt1-N1 
N2-Pt1-N11 
N21-Pt1-N11 
180.0 
100.61(16) 
79.39(16) 
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Figure 2.21: Molecular structure and crystal packing of PtL22. 
Table 2.3: Selected bond lengths and angles for PtL22. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
2.026(4) 
1.996(4) 
N11-Pt1-N1 
N2-Pt1-N11 
N2-Pt1-N1 
180.0 
101.04(15) 
78.97(15) 
 
In Pt(ppy)2 the bond distances are reported as being Pt—N = 2.13 Å and Pt—C = 1.99 Å.115 In 
both PtL12 and PtL22, however, the Pt—N— and Pt—N  bond lengths are virtually identical, at 
2.0 Å.   
Due to solubility issues with complex PtL22, the complex PtL42 was synthesised containing an 
OBu chain instead of an OMe chain. Unfortunately, the solubility in common organic 
solvents was still not improved in the absence of TFA. Crystals of PtL42 were easily obtained 
by leaving the complex to stand in CDCl3 containing TFA overnight. This revealed the 
protonation of the exterior N atom, N4, which allowed a hydrogen bonding network to 
form between the N—H of the N4 on the triazole and the trifluoroacetate anions with a  
N—HO distance of 2.71 Å (Fig. 2.22). The packing thus consisted of layers of π-π linked 
metal complexes with layers of acid molecules between both ligands. 
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Figure 2.22: Molecular structure, hydrogen bonding between TFA and crystal packing for 
protonated PtL42. 
Bond lengths and angles between the Pt centre and the N atoms on both the triazole and 
the pyridine rings did not show any significant change in comparison to the non-protonated 
complexes discussed earlier (Table 2.4).  
Table 2.4: Selected bond lengths and angles for PtL42. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—N21 
Pt1—N22 
2.040(3) 
1.995(3) 
2.031(3) 
1.984(3) 
N2-Pt1-N1 
N2-Pt1-N21 
N21-Pt1-N1 
79.30(11) 
100.78(11) 
178.97(11) 
Synthesis of complexes PtL7-92 was attempted in the same solvents as before (EtOH/H2O 
3:1) but was not successful. As a result, many other solvent combinations were attempted 
as well as using different sources of Pt including Pt(DMSO)2Cl2 and Pt(COD)Cl2, but the 
highest yielding syntheses were achieved using K2PtCl4 in a MeCN/H2O (3:1) solvent system 
at reflux (Scheme 2.8). Syntheses of complexes PtL7-92 proceeded in lower yields than those 
of PtL1-42 and this was partly due to the more difficult purification of complexes which 
required column chromatography on alumina followed by recrystallization. Synthesis of 
PtL102 was attempted and the complex was formed but could not be purified.  
37 
 
 
Scheme 2.8: Synthesis of homoleptic 1,2,4-triazole complexes PtL7-92 
 
Figure 2.23: 400 MHz 298K 1H NMR spectrum in CDCl3 showing comparison between HL7 
(top) and PtL72 (bottom). 
Similar to PtL12, these complexes were analysed by 1H NMR and Figure 2.23 shows the 
comparison of the free ligand HL7 and the corresponding homoleptic complex PtL72. The 
downfield shift of H6 to higher ppm was indicative of complexation and this was 
accompanied by upfield shifts of the other signals. Signals for H3 and H5 were significantly 
shifted upfield (signal 3 is partially masked by the residual solvent peak at 7.25 ppm).  
Crystals suitable for X-ray diffraction were obtained for complex PtL72 by recrystallization 
from DCM/Hexane (Fig. 2.24). An off-centred stacking was displayed for this complex with 
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no close contacts between Pt centres. Bond lengths and angles were like those for PtL12 
(Table 2.5).  
 
 
Figure 2.24: Molecular structure and packing for PtL72. 
Table 2.5: Selected bond lengths and distances for PtL72. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N11 
Pt1—N4 
Pt1—N41 
1.996(3) 
1.997(3) 
2.024(3) 
2.024(3) 
N1-Pt1-N11 
N11-Pt1-N41 
N11-Pt1-N4 
180.00(11) 
79.05(11) 
100.95(11) 
 
2.3.1.2 Photophysical properties  
The absorption spectra of complexes PtL12,PtL24 and PtL42 and PtL7-92 were measured in 
DCM at RT unless otherwise stated (Fig. 2.25). PtL32 was too insoluble to study in all 
common organic solvents. Bands with high extinction coefficients were observed at high 
energy between 250 and 325 nm which can be described as a spin-allowed transition, LC in 
nature, involving mainly the triazole ligand (π→π*) similar to other Pt-azolate 
complexes.116,117 An additional band at lower energy (λmax at ~425 nm) was assigned as the 
lowest-lying MLCT transition, in line with those already reported for comparable 
compounds. These bands are the S0→S1 transitions and mainly involve the platinum d 
orbitals and π* orbitals of the triazole ligand. 
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Figure 2.25: UV-Vis absorption of complexes PtLn2 in DCM solution except PtL22 which was in 
DMF due to its very poor solubility in DCM.  
For complexes PtL7-92 a band and shoulder between approximately 350 and 370 nm are 
noticeable but are not present for PtL1-42 which suggests that these may originate from a 
transition with mixed MLCT/LC character owing to the presence of the conjugated 
functionalisation on the pyridine of the ligand.  
The complexes were luminescent with quantum yields ranging from 21 to 48 %. These are 
high efficiencies which are comparable with and exceed many cyclometallated Pt(N^C)2 
complexes. Emission profiles of complexes PtLn2 show a distinct band with vibrational 
structure (Fig. 2.26). This has been assigned as a HOMO→LUMO transition from TD-DFT 
data where the HOMO is mainly localised on the triazole and aryl rings and the LUMO on 
the pyridyl ring (see DFT section 2.3.3).  The lowest energy emission is seen to emanate 
from PtL92 which contains stabilising CF3 groups on the LUMO to red-shift the emission 
relative to PtL72 which contains slightly electron donating tBu groups to destabilise the 
LUMO.  Lifetimes of the complexes PtLn2 where n=1, 7, 8 and 9 were seen to range between 
3.9 and 5.1 µs, whilst those with n= 2 and 4 were longer at 12 and 13 µs (Table 2.7).  
  
Figure 2.26: Emission of complexes Pt(Ln)2 in 1 x 10-6 M solution DCM at RT. 
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Concentration-dependent emission spectra were run at RT on the most soluble complexes 
namely: PtL12, PtL72 and PtL92. The spectra for complex PtL12 revealed the formation and 
development of a broad and structureless band at λmax 580 nm with a subsequent decrease 
in intensity of the monomer band (Fig. 2.27A). On the other hand, complexes PtL72 and PtL92 
showed the development of red-shifted bands at 615 and 630 nm respectively, whilst the 
relative intensity of their monomer bands was retained (Figs 2.27B and C). The assignment 
of these red-shifted emission bands as excimeric is supported by the linear dependence of 
the decay rate upon concentration when fitted to the Stern-Volmer equation shown below, 
where ksq is the self-quenching rate constant, [Pt] is the concentration of the platinum 
complex, and k0 is the decay rate for the monomer complex obtained from lifetime data.118 
𝑘𝑜𝑏𝑠 =  𝑘𝑠𝑞[𝑃𝑡] + 𝑘0       (8) 
It was apparent that PtL12 was the most susceptible to excimer formation from the intensity 
of the excimer band compared to PtL72 and PtL92. Indeed, the ksq value for PtL12 (5.1 x 108 
mol-1 dm3 s -1) was higher than those of PtL72 and PtL92 (3.3 x 108 and 2.0 x 108 mol-1 dm3 s -1) 
which supports this. 
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Figure 2.27: Concentration-dependent emission and Stern-Volmer plots of: A) PtL12 
normalised to 501 nm, B) PtL72 normalised to 510 nm and C) PtL92 normalised to 535 nm. 
We attempted to record the low-temperature spectra at 77 K for all triazole complexes. 
Attempts were initially run in butryonitrile/EPA glass and these displayed broad emission 
peaks in the red-region with λmax of over 600 nm in each case, independent of 
concentration. Using a 1:1 DCM/DMSO mixture, the emission was seen to be 
concentration-dependent. At very low concentrations (<10-7 M), weak structured emission 
with λmax of 491 and 495 nm for PtL12 and PtL72 respectively was observed (Fig. 2.28). In 
more concentrated solutions, red-shifted and structureless emission was observed with λmax 
values of 615 and 675 nm for PtL12 and PtL72 respectively.  
  
Figure 2.28: 77 K spectra of PtL12 (blue) and PtL72 (red) in DCM/DMSO at low concentration 
(left) and at high concentration (right). 
The structured emission observed at low-concentrations is assigned to monomer emission 
owing to the similarity of the emission peaks to the low-concentration RT emission. The 
emission at higher concentrations is ascribed to either aggregate or excimeric emission. The 
lifetimes of the 77 K emission were recorded for each complex where dilute solutions 
showed mono-exponential decay, indicative of one species, i.e. the monomer, in each case 
(Table 2.6). The concentrated solutions displayed a biexponential decay which was fitted to 
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obtain two lifetimes indicative of trace amounts of monomer and an aggregate/excimer in 
each case. The aggregate/excimer lifetimes were an order of magnitude smaller than the 
monomer lifetimes. 
Table 2.6: 77 K lifetimes of PtL12 and PtL72 in DCM/DMSO (dilute and concentrated, the 
wavelengths of emission are given in the parentheses).  
 
Complex τ77K (dilute)/ μs τ77K (concentrated) /μs 
τ1 τ2 
PtL12 12 (480 nm) 1.1 (625 nm) 12 (625 nm) 
PtL72 13 (490 nm) 1.4 (650 nm) 12 (650 nm) 
 
At high concentrations, the λmax values of the red-shifted bands at 77 K are seen to be 
considerably longer than those recorded at RT for PtL12 (615 vs. 580 nm) and PtL72 (675 vs. 
615 nm). This possibly supports the formation of excimers in solution at RT and aggregates 
at 77 K, where the complexes exhibit reduced solubility at low-temperature.   
 
43 
 
 
 
 
Table 2.7: Photophysical data for complexes PtLn2. Emission was run in degassed DCM at a concentration of 10-6 M and 77 K spectra were run in 
DCM/DMSO 1:1 v/v solutions.    
 
Complex 
298 K 77 K 
λabs  
(nm) 
λem  
(nm) 
τdeg  
(μs) 
τaer  
(ns) 
τ0 
(μs) 
φ 
(%) 
kr  
(103 s-1) 
knr  
(105 s-1) 
kq (O2) 
(108 M-1 s -1) 
ksq  
(M-1 s -1) 
λem  
(nm) 
τ  
(μs) 
PtL12 275 (79,880), 290 
(86,260), 310 (58,870), 
325 (27,240), 425 
(4,050). 
500, 532 5.1 300 5.0 21 41.2 1.55 14.3 5.1 x 108 491, 530, 
568 
12 
PtL22 275 (55840), 290 
(55210), 310 (41020), 
325 (52010), 425 (2770). 
515, 547 12 260 / 41 35 0.5 17 / 500, 630 12 
PtL42 273 (19725), 295 
(18221), 310 (13803), 
425 (1018). 
518, 552 13 280 / 35 28 0.5 16 / 514, 557, 
610. 
13 
PtL72 270 (117,767), 304 
(110,242), 352 (85,109), 
420 (5,868). 
513, 539 4.6 500 4.5 48 100 1.1 8.1 3.3 x 108 495, 532, 
570, 610 
13 
PtL82 277 (63,070), 300 
(43,124), 311 (35,892), 
360 (31,997), 425 
(5,551). 
502, 531, 
571sh 
3.9 430 / 30 77 1.8 9.4 / 513, 547, 
592sh 
12 
PtL92 276 (26,256), 316 
(20782), 341 (11,054), 
430 (1,627). 
528, 553 4.6 540 5.3 23 50 1.7 7.4 2.0 x 108 490, 532, 
644 
12 
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2.3.1.3 Investigation into OLED devices  
The type of processing of an OLED determines which kinds of complexes are suitable for 
devices. For solution-processed devices, complexes must have good solubility in solvents 
which are readily vaporised e.g. chlorobenzene. For VTE devices, complexes must have high 
thermal stability and thus high degradation temperatures.  
Thin-film photophysical characterisation 
From the initial photophysical characterisation, PtL12 was seen to have good attributes for 
both kinds of OLED testing and thus was studied for its photophysical properties in the 
solid-state when doped into OLED host materials. Two films were made with PtL12 as the 
dopant:  
1. 6 wt. % in an evaporated film with 3,3-di(9H-carbazol-9-yl)biphenyl (mCBP) as the 
host  
2. 10 wt. % in a spin-coated film with poly(methyl methacrylate) (PMMA) as the host 
Film 1 displayed a quantum yield of 72 %, whilst film 2 displayed a quantum yield of 92 %. 
The lifetime of the complex was the same in both films, as in solution, at 5 µs. The emission 
in film 1 shows two bands with λmax of 502 nm and 580 nm which are consistent with the 
bands previously attributed to monomer and excimer in solution (Fig. 2.29). In film 2 the 
loading percentage of PtL12 was higher than in film 1 and a narrower and mainly 
structureless emission profile was observed with λmax of 610 nm. This is red-shifted by        
30 nm relative to the excimer emission peak in solution and in film 1, suggesting that the 
origin of this emission may be an aggregate rather than an excimer.  
 
 
 
 
φ DCM (%) 
 
 
 
21 
τ DCM (μs) 5 
φ powder (%) 5 
φ Film 1 (%) 72 
φ Film 2 (%) 92 
Figure 2.29: Solid-state emission of PtL12 in thin films 1 and 2 and photophysical properties 
in solution and in the solid-state. 
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Device Fabrication 
Vacuum thermal evaporation (VTE) devices  
VTE OLED device fabrication was carried out for PtL12 owing to its high quantum yield in the 
film. Two devices were fabricated with the aim of device optimisation to improve the EQE. 
The first device had an OLED architecture containing 6 wt. % PtL12 doped in a mCBP EML 
with a 2,2’,2”-(1,3,5-benzenetriyl)tris(1-phenyl-1-H-benzimidazole) (TPBi) electron 
transport layer (ETL) and a N,N'-Bis-(1-naphthalenyl)-N,N'-bis-phenyl-(1,1'-biphenyl)-4,4'-
diamine (λ-NPD) hole transport layer (HTL) (Fig. 2.30). This gave a maximum EQE of 4.1 % 
(at 13.7 mA cm-2) (Table 2.8). To try to improve this device by reducing the recombination 
of holes and electrons within the device, an electron-blocking layer (EBL) 1,3-Bis(N-
carbazolyl)benzene (mCP) and hole-blocking layer (HBL) 2,4,6-Tris(biphenyl-3-yl)-1,3,5-
triazine (T2T) were added. Unfortunately, this reduced the maximum EQE to 3.0 % (at     
39.5 mA cm-2). The performances of devices 1 and 2 are shown in Table 2.8 and 2.9 and 
reveal purely monomer-based emission in each device.  
Table 2.8: VTE device properties for PtL12 (fabricated in the Adachi Lab by me). 
Device architecture λmax(nm) 
 
Current density 
(mA cm-2) 
EQE 
(%) 
1 Al (100nm) / LiF (0.8nm) / TPBI (40 nm)/ mCBP : 6 
wt. % PtL12 (30 nm)/ λ-NPD (30 nm) / ITO. 
503, 533 13.7 4.1 
2 Al (100nm) / LiF (0.8nm) / TPBI (40 nm) / T2T 
(30nm) / mCBP : 6 wt. % PtL12 (30 nm / mCP 
(10nm) / λ-NPD (30 nm)/ ITO. 
507, 542 39.5 3.0 
 
  
Figure 2.30: Structure of device 1 (left) and picture of the device turned on with green 
emission (right). 
The properties displayed by these devices are not very impressive considering the high 
quantum yields of over 70 % that have been obtained in the film for this complex.  The low 
EQEs displayed in these devices may be due to the mis-match in energy levels between the 
EML and the HTL/ETL. Fine-tuning of the device structure would need to be done to 
improve these properties.  
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Table 2.9:  EL at different current densities, voltage vs. current density and current density vs. EQE plots for PtL12 in devices 1 and 2. 
1 
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Solution-processed devices 
PtL12 and PtL72 were selected for solution-processed OLED fabrication owing to their high 
solubility. These devices were fabricated by Piotr Pander (Durham University Physics 
Department) with the device structure of: ITO | HIL 1.3N (45 nm) | mCP : OXD7 (80 : 20)   
co. x % PtL12/PtL72 (62 nm) | TPBi (50 nm) | LiF (0.8 nm) | Al (100 nm). PtL12 was also 
incorporated into a VTE with the device architecture of ITO | NPB (35 nm) | TSBPA (10 nm) 
| mCP (5 nm) | mCP co. 30 % PtL12 (20 nm) | TPBi (50 nm) | LiF (0.8 nm) | Al (100 nm) at     
30 wt. % for comparison with both the solution-processed devices and the previously 
synthesised VTE devices of different device architecture. The solution-processed devices 
showed maximum EQE values between 8.7 and 12.5 %, very low roll-off and high maximum 
brightness of up to 28620 cd m-2 (device 2, Table 2.10).  
Table 2.10: Solution-processed device properties for PtL12 and PtL72. * Denotes VTE device. 
Device No.  Complex (wt. %) EL λmax 
(nm) 
Current density 
(mA cm-2) 
Brightness 
(cd m-2) 
EQE 
(%) 
1 PtL12 (5) 507, 542 61.68 10550 10.4 
2 PtL12 (20) 575 74.68 28620 12.5 
3 PtL12 (30) 585 107.6 17270 9.6 
4 PtL12(30)* 507(sh), 580 352.0 38750 14.9 
5 PtL72 (5) 512, 544 109.6 17777 9.9 
6 PtL72 (20) 533(sh), 587 110.2 20740 11.2 
7 PtL72 (30) 533(sh), 606 80.9 13200 8.7 
At the lowest doping concentrations investigated, device 1 (5 wt. % PtL12) was dominated 
by broad, red-shifted emission likely to be excimeric in nature. In contrast, device 5 (5 wt. % 
PtL72) displayed structured emission reminiscent of the monomer seen in the PL spectra at 
low-concentrations (Table 2.11). The colour-tuning of these devices is evident from the EL 
spectra, particularly in the devices containing PtL72 which exhibit yellow-green monomer 
emission at low doping concentrations and orange-red emission at higher doping 
concentrations. In comparison to the solution-processed devices, the VTE device 4 proved 
to be the most efficient device with an EQE of 14.9 % and high brightness of 38750 cd m-2. 
The emission in this device displayed mostly excimeric emission with a small amount of 
monomer emission still present. The solution-processed devices 2 and 6 with dopant 
concentrations of 20 % for each complex were seen to be close contenders to this VTE with 
EQEs of 12.5 and 11.2 % respectively. These results highlight the value of solution-
processing as an effective technique to produce high efficiency devices incorporating these 
soluble triazole complexes. In terms of large-scale production this is favourable owing to 
the ease of fabrication and ultimately lower cost of production in solution-processed 
devices compared to VTE devices.  
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Table 2.11:  EL spectra, brightness and current density vs. voltage and current density vs. EQE for solution-processed OLEDs containing PtL12 and 
PtL72 at different doping concentrations. Devices were fabricated by Piotr Pander (Durham University, Physics department). 
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2.3.2 Heteroleptic 1,2,4-Triazole Complexes 
Heteroleptic complexes featuring 1,2,4-triazole ligands in combination with N^C— and N^N 
ligands were investigated to give both neutral and charged complexes respectively. Many 
typical synthesis routes for other heteroleptic neutral complexes involve the formation of a 
Pt(N^C) chloro-bridged dimer which is then cleaved by reaction with an appropriate 
ligand.119 In this way, a range of Pt dimers were synthesised and cleaved with varying 1,2,4-
triazole ligands to form neutral heteroleptic complexes. The cationic complexes on the 
other hand were formed via reaction of Pt(N^N)Cl2 compounds with the triazole ligands 
(where N^N = bpy or phen). 
2.3.2.1 Neutral Heteroleptic Complexes 
Synthesis 
Thienylpyridine complexes 
Initially the [Pt(thpy)(μ-Cl)]2 chloro-bridged dimer was formed and isolated in good yield.  
To afford a range of complexes, this dimer was subsequently cleaved with the 1,2,4-triazole 
ligands HLn where n= 1,2,3,7,8,9 and 10 in DCM/MeOH (1:1) at 60 °C (Scheme 2.9). The 
complexes were purified by alumina column chromatography followed by recrystallization 
in DCM/Hexane. The yields of the final complexes varied widely from 22 to 95 %. The 
complexes with aryl substituents on the pyridyl ring, Pt(thpy)L7-10, were formed in superior 
yields to those with no pyridyl substituent, Pt(thpy)L1-3.  
Phenylquinoline complexes 
Initially the chloro-bridged [Pt(pquin)(μ-Cl)]2 dimer was isolated and then cleaved with the 
1,2,4-triazole ligand in DCM/MeOH (1:1) at 60 °C (Scheme 2.10). The complexes were 
purified by washing with MeOH and Et2O followed by recrystallization from DCM/Hexane.  
Yields of the purified complexes ranged from 60 to 77 %.  
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Scheme 2.9: Synthesis of [Pt(thpy)(μ-Cl)]2 dimer and subsequent cleavage with 1,2,4-triazole 
ligands to form Pt(thpy)L1-3 and Pt(thpy)L7-10.  
 
 
Scheme 2.10: Synthesis of [Pt(pquin)(μ-Cl)]2 dimer and subsequent cleavage with 1,2,4-
triazole ligands to form Pt(pquin)Ln complexes. 
Characterisation 
Thienylpyridine complexes  
The 1H NMR comparison of the of the free ligand HL1 and the complex Pt(thpy)L1 was a 
useful tool in confirming the identity of the thienylpyridine complexes (Fig. 2.31). The 
presence of signals at 10.5 and 9.3 ppm for Pt(thpy)L1 show satellites for coupling to 195Pt 
and were assigned as H6triz and H6thpy respectively after 2D NMR analysis.  
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Figure 2.31: 700 MHz 298K 1H NMR spectrum in CDCl3 showing comparison between HL1 
(top) and Pt(thpy)L1 (bottom). 
Phenylquinoline complexes  
Crystals of Pt(pquin)L3 were obtained by slow evaporation from a DCM solution (Fig. 2.32). 
The crystal structure revealed the presence of two molecules of the complex in the unit cell 
which differed only in the orientation of the CF3 group in one complex relative to the other. 
These complexes were arranged in a head-to-tail conformation and displayed a nearest 
PtPt distance of 3.734 Å. Interestingly, the structure is seen to be twisted away from 
planarity and the torsion angle between the planes of the two 5 membered rings               
Pt1-N3-C21-C20-N2 and Pt1-N1-C1-C10-C15 was found to be 20.3 ° owing to large steric 
hindrance This contrasts with the planarity of the homoleptic structures discussed 
previously in this chapter. The Pt1—C15 bond is the shortest at 1.975 Å owing to its 
cyclometallated nature and Pt1—N3, which involves the bonding of the N— atom, is seen to 
be of a similar length at 2.002 Å (Table 2.12). Both Pt—N bonds, where N is a neutral N 
donor, are slightly longer.  
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Figure 2.32: Crystal structure and packing of Pt(pquin)L3. 
 
Table 2.12: Selected bond lengths and angles for Pt(pquin)L3. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—N3 
Pt1—C15 
 
2.037(6) 
2.177(7) 
2.002(6) 
1.975(7) 
N1-Pt1-N2 
N3-Pt1-N1 
N3-Pt1-N2 
C15-Pt1-N1 
C15-Pt1-N2 
C15-Pt1-N3 
103.9(2) 
175.0(3) 
76.9(3) 
80.6(3) 
166.7(3) 
99.8(3) 
 
53 
 
 
Figure 2.33: Pt(pquin)L1, Pt(pquin)L2 and Pt(pquin)L3 400 MHz NMR in CDCl3 from top to 
bottom. 
 
The 1H NMR spectra were compared for Pt(pquin)Ln where n=1, 2 and 3 (Fig. 2.33). The 
chemical shifts of the H6triz protons are not vastly different for the complexes, however, the 
most de-shielded proton is seen to be in Pt(pquin)L1. The protons on the aromatic phenyl 
ring of the triazole ligand are most affected by the nature of the R group. In comparison to 
Pt(pquin)L1 where R=tBu, the Hc’ proton in Pt(pquin)L2 where R= OMe is shifted to a lower 
ppm value, whilst in Pt(pquin)L3 it is shifted to a higher ppm value. This is due to the 
electron-donating nature of OMe and the electron-withdrawing nature of CF3 which affect 
the shielding of the appropriate protons.  
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Photophysical properties  
Thienylpyridine complexes  
 
 
Figure 2.34: Absorption spectra of Pt(thpy)L1-3 and Pt(thpy)L7-10 in DCM at RT. 
Pt(thpy)L1-3 displayed absorption spectra with two main bands between 250-320 nm 
assigned as LC transitions (Fig. 2.34). Weaker bands/shoulders are present at ~350 nm and 
broader bands at longer wavelength centred at λmax 440 nm are characteristic of MLCT 
transitions. For complexes Pt(thpy)L7-10 similar absorption profiles were observed, but with 
more pronounced bands centred at 365 nm. Moreover, the absorption spectra are seen to 
be red-shifted in comparison to Pt(thpy)L1-3, whereby the absorption extends to 490 nm (vs. 
480 nm for Pt(thpy)L1-3), owing to the extended conjugation offered by the phenyl groups 
on the pyridyl ring of the triazole ligand.  
The emission of these complexes in degassed DCM at RT was studied and all complexes 
show similar vibrationally-resolved emission spectra to one another with bands at 570, 615 
and a shoulder at 665 nm (Fig. 2.35).  
 
Figure 2.35: Pt(thpy)L1-3 and Pt(thpy)L7-10 RT emission in 1 x 10-6 M degassed DCM solution. 
The PLQY values for Pt(thpy)Ln ranged from 30-37 % with lifetimes of 13 to 17 µs and thus 
all complexes displayed similar photophysical properties in degassed DCM solution (Table 
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2.13). The concentration-dependent emission spectra were measured for Pt(thpy)L7-10 and 
are shown in Figure 2.36. As the concentration is increased, they show the introduction of a 
broad and structureless band with λmax values of 740 nm for all complexes. These are likely 
to be excimeric in nature as Stern-Volmer plots show the correlation between the 
concentration and inverse of the lifetimes for each solution measured (Fig. 2.36). 
Pt(thypy)L7 and Pt(thpy)L8 were calculated as having larger ksq values which is consistent 
with their concentration-dependent emission spectra which show more intense excimeric 
emission in comparison to Pt(thpy)L9 and Pt(thpy)L10.  
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Figure 2.36: From top to bottom: Pt(thpy)L7, Pt(thpy)L8, Pt(thpy)L9 and Pt(thpy)L10 
concentration-dependent emission spectra in degassed DCM where concentrations are 
given in mol dm-3 (left) and their corresponding Stern-Volmer plots (right). 
The 77 K emission spectra were recorded for each complex and show sharper peaks than 
the RT emission spectra with increased vibrational resolution (Fig. 2.37). The structure is 
particularly well-resolved for complexes Pt(thpy)L7-10, presumably associated with the 
phenyl rings on the 4 positions of the pyridyl rings. Upon going from RT to 77 K there is 
virtually no change in the wavelength of the 0-0 transition for all complexes (Table 2.13), 
implying that there is little excited state distortion even at RT, which is also reflected in 
their high PLQY values.  
  
Figure 2.37: Pt(thpy)L1-3 (left) and Pt(thpy)L7-10(right) 77 K emission spectra in butyronitrile. 
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Table 2.13: Photophysical data for complexes Pt(thpy)L1-10. Emission was run in degassed DCM at a concentration of 10-6 M and 77 K spectra were 
run in butyronitrile glass.   
 
Complex 
298 K 77 K 
λabs  
(nm) 
λem  
(nm) 
τdeg  
(μs) 
τaer  
(ns) 
τ0 
(μs) 
φ 
(%) 
kr  
(104 s-1) 
knr  
(104 s-1) 
kq (O2) 
(108 M-1 s -1) 
ksq  
(108 M-1 s -1) 
λem  
(nm) 
τ  
(μs) 
Pt(thpy)L1 262 (60340), 301 
(59057), 328 (31280), 
352 (18975), 430 
(5773), 451 (6200). 
569, 585(sh), 
616, 660(sh) 
16 480 / 34 2.1 4.1 9.2 / 568, 593(sh), 
606, 633(sh), 
662. 
18 
Pt(thpy)L2 262 (42965), 301 
(41898), 328 (22439), 
351 (13754), 434 
(4106), 455 (4325). 
568, 581(sh), 
615, 656(sh) 
17 510 / 30 1.8 4.2 8.6 / 568, 590(sh), 
614, 635(sh), 
667. 
15 
Pt(thpy)L3 259 (48523), 298 
(71486), 323 (41698), 
345 (23526), 425 
(6346), 448 (6793). 
568, 587(sh), 
615, 661(sh) 
16 590 / 32 2.0 4.2 7.5 / 568, 588, 615, 
638(sh), 663. 
15 
Pt(thpy)L7 284 (30241), 298 
(37099), 362 (23434), 
440 (3772). 
570, 586(sh), 
617, 668 
15 700 17 37 2.5 4.2 6.2 3.1  568, 592, 619, 
646, 674, 
706(sh) 
16 
Pt(thpy)L8 268 (28801), 325 
(39543), 368 (25650), 
437 (3290). 
568, 585(sh), 
614, 662(sh) 
14 610 16 37 2.6 4.4 7.2 3.5 569, 590, 617, 
643, 673, 
709(sh) 
16 
Pt(thpy)L9 270 (57790), 304 
(42439), 329 (25902), 
359 (19646), 450 
(3990). 
570, 587(sh), 
617, 670(sh) 
13 530 13 37 2.8 4.8 8.3 0.2 572, 591(sh), 
622, 650(sh), 
682(sh) 
16 
Pt(thpy)L10 283 (25621), 324 
(49702), 367 (32393), 
438 (4021). 
568, 585(sh), 
615, 664(sh) 
14 520 14 36 2.5 4.5 8.5 0.3 570, 589, 615, 
642, 673(sh), 
706(sh). 
14 
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Phenylquinoline complexes  
The absorption spectra of the complexes Pt(pquin)L1 and Pt(pquin)L2 show three main 
peaks in the region of 250 to 300 nm (Fig. 2.38). For Pt(pquin)L3, however, only one main 
peak is observed at 300 nm with a shoulder between 275 and 300 nm. For all complexes, 
vibronic bands are seen at 325 to 375 nm and the MLCT band is observed at λmax~425 nm. 
Pt(pquin)L3 has a slightly blue-shifted absorption in comparison to the other complexes, 
probably reflecting the stabilising effect of the electron-withdrawing CF3 group on the 
HOMO.  
 
Figure 2.38: Absorption spectra of Pt(pquin)L1-3 in DCM at RT. 
The complexes Pt(pquin)L1-3 were weakly emissive with similar PLQYs ranging between 3.4 
and 3.7 % and lifetimes between 1.1 and 1.5 μs. The emission spectra of the complexes 
show very similar profiles to one another in DCM at RT (Fig. 2.39). Even at low 
concentrations (10-6 M) broad emission is observed with no defined peaks. As in the 
absorption spectra, there is a slight blue-shift in the emission of Pt(pquin)L3, presumably 
stemming from the stabilisation of the HOMO via the CF3 group.  
 
 
Figure 2.39: Emission spectra of Pt(pquin)L1-3 in DCM at RT (left) and at 77 K in butyronitrile 
glass (right).  
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The emission profile at 77 K for all three complexes clearly show vibrational components in 
defined peaks at ≈ 565 and 610 nm with a shoulder at 665 nm, in contrast to the emission 
in DCM at RT. This suggests that the excited state distortion is high at RT.  Moreover, the 
luminescence lifetimes were seen to increase by an order of magnitude for these 
complexes on cooling to 77 K (Table 2.14). 
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Table 2.14: Photophysical properties of Pt(pquin)L1-3. Emission was run in degassed DCM at a concentration of 10-6 M and 77 K spectra were run in 
butyronitrile glass. 
 
Complex 
298 K 77 K 
λabs  
(nm) 
λem  
(nm) 
τdeg 
(μs) 
τaer 
(ns) 
φ 
 (%) 
kr  
(104 s-1) 
knr  
(105 s-1) 
kq (O2) 
(108 M-1 s -1) 
λem  
(nm) 
τ  
(μs) 
Pt(pquin)L1 299 (91057), 340 (26610), 361 (23992), 
412 (16762). 
618 1.3 500 3.4 2.6 7.4 5.7 566, 612, 
664(sh).  
15 
Pt(pquin)L2 277 (26554), 299 (24929), 343 (8180), 
361 (8275), 418 (5003). 
618 1.5 520 3.7 2.5 6.4 5.7 566, 612, 
664(sh).  
14 
Pt(pquin)L3 298 (126192), 339 (37889), 359 
(34493), 410 (23839). 
618 1.1 450 3.5 3.2 8.8 6.0 564, 608, 
664(sh). 
14 
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2.3.2.2 Cationic heteroleptic complexes  
Synthesis 
Bipyridine complexes 
Complexes [Pt(bpy)L1-3]PF6 were synthesised via initial formation of Pt(bpy)Cl2. This was 
then refluxed in DCM with the selected triazole ligand and AgOTf was present to strip the 
chloride ions from Pt(bpy)Cl2. Ion exchange was performed with KPF6 to obtain the more 
organic soluble PF6— salt as opposed to the Cl— salt and complexes were purified by 
subsequent water washes (Scheme 2.11). Yields of the purified complexes varied from 27 to 
75 %.  
 
Scheme 2.11: Synthesis of [Pt(bpy)L1-3]PF6 complexes.  
Phenanthroline complexes 
Complexes [Pt(phen)L1-3]PF6 were synthesised in the same way as for [Pt(bpy)L1-3]PF6 
discussed previously, but via initial formation of Pt(phen)Cl2 as the intermediate (Scheme 
2.12). Yields of the purified complexes varied from 12 to 60 %. [Pt(phen)L3]+ was insoluble 
for photophysical study, however, was characterised by NMR in d6-DMSO at elevated 
temperature.   
 
Scheme 2.12: Synthesis of [Pt(phen)L1-3]PF6 complexes.  
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Characterisation 
Bipyridine complexes  
Crystals of [Pt(bpy)L2]PF6 suitable for X-ray diffraction were obtained by slow cooling from 
hot DMSO solution (Fig. 2.40).  The cations form off-centred stacks and the closest PtPt 
distance is 3.429 Å. The Pt1—N5 bond distance is seen to be slightly longer than that of 
Pt1—N6 (2.036 vs. 1.993 Å) due to the stronger trans influence exerted by the N— atom on 
the triazole ring compared to the neutral N on the pyridine ring of the triazole ligand (Table 
2.15).  
 
 
 
Figure 2.40: Crystal structure and packing for [Pt(bpy)L2]PF6. 
Table 2.15: Selected bond lengths and angles for [Pt(bpy)L2]PF6. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—N5 
Pt1—N6 
2.082(5) 
1.996(6) 
2.036(5) 
1.993(6) 
N2-Pt1-N1 
N2-Pt1-N5 
N5-Pt1-N1 
N6-Pt1-N1 
N6-Pt1-N2 
N6-Pt1-N5 
78.4(2) 
178.4(2) 
102.8(2) 
173.6(2) 
99.0(2) 
79.9(2) 
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Phenanthroline complexes  
1H NMR spectroscopy was used to confirm the identity of the phenanthroline complexes 
(Fig. 2.41). The ortho positions on the phenanthroline ligand (H9 and H2) displayed the 
highest ppm values. All signals in [Pt(phen)L1]+ were shifted downfield compared to those in 
[Pt(phen)L3]+ (e.g. H9 at 10.11 vs. 9.83 ppm) except signals Hb’ and Hc’. These protons 
exhibited a de-shielding effect from the inductively electron-withdrawing CF3 group and as 
a result had slightly higher ppm values than for the same signals in [Pt(phen)L1]+ which 
contained a tBu group instead of the CF3 group.  
 
Figure 2.41: Pt(phen)L1 (top) and Pt(phen)L3 (bottom) 700 MHz NMR in DMSO-d6.  
Photophysical properties 
Bipyridine complexes 
The absorption spectra of complexes [Pt(bpy)L1-3]+ in MeCN solution show bands with high 
extinction coefficients at low energy between 250 and 305 nm which can be described as 
spin-allowed and LC  in nature, involving mainly the triazole ligand (π→π*) (Fig. 2.42). The 
bands at 320 to 355 nm could be the result of a different transition with largely LC 
character but also some metal contribution. The bands at 385 nm for [Pt(bpy)L3]+ and at 
410 nm for   [Pt(bpy)L1-2]+ are assigned as MLCT in character owing to their low intensity at 
longer wavelengths.  
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Figure 2.42: [Pt(bpy)L1-3]+ absorption in MeCN solution at RT (left) and 77 K emission in 
butyronitrile glass (right).  
Complexes [Pt(bpy)L1-3]+ were non-emissive in degassed MeCN at RT however, at 77 K in 
butyronitrile glass they showed intense emission (Fig. 2.42). This suggests that non-
radiative decay is high in these complexes at RT and is majorly suppressed at lower 
temperatures. On increasing the concentration in butyronitrile at 77 K, all three complexes 
show evidence of excimeric/aggregate emission. Indeed, for [Pt(bpy)L2]+ purely monomeric 
emission was only seen when the concentration of the sample was very low. As a result, the 
monomer emission was extremely weak and barely observable. Instead, intense, red-
shifted emission was present at the same concentrations used for [Pt(bpy)L1]+ and 
[Pt(bpy)L3]+.  
Table 2.16: Photophysical data of complexes [Pt(bpy)L1-3]+ in butyronitrile glass at 77 K.  
Complex 298 K 77 K 
λabs  (nm) λem  (nm) τ (μs) 
[Pt(bpy)L1]+ 65(24971), 310(10883), 
322(11384), 344(5461), 398(1584). 
511, 542, 582(sh) 17 
[Pt(bpy)L2]+ 268(10711), 321 (5242), 405(609). 532 20 
[Pt(bpy)L3]+ 279(24468) 313(11447), 
324(12593), 385(1892). 
478, 510, 545 15 
 
Phenanthroline complexes 
The absorption spectra for [Pt(phen)L1]+ and [Pt(phen)L2]+ are very similar to one another 
with high intensity bands between 200 and 300 nm (Fig. 2.43) which are assigned as LC 
π→π* transitions owing to their resemblance to the absorption of phenanthroline as 
described in the literature.120 The lower energy bands of lower intensity are assigned as 
MLCT transitions owing to contribution from the Pt centre. The solubility of [Pt(phen)L3]+ 
was too low to show any absorption in all common organic solvents.  
0
0.2
0.4
0.6
0.8
1
250 350 450 550
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
[Pt(bpy)L1]+
[Pt(bpy)L2]+
[Pt(bpy)L3]+
0
0.2
0.4
0.6
0.8
1
450 550 650 750
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
tbu
ome
cf3
[Pt(bpy)L1]+ 
[Pt(bpy)L2]+ 
[Pt(bpy)L3]+ 
 
 
[Pt(bpy)L1]+ 
[Pt(bpy)L2]+ 
[Pt(bpy)L3]+ 
 
 
65 
 
  
Figure 2.43: Absorption of [Pt(phenL1-2]+ in MeCN solution (left) and emission in butyronitrile 
glass at 77 K (right). 
All complexes were too weak to show any emissive properties at RT and were only slightly 
emissive at 77 K.  The 77 K emission was run in butyronitrile glass and shows structured 
emission at similar wavelengths for both complexes (Fig. 2.43). The 77 K emission lifetimes 
were extremely long, ranging from 140 to 150 μs and this feature is discussed in more 
detail in the next section (Table 2.17). 
Table 2.17: Photophysical data of complexes [Pt(phen)L1-2]+  in butyronitrile glass at 77 K.  
Complex 298 K 77 K 
λabs (nm) λem (nm) τ (μs) 
[Pt(phen)L1]+ 274 (59393), 345 (9128), 401 
(3191). 
453, 485, 518, 560, 
610(sh) 
150 
[Pt(phen)L2]+ 275 (58680), 345 (9098), 400 
(3254). 
452, 483, 520, 560, 
610(sh) 
140 
 
2.3.3 DFT studies on selected triazole complexes   
To better understand the nature of the electronic transitions occurring in these complexes, 
DFT calculations and time-dependent DFT (TD-DFT) were performed using the B3LYP 
method and LANL2DZ basis set for all atoms, with the Gaussian09 program. TD-DFT 
calculated the main contributions from specific orbitals to the S0→S1 transition and these 
orbitals are shown in Table 2.18. For the majority of complexes, the transition was largely 
HOMO→LUMO based, excluding [Pt(phen)L1]+ which was calculated as having a 
HOMO→LUMO+1 transition (Table 2.19).  
In all neutral complexes, the HOMO is largely situated on the triazole and conjugated 
aromatic rings, with a large contribution from the Pt centre. For the homoleptic complexes, 
the LUMO is based on the pyridyl rings with contribution from the phenyl rings on the        
4-position of the pyridine in the case of PtL72. In contrast, for both heteroleptic thienyl 
pyridine complexes Pt(thpy)L1 and Pt(thpy)L7 the LUMO resides on the thienyl group whilst 
the phenyl rings on the 4-position of the pyridyl group were seen to play no part in the 
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transition. This could explain the similarity in the two groups of thienyl pyridine complexes 
for which the emission spectra, quantum yields and lifetimes were almost identical (as 
discussed earlier). Similarly, for Pt(pquin)L1 the LUMO is based on the quinoline moiety 
instead of the pyridyl ring and some metal character was retained. In terms of these neutral 
complexes, the transitions were thus ascribed as mixed with metal and ligand contributions 
i.e. dPt/πtriz→π*.  
For the charged complexes [Pt(bpy)L1]+ and [Pt(phen)L1]+, the HOMO and LUMO/LUMO+1 
orbitals are less defined and are spread more diffusely across the molecule. In [Pt(bpy)L1]+ 
the HOMO is more centred on the bipyridine and the LUMO on the pyridyl ring of the 
triazole ligand. In [Pt(phen)L1]+ however, both the HOMO and the LUMO+1 are based 
mainly on the phenanthroline ligand and the triazole ring is seen to have little to no 
contribution to the main orbitals, hence these transitions are described as having much 
weaker MLCT character. This could explain the poor photophysical properties displayed by 
these complexes, particularly for [Pt(phen)L1]+.  
Colour tuning of the homoleptic complexes was achieved by changes to the pyridyl and 
aromatic groups. Indeed, upon going from PtL12 with no pyridyl substitution to PtL72 with 
phenyl ring incorporation on the 4-position of the pyridine, a noticeable decrease in the 
energy of the excited state was observed from 489 nm to 499 nm which resulted in a red-
shift in the emission, as shown earlier. This can be explained by the apparent contribution 
of the substituted phenyl rings to stabilising the LUMO. Moreover, this is extended to 
complex PtL92 which incorporated CF3-substituted phenyl groups to reduce the HOMO-
LUMO gap, giving a further red-shift of emission. This demonstrates the effective 
conjugation, owing to the planarity of the structure, whereby the CF3 group has a strongly 
stabilising effect on the LUMO (Fig. 2.44).   
  
Figure 2.44: HOMO and LUMO orbitals of PtL92.
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Table 2.18: Major contributions to the S0→S1 transitions in selected triazole complexes as calculated by TD-DFT.  
Complex PtL12 PtL72 Pt(thpy)L1 Pt(thpy)L7 Pt(pquin)L1 [Pt(bpy)L1]+ [Pt(phen)L1]+ 
Energy 
(eV/ nm) 
2.53  
/489 
2.49 
/498.81 
1.3196  
/ 939.59 
1.3179 
/ 940.76 
2.5428 
/ 487.59 
0.9492 
/ 1306.16 
0.6616 
/ 1873.90 
Oscillator Strength 0.0296 0.0453 0.0001 0.0001 0.0298 0.0721 0.0129 
Main contribution (%) HOMO→LUMO  
(70) 
HOMO-4→LUMO+1 
(10) 
HOMO→LUMO 
(70) 
HOMO→LUMO 
 (55) 
HOMO-1→LUMO 
 (43) 
HOMO→LUMO 
 (56) 
HOMO-1→LUMO  
(43) 
HOMO→LUMO 
(64) 
HOMO→LUMO 
(99) 
HOMO→ LUMO+1 
(86) 
Assignment  Mixed  
MLCT/ILCT 
Mixed 
MLCT/ILCT 
Mixed  
MLCT/LLCT 
Mixed  
MLCT/LLCT 
Mixed  
MLCT/LLCT  
Mixed 
MLCT/LLCT 
Mixed  
MLCT/LLCT 
 
Table 2.19: HOMO and LUMO orbital plots for selected triazole complexes using B3LYP/LANL2DZ. * Indicates the LUMO+1 is shown for [Pt(phen)L1]+ instead 
of the LUMO. 
Complex PtL12 PtL72 Pt(thpy)L1 Pt(thpy)L7 Pt(pquin)L1 [Pt(bpy)L1]+ [Pt(phen)L1]+  
HOMO 
  
 
 
   
LUMO 
 
  
 
 
   
* 
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2.4 Results and discussion: Pt complexes containing bidentate tetrazole 
ligands 
With similar structures to the 1,2,4-triazoles discussed previously, the synthesis of tetrazole 
ligands for complexation with Pt was investigated. Many of the tetrazole complexes that 
were synthesised were insoluble due to their square planar conformation and lack of 
possible functionalisation of the saturated tetrazole group. This contrasts with the triazole 
complexes which allowed functionalisation on the 5-position of the triazole ring to 
accommodate substituted aryl groups and improve solubility. Consequently, although many 
complexes were synthesised, only a couple were able to be studied in depth.  
2.4.1 Synthesis  
The synthesis of two types of tetrazole complex was attempted: 
1. Homoleptic bidentate complexes containing CF3-functionalised pyridyl rings (Group 
A, Scheme 2.13) 
2. Homoleptic bidentate complexes containing substituted phenyl ring- functionalised 
pyridyl rings (Group B, Scheme 2.14) 
 
Scheme 2.13: Synthesis of group A tetrazole complexes. 
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Scheme 2.14: Synthesis of group B tetrazole complexes. 
The tetrazole ligands in each group were synthesised by 1,3-dipolar cycloaddition of a 
substituted cyanopyridine with NaN3 in the presence of NH4Cl in refluxing DMF, followed by 
addition of HCl to precipitate the protonated tetrazole according to the procedure devised 
by Sharpless et al.92 Group A tetrazoles were obtained by reaction of commercial 
cyanopyridines with the subsequent reagents mentioned whilst group B tetrazoles were 
obtained by prior Suzuki cross-coupling of the appropriate bromo-substituted 
cyanopyridine with 4-tert-butyl boronic acid, as was the case for the triazole precursors 
discussed in the previous section. Complexations were performed by reaction of 2 
equivalents of the tetrazole ligands with 1.1 equivalent of K2PtCl4 in a 3:1 mixture of 
EtOH/H2O, refluxing for 24 hours. Complexes were purified by washes in H2O, MeOH and 
diethyl ether (Et2O). Yields for the group A complexes varied from 58 to 82 % whilst those 
for group B complexes were similar at 73 % for PtL142 and 78 % for PtL152.  
2.4.2 Photophysical properties 
The incorporation of CF3 groups in group A complexes was chosen initially to see if the 
molecular orientation of the compound in films could be changed, depending upon the 
position of substitution on the pyridyl ring. This has been known to have large effects in the 
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photophysical properties of complexes due to a change in the molecular dipole as briefly 
discussed in the general introduction. Unfortunately, these group A complexes were only 
able to be characterised by high temperature NMR due to their limited solubility and thus 
were unable to be studied for their photoluminescence properties. Therefore, future 
complexes of this sort would need to include other groups to aid solubility for further 
research.  
Complexes PtL142 and PtL152 in group B were soluble enough for complete photophysical 
analysis to be performed. PtL142 was readily soluble in DCM whereas PtL152 was only slightly 
soluble in this medium which prevented concentration-dependent studies from being 
performed. The photophysical properties of each complex are outlined in Table 2.22. The 
absorption spectra of the ligands and of the complexes were compared to assign the 
different transitions occurring. The PtL142 absorption spectrum showed LC transitions 
occurring between 250 and 320 nm and the absorption with a peak maximum of 345 nm 
was much greater in intensity, suggesting intra-ligand charge transfer (ILCT) as opposed to 
MLCT character. For PtL152 more absorption peaks were present and, again the peaks 
between 250 and 365 nm were assigned as ILCT, whilst the peak at longer wavelengths   
(370 nm) was assigned as MLCT (Fig. 2.45).   
 
Figure 2.45: Absorption spectra of ligands HL14 and HL15, and their corresponding complexes 
PtL142 and PtL152 in DCM. 
Emission studies for PtL142 were run in degassed DCM solution and in the solid-state as a    
10 wt. % doped PMMA film and as a powder. When PtL142 was excited at 350 nm in 
degassed DCM solution, structured monomeric emission was observed. In contrast, when 
excited at 420 nm broad, red-shifted emission was observed. To identify the nature of the 
active species involved, concentration-dependent absorption and emission studies were 
performed. The concentration-dependent absorption revealed the development of a new 
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absorption band at 450 nm for concentrations over 2.66 x 10 -4 M (Fig 2.46 inset). The 
concentration-dependent emission (excited at 350 nm) showed structured monomeric 
emission which increased in intensity between 2.66 x 10-7 and 2.66 x 10-5 M but which then 
drastically decreased above this concentration. This implied that on increasing the 
concentration above 2.66 x 10-5 M, a new species was forming (as supported by the 
concentration-dependent absorption) which quenches the emission intensity, and which is 
therefore likely to be aggregate in character.  
  
Figure 2.46: Concentration-dependent absorption (λex at 350 nm) with inset showing the 
introduction of a new longer wavelength band at increased concentrations (left) and 
emission (right) of PtL142 in DCM solution. Concentrations are quoted in mol dm-3. 
In the film the emission peak maximum for PtL142 was largely unstructured and centred at 
560 nm with some evidence of monomer emission present. In solution at 420 nm 
excitation, the peak maximum was at 613 nm and thus considerably red-shifted in 
comparison to the emission peak maximum in solution when excited at 350 nm.  As can be 
seen from Figure 2.47 below, the broad and structureless red emission is from the 
excitation at 420 nm whilst the highly structured emission at shorter wavelength results 
from excitation at 350 nm. In the powder form, no monomer emission was present, and the 
emission had a narrow bandwidth centred 610 nm. The 77 K spectrum of PtL142 in dilute 
butyronitrile glass, and excited at 350 nm, showed a structured emission profile similar to 
the RT emission. 
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Figure 2.47: Normalised absorption and emission spectra of PtL142 and PtL152. The PtL152  film 
was spin-coated at 10 wt. % in PMMA. All solution-state absorption and emission spectra 
were run in degassed DCM at RT.  
As PtL152 was only partially soluble in DCM, concentration-dependent studies could not be 
performed on this complex. When PtL152 was excited at 350 nm, the RT emission displayed 
a structured spectrum with vibrational progression and peak maxima of 502, 539 and 
574(sh) nm which are red-shifted in comparison to PtL142 (Table 2.22). At 77 K the emission 
spectrum of PtL152 was blue-shifted and showed higher resolution of the structure relative 
to the RT emission in solution. Only the lifetime of PtL152 was able to be measured due to 
the use of the 404 nm laser which could not detect emission for PtL142 and this was found to 
be 6.5 μs.  
PtL152 and PtL142 exhibited similar quantum yields in degassed DCM solution (1.6 and 0.7 %). 
On the contrary, in the solid-state, the PtL142 powder gave a higher quantum yield than 
PtL152 by an order of magnitude (Table 2.22). Moreover, in the film a PLQY of 24 % was 
obtained for PtL142 which reveals its superior solid-state photoluminescence properties 
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through the formation of aggregates, in comparison to the monomer in solution. The 
aggregate species in solution for PtL142 and PtL152 showed emission maxima of 613 and    
633 nm respectively and PLQYs for these species were measured as 0.3 and 0.6 %.  
2.4.3 DFT studies on tetrazole complexes 
From TD-DFT calculations the main contributions to the S0→S1 transition were shown as 
emanating from the HOMO-1→LUMO orbitals in PtL142 and the HOMO→LUMO orbitals in 
PtL152 (Table 2.20). From the orbital plots shown in Figure 2.21, the HOMO-1 orbital in PtL142 
is seen to be largely based on the tetrazole rings with the LUMO being more centred on the 
pyridyl rings and no metal character is observed. The transition is thus assigned as being 
mixed MLCT in character. For PtL152, the HOMO is spread across the whole molecule and 
the LUMO is centred on the pyridyl rings with some metal character being retained and 
again this is assigned as having mixed MLCT character. The higher energy of the transition 
in PtL142 is matched with the blue-shifted emission observed in comparison to PtL152. 
Table 2.20: Major contributions to the S0→S1 transitions in PtL142 and PtL152 as calculated by 
TD-DFT. 
Complex PtL142 PtL152 
Energy (eV/nm) 3.2557/ 380.83 3.1678/ 391.39 
Oscillator Strength 0.002 0.2113   
Main contribution (%) HOMO-1→LUMO (56) HOMO→LUMO (64) 
Assignment  Mixed MLCT Mixed MLCT 
 
Table 2.21: HOMO-1 and LUMO of PtL142 (left) and HOMO and LUMO orbital diagrams of 
PtL152 (right). 
Complex PtL142  PtL152 
HOMO-1 
 
HOMO 
 
LUMO 
 
LUMO 
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Table 2.22: Photophysical properties of PtL142 and PtL152 in DCM solutions. Quinine sulfate was used as the reference for PLQY calculations.121 All 
values are for excitation at 350 nm except those with square brackets which are values for excitations at 420 nm i.e. aggregate species. PLQYs and 
lifetimes are for the monomer in degassed DCM solutions.  
Complex Solution 77 K Solid-state 
λabs  
(nm) 
λem 
 (nm) 
 
φ  
(%)  
 
τ  
(μs)  
 
λmax  
(nm) 
τ  
(μs) 
Powder  PMMA film  
λmax 
(nm) 
φ  
(%) 
λmax 
(nm) 
φ  
(%) 
PtL142 260 (26272), 296 
(26418), 345 
(52861). 
469, 500, 537, 
587, 639 [613] 
0.7 [0.3]  *unable to 
obtain lifetime 
data as too 
weak for 404 
nm laser 
463, 495, 532, 
569, 622 (sh).  
44 597 9.9  560 24 
PtL152 295 (27424), 349 
(20411), 364 (9792). 
502, 539, 574 
(sh) 
[553, 633] 
1.6 [0.6] 6.5  463, 493, 528, 
582.  
12 556  0.35 - - 
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2.4.4 OLED testing 
The tetrazole complexes could not be sublimed and as a result were not suitable for VTE 
OLEDs. PtL142 was tested for incorporation into a solution-processed OLED, but the lower 
solubility of PtL152 excluded it from being tested in this way. Two solution-processed devices 
were tested with different doping concentrations of PtL142 with the device architecture: ITO 
| HIL 1.3N (45 nm) | PVK : OXD7 (50 : 50) co. x % PtL142 (60 nm)| TPBi (50 nm) | LiF (0.8 nm) 
| Al (100 nm). The device properties are summarised in Table 2.23 and Figure 2.48 below.   
Table 2.23: Properties of tetrazole devices with PtL142 as the dopant.  
Device Complex (wt. %) EL λmax 
(nm) 
Current density 
(mA cm-2) 
Brightness 
(cd m-2) 
EQE 
(%) 
1 PtL142  (5) 560 29.0 940.5 2.6 
2 PtL142 (10) 560 15.3 913.4 3.8 
 
  
  
Figure 2.48:  Device 1 and 2 properties where A= EL spectra, B= voltage vs. brightness 
and current density, C= current efficiency at different current densities and D= EQE.   
Device 2 showed a superior EQE value of 3.8 % in comparison to device 1 (2.6 %) which 
suggests that the higher doping concentration of 10 % leads to more efficient aggregate 
formation. The EL spectra of each device were almost identical with λmax of 560 nm. This is 
in accordance with the thin-film photoluminescence spectra carried out in PMMA at           
10 wt. % as shown earlier. Despite the much lower EQEs in comparison to the triazole 
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devices reported earlier, these values are in line with those of other tetrazole complexes in 
the literature of which there are not many examples (Table 2.1).  
2.5 Chapter 2 Summary  
In summary, heteroleptic and homoleptic 1,2,4-triazole complexes and homoleptic 
tetrazole complexes have been studied which have demonstrated photophysical properties 
suitable for incorporation into both VTE and solution-processed OLED devices.  
The neutral homoleptic triazole complexes and heteroleptic thienyl pyridine triazole 
complexes displayed impressive photophysical properties with quantum yields ranging 
from 21 to 48 %. Concentration-dependent emission studies of these complexes revealed 
the formation of excimers which substantially red-shifted the emission and demonstrated 
colour tuning possibilities.  
Neutral heteroleptic pquin complexes, as well as charged bpy and phen complexes, 
containing 1,2,4-triazole ligands displayed less impressive photophysical properties and this 
was thought to be due to the weaker MLCT transitions brought about by the more diffuse 
orbital arrangement as evidenced by DFT.  
On comparing the tetrazole complex PtL142 with the triazole analogue PtL72, it is clear that 
the triazole complex displays more impressive photophysical properties where the PLQY 
value for PtL142 at 0.6 % fades in comparison to 48 % for PtL72.  Moreover, the versatility of 
the triazole complex was displayed through incorporation into both VTE and solution-
processed devices with good efficiency, whilst the tetrazole complex was limited by thermal 
instability to degradation which prevented sublimation for a VTE device to be prepared. The 
tetrazole complexes in general were also seen to have more limited solubility in comparison 
to the triazole complexes, mainly due to the lack of possible functionalisation of the N4 
tetrazole ring.  This poor solubility also led to the formation of aggregates in solution at RT 
which were seen to quench the emission, in comparison to the formation of excimers for 
the triazole complexes which were emissive in their own right.  
This work in particular has evidenced the promising potential of Pt complexes containing 
bidentate 1,2,4-triazole ligands in solution-processed OLED devices.  
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3. Mononuclear Pt and Ir complexes 
containing tridentate ligands 
3.1 Overview 
This section will be divided into three main parts: 
1. Mononuclear PtII complexes containing tridentate N^C^N ligands and their 
oxidation to PtIV complexes 
2. Mononuclear IrIII complexes containing tridentate N^C^N ligands 
3. Comparison between isoelectronic PtIV and IrIII complexes containing N^C^N 
tridentate ligands 
 
3.2 Mononuclear PtII complexes containing N^C^N ligands and their oxidation 
to PtIV complexes 
3.2.1 Introduction 
3.2.1.1 PtII complexes containing tridentate ligands 
PtII complexes with tridentate ligands are of great interest for their luminescence 
properties. Some common tridentate ligands and their binding modes to transition metals 
are shown below and include N^N^N, N^N^C, N^C^N and C^N^C-coordinating ligands (Fig. 
3.1). Their complexes sometimes exhibit improved quantum yields in comparison to those 
of bidentate analogues owing to their enhanced rigidity which can help to minimise non-
radiative decay of the excited state. For example, Pt(C^N-ppy)2 is virtually non-emissive in 
degassed solution at RT21 whilst Pt(N^C^N-dpyb)Cl displays a quantum yield of 0.6.20  
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Figure 3.1: Structures and binding modes of tridentate ligands in metal complexes where M 
denotes any transition metal (top) and structures of representative PtII complexes with their 
respective PLQY values in degassed solution at RT (bottom). 
Within these classes of complexes it can be seen that the PLQY increases upon introduction 
of a cyclometallating carbon atom from N^N^N to N^N^C or N^C^N. [Pt(tpy)Cl]+ is non-
emissive in solution at RT whilst Pt(phbpy)Cl is weakly emissive with a PLQY of 0.025 and 
Pt(dpyb)Cl displays impressive luminescence. There are, however, other factors to consider 
regarding the PLQY values for these complexes and not just the number of cyclometallating 
carbon atoms. The fact that the N^C^N complexes display improved luminescence 
properties in comparison to the N^N^C complexes, despite the fact they have the same 
number of cyclometallating carbons, proves this. Moreover, some C^N^C complexes with 
two cyclometallating carbons, are non-emissive in solution at RT. These phenomena have 
been investigated by Tong et al. in a comprehensive theoretical study regarding the excited 
states of different tridentate cyclometallated Pt complexes.122 They attribute the lower 
PLQY for Pt(N^N^C)Cl largely to structural distortion of the first triplet excited state where, 
from TD-DFT calculations, it can be seen that the lateral aryl rings of its cyclometalated 
ligand flip up which results in a smaller d-d splitting making metal-centred excited states 
more thermally accessible to quench emission (Fig. 3.2). Even greater structural distortion 
was observed for Pt(C^N^C) complexes in comparison to Pt(N^C^N) complexes. 
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Figure 3.2: Optimised geometries of the singlet ground state and first excited triplet state 
for Pt(N^N^C) (top) and Pt(C^N^C) (bottom) complexes as calculated by TD-DFT. 
Reproduced from Tong et al. by permission of John Wiley and Sons.122  
3.2.1.2 PtII (C^N^C) Complexes 
The first examples of [Pt(C^N^C)L] complexes were described in 1988 by Cornioley‐
Deuschel et al. with L= py and Et2S.123 A more straightforward synthesis route to these 
[Pt(C^N^C)L] complexes with high yields was devised by Cave et al., where                          
2,6-diphenylpyridine (dppyH) is metallated twice by K2PtCl4 in acetic acid to give a dinuclear 
species.124 This species can then be reacted in DMSO to give the resulting complex 
Pt(C^N^C)DMSO (obtained in 98 % yield) which can be further modified by changing the 
ligand L to give complexes 33 and 34 (Scheme 3.1). The luminescence of these complexes 
was not studied but this facile synthesis method has since been adopted by many other 
groups who have investigated the Pt(C^N^C)L complexes further. 
Scheme 3.1: Synthesis of Pt(C^N^C)L complexes 33 and 34. 
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Lu et al. have reported on the photophysical characteristics of these types of complexes.125 
Amongst others, they synthesised the Pt(C^N^C)L complex bearing L as 4-tert-butylpyridine 
(35, Fig. 3.3). This had lowest-energy UV-vis absorption bands which are proposed to be an 
admixture of triplet Pt(d)→π*(C^N^C) and π→π* transitions. It was non-emissive in DCM at 
RT, although it did show emission in the solid-state and in alcohols at 77 K. The 77 K 
emission was seen to be concentration-dependent and broad, red-shifted emission was 
observed at concentrations above 5 x 10-7 M which was tentatively assigned as excimeric in 
nature (Fig. 3.3).  
 
 
  
Figure 3.3: Structure of [Pt(C^N^C)L] complex 35 and its concentration-dependent emission 
at 77 K in MeOH/EtOH/DMF (5:5:1) glass. Reprinted with permission from Lu et al.125 
Copyright 2001 American Chemical Society. 
Since then Kui et al. have made significant progress in the field of Pt(C^N^C)L complex 
synthesis including one with a highest PLQY of 0.26 for complex 36 (Fig. 3.4) which had an 
isocyanide group as the ancillary ligand. This complex was also incorporated into an OLED 
with an EQE of 12.6 %.126 A series of compounds were made which had different C^N^C and 
L ligands and it was found that thiophene units on the C^N^C ligand gave the best emission 
in solution. In addition to this, it was found that by swapping L from DMSO to isocyanide, 
the PLQY doubled from 13 to 26 %.  
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Figure 3.4: Structure of complex 36 and its PL and EL emission spectra. Reproduced from Kui 
et al. by permission of John Wiley and Sons.126 
Therefore, although significant progress has been made for Pt(C^N^C) complexes there is 
still a long way to go for them to rival the likes of similar complexes with tridentate ligands, 
such as those based on Pt(N^C^N) systems.  
3.2.1.3 PtII (N^C^N) Complexes  
Far more work has subsequently been done on Pt(N^C^N) complexes. The most common 
N^C^N ligand for platinum complexes that has been studied is dipyridylbenzene (dpybH). 
Its platinum complex Pt(dpyb)Cl has been studied by the Williams group owing to its 
intensely luminescent nature in solution at RT as mentioned previously.20 This is attributed 
to its cyclometallating carbon atom which provides good σ-donating ability through the 
short C—Pt bond and helps increase the ligand field strength in synergy with the π-
accepting pyridyl groups.  
Tuning of the substituents on the dpybH backbone can allow good control over the 
photophysical properties of the complex. By changing substituents at the 4-position of the 
central phenyl ring, absorption and emission maxima can be influenced allowing versatile 
colour-tuning. The introduction of aryl groups shifts the emission increasingly to the red 
according to their electron-donating ability, e.g. λmax increases in the order R=CO2Me <H< 
mesityl < Me < 2-pyridyl < 4-tolyl < 4-biphenylyl < 3,4-dimethoxyphenyl < 2-thienyl (Fig. 
3.5).127 
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Figure 3.5: Normalised emission spectra of the various Pt(dpyb)Cl complexes with different 
substituents. Reproduced from Williams et al. by permission of the Royal Society of 
Chemistry.127 
Rossi et al. investigated the effect of chloride metathesis by synthesis of two new  
Pt(N^C^N) acetylide complexes, 37 and 38, in an effort to further improve their 
efficiencies.128 The incorporation of a strong-field acetylide ligand in place of the weak-field 
chloride helps to raise the energies of otherwise deactivating d–d states, making them less 
thermally inaccessible and thus reducing non-radiative decay pathways. Synthesis of the 
complexes [Pt(Ln)-C≡C-C6H3F2], where (-C≡C-C6H3F2) is 3,5-difluorophenylacetylide, was 
achieved by reaction of  1-ethynyl-3,5-difluorobenzene with sodium methoxide (NaOMe) to 
remove the alkyne proton, followed by addition of a solution of the Pt(N^C^N)Cl complex in 
MeOH /DCM (1:4). Complexes 37 and 38 were achieved in almost quantitative yields after 
stirring for 1 day at ambient temperature (Scheme 3.2).  
 
Scheme 3.2: Synthesis of Pt(N^C^N) acetylide complexes 37 and 38. 
The parent complexes of 37 and 38, which contained chloride ligands as opposed to 
acetylide ligands, were previously reported to display quantum yields of 0.6820 and 0.62129 
respectively. By metathesis of the chloride ligands with the acetylide ligands these values 
were seen to increase to 0.77 and 0.66. Moreover, they displayed vibrationally resolved 
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spectra, with the 0–0 band at around 510 nm and, like their parent complexes, they formed 
excimers at elevated concentration in solution which had λmax values at around 700 nm. 
OLED devices were subsequently fabricated with both complexes and the corresponding EL 
spectra and EQE plots for each device are shown below in Fig. 3.6.  
  
Figure 3.6: EL spectra of complexes 37 and 38 either as a dopant at 5 wt. % in TCTA, or as 
the neat emitting layer (left) and EQEs versus electric current density for the four OLEDs 
(right). Reproduced from Rossi et al. by permission of the Royal Society of Chemistry.128  
OLEDs were prepared with 5 wt. % dopant in a TCTA host, as well as 100 % neat films of 
each complex. It is evident from the EL spectra that both complexes show 
excimeric/aggregate emission in the neat films, whilst structured emission similar to that 
observed in the PL is retained for the 5 wt. % doping concentrations in TCTA. The EQE 
values for the 5 wt. % films are 5 and 12 % for complexes 37 and 38 respectively, showing 
the mesityl group to have a positive influence on the efficiency of the luminescence. This is 
also reflected in the neat films where the device EQE for complex 38 is an order of 
magnitude higher than for complex 37. It was postulated that the mesityl groups favour a 
head-to-tail arrangement of molecules, whilst the methyl-substituted complexes prefer a 
head-to-head arrangement. Changing the arrangements of these molecules with respect to 
one another in the EML may, therefore, be associated with aggregation that can cause 
quenching. 
As one can see, there has been a substantial amount of work done on mononuclear PtII 
complexes with tridentate ligands, particularly with N^C^N ligands, owing to their 
impressive photophysical properties. These may emit across most of the visible region and 
recently research which incorporates these types of complexes into dinuclear/bimetallic 
complexes for NIR emission is becoming of interest and will be discussed in the next 
chapter.   
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3.2.1.4 Oxidation of cyclometallated complexes from PtII to PtIV 
The oxidation of PtII complexes to PtIV complexes is an area which has received less 
attention. PtIV is isoelectronic with IrIII. In degassed DCM at 298 K, Ir(ppy)3 shows an 
emission maximum at λem = 510 nm and a luminescence lifetime of τ = 1.9 µs with a 
quantum yield measured to be φ = 0.97.15 These impressive photophysical properties for IrIII 
complexes suggest good potential for luminescence in PtIV complexes. In comparison to PtII 
complexes however, there has been little research on PtIV complexes. This is likely to be due 
to the high charge on the metal centre. This may act to reduce the energy of the metal d 
orbitals and lead to a lower metal character in the excited state and ultimately to lower 
values of kr. Moreover, PtIV has very low reactivity in comparison to PtII. It has a low-spin d6 
configuration and is thus very chemically inert whilst PtII has a d8 configuration and is more 
reactive.  
As seen in the previous chapter, PtII complexes commonly display square planar geometry 
which can lead to the formation of excimers and aggregates. Sometimes this is 
advantageous in terms of the red-shifted emission that can be observed, but in other cases 
it can lead to emission quenching. Like IrIII complexes, PtIV complexes display octahedral 
geometry. Specifically in PtIV complexes, this reduces many of the intermolecular 
interactions which could diminish luminescence efficiency. From the literature there are 
examples of oxidation of cyclometallated PtII complexes to PtIV but this is largely only for 
bidentate C^N ligands and not for tri- or tetradentate ligands. Here, a few examples of 
complexes containing bidentate ligands will be discussed in terms of their synthesis and 
luminescence properties, which could impact on the development of PtIV complexes 
containing tridentate ligands.  
The use of hydrogen peroxide (H2O2) to achieve oxidation of PtII to PtIV has been used by 
Newman et al.130 The oxidations were performed typically with pendant ppy complex 
(Pt(ppyF)(HppyF)Cl, Scheme 3.3) in d6-acetone so that NMR could be used as a monitoring 
tool. Excess H2O2 (30 % in H2O) was added at RT and in the presence of air. In addition, 
potassium chloride (KCl) was added to ensure sufficient chloride was present to convert any 
potential platinum hydroxides to chlorides. Reactions were fast with all the initial PtII 
material (Pt(ppyF)(HppyF)Cl) being consumed in less than an hour. On the downside, the 
reaction did not proceed cleanly, and several complexes were reported thought to be 
isomers and hydroxide complexes. The final reported products 39a and 39b are shown in 
Scheme 3.3.  
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Scheme 3.3: Different isomeric products formed by the oxidation of PtII complexes with 
H2O2.  
Mamtora et al.131 used iodobenzenedichloride (PhICl2) as an oxidising agent for a similar 
process. Isomeric products 40a and 40b were observed in the reaction of Pt(ppyF)(py)Cl 
with PhICl2 in acetone (Scheme 3.4), but in chloroform a clean reaction took place. An SN2-
type attack on the PhICl2 is proposed as the mechanism of the reaction in acetone which 
would result in a five-coordinate cationic intermediate of the type [Pt(ppyF)(py)Cl2]+ 
(Scheme 3.4). It is thought that this cationic intermediate exists as a tight ion-pair and when 
the liberated chloride combines with the platinum centre, it will approach from the same 
side as the initial attack. This would force one of the existing ligands to move to the vacant 
coordination site, rather than fill it directly, resulting in two products. In chloroform, 
however, only one product is observed. Chloroform is known to be able to solubilise 
chloride anions via a hydrogen bond type of interaction.32 This would allow the liberated 
chloride to move more freely in solution and subsequently allow it to come around to the 
other side of the platinum centre. This would mean it would bond directly in the vacant 
site, forming only the thermodynamic product 40a.  
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Scheme 3.4: Oxidation of Pt(ppyF)(py)Cl in acetone with PhICl2 to form 40a and 40b.  
The luminescence properties of these complexes were not investigated, but since then, 
there have been a few groups who have synthesised similar PtIV complexes with bidentate 
ligands which display respectable PLQYs including Jenkins in 2010132 and Juliá in 2014.133  
Jenkins adopted the method developed by Mamtora utilising PhICl2 as an oxidising agent to 
synthesise complexes of the type [Pt(C^N)2(N^N)][PF6]2 and the synthesis of complex 41, 
where C^N is ppy and N^N is bpy, is shown in Scheme 3.5. Initially the neutral Pt(N^C)2Cl2 
complex is formed which is then reacted with bipyridine in the presence of AgOTf as a 
chloride scavenger to afford the final charged complexes. They synthesised a range of 
complexes by varying the substituents on the C^N and N^N ligands to probe structure-
property relations.  
 
Scheme 3.5: Synthesis of [Pt(C^N)2(N^N)][PF6]2 complex 41.  
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Figure 3.7: The corresponding C^N and N^N structures for [Pt(C^N)2(N^N)][PF6]2 complexes 
42 and 43. 
It was found that the complexes containing the C^N ligands as ppy exhibited blue, 
structured luminescence. The emission maxima were also seen to be highly blue-shifted in 
comparison to their Ir analogues e.g. 482 nm for 41 versus 582 nm for [Ir(ppy)2(bpy)](PF6). A 
range of PLQY values from 0.05 - 1.1 % was observed with lifetimes ranging from 1.1 to     
15 μs for complexes containing ppy ligands and substituted bpy ligands. They expanded this 
series of complexes to derivatives with the C^N ligand 5-methyl-2-(biphen-4-yl)pyridine (Ph-
mppyH) for its extended π-system with the aim of increasing quantum yield and influencing 
the emission colour (Fig. 3.7).  
 
Figure 3.8: Emission spectra and relative intensities of [Pt(C^N)2(N^N)](PF6)2 complexes 41-
43. Reprinted with permission from Jenkins et al.132 Copyright 2010 American Chemical 
Society. 
Subsequently a shift of emission energies of 70 nm and an 11-fold increase in quantum 
yield compared to 41 was attained in the Ph-mppy derivatives 42 and 43 (Fig. 3.8). 
Furthermore, longer lived excited-state lifetimes as high as 260 μs were observed which 
demonstrated a high sensitivity to oxygen quenching. All of which show good potential for 
PtIV complexes with luminescent properties, in this case particularly for oxygen sensing 
applications.  
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Juliá et al. developed this work with the same synthetic route using PhICl2 to afford similar 
bidentate PtIV complexes. Initially they synthesised meridional and facial isomers of tris-
cyclometalated PtIV complexes, [Pt(C^N)3]OTf, where C^N is a phenylpyridine-based ligand 
or 1-phenylpyrazole (Scheme 3.6). They assigned the emission as coming from a 3LC excited 
state and also reported significantly blue-shifted emission in comparison to isoelectronic IrIII 
analogues. They reported the highest known PtIV quantum yield of 0.49 at the time in 
degassed solution at RT for fac-[Pt(ppy)3]OTf (44) and also revealed high promise for these 
complexes for use as oxygen sensors owing to the long lifetimes of over 200 µs. They have 
since developed this work to afford PtIV complexes with PLQYs of up to 81 % for complex 45 
(Scheme 3.6) and similar long lifetimes.134 
 
 
 
 
Scheme 3.6: Synthesis of fac and mer PtIV complexes where a) PhICl2 and DCM, b) AgOTf, 
N^CH, dichloroethane, 90 °C and c) hν, MeCN (left) and complex 45 (right).  
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3.2.2 Objectives 
Most PtIV complexes that have been reported in the literature appear to feature bidentate 
ligands and they have made huge progress in terms of luminescence efficiency in the last 
few years. The main objectives of the present work are to investigate the synthesis of PtIV 
complexes containing tridentate N^C^N ligands. The preliminary investigation into this 
work was started by a previous Ph. D student in our group, Gemma Freeman,135 and this 
will be the basis for the development of PtIV compounds containing tridentate ligands in this 
work.  
3.2.3 Results and Discussion 
3.2.3.1 Synthesis 
Pt(dpyb)Cl 
The dpybH ligand was synthesised via the Suzuki-Miyaura cross-coupling procedure with 
Na2CO3 as the base and Pd(PPh3)4 as the catalyst (Scheme 3.7) as previously employed in 
past research.18 All reagents were initially degassed and placed under an atmosphere of 
argon, before addition of the catalyst. The mixture was then heated under nitrogen at 85 °C 
for two days, before purification by column chromatography on silica. Yields of 
approximately 70 % were obtained from this one-step process.  
Cyclometallation to give the PtII complex Pt(dpyb)Cl was then achieved via one of two 
methods. The first was the reaction of dpybH with K2PtCl4 in acetic acid (15 mL) at reflux for 
60 hours (Scheme 3.7). The second was the microwave reaction of the same reagents at a 
higher concentration (1.5 mL solvent) at 160 oC for 30 minutes. This microwave synthesis 
has been employed by the group in previous work and was adapted from the method 
developed by Wang et al.136 The yield of the first method was approximately 50 % whilst 
the microwave method gave a yield closer to 70 % in less than 1 % of the time.    
Pt(dpyb)Cl3 
The main method that was used to oxidise the PtII complex, Pt(dpyb)Cl, through to the PtIV 
complex, Pt(dpyb)Cl3, was via a procedure developed by Lisa Murphy137 for related N^C^N-
coordinated PtII complexes. The oxidation was achieved by taking up the PtII complex in a 
small volume of chloroform and bubbling chlorine gas through the solution for 30 minutes, 
with the exclusion of light. The chlorine gas was generated by reacting concentrated HCl 
with potassium permanganate (KMnO4) in a separate vessel. Upon reaction, the solution 
became paler in colour after just a couple of minutes, indicating that oxidation had taken 
place. The steady supply of Cl2 was maintained for approximately 30 minutes to ensure 
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complete conversion, but care was taken not to exceed this time frame owing to potential 
degradation of the complex for example through chlorination of the ligand. The solvent was 
also then removed quickly under reduced pressure to prevent possible photo-activated 
decomposition back to PtII in the presence of light.  
[Pt(dpyb)L1Cl]+ 
Pt(dpyb)Cl3 and the bidentate triazole ligand HL1 (see chapter 2) were reacted in refluxing 
toluene under argon with AgOTf as a chloride scavenger (Scheme 3.7). This was followed by 
anion exchange with saturated aqueous KPF6 and resulted in the formation of 
[Pt(dpyb)L1Cl]PF6. The complex was purified by recrystallization from a DCM/Hexane 
solution in a 7 % yield. This is one of the very few examples of a PtIV 3+2+1 complex, where 
3+2+1 describes the denticity of the three ligands bound to the Pt centre and which will 
also be discussed in terms of IrIII complexes in the next section.  
 
Scheme 3.7: Synthesis of Pt(dpyb)Cl, its oxidation to Pt(dpyb)Cl3 and subsequent reaction 
with a pyridyl triazole to form [Pt(dpyb)L1Cl]PF6. 
Crystals of [Pt(dpyb)L1Cl]PF6 suitable for X-ray diffraction were obtained by slow 
evaporation from an acetone solution (Fig. 3.9). The crystal structure confirmed the 
oxidation state of Pt to be +4 showing the binding mode of the N^N ligand to be via the 
deprotonated N with the presence of only one counter PF6— ion to balance the charge. Two 
independent ionic pairs were revealed which differ only by the orientation of the phenyl 
group on the triazole ligand. The complex co-crystallised with a molecule of acetone.   
The longest bond length was for Pt—Cl at 2.29 Å whilst the shortest bond length to Pt was 
Pt—C7 at 1.95 Å (Table 3.1). This reflects the weaker bond between Pt and Cl in comparison 
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to the cyclometallated bond between Pt and the C— atom which is the case in many other 
cyclometallated complexes such as Pt(dpyb)Cl.20 The Pt1—N3 bond length which is trans to 
Pt1—C7 displayed the longest bond length for the Pt to any of the nitrogen atoms and this 
is due to the high trans influence of the cyclometallating carbon. Subsequently it can be 
seen that the N— atom has a weaker trans influence than the C— of the cyclometallating 
ligand. The bond angle of N3-Pt1-C7 is close to linear at 177 ° whilst those for N4-Pt1-Cl1 
and N1-Pt1-N2 are 170.6 °and 161.3 ° respectively.  
 
 
 
Figure 3.9: Molecular structure of the cation [Pt(dpyb)L1Cl]+, crystal packing in its PF6—salt 
and the structure of two independent ionic pairs in the crystal lattice. 
Table 3.1: Selected bond lengths and angles for [Pt(dpyb)L1Cl]+. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—N3 
Pt1—N4 
Pt1—C7 
Pt1—Cl1 
2.056(3) 
2.051(3) 
2.171(3) 
2.010(3) 
1.952(3) 
2.2919(9) 
N1-Pt1-N2 
N3-Pt1-C7 
N4-Pt1-Cl1 
 
161.33(11) 
177.24(11) 
170.64(11) 
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[Pt(dpyb)(L16)]+ 
The other PtIV complex that was successfully synthesised was the bis-tridentate 
[Pt(dpyb)L16]+ complex which is similar to [Pt(dpyb)L1Cl]+, but contains the tridentate 
triazole ligand L16 in place of both the bidentate triazole ligand and chloride ligand (Scheme 
3.8). The tridentate triazole ligand H2L16 was one of a series of ligands synthesised according 
to an adapted procedure by De Cola et al.91 in the same manner as for the bidentate 
triazole ligands discussed in Chapter 2, but starting from 2,6-dicyanopyridine. This synthesis 
is outlined in more detail in the next section in relation to analogous Ir complexes (see 
Scheme 3.9).  
The introduction of L16 into the PtIV(N^C^N) coordination sphere was initially attempted by 
reaction of Pt(dpyb)Cl3 with triazole ligand H2L16 in MeCN but this was not successful, 
probably due to the low solubility of the triazole. To try to improve solubility, ethylene 
glycol was then used as a higher boiling-point solvent at a temperature of 195 oC. The 
reaction was run for 3 days under argon to give the complex which was evident by MS (ES+). 
The reaction mixture was then cooled to RT and water was added to precipitate out a solid 
which was thought to be the chloride/triflate salt of the final product. This was dissolved in 
MeOH and then saturated KPF6 aqueous solution was added for anion exchange. The 
hexafluorophosphate salt of the pure product was isolated by filtration, extraction into 
DCM and three DCM/hexane recrystallizations. The yield of the complex was 20 % and it is 
the first example of a PtIV bis-tridentate complex as far as we are aware.  
 
Scheme 3.8: Synthesis of the bis-tridentate PtIV complex via the ligand H2L16. 
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3.2.3.2 Photophysical properties  
[Pt(dpyb)L1Cl]+ 
The photophysical properties of the 3+2+1 PtIV complex [Pt(dpyb)L1Cl]+ are summarised in 
Figure 3.10. [Pt(dpyb)L1Cl]+ showed high energy absorption between 250 and 350 nm in 
DCM solution and these are assigned as LC π→π* transitions. Weak absorption extended to 
longer wavelengths of up to 450 nm, showing a red-shifted absorption in comparison to the 
triazole ligand and similar observations have previously been made for other PtIV 
complexes.138 This absorption is regarded as a mixture of the LC absorption with introduced 
metal character. The emission spectrum at RT in degassed DCM solution showed a 
relatively broad and unstructured band with λmax at 505 nm, a lifetime of 3.1 μs and PLQY of 
5.9 %, whilst at 77 K the emission was highly structured and displayed a blue-shifted λmax to 
480 nm with an increased lifetime of 230 μs. This suggests emission originates from either a 
3LC or 3MLCT state owing to long lifetimes and the rigidochromism which is observed on 
going to 77 K.139 It is interesting also to compare this compound with an IrIII analogue and 
this will be discussed in the following section in this chapter.  
 
φ = 5.9 % 
τdeg = 3.1 µs 
τaer = 590 ns 
τ77K =230 μs 
kr = 1.9 x 104  s-1 
knr = 3.0 x 105  s-1 
kq(O2) = 6.3 x 108   
mol-1dm3 s-1 
 
Figure 3.10: RT absorption and degassed emission spectra of [Pt(dpyb)L1Cl]+ in DCM and     
77 K spectrum in EPA. 
[Pt(dpyb)L16]+ 
The photophysical properties of the bis-tridentate complex [Pt(dpyb)L16]+ are summarised in 
Figure 3.11. [Pt(dpyb)L16]+ showed absorption from 250 to 350 nm assigned as LC π→π* and 
the absorption band between 350 and 420 nm of lower intensity was assigned to a MLCT 
transition or charge-transfer state with enhanced metal character. This MLCT band in the 
absorption was not noticeable for [Pt(dpyb)L1Cl]+ which suggests that there is more metal 
character in the absorption for this [Pt(dpyb)L16]+ complex. The degassed RT emission in 
DCM shows a highly structured spectrum with a sharp 0-0 transition centred at 480 nm. The 
emission at 77 K is seen to be slightly blue-shifted from the RT emission with evidence of 
more vibrational bands. This compound exhibits an impressive PLQY of 28 % in degassed 
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DCM solution at RT with a lifetime of 11 μs. The knr value is seen to be lower than that of 
[Pt(dpyb)L1Cl]+ (6.4 x 104  vs. 3.0 x 105  s-1) which is a sign of enhanced rigidity and which is 
reflected by the more structured emission for [Pt(dpyb)L16]+, in addition to the higher PLQY. 
In this case it seems as though the bis-tridentate structure (containing two tridentate 
ligands) confers more rigidity to the structure in comparison to the 3+2+1 [Pt(dpyb)L1Cl]+ 
complex (containing 1 tridentate ligand).  
 
φ = 28 % 
τdeg = 11 µs 
τaer = 2.1 µs 
τ77K = 14 μs 
kr = 2.5 x 104  s-1 
knr = 6.4 x 104  s-1 
kq(O2) = 1.8 x 108   
mol-1dm3 s-1 
 
Figure 3.11: Absorption and emission spectra of [Pt(dpyb)L16]+ in DCM and 77 K spectrum in 
EPA.  
3.2.3.3 DFT studies on PtIV complexes 
DFT calculations were performed for these PtIV complexes in order to try to identify the 
nature of the excited state transitions in each case.  The HOMO→LUMO transitions in both 
[Pt(dpyb)L1Cl]+ and [Pt(dpyb)L16]+ are assigned in Table 3.2. The orbital plots for the 3+2+1 
Pt complex show that there is a large contribution to the HOMO from the triazole ring and 
phenyl group on the triazole ligand, as well as a much smaller contribution from the metal 
centre (Fig. 3.12). The LUMO is delocalised over the N^C^N ligand, the chloride ligand and 
the triazole ring, with a large contribution from the metal centre and thus the 
HOMO→LUMO transition can be thought of as having mixed LMCT/LLCT character. 
For the bis-tridentate Pt complex, the HOMO has a large contribution from the triazole 
ligand and a smaller contribution from the metal centre. The LUMO is based mainly on the 
triazole rings of the N—^C^N— ligand and the pyridine of the N^C^N ligand with a large 
contribution from the metal centre giving good overlap between the HOMO and LUMO 
orbitals. This could help to explain the relatively high PLQY value for this complex. The 
HOMO→LUMO transition can thus be thought of as having predominantly LMCT/LLCT 
character.
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Table 3.2: Summary of transitions for [Pt(dpyb)L1Cl]+ and [Pt(dpyb)L16]+.  
Complex [Pt(dpyb)L1Cl]+ [Pt(dpyb)L16]+ 
Transition HOMO→LUMO  HOMO→LUMO  
Assignment  Mixed LMCT/LLCT Mixed LMCT/LLCT 
 
 
Complex HOMO LUMO 
[Pt(dpyb)L1Cl]+ 
 
 
 
 
 
 
 
[Pt(dpyb)L16]+ 
 
 
 
 
 
Figure 3.12: Orbital plots of the HOMO and LUMO for [Pt(dpyb)L1Cl]+ and [Pt(dpyb)L16]+ as 
calculated by DFT.  
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3.3 Mononuclear IrIII complexes containing tridentate N^C^N ligands 
This next section discusses IrIII complexes which are isoelectronic with PtIV complexes and 
which can display analogous structures based on their octahedral complex geometries. 
Table 3.3 at the end of this introductory section summarises the photophysical properties 
of selected Ir complexes.  
3.3.1 Introduction 
The most commonly reported luminescent Ir complexes are of the form Ir(N^C)3 bearing 
three bidentate mono-anionic ligands to form a neutral Ir complex in which the metal is in 
its +3 oxidation state. These have been widely recognised for their intense luminescence.  
Indeed, IrIII complexes such as tris(2-phenylpyridine)iridium [Ir(ppy)3],                               
tris(1-phenylisoquinoline)iridium [Ir(piq)3] and bis([4,6-di-fluorophenyl]-pyridinato-
N,C2′)(picolinato)IrIII, FIrpic, are well known red, green and blue emitters with quantum 
yields of 0.9715, 0.53140 and 0.89141 in solution respectively. Since then, other Ir complexes 
with different ligand binding modes have been investigated including bis-tridentate and 
‘3+2+1’ conformations which contain a combination of one tridentate, one bidentate and 
one monodentate ligand as was seen for [Pt(dpyb)L1Cl]+ (Fig. 3.13). 
 
Figure 3.13: Examples of the binding modes of IrIII complexes. 
In terms of bis-tridentate complexes, historically Ir bis-terpyridine [Ir(tpy)2]3+ was the focus 
of much attention after optimisation of the synthesis procedure was achieved by Collin et 
al. in 1999.142 IrCl3.3H2O and tpy were reacted in ethylene glycol at 160 °C to afford 
Ir(tpy)Cl3 which was subsequently refluxed with a second amount of tpy at higher 
temperatures (from 196 to 198 °C). Purification was achieved by ion-exchange to the 
hexafluorophosphate salt, which offers greater solubility in polar organic solvents, followed 
by column chromatography on either silica or alumina. [Ir(tpy)2]3+ showed structured 
emission with peak maxima at 458, 491 and 523 nm, and PLQY values ranging between 0.02 
and 0.06, depending on the counter anion and solvent. Lifetimes were reported in the 
range of 0.7 to 1.2 µs in air- equilibrated solution at RT.143     
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This research soon extended to other charged bis-tridentate Ir complexes where Haga’s 
group synthesised complexes containing tridentate ligands that ligate through 
benzimidazole nitrogen atoms.144 The homoleptic complex [Ir(Mebip)2]3+ (46) was prepared 
in a similar manner to [Ir(tpy)2]3+ where the dimethylated ligand, 2,6-bis(1-methyl-
benzimidazol-2-yl)pyridine (Mebip) was reacted with IrCl3·nH2O in a 1:1 ratio at 100 °C, to 
give [Ir(Mebip)Cl3] as a red precipitate, followed by reaction with a second equivalent of the 
ligand in refluxing ethylene glycol. They also prepared the dicationic complex containing 
1,3-bis(1-methyl-benzimidazol-2-yl)benzene (Mebib) and Mebip, 47. The comparison of the 
emission spectra of 46 and 47 is shown below. 46 had emission peak maxima of 550 and 
592 nm with a quantum yield of 3.7 % at RT whilst 47 displayed red-shifted emission. This 
work also included the synthesis of a 3+2+1 complex [Ir(Mebip)(bpy)Cl]2+ (48) which 
showed the highest PLQY of 19 % and emission peak maxima of 547 and 582 nm (Fig. 3.14).  
                       
 
 
Figure 3.14: Structures of complexes 46, 47 and 48 along with their emission spectra where 
solid lines are at RT (in MeCN), and dotted lines are at 77 K in DMF-MeOH-EtOH [1:5:5(v/v)]. 
Reprinted with permission from Haga et al.144 Copyright 2005 American Chemical Society.  
(47) 
(46) 
(48) 
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The fact that these complexes are ionic limits their use in many applications such as OLEDs 
where vacuum sublimation is required. Thus, a move towards mono-anionic ligands, as 
opposed to tpy, to give charge neutral complexes was investigated. 
Williams et al. demonstrated the synthesis of a neutral bis-tridentate IrIII complex 
Ir(dpyx)(dppy) (49) where dpyxH = 1,3-di(2-pyridyl)-4,6-dimethylbenzene in their 2004 
communication.145 Initial attempts to coordinate dipyridylbenzene to IrIII in an N^C^N 
fashion failed owing to the adoption of binding mode II as shown below (Fig. 3.15). Methyl 
groups were subsequently incorporated on the 4 and 6 positions of the central ring to block 
this binding mode and favour N^C^N binding. The desired product 50 was then obtained as 
an orange solid by heating the chloro-bridged dimer [Ir(dpyx)Cl(µ-Cl)]2 with AgOTf in molten 
dppyH2 at 110 °C, followed by column chromatography purification. The complex was found 
to be highly luminescent with a λmax of 585 nm and quantum yield of 21 % with a lifetime of 
3.9 µs in degassed MeCN solution at RT.  
 
Figure 3.15: Different possible binding modes of dipyridylbenzene (I and II, top) and 
structures of the bis-tridentate complex 49 and 3+2+1 complex 50 (bottom). 
The downside to this bis-tridentate complex was its instability under prolonged irradiation 
in polar solvents. It was observed by 1H NMR that after irradiation in MeCN, a new product 
was formed that contained dppy bound asymmetrically as a C^N— coordinating ligand with 
the second phenyl group unbound. This indicated a cleavage of one of the mutually trans 
Ir—C bonds. This instability was only observed in solution but raises concern as to its likely 
stability in a device, as well as rendering its synthesis and purification very difficult.  
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They also demonstrated the 3+2+1 arrangement adopted by the charge-neutral complex 
[Ir(dpyx)(ppy)Cl] (50, Fig. 3.15), containing a tridentate, bidentate and monodentate 
ligand.146 This complex was synthesised via reaction of the chloro-bridged dimer 
[Ir(dpyx)Cl(µ-Cl)]2 with 2-phenylpyridine (ppyH) in the presence of AgOTf.  
 
Figure 3.16: Absorption and emission spectra of 49 and 50. The low-energy portion of the 
excitation spectrum of 49, registered at 507 nm under the same conditions, is also shown 
(blue dotted line). Reproduced with permission from Williams et al.146 Copyright 2006 
American Chemical Society. 
Complex 50 was seen to be highly emissive in solution with a PLQY of 0.76 in degassed 
MeCN solution. The emission spectra of both 49 and 50 are shown in Fig. 3.16. Complex 50 
shows a structured, blue-shifted emission in comparison to the bis-tridentate complex 49. 
The blue-shift in emission is explained by the lowering of the HOMO energy upon 
substitution of the strong-field cyclometallating carbon by a chloride ligand, without 
significantly affecting the dpyx-based LUMO. Moreover, the more structured spectrum is 
suggestive of an increase in LC character, therefore, the emission is assigned to a heavily 
mixed π-(dpyx)/d(Ir)→π*(dpyx) (LC/MLCT) excited state.  
Other examples of the 3+2+1 arrangement have also been reported by Haga’s group who 
synthesised a series of neutral IrIII complexes with the formula [Ir(N^C^N)(ppy)X] where 
(N^C^N) represents  Mebib and X = CN or Cl.147 The reaction of Mebib with IrCl3.4H2O in 
methanol gave an insoluble yellow precipitate which was then reacted with ppy under 
microwave conditions in glycerol to afford the Cl-containing product. The chloride could be 
metathesized to cyanide upon treatment with KCN in ethylene glycol. The phosphorescence 
of [Ir(Mebib)(ppy)X] was observed at 555 nm for X = Cl (51) and 526 nm for X = CN (52), 
with high quantum yields in the range of 0.77 to 0.86 at RT (Fig. 3.17).  
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Figure 3.17: Structure of Haga Ir complexes 51-54 (left) and absorption and emission 
spectra of complexes 53 and 54 where the dotted line represents complex 53 and the solid 
line is 54 (right). Reproduced from Haga et al. by permission of the Royal Society of 
Chemistry.148  
Moreover, they later reported the synthesis of iridium complexes bearing asymmetric 
tridentate N-methylimidazole derivatives which could be separated into pairs of optically 
pure enantiomers (53 and 54, Fig. 3.17).148 In the absorption spectrum, upon the 
substitution of a chlorine atom by CN, a shorter wavelength shift of both the π→π* and 
MLCT (or LLCT) bands was observed. The weak absorption band around 450 to 460 nm was 
attributed to the 3LC transitions mixed with 3MLCT. The complex 54 exhibited a strong 
emission band with vibrational structure at 468 nm, a lifetime of 1.4 µs and quantum yield 
of 0.63 at RT. Determination of the lifetime and quantum yield for 53 was not possible due 
to photochemical dissociation of 53 in DCM. The two enantiomers of this complex were 
resolved on a chiral HPLC column and CD spectra confirmed their successful separation.    
It is evident from these examples that significant developments in luminescent IrIII 
complexes, away from the archetypal Ir(L)3 structure, have been made. The 3+2+1 Ir 
complexes display unprecedently high quantum yields. However, Ir complexes with 
tridentate ligands were not investigated for incorporation into devices prior to 2012.   
In 2012, in collaboration with Haga, Kuwabara et al. made the first steps to incorporating 
these types of 3+2+1 and bis-tridentate complexes into OLEDs.149 They reported the 
synthesis of Ir complexes composed of benzothiazole-based pincer ligands with 1,3-bis(2-
benzothiazolyl)-4,6-dimethylbenzene (bbtxH). The reaction of the chloro-bridged dimer 
[Ir(bbtx)(μ-Cl)Cl]2 with ppyH was carried out by applying microwave radiation for 4 minutes 
and resulted in the neutral 3+2+1 complex, Ir(bbtx)(ppy)Cl (55), in 76 % yield. Complex 55 
displayed an extremely high quantum yield of 89 % in degassed DCM at RT and had an 
emission lifetime of 1.1 µs. The performance of this complex was then investigated in an 
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OLED owing to its impressive photophysical properties and the resulting EQE of the device 
was 10.5 % (Fig. 3.18).  
 
 
 
 
Figure 3.18: Structure of 55 and EL spectrum of the device (inset: photograph of EL of the 
device at 3 V). Reproduced from Kuwabara et al. by permission of the Royal Society of 
Chemistry.149 
Since then, Yun Chi’s group have reported a number of charge-neutral bis-tridentate 
complexes with high luminescence quantum yields and facile synthesis procedures for 
incorporation into OLED devices.150,151,152 In 2015, they  synthesised six charge-neutral bis-
tridentate IrIII complexes containing 2-pyrazol-3-yl-6-phenylpyridine functional groups.152 
The synthesis of complexes 56-61 (Fig. 3.19) was conducted at lower temperatures than 
those needed with dppy-containing ligands, by reaction of IrIII dimers with the pyrazolo 
ligands in decalin and in the presence of sodium acetate (NaOAc). The presence of NaOAc 
acting as a base was proven invaluable in the synthesis for quick reaction times and high 
yields of between 52 and 72 %.  
 
Figure 3.19: Structures of bis-tridentate complexes 56-61.  
Complexes 56 and 60 were chosen as representative green and red emitters for the 
fabrication of OLEDs owing to their high PLQY values of 72 and 63 % respectively in 
degassed DCM solution at RT. A maximum EQE of 13.2 %, luminance efficiency of             
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41.4 cd A-1 and power efficiency of 35.5 lm W-1 were obtained for the green OLED (complex 
56), as opposed to 15.4 %, 21.0 cd A-1 and 16.3 lm W-1 for the red emitting device (complex 
60).  
By incorporating imidazole-based carbene units, Chi’s group has since managed to increase 
the PLQY values of charge-neutral bis-tridentate Ir complexes to near unitary efficiency and 
subsequently give EQE values of well over 20 %.153,151 They are striving towards deep blue 
emission and have produced a multitude of complexes containing bis(imidazolylidene) 
benzenes, acting  as NHCs, in combination with both 2-pyrazolyl-6-ppy and 6-pyrazolyl-2-
phenoxylpyridine  ligands (62-64, Fig. 3.20). The OLED derived from the complex 62 gave a 
maximum EQE of 27 % but CIE coordinates of (0.18, 0.40) which is less good than OLEDs 
fabricated from FIrpic.153 As a result they moved on to the complexes containing 6-
pyrazolyl-2-phenoxylpyridine ligands as opposed to 2-pyrazolyl-6-ppy, complexes 63 and 
64. Complex 64 was seen to have much improved CIE coordinates of (0.15, 0.17) despite a 
lower, but still extremely high, maximum EQE of 20.7 %.151 
 
Figure 3.20: Structures of bis-tridentate complexes 62-64. 
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Table 3.3: PL (in degassed solution) and EL properties of literature IrIII complexes where the EL performance records the maximum values obtained. Please 
refer to the list of abbreviations for the device architecture column.  
Compound 
no./Ref 
Device Architecture PL performance EL performance  
λmax 
(nm) 
 
PLQY 
(%)  
Lifetime 
(µs) 
 
λmax(nm) 
 
CE 
(cd A-1) 
PE 
(lm W-1) 
Brightness 
(cd m-2) 
EQE 
(%) 
55 149 Al (200 nm)/ LiF (0.5 nm) / 4,7-diphenyl-1,10-
phenanthroline (4 nm)/ arylanthracene (35 nm) / CBP + 
55/ NBP (30 nm)  / Triarylamine (30 nm) / ITO (100 nm).  
572, 
675 
89 1.1 572, 675 - - - 10.5 
Al (200 nm)/ LiF (0.5 nm) / 4,7-diphenyl-1,10-
phenanthroline (4 nm) / arylanthracene (35 nm) / BAlq2 
+ 55/ NBP (30 nm)  / Triarylamine (30 nm)/ ITO (100 
nm). 
- - - - 14 
56152 ITO / TAPC (40 nm) / mCP with 8 wt% 56 (30 nm) / 
BP4mPy (50 nm) / LiF (0.8 nm) /Al (150 nm). 
490, 
526, 
570 
72 1.8 490, 526, 
570 
37.8 30.3 9696 12.1 
ITO / TAPC (40 nm) / mCP with 8 wt% 56 (30 nm) / 
TmPyPB (50 nm) / LiF (0.8 nm) / Al (150 nm). 
41.4 35.5 15781 13.2 
60152 
 
ITO/TAPC (40 nm) / mCP with 8 wt% 60 (30 nm) / 
BP4mPy (50 nm) / LiF (0.8 nm) /Al (150 nm). 
594, 
641 
63 1.8 594, 641 21.0 16.3 19085 15.4 
ITO / TAPC (40 nm )/ mCP with 8 wt% 60 (30 nm) / 
TmPyPB (50 nm) / LiF (0.8 nm) / Al (150 nm). 
21.7 20.1 29749 15.0 
63151 ITO / MoO3 (1 nm) / TAPC (40 nm) / mCP (10 nm) / 
DPEPO + 12 wt. % 63 (20 nm) / 3TPYMB (50 nm) / LiF (1 
nm) / Al (100 nm). 
- - - 476 33.5 26.3 - 19.7 
64151 ITO/MoO3 (1 nm) / TAPC (40 nm) / mCP (10 nm) / DPEPO 
+ 12 wt. % 64 (20 nm) / 3TPYMB (50 nm) / LiF (1 nm) / Al 
(100 nm). 
- - - 467 28.8 22.6 - 20.7 
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3.3.2 Objectives 
We aim to investigate the synthesis and photophysical properties of IrIII complexes 
containing tridentate N^C^N ligands, in combination with both bidentate and tridentate 
triazole ligands.  
The main set of complexes that will be studied are bis-tridentate IrIII complexes which 
incorporate cyclometallating N^C^N ligands and pseudo-cyclometallating triazole ligands. 
Primarily, we seek to prepare Ir(N^C^N)(N-^N^N-) complexes in place of the 
Ir(N^C^N)(C^N^C) complexes which were found to be unstable in solution as discussed 
earlier.  
Already we have seen the lower trans influence of the N— atom in the bidentate triazole 
ligand L1 compared to the cyclometallating C— atom of dpyb displayed in complex 
[Pt(dpyb)L1Cl]+. Subsequently, here we aim to answer the question of: is the trans effect in 
these bis-tridentate complexes lower for those containing N—^N^N— or C^N^C ligands? 
In addition to this, the synthesis of complexes with the 3+2+1 conformation which 
incorporate bidentate triazole ligands will be attempted. It is also the aim to confirm the 
binding mode of the N^N ligand in these cases, i.e. is the binding mode in this case N^N, 
with a neutral coordinating nitrogen atom to form a charged Ir complex, or N^N— with a 
negatively charged nitrogen atom to form a neutral Ir complex? 
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3.3.3 Results and discussion 
3.3.3.1 Bis-tridentate IrIII triazole complexes 
Synthesis  
Tridentate triazole ligands H2Ln where n = 16-18 were synthesised according to an adapted 
procedure by de Cola et al.91 in the same manner as for the bidentate triazole ligands 
discussed in Chapter 2, but starting from 2,6-dicyanopyridine (Scheme 3.9). Yields for each 
step were above 80 % except when the OMe substituent was present. This electron-
donating group was also seen to have a reducing impact on the yield of the bidentate 
triazole ligands from chapter 2. This may be due, in the case of intermediate 2 (I2l) 
formation, to the fact that the electron donating group makes the δ+ charge on the 
carbonyl less positive and hence not as susceptible to attack from intermediate 1 (I1h). In 
the formation of the triazole itself this could also be the case whereby the elimination of 
water for the ring closure in this step favours a more δ+ site on the carbonyl for attack.  
Scheme 3.9: Synthesis of tridentate triazole ligand intermediates and resulting ligands      
H2L16-18. 
The iridium complexes Ir(dpybX)(L16-18), where X= 3,5-difluoro (F2), 3,5-dimethyl (Me2) and 
4-OMe (OMe) on the phenyl ring (Scheme 3.10), were synthesised via cleavage of the 
corresponding [Ir(dpybX)Cl(µ-Cl)]2 chloro-bridged dimers154 with H2L16-18 in the presence of 
AgOTf as a chloride scavenger. The reactions failed to proceed in toluene but use of the 
higher boiling-point solvent ethylene glycol allowed the desired compounds to be formed in 
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good yields. Purification was achieved by precipitation from H2O followed by washing with 
H2O, MeOH and Et2O and finally a short column on silica in DCM/MeOH (90:10). Yields of 
the final complexes ranged from 45 to 74 %. The fact that these complexes were stable on 
the column and in solution for long periods of time suggests that the trans effect is weaker 
in these complexes containing two N— atoms and one cyclometallating C— atom, compared 
to analogous Ir(N^C^N)(C^N^C) complexes containing 3 cyclometallating C— atoms which 
were unstable under similar conditions as discussed earlier.  
 
 
Scheme 3.10: Synthesis of bis-tridentate IrIII triazole complexes starting from the Ir chloro-
bridged dimers.  
X-ray diffraction analysis of single crystals grown from slow diffusion of hexane into a DCM 
solution confirmed the bis-tridentate nature of the complexes Ir(dpybMe2)L16 and  
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Ir(dpybF2)L16 with mutually orthogonal chelates (Figs. 3.21 and 3.22). Tables 3.4 and 3.5 give 
the selected bond lengths and bond angles for complexes Ir(dpybMe2)L16 and  Ir(dpybF2)L16 
respectively. The Ir1—C7 bond is shorter than the corresponding Ir—N6 bond lengths in 
each complex which is in line with the trans influence seen in many cyclometallated 
complexes owing to the strong σ donation from C— atoms.  Ir—N7 and Ir—N3 bond lengths 
in each complex are also seen to be of similar length (ca. 2.0 Å) which demonstrates the 
slightly weaker trans influence of the pseudocylometallating N— atoms compared to the 
cyclometallating C— atoms for which the Ir—C7 bond length is ca. 1.9 Å.  The C7-Ir1-N6 
angle in Ir(dpybMe2)L16 is essentially linear at 177. 4° whilst the angles for N1-Ir1-N2 and 
N7-Ir-N3 are 160.9 and 150.9° respectively. The crystal structure of Ir(dpybMe2)L16 has 
disordered tBu groups and for Ir(dpybF2)L16 there are two DMF solvent molecules per unit of 
crystallization. 
 
 
 
Figure 3.21: Molecular structure and crystal packing of Ir(dpybMe2)L16, hydrogen atoms are 
omitted for clarity. 
Table 3.4: Selected bond lengths and angles of Ir(dpybMe2)L16. 
Bond Lengths/ Å Bond Angles /   ̊ 
Ir1—N1 
Ir1—N2 
Ir1—N3 
Ir1—N6 
Ir1—N7 
Ir1—C7 
2.030(5) 
2.065(5) 
2.039(5) 
2.081(5) 
2.028(5) 
1.954(6) 
N1-Ir1-N2 
N7-Ir1-N3 
C7-Ir1-N6 
160.90(19) 
154.54(19) 
177.4(2) 
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Figure 3.22: Molecular structure and crystal packing of Ir(dpybF2)L16, hydrogen atoms are 
omitted for clarity. 
Table 3.5: Selected bond lengths and angles of Ir(dpybF2)L16. 
Bond Lengths/ Å Bond Angles /   ̊ 
Ir1—N1 
Ir1—N2 
Ir1—N3 
Ir1—N6 
Ir1—N7 
Ir1—C7 
2.049(3) 
2.050(3) 
2.032(3) 
2.066(3) 
2.033(3) 
1.937(4) 
N1-Ir1-N2 
N7-Ir1-N3 
C7-Ir1-N6 
160.02(12) 
155.05(12) 
178.95(14) 
 
Photophysical Properties 
The effect on the spectral properties of changing the N—^N^N— ligand (L16-18) in each 
complex was seen to be negligible. Consequently, for clarity, the Ir complexes have been 
subdivided into 3 sets for comparison, keeping Ln constant in each of the 
absorption/emission spectra shown below (Fig. 3.23) and only changing the N^C^N ligand 
dpybX. Set 1 contains the ligand L16 (tBu), set 2 contains L17 (OMe) and set 3 contains L18 
(CF3).  
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The absorption of the complexes in each group is seen to red-shift in the order of X= OMe > 
Me2 > F2 for the different substituents on the N^C^N ligand. This is anticipated due to the 
destabilising effect of electron-donating or accepting groups on the HOMO of the N^C^N 
ligand (phenyl group). Within each set of compounds, all complexes show strong absorption 
bands below 350 nm due to 1π→π* transitions localised on both tridentate ligands, 
together with less intense bands in the region >400 nm, which are attributed to MLCT 
transitions from the IrIII metal ion to the tridentate ligands.  
Set 1  
  
Set 2  
 
 
Set 3  
 
 
Figure 3.23: Absorption (left) and emission (right) of bis-tridentate Ir complexes in DCM at 
RT. 
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These complexes were weakly emissive in degassed DCM solution with quantum yields 
ranging from 0.35 to 1.8 % (Table 3.6). These values are significantly lower than those of 
some other bis-tridentate complexes in the literature discussed previously where, for 
example, Ir(dpybMe2)(C^N^C) exhibited a PLQY of 21 %.145 In each set of complexes, the 
onset of emission is seen to red-shift significantly for those with X = OMe on the N^C^N 
ligand. The 77 K spectra of all complexes display pronounced vibrational structure (Fig. 
3.24).    
 
 
 
Figure 3.24: 77 K emission of Ir complexes in butyronitrile glass. 
The strength of the σ-donation from the triazole N— atoms is called into question when 
taking all of the photophysical properties of these complexes into consideration. Indeed, as 
alluded to earlier, the previously reported Ir(N^C^N)(C^N^C) complex with three 
cyclometallating carbon atoms displays impressive photophysical properties but is unstable 
with respect to cleavage of one of the trans-related Ir—C bonds.145 In contrast, it has also 
been reported that an [Ir(N^N^N)(N^C^N)]2+ complex containing only one cyclometallating 
carbon shows a low PLQY value of 0.5 %, but does not suffer from the same instability.155  
This suggests that the number of cyclometallating carbon atoms has a significant impact on 
both the luminescence efficiency and the stability of the complex where the greater the 
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number of C— atoms, the greater the PLQY, but the more unstable the complex with respect 
to bond cleavage. This is seen to be true in the case of these Ir(N—^N^N—)(C^N^C) 
complexes which technically also only contain one cyclometallating carbon and which are 
also stable like [Ir(N^N^N)(N^C^N)]2+. When referring back to the bond lengths for each of 
the crystal structures obtained, it is apparent that the Ir—N6 bond lengths (2.081 and   
2.066 Å) are very similar to the Ir—N— bond lengths (between 2.028 and 2.039 Å). This 
demonstrates a similar magnitude of trans influence for the N— atoms on the triazole as for 
the N atoms on the pyridine. This could explain the very similar photophysical properties 
for these Ir(N^C^N)(N—^N^N—) to the previously reported [Ir(N^N^N)(N^C^N)]2+complex, 
whereby the N— atoms on the triazole do not display particularly strong σ-donation in these 
tridentate 1,2,4-triazole ligands and are in fact more akin to tpy ligands in terms of their 
electronic behaviour.      
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Table 3.6: Photophysical properties of the IrIII bis tridentate and 3+2+1 complexes. All solution-state measurements were conducted in degassed DCM 
solution unless otherwise stated, whilst 77 K measurements were conducted in either butyronitrile or EPA glass.  
 
Complex 
298 K 77 K 
ε ( mol-1 dm3 cm-1) 
 
λem  
(nm) 
τdeg  
(μs) 
τaer 
(μs) 
φ 
 (%) 
kr  
(102 s-1) 
knr  
(104 s-1) 
kq [O2] 
(105 M-1  s -1) 
λem  
(nm) 
τ  
(μs) 
Ir(dpybF2)L16  275 (101140), 352 (24349), 422 
(5760). 
496, 523 12 12 0.63 5.1 8.1 9.8 474, 507, 545, 586 11 
Ir(dpybF2)L17 285 (72409), 299 (55837), 361 
(18778). 
506, 533 11 11 1.6 14 8.9 / 482, 516, 552, 594 14 
Ir(dpybF2)L18 293 (36958), 348 (7636), 373 
(6367), 420 (1323). 
484, 512, 
597 
12 12 0.35 2.9 8.3 5.1 462, 494, 525, 569 12 
Ir(dpybMe2)L16 281 (94577), 300 (93241), 396 
(21678). 
482, 517, 
547 
12 11 0.38 3.1 8.1 51 470, 509, 544, 581 12 
Ir(dpybMe2)L17 280 (35489), 394 (16548), 440 
(3472). 
484, 531 12 13 0.38 3.3 8.6 / 484, 514, 552, 599 
(sh) 
12  
Ir(dpybMe2)L18 283 (34,783), 298 (50,759), 359 
(9854), 393 (11209). 
509, 
541 
11 13 0.45 4.0 8.7 / 470, 501, 539 11 
Ir(dpybOMe)L16 288 (18092), 299 (16684), 360 
(2748), 406 (3115), 434 (2889). 
537, 
574 
12 12 0.87 7.3 8.2 2.9 520, 562, 604 17 
Ir(dpybOMe)L17 282 (36127), 296 (37384), 361 
(7464), 404 (8446). 
537, 574 12 12 1.8 15 8.2 2.2 520, 564, 603 14 
Ir(dpybOMe)L18 286 (29037), 299 (52943), 351 
(7942), 438 (9040). 
535, 571 12 13 0.73 5.9 8.0 / 518, 561, 604 17 
Ir(dpybMe2)L1Cl 264(38403), 286 (34172), 392 
(7299). 
- - - - - - - 
 
470, 499, 507, 538, 
581 
12 
Ir(dpybMe2)L2Cl 265(37657), 292(27546), 
361(6548) 
- - - - - - - 
 
470, 486, 508, 547 12 
Ir(dpybMe2)L3Cl 275(36540), 379(6450) - - - - - - - 
 
470, 478, 483, 504, 
537 
13 
113 
 
 
 
3.3.3.2 Ir(N^C^N)(N^N)Cl triazole complexes of the 3+2+1-type 
Investigation into novel 3+2+1 complexes containing N^C^N, N^N or N^N— triazole and Cl 
ligands was also carried out to see the differences in their photophysical properties in 
comparison to the bis-tridentate complexes. These types of complex have two potential 
structures owing to the nature of the triazole where binding could occur through the 
deprotonated N— atom (I, Fig. 3.25) or the non-protonated N atom (II, Fig. 3.25) as shown 
below. Characterisation of the complexes will aim to elucidate the correct structure in this 
case. As discussed earlier, although there isn’t a large literature precedent for 3+2+1-type Ir 
complexes, those that have been reported do have impressive photophysical properties.  
 
Figure 3.25: Different possible binding modes I and II of the 1,2,4-triazole ligand in 3+2+1 Ir 
complexes. 
Synthesis  
The synthesis of complexes with the general structure Ir(dpybX)L1-3Cl was attempted    
where dpybX has X= 3,5-dimethyl on the phenyl ring and where Ln =                                         
4-(tert-butyl)phenyltriazolylpyridine (L1),  4-(methoxy)phenyltriazolylpyridine (L2) and            
4-(trifluoromethyl)phenyltriazolylpyridine (L3) (Scheme 3.11).  The synthesis of these HLn 
ligands are discussed in Chapter 2. Reaction of the chloro-bridged dimer [Ir(dpybX)(μ-Cl)Cl]2 
with the bidentate triazole ligand (HLn) and 2.5 equivalents of AgOTf in refluxing toluene 
was attempted for each complex. Purification was achieved by removal of the solvent and 
recrystallization from MeOH/Et2O, giving the complexes in 82, 14 and 18 % yields for 
Ir(dpybMe2)L1Cl, Ir(dpybMe2)L2Cl and Ir(dpybMe2)L3Cl respectively. The lower yields for 
Ir(dpybMe2)L2Cl and Ir(dpybMe2)L3Cl were due to the formation of many unknown side 
products which meant that multiple recrystallization attempts were needed until the pure 
product was obtained.  
 
114 
 
 
 
Scheme 3.11: Synthesis of Ir(dpybMe2)L1-3Cl complexes. 
Unfortunately, no crystal structure was obtained to confirm the nature of the triazole 
binding mode. Moreover, other results such as MS, CHN and NMR remain inconclusive. If 
analogous to the isoelectronic PtIV complex for which the crystal structure was shown in the 
last section, it would bind through the deprotonated N to form a neutral complex. This is 
the likely conformation owing to the preference of the triazole ligand to bind through the 
N— atom rather than the non-protonated N atom as seen in all previous complexes 
containing triazole ligands of both bidentate and tridentate nature.  
Photophysical characterisation 
The absorption of the complexes is shown in the figure below and shows high energy bands 
between 250 and 330 nm which are representative of LC π→π* transitions, whilst the lower 
intensity bands at 390 nm show absorption with more MLCT character (Fig. 3.26). All 
complexes were found to be very weakly emissive with PLQYs of less than 10-3 when 
measured in degassed DCM solution. When measured in an EPA glass at 77 K they all 
showed high intensity structured emission with sharp 0-0 transitions centred at 470 nm. 
Ir(dpybMe2)L3Cl showed higher intensity vibronic bands and a blue-shifted cut-off for the 
emission in comparison to the other complexes. The complexes were too weak to obtain 
lifetimes at RT, but at 77 K the recorded lifetimes ranged from 12 to 13 µs (Table 3.6).  
115 
 
 
 
Figure 3.26: RT absorption in DCM and 77 K spectra in EPA of Ir(dpybMe2)L1-3Cl. 
3.3.3.3 DFT Calculations for bis-tridentate and 3+2+1 Ir complexes 
TD-DFT calculations showed that the largest contribution to the first excited states in the Ir 
complexes emanate from a HOMO→LUMO transition (Table 3.7). For the bis-tridentate 
complexes it is evident from the orbital plots calculated by DFT that the HOMO and LUMO 
orbitals are localised primarily on the triazole and N^C^N ligands respectively (Fig. 3.27). 
This is in accordance with other reported bis-tridentate IrIII complexes as mentioned in the 
introduction.152 The fact, however, that there is little or no overlap between the HOMO and 
LUMO differs from the complexes previously reported in the literature (such as the pyrazol-
3-yl-6-ppy-containing bis tridentate Ir complexes 56-61 discussed in the introduction) and 
can help to explain the low radiative rate constants for these molecules which have a 
negative impact on the resulting PLQY values. It has been previously reported that this low 
overlap between frontier molecular orbitals results in a decreased oscillator strength for 
the transitions in many compounds including organic molecules and metal complexes.156  
In stark contrast to the bis-tridentate complex, the overlap between the HOMO and LUMO 
for the 3+2+1 analogue Ir(dpybMe2)LnCl is much greater when the triazole ligand is 
considered as binding through the deprotonated N atom (Fig. 3.27). The main contributors 
to the HOMO are seen to be the Cl ligand and the triazole ring and phenyl group of the 
triazole ligand, with weak contribution from the metal centre. The LUMO is very delocalised 
with orbitals spread across the entire N^C^N ligand, the Ir centre and the pyridine of the 
triazole ligand. In this case the HOMO→LUMO transition is thought of as having a mix of 
weak LLCT and stronger ILCT. This could help explain why the Ir complexes were non-
emissive at RT. The nature of the binding mode of the triazole ligand is not unequivocally 
confirmed so one cannot state this with absolute certainty.  
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Table 3.7: Summary of main orbitals involved in first excited state transitions for 
Ir(dpybMe2)L16 and Ir(dpybMe2)L1Cl as calculated by TD-DFT.  
Complex Ir(dpybMe2)L16 Ir(dpybMe2)L1Cl 
Energy (eV/nm) 2.5047/495.01 2.8482/435.31 
Oscillator Strength 0.0552 0.0446 
Main contribution (%) HOMO→LUMO (70) HOMO→LUMO (65) 
Assignment  Mixed LLCT/MLCT Mixed ILCT/LLCT  
 
Complex HOMO LUMO 
Ir(dpybMe2)L16 
  
Ir(dpybMe2)L1Cl 
  
Figure 3.27: Orbital diagrams of the HOMO and LUMO for Ir(dpybMe2)L16 and 
Ir(dpybMe2)L1Cl complexes as calculated by DFT. 
To summarise, a range of Ir complexes containing tridentate N^C^N ligands have been 
synthesised. The bis-tridentate complexes of the form Ir(N^C^N)(N—^N^N—) were seen to 
be weakly emissive in degassed DCM solution with quantum yields ranging from 0.35 to 
1.75 %. Compared to other Ir bis-tridentate complexes in the literature, these quantum 
yields are much lower, mainly owing to the poor overlap of the HOMO and LUMO as 
evidenced by DFT. The trans effect in these complexes is seen to be lower than for 
analogous Ir(N^C^N)(C^N^C) complexes owing to the weaker trans influence of the N— 
atoms when compared to cyclometallating C— atoms, and this helps confer enhanced 
stability when in solution.   
The 3+2+1 complexes were synthesised via a facile synthetic procedure and purification. All 
complexes were highly emissive at 77 K, showing structured phosphorescence, but they 
showed only weak or no luminescence at RT in degassed solution. This may be due to a 
combination of factors including the weak-field chloride ligand that allows thermal 
population of the quenching d-d states. Moreover, DFT analysis shows the emission to be of 
weak ILCT/LLCT character, but one must also consider the possibility of different binding 
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modes for these types of complexes which have not yet been fully confirmed. As a result of 
their poor solution-state photoluminescence properties, neither type of Ir complex was not 
chosen for incorporation into OLEDs. 
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3.4 Comparison of PtIV complexes with IrIII complexes analogues 
By investigating both types of PtIV and IrIII complexes containing N^C^N ligands we hope to 
compare their photophysical properties. As discussed throughout the chapter, PtIV and IrIII 
are isoelectronic and their complexes might thus be expected to display similar properties 
to one another. Figure 3.28 below shows the complexes that will be compared, limited by 
the synthesis of only two PtIV complexes. The Ir analogues have methyl groups on the 
phenyl ring of the N^C^N ligand which are needed to force the tridentate N^C^N binding 
conformation of the ligand as opposed to a bidentate N^C— conformation (refer back to Fig. 
3.15 in section 3.3.1 of this chapter). Photophysical studies show that these methyl groups 
do not significantly affect the photophysical properties of the Pt complex in comparison to 
the parent complex Pt(dpyb)Cl (see Appendix, Fig. A1). The comparison of the methyl group 
containing Ir complexes with the Pt complexes that contain methyl-free N^C^N groups is 
thus justified.  
 
Figure 3.28: Structures of PtIV complexes and their IrIII analogues for comparison. 
Table 3.8 displays the absorption and emission spectra of the PtIV and IrIII complexes which 
have been discussed independently in previous sections. From the absorption spectra, it is 
noticeable that the IrIII complexes display more metal character at the longer wavelength 
absorptions than the PtIV complexes. The absorption cut-off for all complexes is very similar 
ending at 450 nm.  
RT emission comparison was only possible for the bis-tridentate complexes as complex 
Ir(dpybMe2)L1Cl was non-emissive in degassed DCM solution. [Pt(dpyb)L16]+ was seen to 
have much more structured emission in comparison to the Ir analogue. It has a sharp 0-0 
transition at 480 nm, whilst the Ir complex displays a weaker 0-0 transition and broader 
spectrum, suggestive of excited-state structural distortion. This is supported by the 77 K 
emission for the Ir bis-tridentate complex which displays structured emission that is 
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actually blue-shifted relative to the equivalent Pt spectrum. This is owing to the increased 
rigidity observed at low temperature for the Ir complexes (λmax of 480 nm at RT and 470 nm 
at 77 K), whilst the Pt analogue maintains the same λmax of 480 nm, independent of 
temperature. 
The kr value of the bis-tridentate Pt complex is seen to be much larger than that of the Ir 
analogue (2.5 x 104 vs. 3.1 x 102 s-1) which is unexpected owing to the high charge on the Pt 
centre which would normally perhaps be expected to reduce the energy of deactivating d-d 
states to make them more thermally accessible. This low kr value for the bis-tridentate Ir 
complex is in line with the poor luminescence efficiency observed (φ = 0.38 %) relative to 
the Pt complex (φ = 28 %). Moreover, it is also reflected by the observed structural 
distortion in emission at RT for the Ir complex.   
For the 3+2+1 complexes, the 77 K emission profiles are very similar for both Pt and Ir and, 
like the bis-tridentate complexes, they show blue-shifted emission for the Ir complexes 
owing to the rigidification of the structure on cooling. The 77 K lifetime of the Pt complex 
was extremely long in comparison to the Ir complex (τ77K = 226 and 12 μs respectively).  
Figure 3.29 shows a comparison of the molecular orbitals as calculated by DFT for 3+2+1 
and bis-tridentate Ir and Pt analogues.  As discussed earlier the 3+2+1 Pt complex 
HOMO→LUMO transition was of mixed LMCT/LLCT character whilst Ir(dpybMe2)L1Cl 
showed a mix of weak LLCT and stronger ILCT for the HOMO→LUMO transition. This could 
help explain why the Ir complexes were non-emissive at RT as the contribution of the metal 
in [Pt(dpyb)L1Cl]+ plays a greater role in the emission. 
For the bis-tridentate complexes the Ir complex showed little or no overlap between the 
HOMO and LUMO with a small metal contribution to the emission, hence PLQY values were 
very low. In [Pt(dpyb)L16]+, however, the HOMO→ LUMO transition was seen to be 
predominantly LMCT in character with a good overlap between HOMO and LUMO orbitals 
on the metal centre.  
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Complex HOMO LUMO 
[Pt(dpyb)L1Cl]+ 
  
Ir(dpybMe2)L1Cl 
  
[Pt(dpyb)L16]+ 
  
Ir(dpybMe2)L16 
  
Figure 3.29: Orbital diagrams of the HOMO and LUMOs for Ir and Pt complexes as 
calculated by DFT.
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Table 3.8: Absorption and degassed RT emission in DCM and 77 K emission in EPA/butyronitrile of PtIV and IrIII analogues. Note that no RT emission 
comparison is shown for Ir(dpybMe2)L1Cl with [Pt(dpyb)L1Cl]+ as the Ir complex was not luminescent at RT. 
Complexes Absorption RT degassed Emission 77 K Emission 
    
    
 
0
0.2
0.4
0.6
0.8
1
250 350 450 550
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
Ir
0
0.2
0.4
0.6
0.8
1
430 530 630 730 830
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
0
0.2
0.4
0.6
0.8
1
450 500 550 600 650 700 750 800
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
Ir
0
0.2
0.4
0.6
0.8
1
250 350 450 550
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
Ir
0
0.2
0.4
0.6
0.8
1
430 530 630 730 830
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
Ir
0
0.2
0.4
0.6
0.8
1
450 500 550 600 650 700 750 800
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
Pt
Ir
122 
 
 
 
3.5 Chapter 3 summary 
A range of PtIV and IrIII complexes has been synthesised, all of which contain variations of 
the N^C^N ligand dpybX and 1,2,4-triazole ligands with different denticities (either 
bidentate or tridentate). Two novel PtIV complexes were synthesised of bis-tridentate and 
3+2+1 structure. The 3+2+1 Pt complex, which included the bidentate triazole ligand L1 and 
an ancillary chloride ligand, displayed modest photophysical properties with a PLQY of      
5.9 % and lifetime of 3.1 μs at λmax of 490 nm. A large improvement to this was observed on 
going to the bis-tridentate complex which had a high PLQY of 28 % and long lifetime of       
11 μs at λmax of 480 nm. This highlighted the increased rigidity in the bis-tridentate complex 
as a result of the two tridentate ligands surrounding the metal centre. The PtIV complexes 
generally displayed better photophysical properties compared to their isoelectronic IrIII 
counterparts.  
The bis-tridentate Ir complexes which have been synthesised showed relatively low 
luminescence efficiencies with PLQY values ranging from 0.38 to 1.8 %. They were seen to 
undergo a large degree of rigidification upon cooling to 77 K as was shown by the enhanced 
vibrational structure in their low-temperature emission spectra. The relative magnitudes 
for knr ranging from 8.0 to 8.9 x 104 s-1 were also much higher than those for kr which ranged 
from 2.9 to 15 x 102 s-1. The orbital overlap of the HOMO and LUMO from DFT calculations 
was minor and this could also help explain the poor luminescence efficiencies relative to 
the PtIV analogue that was compared, but also to similar bis-tridentate structures in the 
literature. Moreover, the trans influence of the N— atoms on the triazole ring in the 
tridenate 1,2,4-triazole ligands is suggested to be lower than for cyclometallating C— atoms 
and thus ligands L16-18 can perhaps be thought of as similar to tpy in these Ir complexes.   
In terms of the 3+2+1 Ir complexes, like the PtIV analogue, they too experienced a decrease 
in luminescence efficiency, but to the extent that they were non-emissive in degassed 
solution at RT and only emissive at 77 K. They exhibited very similar structured emission 
and lifetimes on the order of 12 to 13 μs at 77 K. It is still unclear the exact binding mode of 
these Ir 3+2+1 structures and as a result, the photophysical properties cannot be 
definitively assigned.  
Overall, the significance of tridentate ligands in conferring rigidity to Pt and Ir complexes 
has been shown. This has been coupled with the effective demonstration of complex 
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manipulation to afford analogous IrIII and PtIV complexes with 3+2+1 and bis-tridentate 
structures, revealing some marked differences in their photophysical properties. The PtIV 
complexes show great promise and should be investigated for their performance in 
applications such as light-emitting electrochemical cells (LEECs) owing to their charged 
structures.  
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4. Pt and Pd complexes containing 
tetradentate ligands 
4.1 Introduction 
From previous chapters it has been demonstrated that, upon going from bidentate to 
tridentate compounds, there can be an increase in complex rigidity which may lead to 
improved quantum yields. The extension of this rigidity to tetradentate compounds can, in 
principle, lead to further improved results. There are numerous examples of tetradentate 
cyclometallated complexes which are based upon the archetypal cis-Pt(ppy)2 (Fig. 4.1). In 
comparison to cis-Pt(ppy)2, which is non-emissive in solution at RT, the effect of the 
tetradentate ligand in conferring enhanced rigidity is striking. Many such complexes have 
high quantum yields, some of which approach unity, as will be discussed in this introductory 
section.  
 
Figure 4.1:  Tetradentate cyclometallating ligands with different coordination geometries 
where A is a linking atom such as N, O or C, compared to cis-Pt(ppy)2. 
The examples shown here in Figure 4.1 illustrate potentially cyclometallating versions of 
tetradentate ligands. This section will focus on some of the best performing Pt complexes 
containing tetradentate ligands and will also discuss the development of analogous Pd 
complexes, of which there are far fewer. Table 4.1 at the end of this introductory section 
summarises the PL and EL properties of selected complexes. 
4.1.1 Platinum Complexes 
4.1.1.1 C^N^N^C/N^C^C^N Complexes 
Vezzu et al. synthesised bis-cyclometallated platinum complexes with general coordination 
patterns of (C^N^N^C)-Pt and (N^C^C^N)-Pt.22 The structures of the C^N^N^C and 
N^C^C^N complexes are shown below (Fig. 4.2) and one can see the similarity with 
Pt(C^N)2 complexes that contain bidentate ligands. The tetradentate structure of the 
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ligands was achieved by linkage of the two phenyl pyridine groups through an amine 
nitrogen atom.  
 
Figure 4.2: Comparison of cis-Pt(ppy)2 , C^N^N^C platinum complexes (65 and 66) and the 
N^C^C^N complex (67). 
All complexes were emissive at RT in degassed 2-methyltetrahydrofuran (2-MeTHF) 
solution.  Complex 65 displayed an emission maximum of 512 nm, a quantum yield of 0.74 
and a lifetime of 7.2 μs, whilst the addition of fluorine substituents in complex 66 slightly 
changed these photophysical properties (Fig. 4.3). This resulted in a red-shift of the 
emission to give a λmax of 488 nm, a lifetime of 11.4 μs and a quantum yield of 0.75. Both 
complexes 65 and 66 were seen to display excimeric emission centred at around 710 nm. 
The assignment of these emission bands as excimeric was supported by the linear 
dependence of the decay rate upon concentration when fitted to the Stern-Volmer 
equation.  
 
Figure 4.3: Absorption (Ligand: pink; 65: black), lowest energy absorption (65, green), and 
normalized emission (65: blue 5.13 x 10-5 M; red 1.54 x 10-4 M) spectra (365 nm excitation) 
and phosphorescence decay of 65 (inset, 4.62 x 10-4 M) in 2-MeTHF at RT. Reprinted with 
permission from Vezzu et al.22 Copyright 2010 American Chemical Society.  
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Upon changing the coordination sphere to the N^C^C^N arrangement, the emission was 
seen to red-shift significantly and complex 67 displayed a λmax of 613 nm and a quantum 
yield of 0.14 which may be reflective of the lower efficiencies normally encountered for 
longer wavelength emission. The lifetime was very similar to complex 65 at 7.6 μs. Complex 
65 was incorporated into an OLED device as an emitter at 4 wt. % in the mixed host of TCTA 
and TPBI. This demonstrated high performance with a maximum EQE of 14.7 % and showed 
the high efficiency that PtII complexes containing tetradentate ligands can have in 
luminescent applications. 
In 2014, Li and co-workers reported on a series of PtII complexes containing carbazole-
based tetradentate ligands that all displayed narrow emission spectral bandwidths in the 
blue region (68-71, Fig. 4.4).157 All complexes had PLQY values above 0.7 in PMMA thin-
films with λmax values centred at ca. 450 nm. It was found that the incorporation of a bulky 
tBu group on the pyridine ring of the tetradentate ligand improved the colour purity of the 
emission by narrowing the bandwidth. This spectral narrowing was attributed to ‘increasing 
the energy of the 1MLCT/3MLCT and 3LC states of the carbazole pyridine moiety’. This was 
then thought to result in a larger energy-separation, minimising the influence of the 
carbazole pyridine on the RT emission. 
  
Figure 4.4: Structures of complexes containing tetradentate carbazole-based ligands 68-71.  
OLED devices employing complexes 69-71 as emitting materials were fabricated showing EL 
spectra similar to the PL emission. The best device performance data was obtained for 
complex 71 bearing an NHC ligand (Fig. 4.5). At 2 wt. % the EQE of the device was 17.2 %, 
but upon increasing the doping concentration to 6 wt. % and employing TAPC in 
conjunction with a higher bandgap electron-transporting material (PO15) at a 1:1 ratio as a 
co-host, an impressive peak EQE of 24.8 % was achieved without significantly affecting 
colour purity.  
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Figure 4.5: EQE vs. luminance for complex 71. The EL Spectra and CIE coordinates are given 
in the inset. Reproduced from Li et al. by permission of John Wiley and Sons.157  
These Pt complexes containing tetradentate ligands can emit across the entire UV-Vis-NIR 
spectrum depending upon changes to the ligands by incorporation of different functional 
groups. In an effort to produce pure white OLEDs or WOLEDs, Norby et al. utilised complex 
68 as a blue emitter, in combination with two complexes also previously synthesised by the 
group which emit in the green and red (Fig. 4.6).158  
 
Figure 4.6: a)-c) EL spectra for the complexes 68, 72 and 73 respectively and d) plots of EQE 
vs. current density for the OLEDs of the 3 individual emitters. Reproduced from Norby et al. 
by permission of Elsevier.158  
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After different OLED testing, the final device with best efficiency was chosen with the 
stacking order: 6 % 73: 26mCPy/ 6 % 68: 26mCPy / 6 % 72: 26mCPy to give red, blue and 
green components of emission respectively. Moreover, by separating the 72- and 73-
containing emissive layers with a thick 68-doped blue emissive layer, a large amount of 
energy transfer was inhibited and a peak EQE of 21.0 % was observed. CIE coordinates of 
(0.33, 0.33) are considered “pure white” and a colour rendering index (CRI) value as close to 
100 as possible is desired. This device displayed promising attributes with a CRI value of 80 
and CIE coordinates of (0.35, 0.35). 
More recently, Wang and co-workers reported a series of seven novel Pt(N^C^C^N) 
complexes with either an oxygen, methylene or carbonyl to link the C^C unit and which 
contained 1,2,3-triazoles substituted with different R groups (74-78, Fig. 4.7). They also 
synthesised complexes 79 and 80 in which the two triazolyl rings were connected by a 
dodecamethylene chain and a 3,6,9-trioxaundecamethylene chain, respectively.159 The 
synthesis of the PtII complexes was performed by reaction of the tetradentate ligand with 
tetra-n-butylammonium bromide (NBu4Br) and K2PtCl4 at 25 °C in glacial acetic acid for one 
day, followed by heating at 140 °C for four days. The final PtII compounds were obtained in 
yields varying from 11 to 52 %.  
Figure 4.7: Synthesis and structure of complexes 74-80. 
All complexes (except complex 77 with a carbonyl linker) were seen to display blue 
emission in solution and in PMMA film with λmax values at 450 nm. Complex 76 showed 
blue-shifted emission and a lower PLQY value (0.14) in comparison to the other complexes 
(PLQYs between 0.39 and 0.62). This was thought to be due to the methylene linker which 
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disrupts the conjugation and which also results in a puckered confirmation of the complex 
as shown by the crystal structure which increases knr (Fig. 4.8).  
  
Figure 4.8: Crystal structure of complex 76 with side view to show the puckering of the 
methylene linker (left) and absorption and emission spectra for complexes 74-80 in 
degassed DCM at RT (right). Reproduced from Wang et al. by permission of John Wiley and 
Sons.159  
Complex 77 differs from all other complexes as its emission is broad, featureless and 
significantly red-shifted by 20-30 nm. This was tentatively explained by greater MLCT 
character in the excited state of 77, facilitated by the electron-withdrawing carbonyl linking 
group that stabilizes the LUMO, thus decreasing the emission energy.  
The effect of the macrocyclic chelate was also investigated in complexes 79 and 80 which 
displayed significantly higher solution-state PLQY values (0.58 and 0.62, respectively) in 
comparison to the related non-macrocyclic compound 75 (0.42). This was attributed to the 
greater structural rigidity imposed by the macrocyclic ligands. Moreover, in 10 wt. %-doped 
PMMA films, compound 79 had the highest PLQY of 0.95, whilst 75 and 80 were much 
lower (0.62 and 0.48, respectively). From the PL performances displayed, complex 79 was 
chosen as a representative for OLED testing owing to its high PLQY and purer colour 
coordinates. The best device featured a dopant concentration of 10 % in a                          
9,9′-(4,4′-(phenylphosphoryl)bis-(4,1-phenylene))bis(9H-carbazole) (BCPO) host, giving an 
EQE of 15.4 %, with CIE coordinates of (0.15, 0.17).  
Liao et al. synthesised a range of tetradentate chelates using spiro-arranged fluorene and 
acridine linking to pyrid-2-yl triazole and pyrazole units which were then complexed with Pt 
to give interesting photophysical properties (81-85, Fig. 4.9).160 A detailed synthesis of the 
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ligands is outlined in their paper and subsequent complexes were then formed by reacting 
these ligands with Pt(DMSO)2Cl2 in DME with an excess of base.  
 
Figure 4.9: Structures of complexes 81-85 containing tetradentate ligands with spiro- 
arranged fluorene and acridine groups.  
The crystal structures of complexes 81 and 83 are shown below and demonstrate the 
dimer-like packing motif in the crystal lattice where the spiro-bridged fluorene unit is tilted 
away from the second molecule in order to avoid steric hindrance (Fig. 4.10).  The nearest 
PtPt interactions were found to be 3.759 Å for 81 and 3.455 Å for complex 83. 
 
 
Figure 4.10: Crystal structures for complexes 81 (left) and 83 (right) where fluorine atoms of 
CF3 fragments were removed for clarity. Reprinted with permission from Liao et al.160 
Copyright 2015 American Chemical Society. 
All complexes showed structured emission in degassed DCM solution and of particular 
interest was complex 85 which showed a high degree of solvatochromism. In cyclohexane it 
had a PLQY of 0.13 and a kr of 6.3 × 103 s-1 whilst in DCM it gave dramatically improved 
results of 0.88 and 3.0 x 105 s-1 (Fig. 4.11).  The increased kr values and disappearance of the 
vibronic fine structures in DCM compared to cyclohexane were ascribed, in part, to a switch 
of emission from LC π→π*/MLCT to ILCT/MLCT based upon observations from another 
group for a series of PtII alkynyl complexes with distinctive tridentate pincer ligands.161 
Complexes 83 and 85 were chosen for OLED testing owing to their high PLQYs (0.82 and 
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0.88 respectively) and they exhibited bright blue stable EL with maximum EQEs of 12.3 and     
15.3 % respectively.   
  
Figure 4.11: Emission spectra for complexes 81-85 in DCM (left) and emission spectra for 
complex 85 in varying solvents (right). Reprinted with permission from Liao et al.160 
Copyright 2015 American Chemical Society. 
4.1.2 Palladium Complexes 
Up until recently there have been significantly fewer examples of Pd tetradentate 
complexes which show strong luminescence applicable to OLED applications. Many Pd 
complexes that have been reported typically show lower-lying deactivating d-d states, 
which are more thermally accessible in comparison to the ones held by their Pt analogues, 
owing to the weaker field splitting of Pd. As a result, a lot of focus has been concentrated 
on Pt complexes like the ones discussed previously, but recent investigations have prevailed 
in achieving high efficiency Pd complexes.  
Pd complexes with lower denticity ligands (particularly bidentate) commonly suffer from 
high distortion and subsequently are only weakly emissive in solution, if at all.162,163 The 
need for a tetradentate ligand to achieve high efficiency is almost certainly a necessity to 
achieve the highest possible efficiencies in Pd compounds and is thus a good place to start 
in terms of molecular design. 
Chow et al. reported PdII complexes containing tetradentate O^N^C^N ligands in 2013.164 
They synthesised two types of Pd(O^N^C^N) complexes as shown below in Figure 4.12, as 
well as the Pt analogue for the type 2 compounds.  
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Figure 4.12: Structures of type 1 and 2 Pt and Pd complexes. 
It was found that all type 1 compounds were weakly-emissive at RT in solution and had 
relatively short lifetimes (λmax of 535-543 nm, φ≈ 0.002 and τ=0.2-0.4 μs). In stark contrast, 
type 2 complexes displayed intense emission with PLQY values ranging from 0.14 to 0.22 
with significantly longer lifetimes ranging from 83 to 120 μs. They attributed the much 
higher efficiencies for the type 2 complexes to the relatively higher kr and lower knr values. 
TD-DFT showed large structural distortion on going from the S0 state to the T1 state in type 
1 compounds, whilst in type 2 compounds; both S0 and T1 states remained coplanar with no 
obvious distortion (Fig. 4.13). Moreover, calculations revealed the origin of emission to be a 
3LLCT(πphol→π*N^C^N) transition in type 1 complexes and N^C^N-localised 3IL(π→π*) 
transition in type 2 complexes with very little 3MLCT(dπ→π*) contribution (calculated as 
<10 % for each).  The type 2 platinum analogue, 89, had a PLQY of 0.79 with lifetime of       
10 μs which is obviously still much higher, but the type 2 Pd complex is impressive in its 
own right. The type 2 complex 88 was subsequently tested in an OLED which had an EQE of 
7.4 % for the simple device structure ITO / NPB (40 nm) /6 wt. % 88: mCP (30 nm) / BAlq (40 
nm) / LiF (0.5 nm) / Al (80 nm.  
 
Figure 4.13: Optimised structures of the T1 excited state for type 1 complex 86 (left) and 
type 2 complex 88 (right). Reproduced from Chow et al. by permission of John Wiley and 
Sons.164  
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Jian Li’s group have since contributed considerable research efforts dedicated to Pd 
complexes containing tetradentate ligands where devices with EQEs of over 20 % have 
been reached.165,166 Of most interest, however, is an example which displays efficient 
excimer emission that can be incorporated into devices. The compound 90 was synthesised 
and its photophysical properties were studied both in a doped 1 wt. % 26mCPy film and 
also in degassed DCM solution at RT.167 In the film only monomer emission was observed at 
the 1 wt. % doping concentration, whilst in dilute DCM solution strong evidence of excimer 
emission was observed (Fig. 4.14).   
 
 
 
Figure 4.14: The structure of 90 and its absorption and emission in a 1 wt. % 26mCPy film 
(blue) and in degassed DCM solution (red). Reproduced from Fleetham et al. by permission 
of the Royal Society of Chemistry.167  
The PLQY of 90 in a doped PMMA film at RT was found to be 87 % with a luminescent 
lifetime of 120 μs and thus the complex showed impressive photophysical properties 
amenable to OLED incorporation. Because of the broad spectrum of emission originating 
from both the monomer and excimer, application into a WOLED was subsequently 
investigated. The device with the best properties was found to give an EQE of over 27 % 
which is the best recorded example of an OLED containing a Pd complex in the EML and 
beats many Pt devices also containing tetradentate ligands. This highlights the potential for 
Pd complexes in OLEDs despite them having been very much overshadowed by their Pt 
counterparts over the years.  
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Table 4.1: PL and EL data for Pt and Pd literature complexes. EL data reflects the maximum values obtained for devices. Please refer to the list of 
abbreviations for the device architecture column. 
Compound 
no. and 
reference 
Device Architecture PL performance EL performance 
λmax (nm) 
[soln/film] 
PLQY  
[soln/film] 
Lifetime (μs) 
[soln/film] 
λmax(nm) 
 
CE 
(cd A-1) 
PE 
(lm W-1) 
Brightness 
(cd m-2) 
EQE 
(%) 
Platinum 
6522 ITO / CFx (1 nm) / NBP (65 nm)/ TCTA (10nm) / TPBI : 
(30 wt. % TCTA + 4 wt. % 65) (35nm) / TPBI (10nm) / 
Alq (40 nm) / Mg:Ag (220 nm) 
514 / - 0.74 / - 7.6 / - 512 50 - 5 14.7 
69157 ITO / HATCN (10 nm) / NPD (40 nm) / TAPC (10 nm) / 
2 wt. % 69  : 26mCPy (25 nm) /DPPS (10nm) / 
BmPyPB (40 nm) / LiF / Al  
446 / - - / 0.70  451 - 13 - 17.2 
ITO / HATCN (10 nm) / NPD (40 nm) / TAPC (10 nm) / 
6 wt.% 69 : 47% TAPC : 47% PO15 (25 nm) / PO15 (10 
nm) / BmPyPB (30 nm) / LiF / Al  
451 - 21 - 24.8 
WOLED-
68,72 and 
73158 
ITO / HATCN / NPD / TAPC / 6% 73: 26mCPy (3 nm) / 
6 wt. % 68 : 26mCPy (20 nm) / 6% 72 : 26mCPy (2.5 
nm) / DPPS / PmPyPB / LiF / Al 
- - - 455, 500, 
595 
- 41 - 21 
79159 (ITO )/ (NPB) (50 nm) / (mCP) (10 nm)/ (BCPO) : 10 
wt. % 79  (20nm) / (DPEPO) (10 nm)/ (TPBi) (30 nm) / 
LiF (1 nm) / Al (100 nm) 
448 / 447 0.58 / 
0.95 
- 451 19 14 13 15.4 
83160 
ITO / TAPC (40 nm) / mCP : 8 wt. % of 83/85 (17 nm) 
/ DPEPO : 8 wt. % of 83/85 (3 nm) / DPEPO (3 nm) / 
TmPyPB (50 nm) / LiF (0.8 nm) / Al (150 nm) 
461, 487, 
521 / - 
0.82 / - 7.8 / - 461, 487, 
521 
27 27 1924 12.3 
85160 520 / - 0.88 / - 2.9 / - 470, 500, 
520 
36 38 4121 15.3 
Palladium 
88164 ITO / NPB (40 nm) / 6 wt. % 88 : mCP (30 nm) / BAlq 
(40 nm) / LiF (0.5 nm) / Al (80 nm) 
498 / - 0.20 / - 120 / - 500, 535, 
589 
20 14 - 7.4 
90167 ITO / HATCN (10 nm) / NPD (40 nm) / TrisPCz (10 
nm) / 20 wt. % 90 : 26mCPy (10 nm) / 6 wt. % 90: 
26mCPy (20 nm) / BAlq (10 nm) / BPyTP (40 nm) / LiF 
(1 nm) / Al 
582 / 477, 
507 
- / 0.87 - / 120 472, 575 - 81 7280 27.3 
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4.2 Objectives 
Previously in the group, a former Ph.D. student Mickaële Bonneau investigated a series of 
tetradentate PtII and PdII complexes of the form M(C^N^N^C) based on the work of Vezzu et 
al. discussed earlier.22 The synthesis and photophysical properties of these PtII and PdII 
complexes were studied, as well as the oxidation to their MIVCl2 counterparts.168 These 
results sparked off interest in the group to continue their investigation, primarily due to 
their potential for excimer formation which could result in NIR emission.  
The main objectives of this work, as a continuation of the previously studied complexes, 
were to: 
• Synthesise PtII and PdII (C^N^N^C) complexes previously studied which have the 
potential to show excimeric emission and investigate their concentration- 
dependent photophysical properties. 
• Synthesise novel Pt/Pd(C^N^N^C) complexes and investigate their photophysical 
properties. 
• Study the electroluminescence of a few selected compounds for incorporation into 
OLEDs.  
• Attempt the oxidation of the PtII(C^N^N^C) complexes to the PtIV complexes. 
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4.3 Results and Discussion 
4.3.1 Pt and Pd C^N^N^C complexes 
4.3.1.1 Synthesis 
Many of the ligands presented here were synthesised according to a method adapted by 
Vezzu et al.22 The first step is a Buchwald-Hartwig amination of a primary aryl amine with 
two equivalents of 2,6-dibromopyridine to afford the precursor P6 (Scheme 4.1). Depending 
upon the type of substituent, the resulting ligands H2Ln were obtained via either a Suzuki or 
Stille Pd-catalysed cross-coupling reaction. The ligands H2L19-20 were obtained using the 
Suzuki method, whilst H2L21-22 were obtained using the Stille method. The Suzuki method 
typically involves palladium-catalysed cross-coupling between organoboronic acids and aryl 
halides whereby the boronic acid is initially activated by base.169 Different types of catalysts, 
solvents and bases have proven successful for this reaction but in this work, we employed a 
mix of DME/H2O (1:1) with Pd(PPh3)4 as the catalyst and Na2CO3 as the base to afford the 
ligands with yields in the range of 43 to 76 %.  
The Stille reaction also utilises a Pd catalyst to couple organotin reagents with aryl 
halides.170 In this method we used Pd(PPh3)2Cl2 as the catalyst with LiCl, and toluene as the 
solvent. LiCl was added owing to its properties in accelerating reaction rates in low-polarity 
solvents where it aids dissociation of the halide on the aryl reactant.171 Yields for the 
resulting ligands H2L21 and H2L22 were 72 % and 26 % respectively. The main drawback with 
the Stille reaction is the toxicity of the organotin reagents, however for these thienyl-
containing ligands an alternative to the Suzuki reaction was necessary owing to the 
competitive deboronation reaction which can occur and significantly reduce the yield.172  
The complexes were then synthesised by reaction of the ligands with either K2PtCl4 or 
Pd(OAc)2 in acetic acid at reflux, under inert argon atmosphere. These conditions are the 
typical conditions needed for cyclometallation reactions to occur and are like those 
employed by Vezzu et al.  
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H2Ln 
 
 
 
 
n = 
Yield (%) 
19 
76 
20 
43 
21 
72 
22 
26 
PtLn 58 63 89 20* 
PdLn 42 80 85 35 
Scheme 4.1: Synthesis of H2Ln and their corresponding complexes MLn with yields. *PtL25 was 
only synthesised by Mickaële Bonneau. 
Mickaële Bonneau previously synthesised complexes PtL19, PtL21 & PtL22and PdL19, PdL20 & 
PdL21, obtaining unambiguous characterisation though in quantity sufficient for only partial 
photophysical characterisation.168 These complexes were synthesised again on a larger 
scale and were investigated for the potential formation of excimers, in addition to the new 
complexes PtL20 and PdL22.  
The change in the 1H NMR signals upon complexation to Pt for H2L19 is shown below (Fig. 
4.15). The complexation was confirmed by the lack of two protons in the NMR of the 
complex compared to that of the ligand, in addition to the presence of Pt satellites for 
signal 2’’ in the complex. The complex is seen to be symmetrical about the N-OMe axis 
owing to the presence of 9 aromatic signals. The most significant shifts in ppm are observed 
for signals 2’’ and 3’ in the complex. Signal 2’’ (called 3’’ in the ligand) undergoes a 
downfield shift from 7.90 to 8.44 ppm whilst signal 3’ undergoes an upfield shift from 7.06 
to 6.55 ppm. The shift for signal 3’ can be explained by the ring current effect173 of the 
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anisyl ring which is seen to be perpendicular to the rest of the molecule in the complex 
crystal structure (discussed later on) and which subsequently shields the proton in this 
position, whilst in the ligand it is freely rotating and does not have the same influence. 
Similar shifts in the peaks were observed for the Pd analogue, PdL19. 
 
Figure 4.15: 400 MHz NMR in CDCl3 comparison for H2L19 and PtL19. 
The shift for the proton labelled 2’’ in the complex can be explained by the loss of electron 
density upon binding to the PtII centre which is observed in many complexes containing 
ligands coordinated to transition metal centres.174  
Crystal structures were previously obtained for complexes PtL19, PtL21,  PtL22,  PdL19, PdL20 
and PdL21.168  These revealed the perpendicular nature of the anisyl ring with respect to the 
rest of the complex. Moreover, the torsion angles of these complexes between the two 
C^N-coordinating units of the tetradentate ligand were measured for each complex, in 
addition to PtL20 and PdL22, and the results are shown in Table 4.2. It is apparent that ML21 
complexes have the smallest torsion angles (3.16 and 2.95 ° for PtL21 and PdL21 respectively) 
whilst ML22 complexes have the largest torsion angles (14.82 and 15.78 °).   
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Table 4.2: Comparison of torsion angles between the two planes defined as M-C-C-C-N for 
Pt and Pd complexes.  
Complex PtL19 PtL20 PtL21 PtL22 PdL19 PdL20 PdL21 PdL22 
Torsion 
Angle/ ° 
11.68 9.17 3.16 14.82 12.32 10.99 2.95 15.78 
In each case, M—N bonds were slightly longer than M—C bonds owing to the higher trans 
influence of the cyclometallating carbon which is typical for cyclometallated complexes, for 
example in cis-Pt(ppy)2 the Pt—C bond length is 1.993 Å whilst the Pt—N bond is 2.127 Å.21 
M—C bonds in these complexes were measured as having an average of 2.000 Å whilst   
M—N bonds had an average of 2.051 Å. In comparison to the analogous complexes 
synthesised by Vezzu et al., where the average of the Pt—C bond lengths is 2.004 Å and the 
average of the Pt—N bonds is 2.051 Å, the corresponding bond lengths for these complexes 
are identical within the error. In this work, crystals of PtL20 and PdL22 were obtained and 
compared to those discussed above. Crystals for PtL20 were obtained by slow diffusion of 
hexane into a DCM solution of the complex, whilst for PdL22, crystals were obtained by slow 
cooling from a hot DMF solution (Figs. 4.16 and 4.17). Very similar bond lengths were 
observed in PtL20 and PdL22 as for the other crystal structures where M—C bond lengths are 
slightly shorter than M—N bond lengths (Tables 4.3 and 4.4).  
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Figure 4.16: Molecular structure and crystal packing of PtL20. 
 
Table 4.3: Selected bond lengths and angles for PtL20. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N3 
Pt1—C23 
Pt1—C25 
 
2.0429(19) 
2.0465(18) 
2.007(2) 
1.991(2) 
N1-Pt1-N3 
C23-Pt1-N1 
C23-Pt1-N3 
C25-Pt1-N1 
C25-Pt1-N3 
C25-Pt1-C23 
93.36(7) 
81.95(8) 
173.10(8) 
174.64(7) 
81.69(8) 
101.16(9) 
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Figure 4.17: Molecular structure and crystal packing of PdL22. 
Table 4.4: Selected bond lengths and angles for PdL22. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pd1—N1 
Pd1—N3 
Pd1—C19 
Pd1—C27 
 
2.0541(17) 
2.0612(17) 
2.010(2) 
2.000(2) 
N1-Pd1-N3 
C19-Pd1-N1 
C19-Pd1-N3 
C27-Pd1-N1 
C27-Pd1-N3 
C27-Pd1-C19 
89.52(7) 
83.07(8) 
168.77(7) 
167.46(8) 
83.07(8) 
105.65(8) 
Interestingly, the PtL20 crystal structure showed the presence of intramolecular hydrogen 
bonding between the fluorine atoms on the phenyl ring and hydrogen atoms on the 
pyridine ring and this was also the case for the PdL20 structure previously reported.  The 
closest MM distances in each complex were found to be 4.179 Å for PtL23 and 7.356 Å for 
PdL22 which suggests there are no MM interactions in the ground state. PdL22 shows more 
steric hindrance in contrast to PtL20 owing to the bulkiness of the benzothiophene group.   
4.3.1.2 Photophysical properties 
Absorption and emission measurements on the Pt complexes PtL19, PtL21 and PtL22 in 
solution were carried out previously. Previous photophysical studies on the Pd compounds 
PdL19, PdL20 and PdL21 were also carried out, but were not conclusive owing to the very 
limited amounts of sample available and doubts about purity. As a result, the photophysical 
properties of all the Pd complexes were repeated on new samples. In addition to this, PtL20 
and PdL22 were also investigated. 
The absorption spectra of the Pt and Pd complexes are shown below in Figure 4.18. The 
absorption spectra of PtL21 and PtL22 were noticeably red-shifted in comparison to PtL19 and 
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PtL20 and the same trend is true of the Pd analogues. For PtL19 and PtL20, intense 
absorptions were observed between 250 and 375 nm which are assigned to LC π→π* 
transitions, in addition to weaker bands between 375 and 420 nm which are more 
characteristic of MLCT transitions. PtL21 and PtL22 also show LC π→π* absorptions between 
250 and 400 nm. The MLCT transition of S0→S1 is observed for PtL21 and PtL22 at 425 and 
450 nm respectively and the low intensity bands at 475 nm in PtL21 and 485 nm in PtL22 are 
ascribed to the direct absorption of S0→T1. The Pd complexes show more structured 
absorption in comparison to the Pt complexes and are generally blue-shifted relative to the 
Pt complexes, for example the absorption cut-off for PtL21 is at ≈ 495 nm whilst for PdL21 it 
has tailed off by ≈ 450 nm. The general blue-shift for Pd complex absorption compared to Pt 
complex absorption has been investigated on a theoretical level by Georgieva et al. in some 
glyoxilic acid oxime complexes and showed that the HOMO-LUMO gap was larger for the Pd 
complexes.175  
 
 
Figure 4.18: Absorption spectra of complexes in DCM (except PdL22 which is in DMSO owing 
to low solubility). 
All complexes were emissive in degassed solution with quantum yields ranging from 4 to   
78 % for the PtLn complexes, and PLQY values of 0.7 and 15 % were obtained for PdL21 and 
PdL22 respectively. The PdL19 and PdL20 emission spectra were more complicated owing to 
the formation of an unknown new species in solution and will be discussed later. The 
solution-state emission of the Pt complexes shows structured emission bands with emission 
emanating from a 3MLCT state (Fig. 4.19). The emission was found to be red-shifted in the 
order of PtL22> PtL21> PtL19 > PtL20 which is explained by the extended conjugation in the 
benzothiophene and thiophene rings, in comparison to the unsubstituted phenyl ring and 
the electron-withdrawing groups on the HOMO of the difluorophenyl ring which blue-shift 
the emission in comparison. This trend is also observed in the Pd analogues.   
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As for the absorption spectra, the emission of the PtLn complexes is red-shifted in 
comparison to the Pd analogues for PtL21 and PtL22. This is the expected trend and is 
supported by TD-DFT calculations (see Table 4.7) but such a trend is not observed for ML19 
and ML20. The λmax values of PtL19 and PtL20 are seen to be 510 and 490 nm respectively 
whereas the corresponding Pd complex values are 535 and 530 nm. This reveals a red-shift 
of the Pd complex emission relative to the Pt complex emission in the phenyl and 
difluorophenyl complexes which is unexpected and is discussed later on.  
  
Figure 4.19: Degassed RT emission spectra of complexes in DCM (except PdL22 which is in 
DMSO). The emission spectra of PdL19 and PdL20 should be treated with caution (see section 
4.3.1.3) 
The 77 K emission spectra of all complexes were run in EPA and show intense, structured 
emission for each complex (Fig. 4.20). The same trend in the red-shift of the emission- 
benzothiophene > thiophene > phenyl > difluorophenyl- is observed in each set of 
complexes. Each Pd complex is seen to be blue-shifted relative to its Pt analogue, in-line 
with the expected results from TD-DFT. The 77 K lifetimes of the Pd complexes are 
extremely long at between 140 and 640 µs (Table 4.6) in comparison to their Pt analogues 
whose values do not differ much from their RT lifetimes and which range from 12 to 17 µs.  
0
0.2
0.4
0.6
0.8
1
450 500 550 600 650 700 750
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
PtL1 PtL2 PtL3 PtL4
0
0.2
0.4
0.6
0.8
1
450 500 550 600 650 700 750
N
o
rm
al
is
ed
 in
te
n
si
ty
Wavelength/ nm
PdL1 PdL2 PdL3 PdL4
PdL19    
 
 
 
 
 
 
PdL20  
 
 
 
 
 
 
PdL21  
 
 
 
 
 
 
PdL22   
 
 
 
 
 
 
PtL19    
 
 
 
 
 
 
PtL20   
 
 
 
 
 
 
PtL21  
 
 
 
 
 
 
PtL22   
 
 
 
 
 
 
144 
 
 
 
 
Figure 4.20: 77 K spectra for complexes ML19-22 in EPA glass. 
Concentration-dependent emission was not studied in any detail for these complexes 
previously. A range of concentrations for each Pt and Pd complex were, therefore, 
investigated in this work and probed for the formation of excimers (Fig. 4.21). All thiophene 
and benzothiophene complexes show no evidence of excimer formation whereas the 
phenyl and difluorophenyl analogues display some excimeric emission at higher 
concentrations. PtL19 and PtL20 decay rates were seen to fit the Stern-Volmer equation and 
gave ksq values of 1.26 and 2.34 x 109 M-1 s-1 respectively (Fig. 4.22). PtL20 shows the 
brightest excimer emission relative to the monomer, out of all the complexes studied, and 
its high value for ksq supports the notion that this complex has the highest propensity to 
excimer formation. PtL19 also shows some evidence of excimer formation but the excimer 
emission relative to the monomer is weak in comparison to PtL20.  
The concentration-dependent emission observed for PdL19 and PdL20 was recorded but, as 
discussed later on, may not be representative of the actual complex emission and instead 
could be arising from a different species in solution. Interestingly, as for PtL19 and PtL20, the 
concentration-dependent emission of the Pd analogues also show the development of 
excimeric emission, as shown by the increase in the relative intensity of the emission 
shoulder with λmax ≈ 625 and 610 nm in PdL19 and PdL20 respectively.  
The lack of excimeric emission displayed by ML21 and ML22 could be due to the 5-membered 
thiophene groups which are electron-donating and thus push up the energy of the HOMO 
in each case. This could prevent the interaction of the metal centres in each case and stop 
any MMLCT emission. The ksq value was determined for PdL21 to be 8.68 x 107 M-1 s-1 which 
is seen to be much smaller than for PtL19-20 (Table 4.6). Furthermore, the changes in the 
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lifetime for PtL21-22 and PdL22 are not significant as shown below, all of which supports a lack 
of excimer formation in these thiophene-containing complexes.  
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PdL21 PdL22 
  
Figure 4.21: Concentration-dependent spectra for Pt and Pd complexes ML19-22. *Emission 
shown for PdL19 and PdL20 may represent a new species forming in solution. 
 
 
 
Figure 4.22: Stern-Volmer plots for complexes PtL19 (top left), PtL20 (top right) and PdL21 
(bottom). 
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4.3.1.3 PdL19 and PdL20 emission 
Owing to the unexpected emission results displayed by PdL19 and PdL20 at RT in solution, 
further investigation into their photophysical properties was undertaken. Both complexes 
PdL19 and PdL20 showed high purity according to their NMR spectra, however, were 
recrystallized to obtain single crystals confirmed by X-ray diffraction with enhanced sample 
purity. After recrystallization, and in degassed DCM solution at RT, PdL19 showed an intense 
emission peak with λmax at 485 nm in addition to the peak at 535 nm that was also observed 
for the non-recrystallized sample. This is suggestive of two independent species in solution 
that are both emissive (Fig. 4.23). Upon cooling to 77 K, the emission is purely 
representative of one species with λmax of ≈ 480 nm. This is thought to be the target 
compound as it is blue-shifted relative to the Pt analogue (λmax of 499 nm at 77 K, Table 
4.6).  
PdL19 PdL20 
  
  
Figure 4.23: Emission of the single crystals of PdL19-20 at RT in DCM and at 77 K in EPA (top) 
and excitation vs. absorbance spectra for PdL19-20 (bottom).  
For PdL20, a λmax of ≈ 530 nm was observed in the degassed RT emission spectrum that was 
also present in the non-recrystallized sample. Alongside this was another band of higher 
intensity with λmax of ≈ 575 nm (Fig. 4.23). On cooling to 77 K, similarly with PdL19, the 
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spectrum shows solely the emission of one species with λmax of 465 nm that is thought to be 
the target compound owing to its blue-shifted emission relative to the Pt analogue (λmax of 
481 nm).  
The excitation spectra were then run for PdL19 and PdL20 and both appear noticeably 
different to their corresponding absorption spectra (Fig. 4.23). This supports the formation 
of new emissive species in solution at RT in both cases. As a result, the RT emission is 
dominated by red-shifted spectra which could be masking that of the target compound, 
whilst at 77 K the target compounds are highly emissive.   
Overall, these findings suggest that that the true emission of PdL19 and PdL20 does originate 
from the peaks which are blue-shifted relative to the Pt analogues i.e. with λmax of 480 nm 
for PdL19 and 465 nm for PdL2 at RT in degassed solution. The evidence to support this lies 
in the following reasons; 
• Crystals of both complexes were obtained and confirmed the correct structures.  
• The absorption spectra of each complex are blue-shifted relative to their Pt 
analogues. 
• The emission for PdL19 and PdL20 at 77 K in EPA showed purely the blue-shifted 
emission. 
The formation of new species in solution is thus expected to be the cause of the other red-
shifted emission in each case where PdL20 is more susceptible to this phenomenon. The 
long lifetimes and the structured emission with vibrational progression of the red-shifted 
emission suggest that these new species contain Pd, however, it has not yet been 
elucidated what these species are.  
4.3.2 Complexes with tetradentate indole-containing ligands 
4.3.2.1 Synthesis 
Another set of complexations with Pt and Pd was attempted starting from a tetradentate 
indole-containing ligand. This indole ligand was similar in structure to the types of carbazole 
ligands that have been investigated by Jian Li’s group and which show good photophysical 
properties when incorporated into Pt and Pd complexes.23,26 
As for the previous set of complexes, the precursor P7 was synthesised via a Buchwald-
Hartwig amination (Scheme 4.2). P7 was then reacted in a consecutive Buchwald-Hartwig 
amination step to obtain the tetradentate ligand H2L23 in good yield. Complexation to afford 
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both Pt and Pd complexes was attempted but was only successful to form PtL23 via the 
typical cyclometallation reaction conditions as discussed previously (Scheme 4.2).  When 
the complexation was attempted with a range of Pd sources (Pd(COD)Cl2, Pd(OAc)2 and 
K2PdCl4), solvents (acetic acid, MeCN/H2O and toluene) and temperatures, in each case 
largely the ligand was recovered. The reaction turned black potentially forming many 
unwanted side products of Pd-catalysed reactions with the indole of which there are many 
examples in the literature.176  
 
 
Scheme 4.2: Synthesis of H2L23 with conditions a= Pd(dba)2, dppf, HP(tBu)3BF4, NaOtBu, Dry 
toluene, 90 °C and subsequent complexation to form PtL23. 
 
As with the previous set of complexes, PtL23 shows an upfield shift of the proton labelled 3’ 
due to the ring current effect of the anisyl ring (Fig. 4.24). Moreover, in the free ligand 
signal 3’’ is a doublet with a chemical shift of 6.64 ppm. Upon complexation, this signal 
experiences a downfield shift to 6.76 ppm and transformation into a singlet peak which 
helps to confirm the successful complexation.  
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Figure 4.24: NMR spectrum of H2L23 and PtL23 in d6-DMSO at 600 MHz. 
 
 
 
Figure 4.25: Molecular structure and crystal packing of PtL23. 
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Table 4.5: Selected bond lengths and angles for PtL23. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N2 
Pt1—N21 
Pt1—C131 
Pt1—C13 
 
2.027 (5) 
2.028 (5) 
1.976 (7) 
1.976 (7) 
N2-Pt1-N21 
C131-Pt1-N2 
C131-Pt1-N21 
C13-Pt1-N21 
C13-Pt1-N2 
C131-Pt1-C13 
94.1 (3) 
175.9 (2) 
81.8 (3) 
175.9 (2) 
81.8 (3) 
102.3(4) 
Crystals suitable for X-ray diffraction were obtained by slow cooling from a hot DMSO 
solution (Fig. 4.25). The crystal structure confirmed the binding of the ligand in a 
tetradentate manner and showed head-to-tail packing of the complexes, similar to the 
other Pt and Pd(C^N^N^C) complexes as discussed earlier. Moreover, the anisyl ring was 
also seen to be perpendicular to the rest of the complex and in this case the torsion angle 
between the N^C planes was negligible at 0.39 °. The closest PtPt distances were shown 
to be 3.678 Å.  
4.3.2.2 Photophysical properties 
All spectra for PtL23 were recorded in DMSO due to a limited solubility of the complex in all 
common organic solvents (Fig. 4.26). The absorption spectrum showed bands at between 
300 and 330 nm which were assigned as LC π→π*, owing to the match with the ligand 
absorption.  The band at 330 to 440 nm was assigned as a mix of MLCT and ILCT as 
supported by the DFT discussed later on.  
 
Figure 4.26: Absorption and emission spectra of PtL23 in DMSO at RT and 77 K emission 
spectrum in butyronitrile glass. 
The complex exhibited an impressive quantum yield of 33 % in degassed DMSO solution 
and a long lifetime of 19 µs (Table 4.6). The emission spectrum at RT showed a slightly 
structured band with λmax at 520 and 548 nm and, on cooling to 77 K, this emission was 
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seen to slightly blue-shift and more vibrational progression was observed.  DMSO is known 
to quench emission in some complexes177 and so making a more soluble derivative of this 
compound would be useful to see if the emission efficiency could be enhanced. 
Concentration-dependent studies were not possible owing to the limited solubility of the 
complex.  
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Table 4.6: Photophysical properties of MLn complexes containing tetradentate ligands. 298 K quantum yields and lifetimes are in degassed DCM 
solutions unless otherwise stated. 77 K measurements are in EPA or butyronitrile. *Results were run in DMSO. 
 
Complex 
298 K 77 K 
λabs  
(nm) 
λem  
(nm) 
τdeg  
(μs) 
τaer  
(ns) 
τ0 
(μs) 
φ 
 
kr  
(102 s-1) 
knr  
(104 s-1) 
kq (O2) 
(108 M-1  s -1) 
ksq (mono) 
(108 M-1  s -1) 
λem  
(nm) 
τ  
(μs) 
PtL19 272 (72400), 289 (57500), 323 
(34600), 337 (38900), 363 
(24500), 399 (7580). 
506, 541, 588sh 8.3 300 11 0.78 940 2.7 14 13 499, 512, 524, 
541, 572 
12  
PtL20 230 (15990), 267 (16300), 330 
(8250), 343 (2060). 
488, 523, 559, 
662 
11 490 14 0.46 410 4.8 9.0 23 481, 518, 559 
 
15 
PtL21 252 (45700), 283 (74100), 325 
(38900), 359 (34600), 378 
(40700), 424 (6700), 468 
(3800). 
587, 640, 699sh 15  330 / 
 
0.74 490 1.7 13 /  559, 585, 598, 
616, 628, 651, 
685 
17  
PtL22 267 (27802), 291 (31881), 349 
(26930), 363 (25300), 382 
(18362), 452 (3636), 481 
(2020). 
647, 703 5.9 390 / 0.04 68 17 11 / 623, 684, 756 12  
PdL19 
298 K data not given for these complexes owing to the formation of other species in solution at RT. 
479, 515, 553, 
596, 653 
350 
PdL20 465, 500, 539, 
580 
640 
PdL21 233 (30800), 279 (22100), 325 
(22100), 342 (20100), 364 
(15000), 386 (9700), 407 
(9400). 
553, 572, 600, 
652 
110 590 150 0.15 14 0.79 7.7 0.87 547, 566, 592, 
611, 644 
350 
PdL22 * 264 (19156), 275 (19441), 295 
(12271), 354 (19181), 369 
(18440), 407 (7159).  
615, 658, 733sh 85 620 / 0.007 0.83 1.2 7.3 / 595, 649, 714, 
797sh 
140 
PtL23* 303 (14560), 312 (17964), 369 
(20349) 
520, 548 19 520 / 0.33 1.8 3.6 8.4 / 498, 537, 580, 
630 
21 
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4.3.3 DFT of Pt complexes containing tetradentate ligands  
Ground state DFT was carried out using the B3LYP/LANL2DZ level of theory to obtain the 
frontier orbital plots for each Pt and Pd complex studied (Fig. 4.27). TD-DFT confirmed the 
nature of the S0→S1 transition in each case to be mainly HOMO→LUMO in character and 
the energies of the first excited state absorptions are shown in Table 4.7. Generally, it was 
found that the HOMO of each complex was based on the phenyl rings (or the indole in 
PtL23) and the metal centre, whilst the LUMOs were spread out across the pyridyl and 
phenyl/indole rings of the molecule but based mainly on the pyridyl rings. As a result, most 
of the excited state transitions are described as being a mixture of MLCT and ILCT (Table 
4.7). This is similar to the PtL19 analogue synthesised by Vezzu et al. which differs only by 
the removal of the OMe group on the anisyl ring.22  
On closer inspection, PtL21 and PtL22 LUMOs contain a large amount of metal contribution. 
PtL21 and PtL22 also show contributions to the excited state from HOMO-3 and HOMO-5 
levels respectively (see Appendix, Fig. A2). The PtL23 LUMO on the other hand, has a large 
contribution from the anisyl ring as well as the pyridyl ring and the HOMO and LUMO in this 
molecule are very clearly separated in comparison to the other Pt complexes. The excited 
state transition is therefore assigned as having more ILCT character in this case. 
For the Pd complexes, PdL19 and PdL20 show largely metal character in the HOMO compared 
to the phenyl ring contribution in the Pt analogues and the transitions are assigned mainly 
to MLCT. This could give some insight to the unusual photophysical behaviour of PdL19-20 
where the increased metal contribution on the HOMO of the complexes could make them 
more prone to oxidation and be the result of the potential new emissive species observed 
at RT in solution.  
PdL21 and PdL22 seem to show the same distribution of the HOMO as their Pt analogues, 
whilst the LUMOs of PdL21 and PdL22 show no visible contribution from the metal centre 
which differs to their Pt equivalents, hence the excited state transitions are described as 
mixed MLCT/ILCT.  
TD-DFT confirmed the blue-shift of the Pd complex absorption relative to the Pt complex 
absorption and the trend in absorption energies in each group of complexes from 
benzothiophene < thiophene < phenyl < difluorophenyl.  
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Table 4.7: Calculated S1 excited state energies for MLn complexes using TD-DFT B3LYP/LANL2DZ.  
Complex PtL19 PtL20 PtL21 PtL22 PtL23 PdL19 PdL20  PdL21 PdL22 
Energy (eV/nm) 2.6824/ 
462.21 
2.9128/ 
425.65 
2.4973/ 
496.48 
2.4642/ 
503.14 
2.5754/ 
481.42 
2.9430/ 
421.29  
3.1918/ 
388.44 
2.8889/ 
429.18 
2.8071/ 
441.68 
Oscillator Strength 0.0015 0.0005 0.0208 0.0228 0.0002 0.0051 0.0054 0.0566 0.0441 
Main contribution 
(%) 
HOMO→ 
LUMO 
(70) 
HOMO→ 
LUMO 
(70) 
HOMO→ 
LUMO 
(69) 
HOMO-3→ 
LUMO 
(12) 
HOMO→ 
LUMO 
(69) 
HOMO-5→ 
LUMO 
(11) 
HOMO→ 
LUMO 
(68) 
 
HOMO→ 
LUMO  
(70) 
 
HOMO→ 
LUMO 
(70) 
 
HOMO→ 
LUMO  
(68) 
HOMO-3→ 
LUMO 
(18) 
HOMO→ 
LUMO  
(69) 
HOMO-5→ 
LUMO 
(18) 
Assignment  Mixed 
MLCT/ILCT 
Mixed 
MLCT/ILCT 
Mixed  
MLCT/ILCT 
Mixed  
MLCT/ILCT 
Mixed 
ILCT/MLCT 
MLCT MLCT Mixed 
MLCT/ILCT 
Mixed 
MLCT/ILCT 
 
Complex  PtL19 PtL20 PtL21 PtL22 PtL23 PdL19 PdL20 PdL21 PdL22 
HOMO          
LUMO          
Figure 4.27: Frontier orbital plots for MLn complexes calculated using B3LYP/LANL2DZ. 
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4.3.4 Pd complex solid-state investigation and OLED devices 
Owing to the lack of Pd relative to Pt complex devices in the literature, investigation into 
the incorporation of the Pd complexes PdL19-21 into OLEDs was made. PdL22 was not chosen 
due to the limited amount of complex synthesised. Initially complex PdL21 was selected due 
to its high quantum yield of 15 % in degassed DCM solution.  The sample was sublimed and 
incorporated into an evaporated thin film of mCBP at 6 wt. % which increased the PLQY to 
45 % and the lifetime from 110 to 220 µs. The solution-state emission was essentially the 
same as for the film emission; however, there was a slight change in absorption profile (Fig. 
4.28).  
 
φ  DCM (%) 15 
τ DCM (µs) 110 
φ  mCBP film (%) 45 
τ mCBP film (µs) 220 
 
  
Figure 4.28: Photophysical properties of PdL21 in degassed DCM solution and in the film 
(top) and absorption and emission of PdL21 complex in degassed DCM solution (bottom left) 
and mCBP film (bottom right). 
The temperature-dependence of the emission and lifetime of PdL21 in the film was also 
measured from 30 K to 350 K by streak camera (Fig. 4.29). This revealled essentially no 
change in the emission lifetime of the complex. The only change observed was in the 
emission intensity which slightly increased on cooling.  
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Figure 4.29: Streak camera temperature-dependence of PdL21 for a) emission and b) 
lifetime.  
This lack of change in the phosphoresence lifetime at different temperatures suggests that 
the complex is very rigid even at RT and consequently does not undergo a lot of 
rearrangement on cooling, which could explain the high quantum yield for this complex 
relative to the other Pd complexes. Indeed, the knr value of this complex was the lowest of 
all the tetradentate complexes synthesised (including the Pt analogues) at 0.79 x 104 s-1 
(Table 4.6).  
Due to the large amounts of complex required for VTE-processed OLEDs (ca. 50 mg for 1 
device), solution-processed OLEDs were then attempted for complexes PdL19-21 where PdL21 
set a precedent for good efficiency, at least in the solid-state film. Again PdL22 was not 
chosen due to small amounts of compound but also due to inferior solubility needed for 
solution-processing. Solution-processed devices were fabricated by Piotr Pander (Durham 
Univeristy Physics Department) with the general device structure: ITO | HIL 1.3N (45 nm) | 
Host co. x% Pd complex (60 nm) | TPBi (50 nm) | LiF (0.8 nm) | Al (100 nm) and the 
properties of each device are shown below in Table 4.8 and Figure 4.30. 
Table 4.8: Maximum device properties for OLEDs of PdL19, PdL20 and PdL21. 
Device no.  Complex  
(wt. %) 
EML Host EL λmax 
(nm) 
Current 
density 
(mA cm-2) 
Brightness 
(cd m-2) 
EQE 
(%) 
1 PdL19   (3) PVK:OXD7 490, 535, 572 24.7 132.0 0.65 
2 PdL20   (5) PVK:PBD 535, 575 72.1 451.8 2.70 
3 PdL20   (5) PVK:OXD7 535, 575 21.3 257.3 1.40 
4 PdL20 (10) PVK:PBD 535, 575 66.3 727.8 3.51 
5 PdL20  (10) PVK:OXD7 535, 575 18.6 297.0 3.24 
6 PdL21   (5) PVK:PBD 560, 605 11.4 141.5 2.25 
7 PdL21   (5) PVK:OXD7  560, 605 16.4 346.6 3.17 
a) b) 
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EQEs of the devices ranged from 0.65 to 3.51 % and the highest EQE was displayed by PdL20 
in device 4 containing 10 wt. % of the complex in a PVK : PBD host. Device 4 also displayed 
the highest brightness at 727.8 cd m-2. Interestingly, both PdL19 and PdL20 display the red-
shifted emission as the major component in their EL spectra that was observed in their PL 
spectra in degassed solution. Owing to the relatively high EQE obtained for device 4, again 
it suggests that this new Pd species that is forming is highly emissive. PdL21 displayed EL 
which was very similar to its PL and, when incorporated into device 7 at 5 wt. %, showed 
good properties with an EQE of 3.17 % and brightness of 346.6 cd m-2. In general, for 
complexes containing tetradentate ligands, these values may not appear to be extremely 
high. When considering that these are solution-processed devices containing Pd complexes, 
however, these results are reflective of the lower efficiencies that Pd complexes typically 
display in comparison to Pt complexes. In no case was there any evidence of excimeric 
emission over the concentration range investigated, and so investigation into devices with 
higher doping concentrations or even neat films would be interesting to see if any excimeric 
emission emerges.  
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Figure 4.30: OLED devices of complexes PdL19, PdL20 and PdL21 with device structure:  ITO | HIL 1.3N (45 nm) | Host co x% Pd complex (60 nm) | TPBi 
(50 nm) | LiF (0.8 nm) | Al (100 nm). 
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4.3.5 Oxidation of PtII to PtIV complexes 
As mentioned in chapter 3, most PtIV complexes in the literature contain bidentate ligands 
and there are not many examples of those containing tridentate or tetradentate ligands. 
We attempted the synthesis of the PtIVLn complexes by some of the different methods that 
were described in the introduction to chapter 3.  
4.3.5.1 Synthesis  
Oxidation via addition of Cl2 gas to the reaction mixture has been employed as a standard 
method in our group previously.53 Alongside this has been used the irradiation of PtII 
complexes suspended in chloroform with UV light. Both methods of Cl2 addition proved to 
be successful in the case of the Pt(N^C^N) complexes and in some Pt(C^N^N^C) 
complexes.51 For example, Mickaële Bonneau successfully synthesised PtL19Cl2, PtL21Cl2 and 
PtL22Cl2 using the method of UV light irradiation in CHCl3. An investigation into clean and 
synthetically less-challenging oxidation strategies for tetradentate complexes has been 
made here. Firstly, oxidation via addition of Cl2 gas was attempted for the tetradentate Pt 
thiophene complex PtL21 to show its amenability to oxidation. As is shown by Figure 4.31, 
the addition of Cl2 gas to the tetradentate thiophene PtII complex in chloroform led to 
destruction of the aromatic region 1H signals over time.  
  
Figure 4.31: 400 MHz CDCl3 NMR evolution of PtL21 with chlorine addition over varying time 
intervals.  
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This suggests a decomposition of the complex and could be due to the reactivity of the 
electron-rich thiophene group with Cl2. It is known that thiophene itself reacts vigorously 
with Cl2 in aqueous solution (Fig. 4.32).178 As a result, an electrophilic attack by the 
thiophene group may be the cause of the destruction of the aromatic region in this case. 
Integration to show removal of 2 protons would show evidence of this, although the 
complete destruction of the aromatic region made it difficult to assign. It is, however, 
noticeable that the signal at 6.4 ppm for PtL21 is shifted to a higher frequency after Cl2 
addition which is indicative of oxidation. 
 
Figure 4.32: Mechanism for the chlorination of thiophene. 
The use of PhICl2 was then attempted to see if it was effective in oxidising the PtL21 
complex. PhICl2 was added to PtL21 and left to stir at RT for 24 hours with the exclusion of 
light (Scheme 4.3). The reaction was attempted with DCM and CHCl3 as solvents and in both 
cases the desired product was formed in solution.  
 
Scheme 4.3: Oxidation of PtL21to PtL21Cl2. 
Mass spectrometry showed clear evidence of product formation (ES+); [M-2Cl]+, [M-Cl]+ and 
[M+H]+. The NMR results are given below (Fig. 4.33) and show that the protons at position 
4’’ and 5’’ are shifted to higher frequency in the PtL21Cl2 complex compared to the PtL21 
complex. This may be due to the effect of the chloride additions which would be likely to 
take an axial conformation and interact with those protons on the thiophene ring to cause 
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significant de-shielding. The protons on the anisyl ring seem largely unaffected. This may be 
due to the distance of the anisyl ring from the chloride additions.  
Figure 4.33: Comparison of 1H NMR results of PtL21 (top) and PtL21Cl2 (bottom) in d6-DMSO, 
400 MHz. 
PtL19 is an example of a Pt(C^N^N^C) complex previously oxidised by the addition of two 
chlorides. In an attempt to achieve an easier synthetic route to the oxidised product, the 
oxidation of PtL19 was attempted with I2. This route proved facile, stirring solid I2 with PtL19 
at RT in acetone for 2 hours (Scheme 4.4).  The oxidised product was obtained in a 70 % 
yield.  
 
Scheme 4.4: Oxidation of PtL19 to PtL19I2. 
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The NMR results (Fig. 4.34) show an upfield shift for the proton labelled 2’’ which is closest 
to the Pt centre. This suggests that the addition of the I atoms serves to shield the protons 
in the 2’’ position. Furthermore, the proton labelled 3’ is seen to experience a downfield 
shift upon oxidation. This suggests it is being affected by a de-shielding influence potentially 
because it is located on the pyridine ring which serves to withdraw more electron density 
than in the PtII complex owing to the added I atoms.  
Figure 4.34: Comparison of PtL19 and PtL19I2 1H NMR spectra in CDCl3 at 400 MHz. 
The emission of these PtIV complexes was not investigated in this work, however Mickaële 
Bonneau found the PtIV complexes she synthesised to be non-emissive at RT and only 
emissive at 77 K. The goal with these PtIV complexes would therefore be to metathesise the 
chloride ligands for higher field strength ligands such as alkyne groups which could push up 
the d-d states to give potentially improved emission.  
4.4 Chapter 4 Summary  
The synthesis of previously studied PtII and PdII complexes with tetradentate ligands has 
been repeated, alongside the synthesis of new derivatives of these complexes.  Their 
photophysical properties, focusing on the concentration-dependent emission for potential 
excimer formation, have been investigated.  
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It was found that thiophene and benzothiophene-containing complexes did not display any 
excimeric emission, thought to be due to the 5-membered thiophene groups which are 
electron-donating and thus push up the energy of the HOMO in each case. This could 
prevent the close interaction of the metals in each case which could sometimes otherwise 
result in MMLCT transitions. Conversely, the phenyl and difluorophenyl complexes were 
seen to exhibit certain degrees of excimeric emission where PtL20 had the highest 
propensity towards excimer formation.  
 
PdL19 and PdL20 were seen to exhibit unusual photophysical behaviour, different to the 
other complexes. This was displayed by the formation of red-shifted emission bands that 
were highly structured and indicative of Pd complexes with a different structure to those 
anticipated. It is still unclear as to what these different species are.  
 
Devices of selected Pd complexes have also been fabricated and revealed a maximum EQE 
of 3.51 % for a 10 wt. % PdL20-containing device and 3.17 % for a 5 wt. % PdL3-containing 
device.  The emission displayed in the PdL20 device was red-shifted to that expected and 
thus is indicative of a different Pd species.  
 
A new PtII complex containing a tetradentate indole-based ligand was also synthesised 
which gave impressive photophysical properties despite its poor solubility and this gives 
potential for more investigation into this type of compound and work towards Pd 
complexes of the same sort.  
 
Finally, oxidation of PtII complexes containing tetradentate ligands has been achieved to 
form the corresponding PtIV species of composition PtLnX2 (where X=halogen) using PhICl2 
and I2 as oxidants. This gives a good basis for possible future metathesis of weak-field I and 
Cl ancillary ligands for strong-field ligands such as alkyne groups.  
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5. Dinuclear PtII complexes containing 
tridentate ligands 
 
5.1 Introduction 
The basis for the work in this chapter surrounds PtII(N^C^N) complexes joined together 
through specific linking groups to form dinuclear complexes containing two PtII(N^C^N) 
sites. The importance of these dinuclear complexes comes to light with regard to efficient 
deep red and NIR emission that is normally hard to achieve. One way in which this emission 
can be accessed is through the formation of square planar PtII complex excimers. These 
excimers can form via intermolecular interactions between separate Pt moieties and/or 
intramolecular interactions when two Pt sites are present. Moreover, NIR emission can also 
be achieved by extending the conjugation in monomeric complexes. The following 
examples highlight some of the best performing NIR Pt emitters, including both 
mononuclear and dinuclear/bimetallic complexes. Table 5.1 at the end of this introductory 
section summarises the photophysical properties of selected complexes.  
5.1.1 Mononuclear Pt complexes  
One of the earlier noteworthy examples of a NIR-emitting OLED featuring a PtII complex 
came from Cocchi et al. in 2007.179 Three different OLEDs were fabricated by vacuum 
sublimation and each contained a neat film of the mononuclear complex based on 
Pt(dpyb)Cl as the EML (Fig. 5.1). Peak electroluminescence emission was centred at 720, 
715 and 705 nm for 91, 92 and 93 respectively, originating from the formation of excimers 
through intermolecular Pt interactions. Complexes 91 and 92 gave the highest EQEs of    
10.5 % each which remains a highly respectable value for NIR emission in OLED devices.  
 
 
 
Figure 5.1: Structures of complexes 91-93 incorporated into OLED devices and their 
corresponding EL spectra. Reproduced from Cocchi et al. by permission of AIP.179  
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In the same year, an OLED incorporating a PtII tetraphenyltetrabenzoporphyrin (Pt(TPBP), 
94) was fabricated by Sun et al.180 This displayed emission in the NIR owing to the extended 
conjugation offered by the TPBP ligand, and had a peak electroluminescence emission of 
772 nm with an EQE of 8.5 % for a 4 wt. % 94 : Alq3 EML. As can be seen from Figure 5.2 the 
emission bandwidth centred at 772 nm is very narrow, suggestive of potential high colour 
purity.  
  
Figure 5.2: a) Normalised electroluminescence intensity and b) EQE & device architecture of 
94. Reproduced from Sun et al. by permission of AIP.180  
More recently, Pt porphyrin derivative OLEDs have been revisited owing to these promising 
performances in the NIR. Huang et al.181 synthesised three compounds (95-97, Fig. 5.3) 
according to a method previously reported by Borisov182 which involved reaction of the 
porphyrin ligand with Pt(C6H5CN)2Cl2 in diphenylether at 160 °C. The replacement of the 
meso carbon atoms in the porphyrin ring with nitrogen was seen to shift the EL emission 
peak nearly 80 nm further into the infrared region which shows an effective colour-tuning 
strategy. For the VTE OLEDs, the parent complex 95 displayed an EL emission peak at        
770 nm with an EQE of 8 %. The EQEs of the other devices decreased to 2.8 % for 96 and 
1.5 % for 97, but the emission peak maxima increased to 848 nm and 846 nm respectively 
and consequently they show promise for infrared device development.   
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Figure 5.3: a) EQE and b) EL of 95, 96 and 97. Reproduced from Huang et al. by permission 
of AIP.181 
In 2017, Zhang et al. described the use of Pt complexes with tetradentate salen-like ligands 
and their performance as red/NIR emitters in OLEDs.183 They took inspiration from NIR-
emitting organic and polymeric fluorescent dyes such as those reported by Wang et al. 
which were based on electron-donating (D) and electron-accepting (A) units separated by π 
spacers, and which displayed emission of λ > 1000 nm.184 The PtII complexes synthesised by 
Zhang thus included D-A groups appended onto a central salophen ligand (Fig. 5.4). It was 
hoped that the two salophen complexes initially synthesised (98 and 99) would show NIR 
emission and also that the appendage of the donor-acceptor groups to either the head or 
the waist of the salophen unit as shown in Figure 5.4 might have some impact on the 
nature of this emission as well. It was found that complex 99 gave the most red-shifted 
emission when the donor-acceptor groups were appended to the head of the complex with 
a peak emission of EL at 695 nm, very close to the NIR. This work was extended to shift the 
emission directly into the NIR by synthesis of a similar salophen complex (100), this time 
changing the D-A unit to contain thiadiazole groups, resulting in emission with a peak EL of 
703 nm and a device EQE of 0.88 %.185   
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Figure 5.4: Structures of PtII tetradentate salophen complexes: 98, 99 and 100.  
As was discussed in Chapter 2, the homoleptic Pt complex containing bidentate pyrazole 
ligands (26) displayed the most impressive EQE for NIR emission of 24 % that remains 
unbeaten, with a peak maximum of 740 nm.108 It is therefore of great interest to investigate 
all potential avenues for NIR emission, looking at the balance between intermolecular 
interactions which can form excimers with red-shifted emission versus those which can 
result in self-quenching through processes such as triplet-triplet annihilation (TTA). Another 
recent area of interest is in bimetallic and dinuclear complexes and how potential 
intramolecular interactions, dependent upon the molecular conformation, could promote 
this NIR emission.  
5.1.2 Dinuclear/bimetallic Pt complexes  
These intramolecular interactions have been previously studied by Develay in 2008 with the 
synthesis of a dinuclear complex in which two N^C^N-coordinated PtII ions were linked via a 
xanthene bridge.186 Synthesis of the complex 101 was achieved by reaction of a N^C^N 
boronic acid with the xanthene derivative to form the ditopic ligand. This ligand was then 
added to a MeCN/H2O (3:1) mixture with K2PtCl4 and stirred at reflux for 3 days to obtain 
the mononuclear product, and for 11 days to achieve the binuclear product (Scheme 5.1).   
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Scheme 5.1: Synthesis of dinuclear complex 101. 
Inspiration for this work was taken from Tanaka et al. who successfully linked two metal 
terpyridyl complexes together to form a dinuclear complex existing in a face-to-face 
conformation.187 This face-to-face conformation has proved beneficial in promoting excimer 
formation, necessary for deep red emission, through intramolecular interactions. Complex 
101 was found to have an emission maximum in the deep red at 690 nm with a quantum 
yield of 20 %. It was compared to its parent compound Pt(dpyb)Cl and it showed excimer-
like emission throughout all concentrations that were measured (2 × 10−7– 5 × 10−4 M) 
whilst Pt(dpyb)Cl only displayed excimeric emission at elevated concentrations and 
monomeric emission was also always evident (Fig. 5.5).  
 
Figure 5.5: Absorption and emission of 101 and emission of the parent compound 
Pt(dpyb)Cl in both dilute and concentrated solutions. Reproduced from Develay et al. by 
permission of the Royal Society of Chemistry.186  
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Chan and colleagues also made use of a xanthene backbone in order to link Pt(salphen) 
units to dibenzofuran and biphenylene resulting in complexes 102, 103 and 104 
respectively (Fig. 5.6).188 
 
Figure 5.6: Structures of dinuclear complexes 102, 103 and 104.  
Crystal structures of 102 and 104 showed that the Pt(salphen) units are twisted relative to 
the plane of the bridging aromatic unit (torsion angles of 43° and 36° respectively). In 
complex 102, despite the intramolecular interplanar separation (defined as the mean 
separation between Pt and the adjacent N2O2 plane) being only 3.22 Å, the twist leads to 
the Pt atoms being displaced relative to one another, leading to a much longer PtPt 
distance of 5.012(2) Å. In complex 104, on the other hand, the Pt atoms are held closer to 
one another, with an intramolecular PtPt distance of 3.359 Å. Though shorter, this is only 
short enough for weak PtPt interaction. No crystal data was available for complex 103, 
but a larger inter-planar distance was expected, given the shape of the dibenzofuran 
bridge. All three complexes were found to emit at similar energies in solution at RT (around 
635 nm) but there was no evidence of MMLCT excited states. The respective quantum 
yields were 0.007, 0.080 and 0.009 for 102, 103 and 104. The higher PLQY of complex 103 is 
attributed to π-π quenching processes in 102 and 104, facilitated by the closer separations 
of the Pt(N2O2) units. 
There is also a literature precedent for bimetallic and dinuclear platinum complexes 
containing strong-field alkyne groups linked by the same xanthene core as for complexes 
101 and  102.189 Muñoz-Rodríguez et al. synthesised a series of  bimetallic and dinuclear 
complexes with tridentate, cyclometallating N^N^C- and C^N^C-coordinating ligands for PtII 
and AuIII respectively. In this way, new dinuclear Pt complexes containing Pt(N^C^N) units 
linked to a xanthene core by acetylide groups were synthesised.  The complex 105, 
containing nBu groups at the 4-position on the pyridyl ring (Fig. 5.7), displayed an emission 
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maximum at 817 nm and a quantum yield of 0.0026 %. It was postulated that a ground 
state intramolecular interaction of the Pt units resulted in an MMLCT character of emission 
and gave rise to its broad, red-shifted emission.  
 
Figure 5.7: Homo-dinuclear Pt complex 105 with N^N^C coordinating ligand. 
None of the aforementioned bimetallic/dinuclear complexes displaying NIR emission have 
been tested in OLED devices, primarily owing to poor PLQY values.  Complexes such as 101 
with a quantum yield of 20 % do, however, have the potential for improved EL properties 
and have sparked off interest into these types of complexes owing to more efficient NIR 
emission through potential intramolecular interactions.  
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Table 5.1: PL and EL data of complexes with red/NIR emission. All EL data presented represents the maximum values obtained. *Also discussed in 
Chapter 2.  
Compound no. and 
reference 
Device Architecture PL performance EL performance 
λmax (nm) 
[soln/film] 
PLQY (%)  
[soln/film] 
Lifetime (μs) 
[soln/film] 
λmax (nm) 
[mono/exc] 
EQE 
(%) 
91179 
ITO/ TPD:PC (70 nm) / CBP (20 nm) / 
91/92/93 / OXA (30 nm) /Ca. 
- / 680 - / 24 - / 0.98 - / 720 10.5 
92179 - - / 35 - / 1.10 - / 715 10.5 
93 179 - - / 31 - / 1.10 - / 705 10.0 
94180 NPD (40 nm) / (4 wt. % 94, TPBD) : Alq3 
(40 nm) / Alq3 (50 nm) / LiF (1nm) / Al 
(110 nm). 
- - - / 45 - / 772 8.5 
95 181 ITO/ PEDOT:PSS / NPD (30nm) / TAPC 
(10nm) / Alq3 : 4 wt. % 95/96/97 (25 nm) / 
BCP (40 nm) / LiF / Al 
770 / - 51 / - 47 / - - / 770 8.0 
96 181 842 / - 22 / - 0.4 / - - / 848 2.8 
97 181 840 / - 17 / - 0.2 / - - / 846 1.5 
98183 
PVK:OXD-7 host and 98/99 dopant 
646 / 628   - / 653 0.1 
99 183 670 / 693   - / 695 1.36 
100185 ITO /PEDOT / PVK : OXD-7 : 100 (50 nm) / 
TPBI (30 nm) / Ba (4 nm) / Al (100 nm) 
697,730 1.2 / - 0.88 / - - / 703 0.88 
101 186 - 690 / - 20 / - 1.7 / - - - 
105 189 - 817/ - 26 / - 26 ns / - - - 
26 108* ITO (100 nm) / HATCN (10 nm) / NPB (50 
nm)/ mCP (15 nm)/ 26 (20 nm)/ TPBi (60 
nm) / Liq (2 nm) / Al (100 nm) 
- / 740  - / 81 - / 310 - / 740 24 
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5.2 Objectives 
We aimed to prepare a larger quantity of 101 (called L24(PtCl)2 in this work, Scheme 5.4) in 
order to test it in an OLED. We also sought to explore other new dinuclear Pt complexes 
incorporating a xanthene linker that have the potential to form intramolecular excimers 
displaying efficient, red-shifted emission nearing the NIR. The distinction between intra- 
and intermolecular excimers in these dinuclear complexes is shown in Figure 5.8. These 
complexes will be studied for their photophysical properties and hopefully performance in 
OLED devices.  
Two classes of complexes have been investigated. The first class is based on the work by 
Develay which link Pt moieties to the xanthene core via the phenyl ring of the N^C^N group 
(class 1) and the second set have the same xanthene core but appended with acetylide 
groups to bind directly to the Pt centres after exchange of the chloride ancillary ligand 
(class 2) (Fig. 5.8).  
 
 
Figure 5.8: Structures of parent class 1 and class 2 dinuclear Pt complexes (left) and the 
representation of intra- and intermolecular excimers in these dinuclear complexes. 
5.3 Results and Discussion 
5.3.1 Class 1 complexes 
5.3.1.1 Synthesis 
In the synthesis of the class 1 complexes, the parent complex L24(PtCl)2 was synthesised in 
the same way as reported by Develay, but it was found that complexation of the Pt ions 
could be achieved by refluxing in acetic acid and water (3:1) for 3 days instead of 
MeCN/H2O (3:1) for 11 days.  
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An analogue incorporating CF3 substituents in the 4-position of the phenyl rings, L25(PtCl)2, 
was also synthesised for comparison.  The first step in this synthesis was a Miyaura 
borylation reaction, first reported in 1995 for reaction between any aryl halide and 
bis(pinacolato)diboron (b2pin2) to form boronates.190 This enabled the formation of the CF3 
substituted N^C^N boronate which was then Suzuki cross-coupled with the dibromo 
xanthene derivative to form the resulting CF3 substituted N^C^N ligand (Scheme 5.2).  
 
Scheme 5.2: Synthesis of N^C^N boronates. 
Attempts were made to synthesise the parent ligand H2L24 in the same manner as the CF3 
substituted compound but the Suzuki reaction between the xanthene derivative and the 
N^C^N boronate was not successful in this case (Scheme 5.3).  
Scheme 5.3: Synthesis of H2L25 and the attempted synthesis of H2L24 via the boronate Suzuki 
method. 
Complexation was carried out in the same manner for both L24(PtCl)2 and L25(PtCl)2 under 
argon, by refluxing the ligand with K2PtCl4 in an acetic acid/H2O (3:1) solvent mixture for 3 
days (Scheme 5.4).  
 
X 
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Scheme 5.4: Synthesis of L24(PtCl)2 and L25(PtCl)2. 
Complexes L24(PtCl)2 and L25(PtCl)2 were obtained in yields of 4 % and 66 % respectively. It 
was not possible to obtain a pure sample of the N^C^N boronic acid and this resulted in 
crude H2L24 which was reacted on to give a poor yield for complexation.  
5.3.1.2 Photophysical Properties 
All photophysical properties for the complexes discussed in this chapter are summarised in 
Table 5.5. The absorption spectra of L24(PtCl)2 and L25(PtCl)2 show similar profiles to one 
another with the latter being slightly red-shifted. Bands in the region of 350 to 450 nm are 
attributed to charge-transfer transitions involving the metal and halide co-ligand (Fig. 5.9). 
Absorbances at shorter wavelengths have higher extinction coefficients owing to π→π* 
transitions associated with the xanthene moiety. A very weak absorption band centred at 
496 nm is also present for the parent compound L24(PtCl)2 (Fig. 5.9 inset) and is suggestive 
of ground-state PtPt interactions (i.e. MMLCT), but this is not present in L25(PtCl)2.  
 
Figure 5.9:  Normalised absorption spectra of L24(PtCl)2 and L25(PtCl)2 and concentration-
dependent absorption of L24(PtCl)2 (inset). 
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The emission of L24(PtCl)2 is virtually all excimer-like with a λmax of 690 nm, independent of 
concentration in the range investigated (2 × 10−7 to 5 × 10−4 M), and trace monomer-
likeemission is observed at lower concentrations (Fig. 5.10). This proves the high propensity 
of L24(PtCl)2 to form excimers, probably owing to a locked face-to-face conformation of the 
two Pt centres. The interactions responsible for excimer formation were therefore assigned 
as intramolecular. As was communicated in the Develay paper, this compound exhibits a 
high quantum yield for red emission, found here to be 15 % with a long lifetime of 5.4 μs.  
In contrast, the emission of L25(PtCl)2 showed both monomer and excimer emission over a 
range of concentrations from 10-7 to 10-4 M (Fig. 5.10). This suggests that, although excimer 
formation is still occurring, it is inhibited by the presence of the CF3 groups, perhaps due to 
steric interference preventing close interactions. Neither purely monomeric nor purely 
excimeric emission was observed in the concentration range investigated which could 
suggest that inter- as well as intramolecular interactions assist in excimer formation here.  
 
 
 
  
Figure 5.10: Concentration-dependent emission of L24(PtCl)2 and L25(PtCl)2. Concentrations 
are given in mol dm-3. 
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L24(PtCl)2 
 
L25(PtCl)2
 
Figure 5.11: Stern-Volmer plots for class 1 complexes showing self-quenching parameters. 
By probing the monomer emission at 510 and 540 nm for L24(PtCl)2 and L25(PtCl)2 
respectively, the change in decay rates as a function of concentration were fitted to a Stern-
Volmer equation and a linear dependence was observed in each case (Fig. 5.11). This 
supports some contribution to excimer formation from intermolecular interactions. 
 
From the Develay paper, it was observed that, at 77 K, the emission of L24(PtCl)2 showed 
only the monomer form and this was reproduced here. For L25(PtCl)2 the 77 K emission 
showed a strong monomer contribution but also some excimer, even in very dilute 
butyronitrile glass (Fig. 5.12).  
 
Figure 5.12: 77 K spectra of L24(PtCl)2 and L25(PtCl)2 in butyronitrile glass. 
It was previously postulated for L24(PtCl)2 that the strong monomeric emission at 77 K was 
due to a lack of thermal activation which is needed for the formation of the excimeric state 
centred at 690 nm. In this case there would need to be some motion of the two 
Pt(N^C^N)Cl units relative to one another. The fact that L25(PtCl)2 displays excimeric 
emission at 77 K may not follow the same trend and in fact the Pt(N^C^N)Cl units may 
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already be positioned in the favourable orientation in the ground state and at low 
temperatures for excimers to form.  
5.3.1.3 Comparison with parent complexes 
In order to try and gain a deeper understanding of the photophysical properties that these 
dinuclear complexes display, it is important to compare them with their mononuclear 
derivatives. In this case, the mononuclear derivatives are Pt(dpyb)Cl and Pt(dpybX)Cl, 
where X= 2 x CF3 on the 4-pyridyl position. The emission of Pt(dpyb)Cl shows the evolution 
of high-intensity excimer emission with increasing concentration, but which does not 
exceed the relative intensity of monomer emission at the highest concentration measured 
(1.6 x 10-4 M) (Fig. 5.13). In L24(PtCl)2 the concentration-dependent emission is purely 
excimeric, independent of concentration, and thus is in stark contrast to the mononuclear 
derivative. The PLQY is higher for the mononuclear complex Pt(dpyb)Cl at a concentration 
displaying purely monomeric emission, in comparison to the dinuclear complex (0.6 vs. 
0.15) which is understandable in terms of the red-shift for the excimeric emission of 
L24(PtCl)2 which is likely to suffer from enhanced knr due to the energy gap law.  
Pt(dpyb)Cl20 Pt(dpybX)Cli   
  
φ = 0.60 φ = 0.21 
λmax = 491, 524, 562 (683) nm λmax = 517, 545 (754) nm 
τ0 = 7.2 μs τ0 = 5.1 μs 
ksq= 5.3 x 109 M-1s-1 ksq = 3.1 x 109 M-1s-1 
Figure 5.13: Concentration-dependent emission of Pt(dpyb)Cl and Pt(dpybX)Cl (X = 2 x CF3 
on the 4-pyridyl position) and their photophysical properties where λmax values for the 
excimer are quoted in the parentheses. 
                                                          
i This complex was synthesised by Chris Harris (MChem student) and the photophysical data carried 
out by me.  
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For Pt(dpybX), purely monomeric emission is displayed at concentrations below                
4.68 x 10-5 M, whilst in the dinuclear complex L25(PtCl)2 a mixture of monomeric and 
excimeric emission is maintained throughout the concentration range investigated (1.06 x 
10-7 – 1.06 x 10-4 M) and the ksq values of each complex are 3.1 and 0.4 x 109 M-1s-1 
respectively. This differs from L24(PtCl)2 where excimeric emission was dominant at all 
concentrations, suggesting that the incorporation of CF3 groups causes some steric 
interference to excimer formation. The emissive behaviour of L25(PtCl)2 supports some 
contribution from intramolecular interactions to the formation of the excimer, however, 
this may be much less pronounced in comparison to L24(PtCl)2. Indeed, intermolecular 
interactions may also have a large contribution to the formation of excimers in L25(PtCl)2, 
like those seen in the mononuclear complex Pt(dpybX)Cl. The PLQY values of 0.21 for 
Pt(dpybX) and 0.05 for L25(PtCl)2 are lower than those for Pt(dpyb)Cl and L24(PtCl)2, probably 
owing to the incorporation of CF3 groups on the pyridyl rings which could increase non-
radiative decay through vibrational relaxation.  
5.3.2 Class 2 complexes  
5.3.2.1 Synthesis  
A range of complexes were synthesised containing different substituents on the N^C^N 
ligand of the form L26(Pt(dpybX))2, where X = A, B, C, D and E that are outlined in Scheme 
5.5. The mononuclear starting complexes of the form Pt(dpybX)Cl were synthesised by 
reaction of the dpybX ligand with K2PtCl4 in refluxing acetic acid.ii The synthesis method that 
was adopted to make the xanthene bis-acetylide bridge (H2L26) followed the work of 
Muñoz-Rodríguez et al. which is also shown in Scheme 5.5. Complexation was then 
achieved by reacting two equivalents of the Pt(dpybX)Cl complex with H2L26 in MeOH/DCM 
in the presence of NaOMe to act as a base for the deprotonation of the alkyne units. The 
reaction was done in the presence of air offering a facile synthesis route to these dinuclear 
complexes, giving scope for many other derivatives. There was no evidence of complex 
formation containing only one Pt unit linked to the xanthene core. Yields varied from 16 % 
to 73 % with L26(Pt(dpybC))2 giving the highest yield. This may be due to the increased 
solubility of the starting mononuclear complex Pt(dpybC)Cl which contains the tBu group.   
                                                          
ii Mononuclear Pt(dpybX)Cl complexes were synthesised by either Chris Harris or Rebecca Salthouse 
(MChem students in our group). 
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Scheme 5.5: Synthesis of group 2 dinuclear Pt compounds. (a) THF dry, nBuLi in hexanes, I2 ,   
-20  C̊ to RT, (b) Pd(PPh3)2Cl2, CuI, trimethylsilylacetylene, NEt3, 60 °C, 24h, (c) K2CO3, 
MeOH/DCM, RT, 12h, (d) PtLXCl, NaOMe, MeOH/DCM, 50 °C, 48h. 
Crystals of L26(Pt(dpybA))2 suitable for X-ray diffraction were obtained by slow evaporation 
of a solution in chloroform. The crystal structure revealed two independent molecules in 
the unit cell which differed only by the orientation of the tBu group (Fig. 5.14). The crystals 
revealed long intramolecular and intermolecular PtPt distances of 4.660 Å and 8.538 Å 
respectively. The Pt atoms are off-centred and, by taking the Pt(N^C^N) unit as a plane, 
torsion angles between the planes of the Pt(N^C^N) units and the xanthene linker were 
125.3 and 129.6 °. Bond lengths were seen to be very similar to Pt(dpyb)Cl, for instance, 
Pt1—C7 and Pt2—C50 were 1.94 and 1.96 Å (cf. the cyclometallated carbon-Pt bond in 
Pt(dpyb)Cl of 1.90 Å20). Interestingly, bond lengths between Pt atoms and acetylide carbons 
were slightly longer (2.06 and 2.07 Å for Pt1—C17 and Pt2—C43 respectively) (Table 5.2).  
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Figure 5.14: Crystal structure and packing for L26(Pt(dpybA))2. 
Table 5.2: Selected bond lengths and angles for L26(Pt(dpybA))2. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—C7 
Pt1—C17 
Pt2—N3 
Pt2—N4 
Pt2—C43 
Pt2—C50 
2.042(9) 
2.038(10) 
1.941(11) 
2.055(11) 
2.046(10) 
2.029(11) 
2.068(11) 
1.959(11) 
N1-Pt1-C17 
N2-Pt1-N1 
N2-Pt1-C17 
C7-Pt1-N1 
C7-Pt1-N2 
C7-Pt1-C17 
N3-Pt2-C43 
N4-Pt2-N3 
N4-Pt2-C43 
C50-Pt2-N3 
C50-Pt2-N4 
C50-Pt2-C43 
100.2(4) 
151.3(4) 
100.3(4) 
79.7(5) 
79.9(4) 
179.4(5) 
99.6(4) 
159.7(4) 
100.7(4) 
79.3(5) 
80.5(2) 
178.4(5) 
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Crystals of L26(Pt(dpybD))2 suitable for X-ray diffraction were also obtained by slow 
evaporation of a solution in chloroform. The crystals revealed long intramolecular and 
intermolecular PtPt distances of approximately 5.0 Å for each (Fig. 5.15). The torsion 
angles between the planes of the Pt(N^C^N) units with the xanthene linker were calculated 
as 136.5 and 137.4° which are greater than those found in the crystal structure of 
L26(Pt(dpybA))2 possibly due to the CF3 groups posing a greater steric hindrance. Bond 
lengths were seen to be very similar to those found in the crystal structure of 
L26(Pt(dpybA))2 (Table 5.3).  
 
  
Figure 5.15: Crystal structure and packing for L26(Pt(dpybD))2. 
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Table 5.3: Selected bond lengths and angles for L26(Pt(dpybD))2. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—C7 
Pt1—C65 
Pt2—N3 
Pt2—N4 
Pt2—C27 
Pt2—C67 
2.017(6) 
2.2024(6) 
1.926(3) 
2.057(7) 
2.005(6) 
2.023(5) 
1.910(3) 
2.036(8) 
N1-Pt1-N2 
N1-Pt1-C65 
N2-Pt1-C65 
C7-Pt1-N1 
C7-Pt1-N2 
C7-Pt1-C65 
N3-Pt2-N4 
N3-Pt2-C67 
N4-Pt2-C67 
C27-Pt2-N3 
C27-Pt2-N4 
C27-Pt2-C67 
161.9(2) 
99.9(3) 
98.2(3) 
80.8(2) 
81.2(2) 
179.2(2) 
161.4(3) 
99.1(3) 
99.5(3) 
79.8(2) 
81.6(2) 
177.1(2) 
Crystals of L26(Pt(dpybE))2 suitable for X-ray diffraction were obtained by slow diffusion of 
hexane into a DCM solution (Fig. 5.16). The crystals revealed much shorter PtPt 
interactions than for L26(Pt(dpybA))2 and L26(Pt(dpybD))2 where the intramolecular PtPt  
distances were 3.976 Å. The Pt atoms are off-centred in the complex and torsion angles 
between the planes of the Pt(N^C^N) units and the xanthene linker were much smaller 
than for those seen in the previous complex crystal structures at 61.34 and 60.15 °. Indeed, 
it is noticeable that the acetylide bonds point inwards in these molecules, facilitating the 
closer intramolecular PtPt interactions compared to L26(Pt(dpybA))2 and L26(Pt(dpybD))2 
where the acetylide bonds appear to point outwards. The complex is seen to pack in a 
head-to-tail manner and the closest intermolecular PtPt distances were 5.260 Å.  
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Figure 5.16: Crystal structure and packing for L26(Pt(dpybE))2. 
Table 5.4: Selected bond lengths and angles for L26(Pt(dpybE))2. 
Bond Lengths/ Å Bond Angles /   ̊ 
Pt1—N1 
Pt1—N2 
Pt1—C11 
Pt1—C25 
Pt2—N3 
Pt2—N4 
Pt2—C51 
Pt2—C62 
2.0068(8) 
2.016(10) 
1.895(11) 
2.014(13) 
1.985(11) 
2.049(11) 
1.983(12) 
1.888(10) 
N1-Pt1-N2 
N1-Pt1-C25 
C11-Pt1-N1 
C11-Pt1-N2 
C11-Pt1-C25 
C25-Pt1-N2 
N3-Pt2-N4 
C51-Pt2-N3 
C51-Pt2-N4 
C62-Pt2-N3 
C62-Pt2-N4 
C62-Pt2-C51 
160.2(4) 
101.5(4) 
79.5(5) 
80.8(5) 
175.0(4) 
98.3(4) 
160.3(4) 
102.2(4) 
97.4(4) 
78.5(4) 
81.8(5) 
179.0(4) 
 
5.3.2.2 Photophysical properties  
The absorption spectra of the class 2 complexes have a similar profile to the class 1 
complexes with red-shifted absorption for the charge transfer transitions centred at        
450 nm and additional absorptions extending to 550 nm are also apparent. Complex 
L26(Pt(dpybE))2 has a higher intensity for these lower energy transitions in comparison to 
the other complexes, likely due to the extended conjugation in the isoquinoline ring         
(Fig. 5.17).  
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Figure 5.17: Absorption spectra of class 2 complexes in DCM solution. 
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Figure 5.18: Normalised concentration-dependent emission spectra of class 2 complexes. 
Like the class 1 complex L24(PtCl)2, complexes L26(Pt(dpybA))2 and L26(Pt(dpybE))2 show only 
a trace amount of monomer emission and a high propensity for excimer formation in 
solution (Fig. 5.18). In comparison to the class 2 complexes which contain CF3 groups, the 
excimeric emission in L26(Pt(dpybA))2 and L26(Pt(dpybE))2 is much more prevalent and again 
suggests that CF3 groups on the pyridyl rings of the N^C^N components may sterically 
inhibit the approach of two Pt units face-to-face in the excited state. The crystal structures 
obtained for L26(Pt(dpybA))2 and L26(Pt(dpybE))2 support these observations where 
L26(Pt(dpybA))2 and L26(Pt(dpybE))2 displayed shorter intramolecular PtPt interactions in 
comparison to the CF3-containing complex L26(Pt(dpybD))2.  
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At the lowest concentration of 1.68 x 10-7 M, complex C displayed purely monomeric 
emission. This contrasts to the class 1 complex L25(PtCl)2 which displays both monomeric 
and excimeric emission, even at 1.06 x 10-7 M concentration. In this case, the arrangement 
of complex C in solution may not be as rigidly fixed due to the bulky and flexible tBu group 
which enables only monomer emission to be observed at low concentrations. This may also 
suggest a greater degree of intermolecular interactions which assist in excimer formation in 
this complex.  
L26(Pt(dpybA))2 
 
L26(Pt(dpybB))2 
 
L26(Pt(dpybC))2 
 
L26(Pt(dpybD))2 
 
L26(Pt(dpybE))2 
 
Figure 5.19: Stern-Volmer plots for class 2 complexes showing self-quenching parameters. 
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By probing the monomer emission, all complexes investigated were seen to follow a linear 
trend with respect to concentration versus the inverse of the lifetime, whilst excimer 
lifetimes were seen to stay constant independent of concentration (Fig. 5.19 and Table 5.5). 
Degassed excimer lifetimes ranged from 410 ns to 1.7 μs at 298 K and at 77 K ranged from 
2.4 μs to 3.0 µs.  
Complex L26(Pt(dpybA))2 had the highest quantum yield of 35 % with a degassed lifetime of 
4.8 μs and a λmax of 690 nm. In comparison to the homo-dinuclear N^N^C complex 105 in 
the Muñoz-Rodríguez paper which had a lifetime of 26 ns, a 0.0026 % PLQY and a λmax of 
817 nm, this shows the great potential for these types of compounds which could be 
incorporated into NIR OLEDs. Moreover, this demonstrates first-hand the superior 
efficiency of luminescence that can be achieved by the N^C^N arrangement in the 
tridentate dpybX ligand compared to the N^N^C arrangement.  
The 77 K emission was also investigated for the class 2 complexes (Fig. 5.20). Similarly, with 
the class 1 parent complex L24(PtCl)2, compound L26(Pt(dpybA))2 showed more structured 
monomeric emission at low temperature in comparison to the CF3-substituted complexes. 
Moreover, as the number of substituents increased on the Pt units, the amount of 
monomer emission was seen to decrease whilst the amount of excimer emission increased 
(the reverse phenomenon for the emission observed at RT for these complexes). This is 
demonstrated by complex L26(Pt(dpybC))2 which had the largest excimeric emission at 77 K, 
but which also displayed purely monomeric emission at 10-7 M at RT.  
  
Figure 5.20: 77 K spectra of complexes L26(Pt(dpybX))2 in butyronitrile glass split into 
complexes with no CF3 substituents (left) and complexes with CF3 substituents (right). 
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5.3.2.3 Comparison with mononuclear analogues  
The comparison with mononuclear analogues containing an acetylide instead of a chloride 
as an ancillary ligand was not possible owing to the fact they have not been synthesised. In 
lieu of this, comparisons with Pt(dpybX)Cl complexes, which were the starting materials in 
the syntheses of these dinuclear complexes, are made. The concentration-dependent 
emission for two of these Pt(dpybX)Cl complexes, namely where X= 2 x CF3 (B) and H (A), 
are shown earlier on for their comparison with class 1 complexes (Fig. 5.13).  
Class 2 complexes L26(Pt(dpybA))2 and L26(Pt(dpybB))2 display similar behaviour to their 
respective class 1 compounds L24(PtCl)2 and L25(PtCl)2 (discussed previously) when 
comparing their emission to their mononuclear analogues. Complex L26(Pt(dpybA))2 has a 
slightly larger ksq value in comparison to Pt(dpyb)Cl (5.7 vs. 5.3 x 109 M-1 s-1) and lower 
quantum yield of 35 % compared to 60 % for Pt(dpyb)Cl. L26(Pt(dpybB))2 on the other hand 
has a slightly larger ksq value in comparison to Pt(dpybB)Cl (1.9 vs. 3.1 x 109 M-1 s-1) and the 
quantum yield is seen to be exactly the same for each at 21 %. The relative intensity of 
excimer formation in complex L26(Pt(dpybA))2 is seen to be higher than Pt(dpyb)Cl but lower 
than that of L25(PtCl)2 which suggests that the class 1 compounds could have an excited 
state geometry for which intramolecular excimer formation is more accessible compared to 
the class 2 compounds. 
L26(Pt(dpybC))2has been highlighted as displaying intriguing photophysical behaviour. At 
very low concentrations and at RT, it displays properties which are very similar to the 
mononuclear complex Pt(dpybC)Cl, where X= 2 x CF3 and 1 x tBu (Fig. 5.21). In contrast to 
this, the extent of excimer formation is still much greater for L26(Pt(dpybC))2 than for 
Pt(dpybC)Cl at equivalent concentrations. 
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Pt(dpybC)Cliii Pt(dpybE)Cliv 
  
φ = 0.48 φ = 0.12 
λmax = 533, 562 (747) nm λmax = 592, 641, 695sh (785) nm 
τ0 = 5.8 μs τ0 = 3.3 μs 
ksq = 1.2 x 109 M–1s–1 ksq = 5.2 x 109 M–1s–1 
Figure 5.21: Concentration-dependent emission of Pt(dpybX)Cl complexes and photophysical 
properties of complexes λmax values for the excimer are quoted in the parentheses.  
On comparing the emission spectra of the mononuclear complex Pt(dpybE)Cl  (Fig. 5.21) 
and the dinuclear complex L26(Pt(dpybE))2 (Fig. 5.18), there is a stark contrast in the amount 
of excimer formation between the two. At the highest concentrations investigated 
(between 2 and 3 x 10-4 M for each complex), Pt(dpybE)Cl  showed a relativley small 
amount of excimer formation. This is also likely to be accentuated due to the fluorimeter 
correction accounting for weaker detection of the lamp in the red and NIR regions, 
particularly for weakly-emitting samples such as this one. On the contrary, the emission of 
L26(Pt(dpybE))2 was dominated by excimeric emission with λmax of 780 nm. This high 
propensity for excimer formation thus reflects the behaviour of complex L26(Pt(dpybA))2 
and its mononuclear derivative Pt(dpyb)Cl.  
                                                          
iii This complex was synthesised by Chris Harris (MChem student) and photophysical data was carried 
out by Professor J. A. Gareth Williams.  
iv This complex was synthesised by Rebecca Salthouse (MChem student) and photophysical data was 
carried out by me. 
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Table 5.5: Photophysical properties of class 1 and 2 complexes in DCM solution at 298 K and in butyronitrile glass at 77 K. Excimer results are shown 
in red. *A triexponential lifetime which had a large error associated with the fit was obtained so is not recorded here.  
 
Complex 
298 K 77 K 
λabs  
(nm) 
λem  
(nm) 
τdeg  
(ns) 
τaer  
(ns) 
τ0 
(μs) 
φ 
(%) 
kr  
(103 s-1) 
knr  
(105 s-1) 
kq (O2) 
(107 M-1  s -1) 
ksq (mono) 
(109 M-1 s -1) 
λem  
(nm) 
τ  
(μs) 
L24(PtCl)2 386 (14650), 412 (9940), 
495sh (350). 
690 5400 
(1400) 
990 
(260) 
7.5 15 28 1.56 37 2.9 500, 538, 
578, 614 
7.3 
/ 
L25(PtCl)2 262 (55721), 301 (30431), 
353 (6741), 384 (5403), 
405 (7217), 429 (6189).   
540, 770 6400 
(440) 
1100 
(290) 
6.7 5 7.8 1.5 34 0.40 544, 573, 
731 
5.6 
(2.6) 
L26(Pt(dpybA))2 268 (34359), 321 (12885), 
374 (4813), 400 (6119) 
690 4800 
(1700) 
3100 
(740) 
6.2 35 73 1.4 5.1 
 
5.7 493, 527, 
565, 638 
5.4 
(3.0) 
L26(Pt(dpybB))2 268 (65245), 287 (46005), 
302 (42998), 404 (14832), 
484 (3495). 
515, 
550, 765 
4600 
(660) 
1000 
(360) 
5.2 21 45 1.7 36 1.9 514, 525, 
548, 586, 
715 
5.0 
(2.6) 
L21(Pt(dpybC))2 260 (99509), 308 (61357), 
435 (13748), 482 (8575).  
530, 
566, 760 
5500 
(690) 
790 
(340) 
6.2 5 9.1 
 
1.7 
 
49 
 
0.99 715 / 
(2.4) 
L26(Pt(dpybD))2 268 (80915), 316 (48318), 
422 (12407), 495 (5073). 
526, 
555, 757 
5600 
(690) 
1100 
(400) 
5.8 16 29 1.5 35 2.4 533, 567, 
729 
13 
(*) 
L26(Pt(dpybE))2 276 (141563), 323(63832), 
345(46716), 449(28262) 
590, 780 3200 
(410) 
540 
(260) 
3.7 5 16 3.0 70 3.8 593, 644, 
758 
5.3 
(2.4) 
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5.3.3 Solid-state photophysical properties of Class 1 and 2 complexes 
Complexes L24(PtCl)2, L25(PtCl)2, L26(Pt(dpybA))2, L26(Pt(dpybC))2 and L26(Pt(dpybE))2 were 
also tested for their photophysical properties in the solid-state by doping into thin films of 
polystyrene (PS) at concentrations of 1, 5 and 20 wt. % and as neat films. Complexes 
L26(Pt(dpybB))2 and L26(Pt(dpybD))2 were not studied due to their inferior solubility needed 
for spin-coating the films. Class 1 complexes were seen to show mainly monomer emission 
at concentrations of 1-20 wt. % doping in PS, but in the neat film L24(PtCl)2 emission was 
dominated by excimer formation and L25(PtCl)2 had a large proportion of excimer emission 
whilst retaining some monomer emission (Fig. 5.22). Class 2 complexes, on the other hand, 
showed largely excimeric emission at all concentrations tested.  
L24(PtCl)2 
 
L25(PtCl)2 
 
L26(Pt(dpybA))2 
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L26(Pt(dpybC))2 
 
L26(Pt(dpybE))2 
 
Figure 5.22: Solid-state emission spectra for the dinuclear complexes at different 
concentrations in polystyrene (PS).v  
Table 5.6: PLQY values of class 2 complexes in the solid-state.  
Film/Complex L26(Pt(dpybA))2 L26(Pt(dpybC))2 L26(Pt(dpybE))2 
1 % in PS 0.57 0.17 0.13 
5 % in PS 0.38 0.09 0.11 
20 % in PS 0.36 0.10 0.07 
Neat film 0.22 0.02 0.04 
In the case of class 1 compounds, intermolecular interactions with the PS matrix (e.g. π-π 
stacking between phenyl rings in PS and on the N^C^N groups of the dinuclear complexes) 
could prevent intramolecular excimer formation at low concentrations and hence may 
explain why only monomer emission is observed. Meanwhile at higher concentrations, 
these intermolecular interactions with PS could be weakened by the preference to form 
intramolecular excimers. This is definitely not the case in class 2 compounds where excimer 
formation of either an intermolecular or intramolecular nature dominates at all 
concentrations.  
The PLQY values were determined for the class 2 compounds (Table 5.6) and 
L26(Pt(dpybA))2 in particular showed impressive results with φ = 0.57 at a 1 wt. % doping 
concentration in PS. At this concentration, although there is still some monomer emission 
present, the vast majority of emission is centred deep into the red with λmax = 680 nm. The 
PLQY values for L26(Pt(dpybE))2 in different films are lower than those for L26(Pt(dpybA))2 
where φ = 0.13 at a 1 wt. % doping concentration in PS, but the emission maximum is 
                                                          
v Solid-state emission carried out by Piotr Pander (Durham University Physics department).   
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centred well into the NIR at ca. 780 nm in this case.  
Consequently, the behaviour in the solid-state identifies the class 2 compounds as the most 
promising in terms of incorporation into NIR OLEDs. Complex L26(Pt(dpybE))2 displays 
impressive photophysical properties with emission at  λmax of 780 nm in PS doped films up 
to 20 wt. % and a λmax of 800 nm in a neat film, making it the most red-shifted out of all the 
compounds investigated. 
5.4 Chapter 5 Summary 
A range of dinuclear PtII complexes containing tridentate N^C^N ligands have been 
synthesised with high PLQY values for red and NIR emitting complexes between 5 and 35 %. 
Investigation into class 1 compounds introduced the dramatic impact that substituents on 
the N^C^N group can have in affecting complex emission and posed the question of 
whether excimer formation occurs through intra/inter molecular interactions, or a mixture 
of both.  
Class 2 compounds were seen to display similar trends in terms of photophysical behaviour 
to class 1 compounds where CF3 substituents on the N^C^N ring appeared to reduce the 
amount of excimer formation in both cases. Complex L26(Pt(dpybC))2 was highlighted as 
displaying unusual behaviour owing to its purely monomeric emission in low concentration 
solution at RT versus its purely excimeric emission at 77 K. Complex L26(Pt(dpybE))2 was 
seen to display emission well into the NIR in the solid-state with λmax at ca. 800 nm and this 
was nearly all excimeric. All of which demonstrates the high potential these complexes 
possess for incorporation into NIR OLEDs.   
This work was undertaken right at the end of the period of study and the question that still 
remains is the extent to which the emission that is observed in these class 1 and 2 
complexes is intra-/intermolecular in origin. 
Evidence for intra-/intermolecular excimers: 
Intra 
• Class 1 complex L24(PtCl)2 shows almost exclusively excimer emission at all 
concentrations investigated in solution-state emission. 
• Class 1 complex L25(PtCl)2 shows presence of both monomer and excimer emission 
at all concentrations investigated and never solely monomer emission 
• The 77 K emission for all complexes except L24(PtCl)2 shows either all excimer or a 
mix of excimer and monomer emission 
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• The crystal structure of L26(Pt(dpybE))2 shows shorter intramolecular PtPt 
distances of 3.98 Å compared to L26(Pt(dpybD))2, which could reflect the possibility 
of even closer distances upon rearrangement in the excited state (i.e. < 3.5 Å). 
• The solid-state emission in PS films of class 2 compounds shows largely excimeric 
emission.  
Inter 
• Stern-Volmer plots follow a linear trend for both class 1 and class 2 complexes i.e. 
as the concentration increases, monomer lifetimes decrease owing to the 
formation of excimers. If purely intramolecular in nature, then the lifetimes would 
not be concentration dependent as they would always reflect the excimer lifetime.  
• Class 2 complex L26(Pt(dpybC))2 shows purely monomeric emission at the lowest 
concentration investigated. 
• The 77 K emission for complex L24(PtCl)2 shows purely monomeric emission. 
• The crystal structure of L26(Pt(dpybD))2 has the longest intramolecular PtPt 
distances of 5.00 Å. 
The photophysical properties of these molecules need further investigation to deduce 
exactly which interactions are present in the excited state, however, possible explanations 
for the above observations are as follows;  
• L24(PtCl)2 has enough energy to orient itself in a face-to-face conformation at RT to 
show intramolecular excimers but at 77 K exists in a state which does not allow 
face-to-face conformation. 
• The presence of CF3 groups in L25(PtCl)2, L26(Pt(dpybB))2, L26(Pt(dpybC))2 and 
L26(Pt(dpybD))2 makes it harder for the complexes to adopt a face-to-face 
conformation at RT owing to steric hindrance and so a mix of intra- and 
intermolecular excimers are displayed and the crystal structures obtained help 
prove this as the PtPt distances are not short enough to support intramolecular 
PtPt interactions 
• Complexes L26(Pt(dpybA))2 and L26(Pt(dpybE))2 are similar to L24(PtCl)2 owing to the 
lack of CF3 substituents, but the presence of the alkyne group on the linker gives 
more flexibility to the molecule so that the face-to-face conformation is not locked 
at RT and so a mix of intra- and intermolecular interactions is observed, although 
intramolecular interactions dominate.  
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Despite the uncertainty in the origin of the excimeric emission in these dinuclear Pt 
complexes containing N^C^N ligands, the fact stands that they show efficient NIR emission 
and have good solubility for potential use in solution-processable NIR OLEDs. Indeed, future 
work on this area would first and foremost aim to determine the origin of excimeric 
emission as intra/intermolecular or as a mixture of both. This would hopefully be 
determined by detailed investigation into the kinetics of excimer formation. These 
complexes are also currently under investigation for incorporation into OLED devices and 
these results will be very informative as to which compounds would give the best 
performance in a scaled-up device. Moreover, the synthesis of other derivatives of these 
dinuclear complexes should be attempted to try to eliminate any visible emission, trace 
amounts of which are still noticeable in both the solid and solution-state spectra, in order 
to obtain pure NIR emission.  There is a lot of promise in this area of work which will 
hopefully be continued.  
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6. Concluding remarks and future work 
A range of complexes based on the transition metals Pt, Pd and Ir has been synthesised. 
Investigation into ligands offering bidentate, tridentate or tetradentate coordination modes 
to the metal centres has led to complexes with interesting photophysical properties. 
Moreover, the incorporation of more than one metal centre to generate dinuclear 
complexes has presented intriguing results which could be the basis of substantial further 
research. Incorporation of selected complexes into both thermally-evaporated and 
solution-processed OLEDs has also shown impressive results for some complexes.  
PtII complexes containing 1,2,4-triazole and tetrazole ligands were synthesised and probed 
for their excimeric emission. The homoleptic triazole complexes PtL12 and PtL72 exhibited 
impressive photophysical properties with PLQY values of 21 and 48 % respectively in 
degassed DCM solutions. These were incorporated into solution-processed devices that 
displayed red emission with maximum EQEs of 12.5 and 11.2 % respectively. At higher 
doping concentrations, the emission became increasingly red-shifted owing to the 
increased excimeric contribution. A VTE device of PtL12 at 30 wt. % in mCP was also 
fabricated. It showed increased efficiency with maximum EQE of 14.9 %. Other complexes 
containing the bidentate triazole ligands that showed impressive solution-state 
photophysical properties included the heteroleptic Pt(thpy)Ln complexes with PLQY values 
ranging from 30 to 37 %. These also showed a concentration-dependence of their emission 
and would be interesting to incorporate into OLED devices. The tetrazole complexes that 
were synthesised were largely difficult to study owing to their limited solubility. The 
exception was complex PtL142 which was soluble enough for incorporation into a solution-
processed OLED at 10 wt. % in a PVK : OXD7 (50 : 50) host and which showed a 3.8 % EQE.  
In order to study more of these tetrazole complexes in the future, more soluble derivatives 
should be made, possibly by incorporating bulky hydrocarbon substituents on the 4-pyridyl 
substituted phenyl rings such as adamantyl groups (Scheme 6.1). 
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Scheme 6.1: Synthesis of tetrazole Pt complex with adamantyl substituents. 
PtIV complexes with ‘3+2+1’ and bis-tridentate conformations displayed impressive 
photophysical properties. The 3+2+1 complex [Pt(dpyb)L1Cl]+ had a PLQY of 5.9 % and a 
lifetime of 3.1 µs. On increasing the denticity of the triazole ligand from bidentate to 
tridentate, a PLQY of 28 % and a lifetime of 11 µs were shown for [Pt(dpyb)L16]+, which 
appears to be the first reported example of a PtIV  bis-tridentate complex. Different series of 
Ir complexes with similar bis-tridentate and 3+2+1 structures were also synthesised and 
showed lower efficiencies overall. PLQY values ranging from 0.35 to 1.8 % were displayed 
for the bis-tridentate Ir(dpybX)(L16-18) complexes, whilst the 3+2+1 Ir(dpybMe2)(L1-3)Cl 
complexes were found to be non-emissive at RT and only emissive at 77 K. In comparison 
with their isoelectronic IrIII analogues, the PtIV complexes displayed more impressive 
properties which should be investigated further through the synthesis of different 
derivatives for potential future incorporation into devices such as LEECs. Moreover, it 
would be interesting to see the effect on the photophysical properties by metathesising the 
ancillary chloride ligand with a strong field ligand such as an acetylide in the case of 
[Pt(dpyb)LnCl]+ complexes (Scheme 6.2).  
 
Scheme 6.2: Metathesis of the ancillary chloride ligand in [Pt(dpyb)L1Cl]+for an acetylide 
using 1-ethynyl-3,5-bis(trifluoromethyl)benzene as the reagent in this case. 
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A range of Pt and Pd complexes containing tetradentate ligands were discussed based on 
the work of former Ph.D. student Mickaële Bonneau. The complexes were investigated for 
their concentration-dependent photophysical properties. PtL20, containing the 
difluorophenyl ligand, showed the highest propensity for excimer formation whereas ML21 
and ML22 (where M = Pt and Pd) showed no evidence of excimer formation but had 
improved photophysical properties in comparison to the others in the series. For this 
reason, the thiophene ligand-containing complex PdL21 was studied for its solid-state 
photophysical properties and was also incorporated into a solution-processed OLED which 
had an EQE of 3.17 %. It would, therefore, be interesting to investigate further these Pd 
complexes for their excimeric emission, by studying more concentrated films of these 
complexes and derivatives. Complex PtL23 was also synthesised which contained an indole-
based tetradentate ligand. It had a PLQY of 33 % in DMSO and it would be interesting to see 
the performance of more soluble derivatives in OLED devicesMoreover, although the 
attempted synthesis of a Pd analogue of PtL23 was unsuccessful, extended efforts to achieve 
another derivative could be attempted to see if high luminescence efficiencies in Pd 
analogues could be obtained (Fig. 6.1).  
 
Figure 6.1: Structures of Pt and Pd complexes containing indole-based tetradentate ligands 
that could potentially be synthesised to achieve higher solubility of the complexes. 
Finally, dinuclear complexes containing Pt(N^C^N) units rigidly linked in a face-to-face 
conformation by a xanthene core were synthesised and displayed intriguing photophysical 
properties. Both monomeric and excimeric emission were shown by these complexes with 
PLQY values ranging from 5 to 35 % in degassed solution and up to 57 % in thin films. The 
excimeric emission extended well into the NIR region and the complex L26(PtdpybE)2 was 
seen to display the most promising properties with mostly excimeric emission (λmax of       
780 nm in solution and 800 nm in a neat film). The emissive properties of these dinuclear 
complexes were seen to differ significantly from the mononuclear derivatives; however, the 
exact nature of the excimeric emission is still unclear. As this work was done at the very end 
of this project, more investigation will be required in the future in order to gain a clearer 
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understanding of the mechanism of emission in each case. A very interesting basis to build 
on has thus been developed where high efficiency NIR OLEDs could be in reach. Overall, a 
diverse range of luminescent metal complexes has been synthesised and more work, 
particularly to synthesise more soluble derivatives of certain complexes for OLED 
incorporation, would be extremely insightful.  
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7. Experimental 
7.1 General Experimental  
7.1.1 Materials  
Reagents were obtained from commercial sources and used without further purification 
unless stated otherwise. All solvents used in preparative work were at least Analar grade 
and water was purified using the PuriteSTILL plusTM system. Dry solvents were obtained from 
HPLC grade solvent that had been passed through a Pure Solv 400 solvent purification 
system and stored over activated 3 or 4 Å molecular sieves. For procedures involving dry 
solvent, glassware was oven-dried for at least 8 hours prior to use. Dedicated oxygen-free 
argon cylinders (BOC, UK) were used to provide an inert atmosphere.   
7.1.2 Physical Measurements 
NMR spectra were recorded on a Bruker Avance-400 (400 MHz 1H and 100 MHz 13C) 
spectrometer. Two-dimensional NMR (COSY, NOESY, HSQC and HMBC) were acquired by 
the solution state NMR service at Durham University on Varian VNMRS-600 (600 MHz) or 
VNMRS-700 (700 MHz) instruments. Chemical shifts (δ) are in ppm, referenced to residual 
protio-solvent resonances, and coupling constants are given in Hertz.  
ES-MS data were obtained on a Waters TQD mass spectrometer interfaced with an Acquity 
UPLC system with acetonitrile as the carrier solvent. ASAP experiments were performed on 
Waters Xevo QToF mass spectrometer. 
Thin-layer chromatography (TLC) was carried out using silica plates (MerckArt 5554) for all 
ligands and alumina plates (Merck 60 neutral) for all complexes, which are fluorescent upon 
irradiation at 254 nm. Column chromatography was carried out using silica (Merck 60, 230-
400 mesh) for all ligands and alumina (Merck aluminium oxide 90, standard) for all 
complexes.  
Melting points were measured on a Gallenkamp melting point apparatus. 
Elemental analysis was performed by Dr. Emily Unsworth using an Exeter CE-440 Elemental 
Analyser device (University of Durham elemental analysis service).  
UV/Vis-Electronic spectra were recorded on a Biotek Instruments UVIKON XS spectrometer 
operating with LabPower software.  
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Solution-based emission spectra were acquired on a Jobin Yvon Spex Fluoromax-2 
spectrometer. All samples were contained within quartz cuvettes of 1 cm path length. 
Samples that were to be measured in the absence of air were degassed within the cuvette 
by three freeze-pump-thaw (FPT) cycles. Emission was recorded at 90° to the excitation 
source, and appropriate filters were used when required to remove second-order peaks. All 
emission spectra were corrected after acquisition for dark count and for the spectral 
response of the detector. The quantum yields were determined relative to a reference of 
an aqueous solution of [Ru(bpy)3]Cl3. The quantum yield of this complex is well established 
in air-equilibrated H2O to be 0.028.191 To measure the quantum yield, a sample of the 
complex was prepared so that the absorbance at the excitation wavelength was below 0.1 
and a solution of [Ru(bpy)3]Cl3 with a similar intensity was prepared. The emission spectra 
of the complex and reference were measured under identical conditions and the quantum 
yield was determined by equation  
𝜑 = 𝜑𝑠𝑡 ×  
𝐼
𝐼𝑠𝑡
×
𝐴𝑠𝑡
𝐴
×
𝑛2
𝑛𝑠𝑡
2       (9) 
φ represents the quantum yield, I the overall integrated intensity, A the absorbance at the 
excitation wavelength and n2 the refractive index of the solvent, the subscript st denotes 
the standard and all other values the sample.  
Lifetimes were determined using an Edinburgh Instruments OB920 fluorimeter. 
Luminescence lifetimes of the complexes up to approximately 10 µs were measured by 
time-correlated single-photon counting method, using an EPL405 pulsed-diode laser as 
excitation source (405 nm excitation, pulse length of 60 ps). The laser repetition rate was 
selected so that the pulse period was at least 5-10 times longer than the complex lifetime. 
The emission was detected at 90° to the excitation source, after passage through a 
monochromator, using a Peltier-cooled R928. Lifetimes in excess of 10 µs were measured 
by multichannel scaling, and a xenon microsecond flash lamp was used as the excitation 
source (excitation wavelength matched to a suitable absorption band of the complex). The 
lifetimes were obtained by least-squares fitting to a mono-exponential decay and 
goodness-of-fit was assessed from the residuals. Low temperature (77 K) experiments were 
performed using a glass vacuum cold finger apparatus built in house. A small amount of 
sample was dissolved in either a 2:2:1 solvent mix of ether/isopentane/ethanol (EPA) or 
butyronitrile and placed into a glass tube. The cold finger was filled with liquid nitrogen and 
the tube containing the sample was inserted.   
204 
 
 
7.1.3 OLED Fabrication 
All solution-processed OLEDs were fabricated by Piotr Pander (Durham Univeristy Physics 
Department) according to the following procedure: 
OLEDs were fabricated by spin-coating / evaporation hybrid methods. The hole injection 
layer (Heraeus Clevios HIL 1.3N) and EML (mCP : OXD-7 or mCP:PO-T2T + dopant) were 
spin-coated, whereas the ETL (TPBi or PO-T2T) and cathode (LiF/Al) were evaporated. 
Devices of 4 x 2 mm pixel size were fabricated. PO-T2T (sublimed, LUMTEC), mCP 
(sublimed, LUMTEC), OXD-7 (sublimed, LUMTEC), TPBi (sublimed, LUMTEC), LiF (99.995%, 
Sigma Aldrich), and aluminium wire (99.9995%, Alfa Aesar) were purchased from the 
companies indicated in parentheses. OLED devices were fabricated using pre-cleaned ITO 
coated glass substrates after ozone plasma treatment with a sheet resistance of 20 Ω cm-2 
and ITO thickness of 100 nm. Heraeus Clevios HIL 1.3N was spin-coated and annealed onto 
a hotplate at 200 ˚C for 3 min to give a 45 nm film. The EML was spin-coated from a 
chloroform : chlorobenzene (95:5 v/v) solution of mCP:OXD-7 (80:20 w/w) or mCP:PO-T2T 
(70:30 w/w) with the total concentration of host + dopant kept at 20 mg/mL. The dopant 
was dissolved in the host solution in order to obtain the final 5-30 % (w/w) concentration in 
the EML. The solution was spin-coated onto the HIL 1.3N layer and then annealed at 50 ˚C 
for 5 min giving a 60 ± 5 nm (mCP : OXD-7) and 70 ± 5nm (mCP : PO-T2T) film. All solutions 
were filtrated directly before application using a syringe filter with 0.45 µm pore size. All 
other organic and cathode layers were thermally evaporated using Kurt J. Lesker Spectros II 
deposition system at 10-6 mbar. All organic materials and aluminum were deposited at a 
rate of 1 Å s-1 and the LiF layer was deposited at 0.1-0.2 Å s-1. Characterisation of OLED 
devices was conducted in 10 inch integrating sphere (Labsphere) connected to a Source 
Measure Unit. 
VTE devices of PtL12 were fabricated by me under the supervision of Kazuya Jinnai at the 
Adachi Laboratory, Kyushu University, Japan.  
7.1.4 Crystallography  
Single-crystal X-ray data were collected on a Bruker D8Venture diffractometer (IμS 
microfocus sources, focusing mirrors, CMOS Photon100 detector) using MoKα (λ =     
0.71073 Å) radiation, equipped with Cryostream (Oxford Cryosystems) open-flow nitrogen 
cryostats, the temperature on the crystals was maintained at 120.0 K. Smaller crystals were 
taken to the synchotron Diamond light source using λ = 0.6889 Å radiation and a 
temperature of 100 K. All structures were solved by direct methods and refined by full-
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matrix least squares on F2 for all data using SHELXTL190 and OLEX2191 software by           
Dr. D. S. Yufit (University of Durham). 
7.1.5 Density Functional Theory 
DFT geometry optimisations, frequency, stability and TD-DFT excitation calculations were 
performed using Gaussian 09. The geometry optimizations of the complexes were 
performed at the B3LYP192,193,194 level of theory and LANL2DZ basis set for all atoms. 
 
7.2 Synthesis Procedures 
The following synthesis procedures were used frequently throughout this work, featuring in 
the synthesis of many ligands and will be referred to in the main experimental chapter.  
7.2.1 Suzuki cross-coupling 
An aryl halide, a boronic acid derivative and Na2CO3 were dissolved in a mixture of 
dimethoxyethane (DME) and water (1:1). The reaction mixture was degassed by 3 x FPT 
cycles and put under an argon atmosphere. The catalyst, tetrakis(triphenylphosphine) 
palladium, Pd(PPh3)4 was then added to the solution and the mixture was heated at 85 °C 
for 24 h. After cooling to RT, the solution was poured into water and the organic layer was 
extracted with DCM (typically 2 × 10 mL) and washed with water (2 × 10 mL). The organic 
layer was dried over MgSO4, filtered, and the solvent was removed in vacuo. The crude 
product was purified by column chromatography on silica gel. 
7.2.2 Stille cross-coupling  
Toluene was added to a mixture of an aryl halide, a stannane derivative and LiCl. The 
mixture was degassed by 3 FPT cycles and the catalyst bis(triphenylphosphine) palladium 
dichloride Pd(PPh3)2Cl2 was then added to the mixture. The reaction was heated at 110 °C 
for 48 h under argon. After cooling to RT, saturated aqueous potassium fluoride (KF) 
solution (ca. 5 mL) was added and left to stir for a further 30 mins. The solution was then 
filtered and an insoluble grey powder was removed by filtration and washed with toluene. 
The combined toluene washings were removed under reduced pressure giving a 
brown/orange oil. This was extracted into 100 mL of DCM and washed with aqueous 
sodium hydrogen carbonate (NaHCO3) (5 % by mass, 2 x 100 mL). The organic layer was 
dried over MgSO4, filtered and the solvent was removed in vacuo. The crude product was 
purified by column chromatography on silica gel.  
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7.3 Chapter 2 Synthesis  
7.3.1     1,2,4-Triazoles 
7.3.1.1. Intermediate and ligand general procedures  
Step 1 intermediates (I1x) 
Hydrazine monohydrate was added to 2-cyanopyridine or derivative thereof in ethanol. The 
reaction mixture was stirred at RT overnight, yielding a suspension. The precipitate was 
filtered off, washed with cold ethanol, and dried in vacuo.  
Step 2 intermediates (I2x) 
An oven-dried, nitrogen-purged Schlenk tube was loaded with I1x and Na2CO3, then 
evacuated, gently heated, and refilled with nitrogen after being cooled to RT. Dry DMF was 
added and the suspension was cooled to 0 °C. In a separately prepared Schlenk tube, a 
solution of a benzoyl chloride in dry DMF was prepared in the same way. This solution was 
then slowly added to the cooled suspension under vigorous stirring. The reaction mixture 
was warmed to RT and then water was added to yield more precipitate. This suspension 
was stirred vigorously for another 1.5 hours, filtered and washed with water thoroughly 
before being dried in vacuo.  
Triazole ligand (HLn) 
I2x was suspended in ethylene glycol in a 100 mg/mL ratio in an open round-bottom flask. 
This suspension was heated to 180 °C, eliminating water. Once the solution turned clear, 
the reaction mixture was heated under reflux for another hour. After the reaction mixture 
was cooled to RT, the product was precipitated with water and stirred vigorously for a 
further hour. The solid was filtered through a Whatman membrane filter (0.2 µm, nylon), 
washed with water, and dried in vacuo.  
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7.3.1.2     1,2,4-Triazoles with no substitution on the pyridyl ring 
Step 1 intermediates 
Compound I1a 
 
2-Cyanopyridine (500 mg, 4.80 mmol) and hydrazine monohydrate (2.5 mL, 48.02 mmol) in 
EtOH (25 mL). A pale yellow solid was obtained (680 mg, 67 %). The experimental data 
obtained were in good agreement with the literature.195  
Compound I1b  
 
Quinoline-2-carbonitrile (1 g, 6.49 mmol) and hydrazine monohydrate (3.2 mL, 64.9 mmol) 
in EtOH (50 mL). A yellow solid was obtained (976 mg, 81 %); 1H NMR (599 MHz, 
Chloroform-d) δ 8.13 – 8.11 (m, 2H, H3 and H4), 8.05 (ddt, J = 8.4, 1.2, 0.7 Hz, 1H, H8), 7.80 
(ddd, J = 8.1, 1.5, 0.6 Hz, 1H, H5), 7.69 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H, H7), 7.52 (ddd, J = 8.1, 
6.9, 1.2 Hz, 1H, H6), 5.39 (s, 2H, Hd), 4.75 (s, 2H, Ha and Hc); 13C NMR (151 MHz, Chloroform-
d) δ 150.5 (C2), 148.6 (Cb), 146.8 (C10), 136.1 (C3/4), 129.5 (C7), 129.3 (C8), 128.3 (C9), 127.5 
(C5), 126.7 (C6), 117.5 (C3/4); ES+) m/z = 187.6 [M + H]+; HRMS (ES+) m/z = 187.0967 [M + H]+; 
calculated for [C10H11N4]+ 187.0984.  
Compound I1c 
 
6-methoxy-2-quinoline carbonitrile (500 mg, 2.71 mmol) and hydrazine monohydrate (2.64 
mL, 54.20 mmol) in ethanol (25 mL). A pale yellow solid was obtained after recrystallization 
in hot EtOH (186 mg, 32 %); 1H NMR (700 MHz, Chloroform-d) δ 8.08 (d, J = 8.7 Hz, 1H, H8), 
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8.01 (d, J = 8.7 Hz, 1H, H7), 7.95 (d, J = 9.1 Hz, 1H, H3), 7.34 (dd, J = 9.2, 2.8 Hz, 1H, H4), 7.07 
(d, J = 2.8 Hz, 1H, H5), 5.36 (s, 2H, Hd), 4.69 (s, 2H, Ha and Hc), 3.93 (s, 3H, HOMe); 13C NMR 
(176 MHz, Chloroform-d) δ 158.0 (Cb), 148.9 (C2), 148.4 (C6), 142.7 (C10),  134.9 (C7), 130.7 
(C3), 129.4 (C9), 122.1 (C4), 117.8 (C8), 105.3 (C5), 55.5 (COMe);  MS (ES+) m/z = 218.0 [M + H]+.  
     
Step 2 intermediates  
Compound I2a 
 
I1a (200 mg, 1.47 mmol), Na2CO3 (187 mg, 1.76 mmol), and dry DMF (6.4 mL) in one 
Schlenk. 4-tBu benzoyl chloride (289 mg, 1.47 mmol) and dry DMF (2.4 mL) in the second 
Schlenk. A yellow solid was obtained (217 mg, 50 %); 1H NMR (700 MHz, DMSO-d6) δ 10.11 
(s, 1H, Hc), 8.57 (d, J = 4.5 Hz, 1H, H6), 8.15 (d, J = 8.0 Hz, 1H, H3), 7.88 (td, J = 7.8, 1.7 Hz, 1H, 
H4), 7.79 (d, J = 8.0 Hz, 2H, Hb’), 7.49 – 7.43 (m, 3H, H5 and Hc’), 6.89 (s, 2H, Ha and Hd), 1.29 
(s, 9H, HtBu2); 13C NMR (176 MHz, DMSO-d6)  233.2 (Cb), 163.6 (Ce), 154.2 (Cd’), 151.1 (C2), 
148.5 (C6), 137.3 (C4), 132.4 (Ca’), 127.9 (Cb’), 125.4 (Cc’), 125.1 (C5), 121.1 (C3), 31.4 (C tBu2), 
35.1 (C tBu1); (ES+) m/z = 296.9 [M + H]+; HRMS (ES+) m/z = 297.1716 [M + H]+; calculated for 
[C17H21N4O]+ 297.1715.  
 
Compound I2b 
 
I1a (500mg, 3.67 mmol), Na2CO3 (857 mg, 8.08 mmol) with dry DMF (16 mL) in one Schlenk. 
4-methoxybenzoyl chloride (689 mg, 4.04 mmol) and dry DMF (6 mL) in the second Schlenk. 
An off-white powder was obtained (852 mg; 86 %); 1H NMR (600 MHz, DMSO-d6) δ 10.02 (s, 
1H, Hc), 8.57 (d, J = 4.5 Hz, 1H, H6), 8.14 (d, J = 8.0 Hz, 1H, H3), 7.92-7.80 (m, 3H, H4 and Hb’), 
7.45 (t, J = 6.2 Hz, 1H, H5), 6.99 (d, J = 8.8 Hz, 2H, Hc’), 6.87 (s, 2H, Ha and Hd), 3.80 (s, 3H, 
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HOMe); 13C NMR (151 MHz, DMSO-d6) δ 163.0 (Ce), 161.9 (C2), 151.4 (Ca’), 148.5 (C6), 147.8 
(Cb), 137.3 (C5), 129.9 (Cb’), 125.1 (C4), 121.1 (C3), 113.8 (Cc’), 110.0 (Cd’), 55.8 (COMe); (ES+) 
m/z = 271.4 [M + H]+; HRMS (ES+) m/z = [M + H]+; 271.1199 calculated for [C14H15N4O2]+ 
271.1195. 
Compound I2c 
 
 
I1a (250 mg, 1.84 mmol), Na2CO3 (214 mg, 2.02 mmol) with dry DMF (8 mL) in one Schlenk. 
4-Trifluoromethylbenzoyl chloride (0.27 mL, 1.84 mmol) and dry DMF (3 mL) in the second 
Schlenk. An off-white powder was obtained (308 mg, 43 %); 1H NMR (700 MHz, DMSO-d6) δ 
10.34 (s, 1H, Hc), 8.59 (d, J = 4.4 Hz, 1H, H6), 8.16 (d, J = 8.0 Hz, 1H, H3), 8.06 (d, J = 8.0 Hz, 
2H, Hc’), 7.89 (td, J = 7.7, 1.7 Hz, 1H, H4), 7.84 (d, J = 8.1 Hz, 2H, Hb’), 7.51 – 7.48 (d, J = 5.6 
Hz, 1H, H5), 6.97 (s, 2H, Ha and Hd); 13C NMR (176 MHz, DMSO-d6) δ 162.4 (Ca’), 150.9 (C2), 
149.3 (Cb’), 148.6 (C6), 138.9 (Ce’), 137.4 (C4), 131.4 (CCF3), 129.1 (Cc’), 125.6 (Cb’), 125.4 (C5), 
123.7 (Cd’), 121.3 (C3); 19F NMR (376 MHz, Chloroform-d) δ -62.79; (ES+) m/z = 309.1 [M + 
H]+; HRMS (ES+) m/z = 309.0966 [M + H]+; calculated for [C14H12F3N4O]+ 309.0963.    
 
Compound I2d 
 
I1a (1.52 g, 11.2 mmol), Na2CO3 (1.3 g, 12.3 mmol) and dry DMF (60 mL).                                   
4-n-Butoxybenzoylchloride (2.13 mL, 11.2 mmol) and dry DMF (25 mL) in the second 
Schlenk.  A white solid was obtained (2.9 g, 95 %); 1H NMR (700 MHz, DMSO-d6) δ 10.03 (s, 
1H, Ha), 8.57 (d, J = 4.8 Hz, 1H, H6), 8.15 (d, J = 8.0 Hz, 1H, H3), 7.87 (t, J = 7.5 Hz, 1H, H4), 
7.84 (d, J = 8.3 Hz, 2H, Hb’), 7.45 (t, J = 6.2 Hz, 1H, H5), 6.98 (d, 2H, J = 8.8 Hz, Hc’), 6.89 (s, 2H, 
Hc and Hd), 4.02 (t, J = 6.5 Hz, 2H, HBu1), 1.70-1.68 (m, 2H, HBu2), 1.49 – 1.32 (m, 2H, HBu3), 
0.92 (t, J = 7.4 Hz, 3H, HBu4); 13C NMR (176 MHz, DMSO-d6) δ 163.0 (Ce), 161.4 (Cd’), 151.2 
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(C2), 148.5 (C6), 147.7 (Cb), 137.3 (C4), 129.9 (Cc’), 127.0 (Ca’), 125.0 (C5), 121.1 (C3), 114.3 
(Cb’), 67.8 (CBu1), 31.1 (CBu2), 19.1 (CBu3), 14.1 (CBu4); ES+) m/z = 313.8 [M + H]+; HRMS (ES+) 
m/z = 313.1649 [M + H]+; calculated for [C17H21N4O2]+ 313.1665. 
Compound I2e 
 
I1b (800 mg, 4.3 mmol), Na2CO3 (456 mg, 5.16 mmol) and dry DMF (26 mL) in one Schlenk. 
4-tert-butylbenzoylchloride (0.84 mL, 4.3 mmol) and dry DMF (10 mL) in the second 
Schlenk.  A cream-coloured solid was obtained (1.3 g, 85 %); 1H NMR (599 MHz, DMSO-d6) δ 
10.24 (s, 1H, Hd), 8.41 (d, J = 8.7 Hz, 1H, H3), 8.30 (d, J = 8.7 Hz, 1H, H4), 8.06 (d, J = 8.4 Hz, 
1H, H8), 8.01 (d, J = 8.0 Hz, 1H, H5), 7.84 – 7.76 (m, 3H, Hb’and H7), 7.63 (t, J = 7.5 Hz, 1H, H6), 
7.50 (d, J = 8.0 Hz, 2H, Hc’), 7.03 (s, 2H, Ha and Hc), 1.30 (s, 9H, HtBu2); 13C NMR (151 MHz, 
DMSO-d6) δ 163.7 (Ce), 154.4 (Cd’), 151.3, 147.3 (C2), 146.6, 137.0 (C3), 132.3 (Ca’), 130.5 (C7), 
129.2 (C8), 128.6, 128.4 (C5), 128.0 (C2’’), 127.7 (C6), 125.4 (C3’’), 118.8 (C4), 35.1 (CtBu1), 31.4 
(CtBu2); ESI+) m/z = 348.8 [M + H]+; HRMS (ES+) m/z = 347.1872 [M + H]+; calculated for 
[C21H23N4O]+ 347.1872. 
Compound I2f 
 
I1c (186 mg, 0.86 mmol), Na2CO3 (100 mg, 0.95 mmol) with dry DMF (5.3 mL) in one 
Schlenk. 4-tert-butylbenzoyl chloride (0.17 mL, 0.86 mmol) and dry DMF (2 mL) in the 
second Schlenk. A white powder was obtained after recrystallization in hot EtOH (56 mg,   
17 %); 1H NMR (700 MHz, DMSO-d6) δ 10.19 (s, 1H, Hc), 8.29 (d, J = 8.7 Hz, 1H, H8), 8.24 (d, J 
= 8.6 Hz, 1H, H7), 7.95 (d, J = 9.0 Hz, 1H, H3), 7.80 (d, J = 8.1 Hz, 2H, Hb’), 7.50 (d, J = 8.1 Hz, 
2H, Hc’), 7.43 (dd, J = 9.0, 2.8 Hz, 1H, Hd), 7.41 (d, J = 2.8 Hz, 1H, H5), 6.96 (s, 2H, Ha and Hd), 
3.90 (s, 3H, HOMe), 1.30 (s, 9H, HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 163.6 (Ce), 158.3 (C6), 
154.2 (Cd’), 148.9 (Cb), 147.6 (C2), 142.4 (C10), 135.7 (C7), 132.2 (Ca’), 130.7 (C3), 129.8 (C9), 
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127.9 (Cb’), 125.4 (Cc’), 122.7 (C4), 119.0 (C8), 106.4 (C5), 56.1 (COMe), 35.1 (CtBu1), 31.4 (CtBu2); 
(ES+) m/z = 377.2 [M + H]+; HRMS (ES+) m/z = 377.1980 [M + H]+; calculated for [C14H10F3N4]+ 
377.1978. 
 
HLn Triazoles 
Compound HL1 
 
I2a (500 mg, 1.69 mmol) suspended in ethylene glycol (5 mL). A white solid was obtained; 
(347 mg, 74 %); 1H NMR (600 MHz, Chloroform-d) δ 8.73 (d, J = 10.3 Hz, 1H, H6), 8.31 (dd, J 
= 8.0, 5.0 Hz, 1H, H3), 8.12 (d, J = 8.3 Hz, 2H, Hb’), 7.88 (dd, J = 7.9, 2.2 Hz, 1H, H4), 7.50 (d, J = 
8.5 Hz, 2H, Hc’), 7.40 (ddt, J = 7.6, 4.8, 1.4 Hz, 1H, H5), 1.36 (s, 9H, HtBu2); 13C NMR (151 MHz, 
Chloroform-d) 163.1 (Ce), 152.8 (Cd’), 149.3 (C6), 146.3 (C2), 137.4 (C4), 127.8 (Ca’), 126.2 
(Cb’), 125.4 (Cc’), 124.7 (C5), 121.8 (C3), 34.8 (CtBu1), 31.3 (CtBu2); (ESI+) m/z = 279.8 [M + H]+; 
HRMS (ES+) m/z = 279.1611 [M + H]+; calculated for [C17H19N4]+ 279.1610.  
 
Compound HL2 
 
I2b (500 mg, 1.85 mmol) was suspended in ethylene glycol (5 mL). An off-white powder was 
obtained (405 mg, 87 %); 1H NMR (400 MHz, Chloroform-d) δ 12.74 (s, 1H, Hc), 8.80 (ddd, J 
= 4.9, 1.8, 0.9 Hz, 1H, H6), 8.35 (dt, J = 7.9, 1.1 Hz, 1H, H3), 8.18 (d, J = 8.8 Hz, 1H, Hb’), 7.92 
(td, J = 7.7, 1.7 Hz, 1H, H4), 7.45 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H, H5), 7.03 (d, J = 8.8 Hz, 1H, HC’), 
3.90 (s, 3H, HOMe); 13C NMR (176 MHz; (CD3)2SO) 160.6 (Ce), 149.6 (C6), 146.4 (C2), 137.5 (C4), 
129.1 (Cb), 128.0 (Cc’), 124.9 (C5), 123.6 (Cd’), 121.7 (C3), 114.5 (Ca’), 114.0 (Cb’), 55.3 (COMe); 
(ES+) m/z = 253.4 [M + H]+; HRMS (ES+) m/z =253.1088 [M + H]+; calculated for [C14H13N4O]+ 
253.1089.  
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Compound HL3 
 
 
I2c (200 mg, 0.65 mmol) was suspended in ethylene glycol (2.5 mL). An off-white powder 
was obtained (153 mg, 29 %); 1H NMR (700 MHz, DMSO-d6) δ 8.72 (dt, J = 4.7, 1.4 Hz, 1H, 
H6), 8.28 (d, J = 8.0 Hz, 2H, Hc’), 8.17 (dt, J = 7.8, 1.1 Hz, 1H, H3), 8.01 (td, J = 7.7, 1.8 Hz, 1H, 
H4), 7.85 (d, J = 8.1 Hz, 2H, Hb’), 7.54 (dd, J = 7.6, 4.9 Hz, 1H, H5); 13C NMR (176 MHz, DMSO-
d6) δ 150.1 (C6), 146.5 (Cb), 138.2 (C4), 135.3 (CCF3), 129.8 (Ca’), 127.4 (C2), 127.0 (Cc’), 126.2 
(Cb’), 125.8 (C5), 125.4 (Cd’), 123.9 (Ce), 121.9 (C3); 19F NMR (376 MHz, Chloroform-d) δ -
62.62; MS (ES+) m/z = 291.1 [M + H]+; HRMS (ES+) m/z = 291.0865 [M + H]+; calculated for 
[C14H10F3N4]+ 291.0858.  
 
Compound HL4 
 
I2d (3.00 g, 11.1 mmol) was suspended in ethylene glycol (30 mL). An off-white powder was 
obtained (2.56 g, 74 %);  1H NMR (599 MHz, Chloroform-d) δ 8.81 (ddd, J = 4.9, 1.8, 1.0 Hz, 
1H, H6), 8.34 (dt, J = 7.8, 1.1 Hz, 1H, H3), 8.14 (d, J = 8.9 Hz, 2H, Hb’), 7.89 (td, J = 7.7, 1.7 Hz, 
1H, H4), 7.42 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H, H5), 6.99 (d, J = 8.9 Hz, 2H, Hc’), 4.02 (t, J = 6.5 Hz, 
2H, H1’’’), 1.80 (ddt, J = 9.1, 7.8, 6.5 Hz, 2H, H2’’’), 1.61 – 1.43 (m, 2H, H3’’’), 0.99 (t, J = 7.4 Hz, 
3H, H4’’’); 13C NMR (151 MHz, Chloroform-d) δ 160.3 (C4’’), 149.5 (C6), 146.6 (C2), 137.6 (C5), 
129.1 (C2’), 128.0 (C2’’), 124.8 (C4), 123.2 (C1’’), 121.9 (C3), 114.9 (C4’), 114.6 (C3’’), 67.8 (C1’’’), 
31.3 (C2’’’), 19.3 (C3’’’), 13.9 (C4’’’); MS (ES+) m/z = 295.1 [M + H]+; HRMS (ES+) m/z = 295.1553 
[M + H]+; calculated for [C17H9N4O]+ 295.1559. 
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Compound HL5 
 
I2e (1.20 g, 3.47 mmol) was suspended in ethylene glycol (14 mL). An off-white powder was 
obtained after recrystallization in hot EtOH (497 mg, 44 %); 1H NMR (599 MHz, DMSO-d6) δ 
8.54 (s, 1H, H3), 8.29 (d, J = 8.5 Hz, 1H, H4), 8.13 (d, J = 8.4 Hz, 1H, H8), 8.07 – 8.00 (m, 3H, Hb’ 
and H5), 7.83 (t, J = 7.8 Hz, 1H, H7), 7.66 (t, J = 7.6 Hz, 1H, H6), 7.53 (d, J = 7.9 Hz, 2H, Hc’), 
1.30 (s, 9H, HtBu2); 13C NMR (151 MHz, DMSO-d6) δ 152.7 (Cd’), 147.7 (C3), 130.9 (C7), 129.3 
(C8), 128.6 (Cb’/5), 127.7 (C6), 126.3 (Cb’/5), 126.1 (C3’’), 119.7 (C4), 35.0 (CtBu1), 31.5 (CtBu2); MS 
(ES+) m/z = 329.2 [M + H]+; HRMS (ES+) m/z = 329.1761 [M + H]+; calculated for [C21H21N4]+ 
329.1766.  
Compound HL6 
 
 
I2f (50 mg, 0.13 mmol) was suspended in ethylene glycol (0.7 mL). A beige powder was 
obtained (35 mg, 75 %); 1H NMR (400 MHz, DMSO-d6) δ 14.80 (s, 1H, Hc), 8.45 (d, J = 8.6 Hz, 
1H, H8), 8.26 (d, J = 8.6 Hz, 1H, H7), 8.09-8.03 (m, 3H, H3 and H5), 7.56 (d, J = 8.0 Hz, 1H, Hb’), 
7.53 – 7.45 (m, 2H, Hc’), 3.95 (s, 3H, HOMe), 1.34 (s, 9H, HtBu2); (ES+) m/z = 359.2 [M + H]+; 
HRMS (ES+) m/z = 359.1877 [M + H]+; calculated for [C22H23N4O]+ 359.1872.  
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7.3.1.3      1,2,4-Triazole ligands with 4-pyridyl substitution  
Precursors 
General procedure for pyridyl-substituted carbonitrile precursors (Pn) 
A substituted-2-carbonitrile (1 eq), 4-substituted phenylboronic acid (1.2 eq) and Na2CO3    
(5 eq) were added to a Schlenk with DME and H2O (1:1) and reacted according to the 
general Suzuki cross-coupling method given earlier.  
Compound P1 
 
4-Bromopyridine-2-carbonitrile (1.00 g, 5.46 mmol), 4-tert-butyl phenylboronic acid (1.07 g, 
6.01 mmol) and Na2CO3 (4.6g, 43.7 mmol) with Pd(PPh3)4 (789 mg, 0.68 mmol) in DME (15 
mL) and H2O (15 mL). A white powder was obtained  (1.17 g, 91 %); 1H NMR (700 MHz, 
Chloroform-d) δ 8.71 (dd, J = 5.2, 0.8 Hz, 1H, H6), 7.90 (dd, J = 1.8, 0.8 Hz, 1H, H3), 7.70 (dd, J 
= 5.2, 1.8 Hz, 1H, H5), 7.58 (d, J = 8.4 Hz, 2H, H2’), 7.54 (d, J = 8.4 Hz 2H, H3’), 1.36 (s, 9H, 
HtBu2’); 13C NMR (176 MHz, Chloroform-d) δ 153.8 (C4’), 151.4 (C6), 149.6 (C4), 134.5 (C2), 
132.9 (C1’), 126.7 (C2’), 126.5 (C3’), 126.2 (C3), 124.3 (C5), 117.4 (CCN), 34.8 (CtBu1’), 31.2 (CtBu2’); 
MS (ES+) m/z = 237.3 [M+H]+; HRMS (ES+) m/z = 237.1394 [M+H]+; calculated for [C16H17N2]+ 
237.1392; 
 
Compound P2 
 
4-Bromopyridine-2-carbonitrile (657 mg, 3.60 mmol), 4-methoxy phenylboronic acid       
(600 mg, 3.95 mmol) and Na2CO3 (3.04 g, 28.7 mmol) with Pd(PPh3)4 (207 mg, 0.18 mmol) in 
DME (10 mL) and H2O (10 mL). A white powder was obtained  (700 mg, 93 %);  1H NMR    
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(700 MHz, Chloroform-d) δ 8.67 (d, J = 5.5 Hz, 1H, H6), 7.85 (dd, J = 1.9, 0.8 Hz, 1H, H3), 7.65 
(dd, J = 5.2, 1.9 Hz, 1H, H5), 7.58 (d, J = 8.9 Hz, 2H, H2’), 7.02 (d, J = 8.9 Hz, 2H, H3’), 3.86 (s, 
3H, HOMe); 13C NMR (176 MHz, Chloroform-d) δ 161.4 (C4’), 151.3 (C6), 149.2 (C4),  134.4 (C2), 
128.2 (C2’), 128.0 (C1’), 125.8 (C3), 123.8 (C5), 117.4 (CCN), 114.9 (C3’), 53.4 (COMe); MS (ES+) 
m/z = 211.1 [M + H]+; HRMS (ES+) m/z = 211.0860 [M + H]+; calculated for [C14H10F3N4]+ 
211.0871. 
 
Compound P3 
 
4-Bromopyridine-2-carbonitrile (1.00 g, 5.46 mmol), 4-trifluoromethylphenylboronic acid 
(1.14 g, 6.01 mmol) and Na2CO3 (4.63 g, 43.68 mmol) with Pd(PPh3)4 (789 mg, 0.68 mmol) in 
DME (15 mL) and H2O (15 mL). A white solid was obtained (925 mg, 68 %); 1H NMR         
(700 MHz, Chloroform-d) δ 8.81 (dd, J = 5.1, 0.8 Hz, 1H, H6), 7.91 (dd, J = 1.8, 0.8 Hz, 1H, H3), 
7.80 (d, J = 8.09 Hz, 2H, H2’), 7.74 (d, J = 8.09 Hz, 2H, H3’), 7.72 (dd, J = 5.1, 1.8 Hz, 1H, H5); 
13C NMR (176 MHz, Chloroform-d) δ 151.7 (C6), 148.4 (C4), 139.6 (C4’), 139.5 (C1’), 134.9 (C2), 
132.1 (CCF3), 127.5 (C3’), 126.5 (C2’), 126.4 (C3), 124.7 (C5), 117.0 (CCN); 19F NMR (376 MHz, 
Chloroform-d) δ -62.84; MS (ES+) m/z = 249.1 [M+H]+; MS (ES+) m/z = 249.1 [M + H]+; HRMS 
(ES+) m/z = 249.0630 [M + H]+; calculated for [C13H8F3N2]+ 249.0640.  
Compound P4 
 
4-Bromopyridine-2-carbonitrile (700 mg, 4.00 mmol), 4-benzyloxyphenylboronic acid     
(1.00 g, 4.39 mmol) and Na2CO3 (2.90 g, 27.90 mmol) with Pd(PPh3)4 (230 mg, 0.20 mmol) in 
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DME (15 mL) and H2O (15 mL). A white solid was obtained (1.1 g, 97 %); 1H NMR (400 MHz, 
Chloroform-d) δ 8.72 (dd, J = 5.2, 0.8 Hz, 1H, H6), 7.89 (dd, J = 1.9, 0.8 Hz, 1H, H3), 7.69 (dd, J 
= 5.2, 1.9 Hz, 1H, H5), 7.62 (d, J = 8.9 Hz, 2H, H2’), 7.51 – 7.37 (m, 5H, HBn2, HBn3 and  HBn4), 
7.14 (d, J = 8.9 Hz, 2H, H3’), 5.17 (s, 2H, HCH2); MS (ES+) m/z = 287.2 [M + H]+; HRMS (ES+) m/z 
= 287.1188 [M + H]+; calculated for [C19H15N2O]+ 287.1184. 
 
Step 1 intermediates  
Compound I1d 
 
P1 (1.00 g, 4.23 mmol) and hydrazine monohydrate (2.06 mL, 42.35 mmol) in EtOH (40 mL). 
A white powder was obtained (1.09 g, 96 %); 1H NMR (700 MHz, Chloroform-d) δ 8.52 (dd, J 
= 5.2, 0.8 Hz, 1H, H6), 8.26 (s, 1H, H3), 7.64 (d, J = 8.2 Hz, 2H, H2’), 7.50 – 7.46 (m, 3H, H5 and 
H3’), 5.31 (s, 2H, Ha and Hc), 4.58 (s, 2H, Hd), 1.35 (s, 9H, HtBu2); 13C NMR (176 MHz, 
Chloroform-d) δ 152.4 (C4’), 151.2 (C2), 148.6 (C4), 148.3 (C6), 134.9 (C1’), 126.7 (C2’), 126.0 
(C3’), 121.6 (C5), 117.2 (C3), 34.7 (CtBu1), 31.3 (CtBu2); MS (ES+) m/z = 269.2 [M + H]+; HRMS 
(ES+) m/z = 269.1774 [M + H]+; calculated for [C14H10F3N4]+ 269.1766. 
 
Compound I1e 
 
P2 (250 mg, 1.19 mmol) and hydrazine monohydrate (0.58 mL, 11.90 mmol) in EtOH           
(10 mL). A white powder was obtained (218 mg, 76 %); 1H NMR (700 MHz, Chloroform-d) δ 
8.50 (d, J = 5.3, 1H, H6), 8.21 (s, 1H, H3), 7.64 (d, J = 8.8, 2H, H2’), 7.45 (dd, J = 5.2, 1.9 Hz, 1H, 
H5), 6.98 (m, J = 8.8, 2H, H3’), 5.31 (s, 2H, Hd), 4.58 (s, 2H, Ha and Hc), 3.85 (s, 3H, HOMe); 13C 
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NMR (176 MHz, Chloroform-d) δ 160.5 (C4’), 151.2 (C2), 149.0 (C4), 148.3 (C6),  130.2 (C1’), 
128.2 (C2’), 121.2 (C5), 116.8 (C3), 114.4 (C3’), 58.4 (Cb), 55.4 (COMe); MS (ES+) m/z = 243.1 [M 
+ H]+; HRMS (ES+) m/z = 243.1255 [M + H]+; calculated for [C13H15N4O]+ 243.1246.  
Compound I1f 
 
P3 (370 mg, 1.49 mmol) and hydrazine monohydrate (0.73 mL, 14.90 mmol) in EtOH           
(20 mL). A yellow powder was obtained (342 mg, 82 %);1H NMR (700 MHz, Chloroform-d) δ 
8.59 (dd, J = 5.1, 0.9 Hz, 1H, H6), 8.26 (dd, J = 1.9, 0.8 Hz, 1H, H3), 7.78 (d, J = 8.1 Hz, 2H, H2’), 
7.72 (d, J = 8.1 Hz, 2H, H3’), 7.48 (dd, J = 5.1, 1.8 Hz, 1H, H5), 5.31 (s, 2H, Hd), 4.61 (s, 2H, Ha 
and Hc); 13C NMR (176 MHz, Chloroform-d) δ 151.6 (C2), 148.6 (C6), 148.4 (Cb), 147.3 (C4), 
141.6 (C4’), 127.5 (C2’), 126.0 (C3’), 124.7 (CCF3), 123.2 (C1’), 121.7 (C5), 117.6 (C3); 19F NMR 
(376 MHz, Chloroform-d) δ -62.68; MS (ES+) m/z = 281.1 [M + H]+; HRMS (ES+) m/z = 
281.1016 [M + H]+; calculated for [C13H12F3N4]+ 281.1014.  
 
Compound I1g 
 
P4 (1.00 g, 3.5 mmol) and hydrazine monohydrate (1.7 mL, 35 mmol) in EtOH (50 mL). A 
white powder was obtained (556 mg, 50 %); 1H NMR (700 MHz, Chloroform-d) δ 8.50 (dd, J 
= 5.2, 0.9 Hz, 1H, H6), 8.24 (s, 1H, H3), 7.65 (d, J = 8.9 Hz, 2H, H2’), 7.47 – 7.43 (m, 3H, H5 and 
HBn2), 7.39 (t, J = 7.3 Hz, 2H, HBn3), 7.34 (t, J = 7.5 Hz, 1H, HBn4), 7.06 (d, J = 8.9 Hz, 2H, H3’), 
5.34 (s, 2H, HCH2), 5.11 (s, 2H, Hd), 4.64 (s, 2H, Ha and Hc); 13C NMR (176 MHz, Chloroform-d) 
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δ 159.7 (C4’), 151.1 (C2), 148.3 (C6), 148.2 (C4), 136.6 (CBn1), 130.4 (C1’), 128.6 (CBn3), 128.3 
(C2’), 128.1 (CBn4), 127.5 (CBn2), 121.3 (C5), 116.9 (C3), 115.3 (C3’), 70.1 (CCH2); MS (ASAP+) m/z 
= 319.2 [M + H]+; HRMS (ASAP+) m/z = 319.1553 [M + H]+; calculated for [C19H19N4O]+ 
319.1559. 
Step 2 intermediates  
Compound I2g 
 
I1d (418 mg, 1.56 mmol), Na2CO3 (198 mg, 1.87 mmol) with dry DMF (15 mL) in one Schlenk. 
4-tert butylbenzoyl chloride (0.34 mL, 1.56 mmol) in dry DMF (5 mL) in the second Schlenk. 
A white powder was obtained (600 mg, 90 %); 1H NMR (599 MHz, DMSO-d6) δ 10.15 (s, 1H, 
Hd), 8.62 (d, J = 5.2 Hz, 1H, H6), 8.39 (s, 1H, H3), 7.79 (d, J = 8.0 Hz, 2H, Hb’), 7.76 (d, J = 5.1 
Hz, 1H, H5), 7.73 (d, J = 8.0 Hz, 2H, H2’), 7.56 (d, J = 8.1 Hz, 2H, H3’), 7.48 (d, J = 8.1 Hz, 2H, 
Hc’), 6.93 (s, 2H, Ha and Hc), 1.31 (s, 9H, H tBu2’), 1.29 (s, 9H, HtBu2); 13C NMR (151 MHz, DMSO-
d6) δ 154.1, 152.6, 149.1 (C6), 134.6, 127.9 (Cb’), 127.0 (C2’), 126.6 (C3’), 125.3 (Cc’), 122.4 
(C5), 117.9 (C3), 35.1 (CtBu1), 34.9 (CtBu1’), 31.5-31.4 (CtBu2’ and CtBu2); MS (ES+) m/z = 429.8 
[M+H]+; HRMS (ES+) m/z = 429.2651 [M+H]+; calculated for [C16H17N2]+ 429.2654. 
 
Compound I2h 
 
I1e (400 mg, 1.51 mmol), Na2CO3 (199 mg, 1.88 mmol) with dry DMF (13 mL) in one Schlenk. 
4-tert butylbenzoyl chloride (0.31 mL, 1.51 mmol) in dry DMF (5 mL) in the second Schlenk. 
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A white powder was obtained (500 mg, 80 %); 1H NMR (599 MHz, DMSO-d6) δ 10.13 (s, 1H, 
Hd), 8.58 (d, J = 5.2 Hz, 1H, H6), 8.35 (s, 1H, H3), 7.81-7.72 (m, 4H, H5, Hb’ and H2’), 7.48 (d, J = 
8.0 Hz, 2H, H3’/5’), 7.09 (dd, J = 8.8, 4.7 Hz, 2H, Hc’), 6.92 (s, 2H, Ha and Hc), 3.81 (d, J = 1.1 Hz, 
3H, HOMe), 1.29 (s, 9H, HtBu2); 13C NMR (151 MHz, DMSO-d6) δ 163.6 (Ce), 149.1 (C6), 128.6, 
127.9, 125.4, 122.1 (C5), 117.4 (C3), 115.2, 55.8 (COMe), 55.4, 40.5, 39.7, 35.1 (CtBu1), 31.4 
(CtBu2); MS (ES+) m/z = 403.3 [M + H]+; HRMS (ES+) m/z = 403.2137 [M + H]+; calculated for 
[C24H27N4O2]+ 403.2134. 
Compound I2i 
 
I1f (500 mg, 1.78 mmol), Na2CO3 (208 mg, 1.96 mmol) with dry DMF (16 mL) in one Schlenk. 
4-tert butylbenzoyl chloride (0.35 mL, 1.78 mmol) in dry DMF (6 mL) in the second Schlenk. 
A white powder was obtained (680 mg, 87 %); 1H NMR (599 MHz, DMSO-d6) δ 10.17 (s, 1H, 
Hd), 8.70 (d, J = 5.2 Hz, 1H, H6), 8.45 (s, 1H, H3), 8.03 (d, J = 8.0 Hz, 2H, H2’), 7.90 (d, J = 8.1 
Hz, 2H, H3’), 7.85 (d, J = 4.7 Hz, 1H, H5), 7.79 (d, J = 8.2 Hz, 2H, Hb’), 7.48 (d, J = 8.1 Hz, 2H, 
Hc’), 6.98 (s, 2H, Ha and Hc), 1.29 (s, 9H, HtBu2); 13C NMR (151 MHz, DMSO-d6) δ 163.6 (Ce), 
154.4 (Cd’), 152.2 (Cb), 149.5 (C6), 146.8 (C4), 141.0 (C1’), 132.3 (Ca’), 130.1 (C4’), 128.4 (C2’), 
127.9 (Cb’), 126.6 (C3’), 125.4 (Cc’), 123.0 (C5), 122.9 (C2), 118.6 (C3), 35.1 (CtBu1), 31.4 (CtBu2);  
19F NMR (376 MHz, Chloroform-d) δ -62.72; MS (ES+) m/z = 441.2 [M + H]+; HRMS (ES+) m/z 
= 441.1913 [M + H]+; calculated for [C24H24F3N4O]+ 441.1902. 
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Compound I2j 
 
I1g (400 mg, 1.26 mmol), Na2CO3 (147 mg, 1.38 mmol) with dry DMF (15 mL) in one Schlenk. 
4-tert butylbenzoyl chloride (0.25 mL, 1.26 mmol) in dry DMF (5 mL) in the second Schlenk. 
A shiny silver powder was obtained and used without purification for the next step          
(434 mg, 72%); (ES+) m/z = 479.4 [M + H]+; HRMS (ES+) m/z = 479.2454 [M + H]+; calculated 
for [C30H31N4O2]+ 479.2447. 
 
HLn Triazoles 
Compound HL7 
 
I2g (570 mg, 1.33 mmol) and ethylene glycol (6 mL). A beige powder was obtained (414 mg, 
76 %); 1H NMR (700 MHz, Chloroform-d) δ 8.79 (dd, J = 5.2, 0.8 Hz, 1H, H6), 8.60 (dd, J = 1.9, 
0.8 Hz, 1H, H3), 8.16 (d, J = 8.4 Hz, 2H, Hb’), 7.74 (d, J = 8.4 Hz, 2H, H2’), 7.64 (dd, J = 5.2, 1.9 
Hz, 1H, H5), 7.55 (d, J = 8.4 Hz, 2H, H3’), 7.50 (d, J = 8.4 Hz,  2H, Hc’), 1.38 (s, 9H, HtBu2’), 1.36 
(s, 9H, HtBu2); 13C NMR (176 MHz, Chloroform-d) δ 153.1 (C4’), 152.6 (Cd’), 150.3 (C4), 149.4 
(C6), 146.7 (C2), 134.2 (C1’), 127.8 (Ca’), 126.9 (C2’), 126.4 (Cb’), 126.2 (C3’), 125.6 (Cc’), 122.4 
(C3), 119.6 (C5), 34.8-34.7 (C tBu1’ and C tBu1), 31.3 (C tBu2), 31.2 (C tBu2’); MS (ES+) m/z = 411.0 
[M + H]+; HRMS (ES+) m/z = 411.2543 [M + H]+; calculated for [C27H30N4]+ 411.2544. 
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Compound HL8 
 
I2h (500 mg, 1.24 mmol) and ethylene glycol (5 mL). A beige powder was obtained (300 mg, 
63 %); 1H NMR (700 MHz, DMSO-d6) δ 8.70 (d, J = 5.2 Hz, 1H, H6), 8.33 (s, 1H, H3), 8.02 (d, J = 
8.3 Hz, 2H, C2’), 7.85 (d, J = 8.4 Hz, 2H, Hb’), 7.78 (s, 1H, H5), 7.51 (d, J = 8.0 Hz, 2H, H3’), 7.10 
(d, J = 8.9 Hz, 2H, Hc’), 3.82 (s, 3H, HOMe), 1.30 (s, 9H, HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 
161.0 (C4’), 152.1 (Cd’), 150.6 (C6), 148.6 (C4), 129.2 (C1’), 128.7 (Cb’), 126.2 (C2’), 126.0 (C3’), 
122.0 (C2), 115.2 (Cc’), 55.8 (COMe), 35.0 (CtBu1), 31.5 (CtBu2); MS (ES+) m/z = 385.2 [M + H]+; 
HRMS (ES+) m/z = 385.2029 [M + H]+; calculated for [C13H12F3N4]+ 385.2028. 
Compound HL9 
 
I2i (680 mg, 1.54 mmol) and ethylene glycol (7 mL). A beige powder was obtained (568 mg, 
87 %); 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 5.3 Hz, 1H, H6), 8.44 (s, 1H, H3), 8.14 (d, J = 
8.1 Hz, 2H, H2’), 8.05 (d, J = 8.5 Hz, 2H, Hb’), 7.94 (d, J = 8.1 Hz, 2H, H3’), 7.58 – 7.49 (m, 3H, 
H5 and Hc’), 1.33 (s, 9H, HtBu2);  19F NMR (376 MHz, DMSO-d6) δ -61.14; MS (ES+) m/z = 423.2 
[M + H]+; HRMS (ES+) m/z = 423.1806 [M + H]+; calculated for [C24H22F3N4]+ 423.1797. 
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Compound HL10 
 
I2j (400 mg, 0.84 mmol) and ethylene glycol (6 mL). A beige powder was obtained (200 mg, 
52 %);  1H NMR (700 MHz, DMSO-d6) δ 8.69 (d, J = 5.1 Hz, 1H, H6), 8.34 (s, 1H, H3), 8.03 (d, J 
= 8.3 Hz, 2H, Hb’), 7.84 (d, J = 8.6 Hz, 2H, H3’), 7.78 (s, 1H, H5), 7.51 (d, J = 8.0 Hz, 2H, Hc’), 
7.46 (d, J = 6.8 Hz, 2H, HBn2), 7.40 (d, J = 7.3 Hz, 2H, HBn3), 7.33 (d, J = 7.4 Hz, 1H, HBn4), 7.18 
(d, J = 8.8 Hz, 2H, H2’), 5.18 (s, 2H, HCH2), 1.30 (s, 9H, HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 
160.1 (C4’), 152.2 (Cd’), 150.6 (C6), 148.4 (C4), 137.3 (CBn1), 129.5 (C1’), 128.9 (CBn3), 128.8, 
128.7 (C3’), 128.4 (CBn4), 128.1 (CBn2), 126.2 (Cb’), 126.0 (Cc’), 121.9 (C5), 118.3 (C3), 116.1 (C2’), 
116.0, 69.8 (CCH2), 35.0 (CtBu1), 31.5 (CtBu2); MS (ES+) m/z = 461.4.  
7.3.2 Homoleptic Pt triazole complexes 
7.3.2.1. Complexes with no pyridyl substitution on the triazole ligand  
General Procedure 
HLn (2.2 eq) was added to a Schlenk with K2PtCl4 (1 eq) in H2O and EtOH (1:3). This was 
degassed via 3 x FPT and set to heat at 80 °C overnight. Upon reaction completion the 
mixture was cooled to RT and the solid was then isolated by centrifuge and washed with 
small amounts of MeOH. The complexes were recrystallized by cooling from a hot DMF 
solution.  
PtL12 
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HL1 (100 mg, 0.36 mmol), K2PtCl4 (68 mg, 0.16 mmol) with H2O (1 mL) and EtOH (3 mL). An 
orange solid was obtained (80 mg, 67 %); 1H NMR (600 MHz, Chloroform-d) δ 9.61 (s, 2H, 
H6), 7.83 (d, J = 7.7 Hz, 4H, Hb’), 7.54 (d, J = 6.9 Hz, 4H, H3), 7.44 (d, J = 7.8 Hz, 4H, Hc’), 7.15 
(d, J = 6.5 Hz, 2H, H4), 6.71 (t, J = 6.4 Hz, 2H, H5), 1.41 (s, 18H HtBu2); 13C NMR (151 MHz, 
Chloroform-d) δ 213.8 (C6), 172.1, 167.4, 151.0, 139.1 (C5) 134.8, 126.0 (Cb’), 125.2 (Cc’), 
124.0 (C4) 120.2, 119.5 (C3), 34.7 (CtBu1), 31.4 (CtBu2); (ESI+) m/z = 750.7 [M + H]+; HRMS (ES+) 
m/z =749.2593 [M + H]+; calculated for [C34H35N8194Pt]+ 749.2611; Mp. >250 °C. 
 
PtL22 
 
HL2 (150 mg, 0.59 mmol) and K2PtCl4 (113 mg, 0.27mmol) with H2O (1.5 mL) and EtOH (4.5 
mL). An orange powder was obtained (65 mg, 35%); 1H NMR (700 MHz, Chloroform-d) δ 
9.59 (s, 2H, H6), 7.84 (d, J = 8.2 Hz, 4H, Hb’), 7.59 (d, J = 7.3 Hz, 2H, H3), 7.23 (d, J = 7.1 Hz, 
2H, H4), 6.97 (d, J = 8.2 Hz, 4H, Hc’), 6.77 (t, J = 6.8 Hz, 2H, H5), 3.92 (s, 6H, HOMe); (ES+) m/z = 
698.3 [M + H]+; HRMS (ES+) m/z = 697.1559 [M + H]+; calculated for [C14H13N4O]+ 697.1571; 
Mp. >250 °C. 
 
PtL32 
 
HL3 (100 mg, 0.34 mmol) and K2PtCl4 (65 mg, 0.16 mmol) with H2O (1 mL) and EtOH (3 mL). 
An orange powder was obtained (30 mg, 24 %) that was insoluble in all common organic 
solvents; MS (ASAP+) m/z = 774.1 [M+H]+; HRMS (ASAP+) m/z = 772.1020 [M+H]+; calculated 
for [C28H17F6N8194Pt]+ 772.1029; Anal. Calcd for C28H16F6N8Pt: C, 43.47; H, 2.08; F, 14.74; N, 
14.49; Found: C, 43.91; H, 1.96; F, 14.62; N, 14.76.  
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PtL42 
 
HL4 (300 mg, 1.02 mmol), K2PtCl4 (233 mg, 0.56 mmol) with H2O (6 mL) and EtOH (18mL). A 
yellow solid was obtained (76 mg, 18 %); 1H NMR (599 MHz, Chloroform-d) δ 10.45 (dt, J = 
5.7, 1.1 Hz, 1H, H6), 8.55 – 8.45 (m, 2H, H3 and H4), 8.03 (d, J = 8.9 Hz, 2H, Hc’), 7.96 (ddd, J = 
6.6, 5.7, 2.7 Hz, 1H, H5), 7.14 (d, J = 8.9 Hz, 2H, Hb’), 4.13 (t, J = 6.6 Hz, 2H, HBu1), 1.94 – 1.79 
(m, 2H, HBu2), 1.62 – 1.48 (m, 2H, HBu3), 1.02 (t, J = 7.4 Hz, 3H, HBu4); 13C NMR (151 MHz, 
Chloroform-d) δ 162.8 (Cd’), 153.4 (C6), 143.7 (C2), 143.3 (C3/4), 128.7 (Cc’), 128.2 (C5), 124.01 
(C3/4), 115.8 (Cb’), 115.3, 68.6 (CBu1), 30.9 (CBu2), 19.0 (CBu3), 13.5 (CBu4); MS (ES+) m/z = 782.3 
[M + H]+; HRMS (ES+) m/z = 779.2466 [M + H]+; calculated for [C34H35N8O2192Pt]+ 779.2493; 
Mp. >250 °C. 
7.3.2.2 Complexes with 4-pyridyl substitution on the triazole ligand  
General procedure 
HLn (2.2 eq) was added to a Schlenk with K2PtCl4 (1 eq) in H2O and MeCN (1:3). This was 
degassed via 3 x FPT and set to heat at 80 °C overnight. Upon reaction completion the 
reaction mixture was cooled to RT and the solid was then isolated by centrifuge and 
washed with H2O, MeOH and Et2O and then further purified by column chromatography on 
alumina (DCM/MeOH, 100:0 to 98:2).  
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PtL72 
 
HL7 (100 mg, 0.24 mmol), K2PtCl4 (56 mg, 0.13 mmol) with H2O (1 mL) and MeCN (3 mL). A 
red powder was obtained after column and recrystallization (30 mg, 22 %); Rf= 0.9 (alumina, 
100 % DCM); 1H NMR (700 MHz, Chloroform-d) δ 9.70 (s(broad), 2H, H6), 7.90 (d, J = 7.6 Hz, 
4H, Hb’), 7.49 (d, J = 7.6 Hz, 4H, H2’), 7.44 (d, J = 7.6 Hz, 4H, H3’), 7.32 (d, J = 7.6 Hz, 4H, Hc’), 
7.25 (s, 2H, H3), 7.12 (d, J = 5.7 Hz, 2H, H5), 1.40 (s, 18H, HtBu2’), 1.37 (s, 18H, HtBu2); 13C NMR 
(176 MHz, Chloroform-d) δ 127.4, 126.3, 126.2, 125.4, 34.9 (CtBu1’), 34.7 (CtBu1), 31.4 (CtBu2), 
31.3 (CtBu2’); (ASAP+) m/z = 1014.4 [M + H]+; HRMS (ES+) m/z =1013.4474 [M + H]+; calculated 
for [C54H59N8194Pt]+ 1013.4489. 
 
PtL82 
 
HL8 (50 mg, 0.13 mmol), K2PtCl4 (30 mg, 0.07 mmol) with H2O (2 mL) and MeCN (6 mL). An 
orange powder was obtained after column and recrystallization (20 mg, 29 %); Rf= 0.9 
(alumina, 100 % DCM)1H NMR (700 MHz, Chloroform-d) δ 9.72 (d, J = 6.0 Hz, 2H, H6), 8.69 
(d, J = 2.2 Hz, 2H, H3), 7.79 (dd, J = 6.1, 2.2 Hz, 2H, H5), 7.73 (d, J = 8.2 Hz, 4H, H3’), 7.58 (d, J 
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= 8.6 Hz, 4H, Hc’), 7.33 (d, J = 8.2 Hz, 4H, H2’), 6.91 (d, J = 8.6 Hz, 4H, Hb’), 3.92 (s, 6H, HOMe), 
1.30 (s, 18H, HtBu2); 13C NMR (176 MHz, Chloroform-d) δ 163.5 (C4’), 157.2 (C2), 156.8 (Cd’), 
155.5 (Ca’), 153.6 (C1’), 151.5 (C6), 143.1 (Cb), 128.9 (C3’), 126.5 (Cc’), 126.2 (Cb’), 124.6 (C4), 
123.1 (C5), 119.9 (C3), 119.8 (Ce), 115.3 (C2’), 55.5 (COMe), 35.0 (CtBu1), 30.8 (CtBu2); (ASAP+) m/z 
= 962.3 [M + H]+.  
PtL92 
 
HL9 (150 mg, 0.36 mmol), K2PtCl4 (81 mg, 0.19 mmol) with H2O (1 mL) and MeCN (3 mL). A 
red powder was obtained after column and recrystallization (14 mg, 7 %); Rf= 0.9 (alumina, 
100 % DCM); 1H NMR (700 MHz, Chloroform-d) δ 10.34 (d, J = 6.0 Hz, 2H, H6), 8.87 (d, J = 2.0 
Hz, 2H, H3), 8.10 (dd, J = 6.1, 2.0 Hz, 2H, H5), 8.02 (d, J = 8.0 Hz, 4H, H2’), 7.92 (d, J = 7.9 Hz, 
4H, Hb’), 7.85 (d, J = 8.0 Hz, 4H, Hc’), 7.58 (d, J = 8.0 Hz, 4H, H3’), 1.36 (s, 18H, HtBu2); 19F NMR 
(376 MHz, Chloroform-d) δ -62.42; (ASAP+) m/z = 1037.3 [M + H]+; HRMS (ES+) m/z 
=1037.2968 [M + H]+; calculated for [C48H41N8194PtF6]+ 1037.2985. 
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7.3.3 Heteroleptic Pt triazole complexes  
7.3.3.1 Neutral complexes  
Dimers 
[Pt(thpy)(μ-Cl)]2 
 
2-(2-Thienyl)pyridine (50 mg, 0.31 mmol), K2PtCl4 (129 mg, 0.31 mmol) with H2O (1 mL) and 
ethoxyethanol (3 mL). A light green solid was obtained (90 mg, 37 %) and used without 
further purification. The experimental data obtained were in good agreement with the 
literature.196 
[Pt(pquin)(μ-Cl)]2 
 
2-phenylquinoline (74 mg, 0.36 mmol), K2PtCl4 (150 mg, 0.36 mmol) with H2O (1.5 mL) and 
ethoxyethanol (4.5 mL). A pale green solid was obtained (83 mg, 27 %) and used without 
any further purification. The experimental data obtained were in good agreement with the 
literature.197 
Thienyl Pyridine Complexes 
General procedure  
[Pt(thpy)(µ-Cl)]2 (1 eq) and HLn (2 eq) were added to a Schlenk with a DCM/MeOH mixture 
(1:1). This was degassed via 3 x FPT then set to reflux at 50 °C for 24 h. Once cooled to RT 
the solvent was removed and the residue was columned on alumina and then recrystallized 
in DCM/Hexane.   
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Pt(thpy)L1 
 
[Pt(thpy)(µ-Cl)]2 (30 mg, 0.04 mmol), HL1 (21 mg, 0.08 mmol) in DCM (1 mL) and MeOH       
(1 mL). A red solid was obtained (12 mg, 49 %); 1H NMR (600 MHz, Chloroform-d) δ 10.54 
(d, J = (195Pt 39.9), 5.9 Hz, 1H, H6triz), 9.29 (d, J = (195Pt 48.1), 5.8 Hz, 1H, H6), 8.18 (d, J = 8.5 
Hz, 2H, Hb’), 8.15 (dt, J = 7.7, 1.3 Hz, 1H, H2th), 7.97 (td, J = 7.6, 1.4 Hz, 1H, H4), 7.72 (td, J = 
7.7, 1.4 Hz, 1H, H4triz), 7.52 – 7.48 (m, 3H, H5 and Hc’), 7.34 (dd, J = 7.9, 1.2 Hz, 1H H3triz), 7.25 
– 7.23 (m, 2H, H3 and H3th), 7.05 (ddd, J = 7.3, 5.8, 1.4 Hz, 1H, H5triz), 1.39 (s, 9H, HtBu2); 13C 
NMR (151 MHz, Chloroform-d) δ 163.3 (Ca’), 163.0 (Cb), 162.7 (C2triz), 152.8 (C6triz), 152.2 (C2), 
151.6 (C9), 151.1 (Cd’), 148.2 (C4th), 142.9 (C5th), 139.3 (C4), 139.3 (C4triz), 130.9 (C3th), 130.2 
(Ce), 127.4 (C5), 126.0 (Cb’), 125.3 (Cc’), 123.5 (C3), 120.9 (C2th), 120.0 (C5’), 116.8 (C3triz), 34.7 
(CtBu1), 31.4 (CtBu2);  MS (ES+) m/z = 633.0 [M+H]+; HRMS (ES+) m/z = 632.1379 [M+H]+; 
calculated for [C26H24N5S194Pt]+ 632.1379.   
 
Pt(thpy)L2 
 
[Pt(thpy)(µ-Cl)]2 (30 mg, 0.04 mmol), HL2 (19 mg, 0.08 mmol), DCM (1 mL) and MeOH          
(1 mL). A red solid was obtained (5 mg, 22 %); 1H NMR (700 MHz, Chloroform-d) δ 10.45 (d, 
J = 5.3 Hz, 1H, H6triz), 9.24 (d, J = 5.8 Hz, 1H, H6), 8.20 (d, J = 8.8 Hz 2H, Hb’), 8.17 (d, J = 5.8 
Hz, 1H, H3), 7.95 (td, J = 7.6, 1.4 Hz, 1H, H4), 7.70 (td, J = 7.6, 1.5 Hz, 1H, H4triz), 7.48 (d, J = 
4.7 Hz, 1H, H2th), 7.31 (d, J = 7.8 Hz, 1H, H3triz), 7.22 (ddd, J = 7.3, 5.7, 1.5 Hz, 1H, H5), 7.20 (d, 
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J = 4.8 Hz, 1H, H3th), 7.03 (t, J = 6.2 Hz, 1H, H5triz), 7.01(d, J = 8.8 Hz, 2H, Hc’), 3.89 (s, 3H, 
HOMe); 13C NMR (176 MHz, Chloroform-d) δ 162.6 (C2triz), 159.9 (Ca’), 152.7 (C6triz), 151.6 (C6), 
147.9 (C4th), 142.9 (C5th), 139.4 (C4), 139.3 (C4triz), 130.8 (C3th), 127.7 (Cb’), 127.3 (C2th), 125.4 
(Cd’),  123.6 (C5), 121.0 (C3), 121.0 (C2), 120.0 (C5triz), 116.8 (C3triz), 113.9 (Cc’), 55.3 (COMe); MS 
(ES+) m/z = 607.0 [M+H]+; HRMS (ES+) m/z = 606.0872 [M+H]+; calculated for 
[C23H18N5OS194Pt]+ 606.0859.  
Pt(thpy)L3 
 
[Pt(thpy)(µ-Cl)]2 (30 mg, 0.04 mmol), HL3 (22 mg, 0.08 mmol) in DCM (1 mL) and MeOH        
(1 mL). A red solid was obtained (9 mg, 37 %); 1H NMR (700 MHz, Chloroform-d) δ 10.32 (d, 
J = 5.7 Hz, 1H, H6triz), 9.16 (d, J = 5.7 Hz, 1H, H6), 8.32 (d, J = 8.0 Hz, 2H, Hb’), 8.04 (d, J = 8.0 
Hz, 1H, H3), 7.90 (td, J = 7.6, 1.4 Hz, 1H, H4), 7.71 (d, J = 8.0 Hz, 2H, Hc’), 7.65 (td, J = 7.6, 1.4 
Hz, 1H, H4triz), 7.43 (d, J = 4.7 Hz, 1H, H2th), 7.26 (d, J = 6.3 Hz, 1H, H3triz), 7.16 (ddd, J = 7.2, 
5.6, 1.6 Hz, 1H, H5), 7.11 (d, J = 4.8 Hz, 1H, H3th), 6.96 (ddd, J = 7.3, 5.7, 1.4 Hz, 1H, H5triz); 13C 
NMR (176 MHz, Chloroform-d) δ 163.6 (C4th), 162.6 (C2triz), 161.3 (Ca’), 152.5 (C6triz), 151.6 
(C2), 151.5 (C6), 147.8 (C5th), 142.7, 139.2 (C4), 139.2 (C4triz), 136.3 (Cd’), 130.7 (C3th), 129.8 
(Cc), 127.2 (C2th), 126.3 (Cb’), 125.4 (Cc’), 125.3 (CCF3), 123.7 (C5), 120.8 (C3), 119.9 (C5triz), 
116.8 (C3triz); 19F NMR (376 MHz, Chloroform-d) δ -62.76; MS (ES+) m/z = 645.8 [M+H]+; 
HRMS (ES+) m/z = 644.0631 [M+H]+; calculated for [C23H15F3N5S194Pt]+ 644.0627.   
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Pt(thpy)L7 
 
[Pt(thpy)(µ-Cl)]2 (27 mg, 0.04 mmol), HL7 (30 mg, 0.07 mmol) in DCM (1 mL) and MeOH       
(1 mL). An orange solid was obtained (21 mg, 69 %);  1H NMR (599 MHz, Chloroform-d) δ 
10.49 (d, J = 5.7 Hz, 1H, H6), 9.16 (d, J = 6.1 Hz, 1H, H6triz), 8.30 (d, J = 2.1 Hz, 1H, H3triz), 8.19 
(d, J = 8.3 Hz, 2H, Hb’), 7.73 (d, J = 8.4 Hz, 2H, H2’), 7.67 (td, J = 7.6, 1.4 Hz, 1H, H4), 7.55 (d, J 
= 8.4 Hz, 2H, H3’), 7.50 (dd, J = 8.2, 1.4 Hz, 2H, Hc’), 7.47 (dd, J = 4.8, 1.2 Hz, 1H, H2th), 7.40 – 
7.37 (m, 1H, H5triz), 7.28 (d, J = 8.0 Hz, 1H, H3), 7.23 (d, J = 4.8 Hz, 1H, H3th), 6.98 (ddd, J = 7.3, 
5.9, 1.4 Hz, 1H, H5), 1.41-1.39 (m, 18H, HtBu2 and HtBu2’ ); 13C NMR (151 MHz, Chloroform-d) δ 
162.9 (Ca’), 154.0 (C4’), 152.8 (C6), 152.0 (C2triz), 151.4 (C6triz), 151.1 (C4triz), 151.0 (Cd’), 148.5 
(C4th), 142.7 (C5th), 139.0 (C4), 133.0 (C1’), 131.0 (C3th), 130.3 (C3’’), 127.1 (C2th), 126.9 (C2’), 
126.3 (C3’), 126.0 (Cb’), 125.3 (Cc’), 120.6 (C5triz), 119.8 (C5), 117.8 (C3triz), 116.7 (C3), 34.9 
(CtBu1), 34.7 (CtBu1’), 31.4 (CtBu2), 31.2 (CtBu2’); MS (ES+) m/z = 765.6 [M + H]+; HRMS (ES+) m/z = 
764.2346 [M + H]+; calculated for [C36H36N5S194Pt]+ 764.2318; Anal. Calcd for C36H35N5SPt: C, 
56.53; H, 4.61; N, 9.16; Found: C, 55.89; H, 4.54, N, 8.78. 
Pt(thpy)L8 
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[Pt(thpy)(µ-Cl)]2 (14 mg, 0.02 mmol), HL8 (15 mg, 0.04 mmol) in DCM (1 mL) and MeOH       
(1 mL). An orange solid was obtained (20 mg, 90 %);  1H NMR (700 MHz, Chloroform-d) δ 
10.48 (dd, J = 6.0, 1.3 Hz, 1H, H6), 9.11 (d, J = 6.1 Hz, 1H, H6triz), 8.25 (d, J = 2.2 Hz, 1H, H3triz), 
8.17 (d, J = 8.4 Hz, 2H, Hb’), 7.73 (d, J = 8.6 Hz, 2H, H3’), 7.66 (td, J = 7.6, 1.4 Hz, 1H, H4), 7.48 
(d, J = 8.6 Hz, 2H, Hc’), 7.46 (d, J = 4.8 Hz, 1H, H2th), 7.32 (dd, J = 6.1, 2.3 Hz, 1H, H5triz), 7.27 
(d, J = 7.6 Hz, 1H, H3), 7.21 (d, J = 4.8 Hz, 1H, H3th), 7.01 (d, J = 8.8 Hz, 2H, H2’), 6.98 (ddd, J = 
7.3, 5.7, 1.4 Hz, 1H, H5), 3.89 (s, 3H, HOMe), 1.39 (s, 9H, HtBu2); 13C NMR (176 MHz, 
Chloroform-d) δ 161.6 (C4’), 152.8 (C6), 151.9 (C2triz), 151.3 (C6triz), 150.9 (Cd’), 150.7 (C4triz), 
142.6 (C3th), 139.0 (C4), 131.1 (C4th), 130.3 (Ca’), 128.6 (C3’), 128.0 (C1’), 127.1 (C2th), 126.0 
(Cb’), 125.3 (Cc’), 120.0 (C5triz), 119.9 (C5), 117.3 (C3triz), 116.7 (C3), 114.7 (C2’), 55.4 (COMe), 
34.7 (CtBu1), 31.4 (CtBu2); MS (ES+) m/z = 738.2 [M+H]+; HRMS (ES+) m/z = 738.1793 [M+H]+; 
calculated for [C33H30N5OS194Pt]+ 738.1798. 
Pt(thpy)L9 
 
[Pt(thpy)(µ-Cl)]2 (26 mg, 0.03 mmol), HL9 (30 mg, 0.07 mmol), DCM (1 mL) and MeOH          
(1 mL). An orange solid was obtained (22 mg, 94 %); 1H NMR (700 MHz, Chloroform-d) δ 
10.33 (d, J = 5.1 Hz, 1H, H6), 9.09 (d, J = 6.0 Hz, 1H, H6triz), 8.21 (s, 1H, H3triz), 8.12 (d, J = 8.4 
Hz, 2H, H3’), 7.78 (d, J = 7.9 Hz, 2H, Hb’), 7.71 (d, J = 8.0 Hz, 2H, Hc’), 7.61 (td, J = 7.5, 1.4 Hz, 
1H, H4), 7.47 (d, J = 8.3 Hz, 2H, H2’), 7.40 (d, J = 4.7 Hz, 1H, H2th), 7.23 (dd, J = 6.0, 2.2 Hz, 1H, 
H5triz), 7.21 (d, J = 7.8 Hz, 1H, H3), 7.13 (d, J = 4.8 Hz, 1H, H3th), 6.91 (t, J = 6.5 Hz, 1H, H5), 1.39 
(s, 9H, HtBu2);  13C NMR (176 MHz, Chloroform-d) δ 152.6 (C6), 151.9 (C6triz), 139.0 (C4), 130.9 
(C3th), 127.5 (Cb), 127.1 (C2th), 126.1 (Cc’), 126.0 (C3’), 125.2 (C2’), 120.9 (C5triz), 119.7 (C5), 
118.2 (C3triz), 116.6 (C3), 34.7 (CtBu1), 31.4 (CtBu2); 19F NMR (376 MHz, Chloroform-d) δ -62.76;  
MS (ES+) m/z = 776.16 [M+H]+; HRMS (ES+) m/z = 776.1575 [M+H]+; calculated for 
[C33H27F3N5S194Pt]+ 776.1566.  
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Pt(thpy)L10 
 
[Pt(thpy)(µ-Cl)]2 (25 mg, 0.03 mmol), HL10 (33 mg, 0.07 mmol) in DCM (1 mL) and MeOH      
(1 mL). An orange solid was obtained (25 mg, 96 %); 1H NMR (400 MHz, Chloroform-d) δ 
10.53 (d, J = 5.7 Hz, 1H, H6), 9.17 (d, J = 6.2 Hz, 1H, H6triz), 8.31 (d, J = 2.2 Hz, 1H, H3triz), 8.22 
(d, J = 8.2 Hz, 2H, H3’), 7.78 (d, J = 8.2 Hz, 2H, Hb’), 7.71 (td, J = 7.7, 1.5 Hz, 1H, H4), 7.56 – 
7.49 (m, 5H, Hc’, H2th and HBn2), 7.47-7.30 (m, 4H, H5triz, H3th, H3 and HBn4), 7.27 (d, J = 5.0 Hz, 
2H, HBn3), 7.13 (d, J = 8.9 Hz, 2H, H2’), 7.04 (td, J = 6.6, 1.6 Hz, 1H, H5), 5.18 (s, 2H, HCH2), 1.42 
(s, 9H, HtBu2); MS (ES+) m/z = 815.2 [M+H]+; HRMS (ES+) m/z = 814.2111 [M+H]+; calculated 
for [C39H34N5OS194Pt]+ 814.2096.  
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Phenylquinoline complexes 
General procedure 
[Pt(pquin)(µ-Cl)]2 (1 eq) and HLn (2.2 eq) were added to a Schlenk containing DCM and 
MeOH (5:4) and degassed via 3 x FPT. This was set to reflux under argon at 50 °C for 24 h 
and then cooled to RT. Purification was then performed by column chromatography 
(DCM/MeOH 98:2 on silica) followed by recrystallization in DCM/Hexane.  
Pt(pquin)L1 
 
[Pt(pquin)(µ-Cl)]2 (25 mg, 0.03 mmol), HL1 (18 mg, 0.06 mmol) with DCM (1 mL) and MeOH 
(0.8 mmol). An orange solid was obtained (14 mg, 71 %); 1H NMR (600 MHz, Chloroform-d) 
δ 9.37 (dd, J = 7.9, 1.1 Hz, 1H, H6triz), 8.61 (d, J = 8.1 Hz, 1H, H2’), 8.38 (d, J = 8.7 Hz, 1H, H5’), 
8.29 (d, J = 8.4 Hz, 2H, Hb’), 8.24 (d, J = 7.6 Hz,  1H, H8), 8.11 (d, J = 5.6 Hz, 1H, H5), 7.97 – 
7.89 (m, 3H, H3/4, H3’and H6/7), 7.69 (d, J = 7.6 Hz, 1H, H3triz), 7.66 – 7.57 (m, 2H, H3/4 and H4’), 
7.51 (d, J = 8.4 Hz, 2H, Hc’), 7.41 (td, J = 7.7, 1.4 Hz, 1H, H5triz), 7.24 (d, J = 7.8 Hz, 1H, H4triz), 
7.15 – 7.09 (m, 1H, H6/7), 1.39 (s, 9H, HtBu2); 13C NMR (151 MHz, Chloroform-d) δ 168.7 (C1), 
163.6 (Ce), 151.0 (Cd’), 150.5 (C5), 146.7 (C2), 145.9 (C2triz), 143.4 (Cb), 139.2 (C3/4, C6/7or C3’), 
138.9 (C5’), 135.7 (C5), 130.4 (C5triz) 130.3 (C3/4 and C4’), 128.5 (C3/4, C6/7 or C3’), 127.90 (C9/10), 
127.1 (C3/4 and C4’), 127.0 (C6’), 126.1 (Cb’), 126.0 (C2’), 125.3 (Cc’), 124.9 (C3triz), 124.4 (C4triz), 
122.7 (C6/7), 120.4 (C8), 117.3 (C3/4, C6/7 or C3’), 34.7 (CtBu1), 31.4 (CtBu2); MS (ES+) m/z = 677.0 
[M+H]+; HRMS (ES+) m/z = 676.1971 [M+H]+; calculated for [C32H28N5194Pt]+ 676.1972.  
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Pt(pquin)L2 
 
[Pt(pquin)(µ-Cl)]2 (25 mg, 0.03 mmol), HL2 (16 mg, 0.06 mmol) with DCM (1 mL) and MeOH 
(0.8 mL). An orange crystalline solid was obtained (15 mg, 77 %); 1H NMR (600 MHz, 
Chloroform-d) δ 9.33 (d, J = 8.2 Hz, 1H, H6triz), 8.57 (d, J = 8.2 Hz, 1H, H2’), 8.35 (d, J = 8.6 Hz, 
1H, H5’), 8.30 (d, J = 8.1 Hz, 2H, Hb’), 8.20 (d, J = 7.8 Hz, 1H, H8), 8.07 (d, J = 5.6 Hz, 1H, H5), 
7.94 – 7.85 (m, 3H, H3/4, H3’ and H6/7), 7.67 (d, J = 7.6 Hz, 1H, H3triz), 7.63-7.56 (m, 2H, H3/4 
and H4’), 7.40 (t, J = 7.3 Hz, 1H, H5triz), 7.23 (t, J = 7.9 Hz, 1H, H4triz), 7.10 (t, J = 6.4 Hz, 1H, 
H6/7), 7.03 (d, J = 8.4 Hz, 2H, Hc’), 3.89 (t, J = 1.2 Hz, 3H, HOMe); 13C NMR (151 MHz, 
Chloroform-d) δ 168.7 (C1’), 164.2 (C6’), 163.5 (Ce), 159.7 (C4’’), 150.9 (C9/10), 150.5 (C5), 146.4 
(C2), 145.9 (C2triz), 143.3 (Cb), 139.2 (C3’ or C6/7), 139.1 (C5’), 135.6 (C6triz), 130.3 (C5triz), 130.2 
(C3/4 and C4’), 128.5 (C3’ or C6/7), 127.9 (C2), 127.7 (Cb’), 127.1 (C3/4and C4’), 126.0 (C2’), 124.9 
(C3triz), 124.4 (C4triz), 122.8 (C6/7), 120.3 (C8), 117.3 (C3’ or C6/7), 113.8 (Cc’), 55.3 (COMe); MS 
(ES+) m/z = 651.0 [M+H]+; HRMS (ES+) m/z = 650.1453 [M+H]+; calculated for 
[C29H22N5O194Pt]+ 650.1451.  
Pt(pquin)L3 
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[Pt(pquin)(µ-Cl)]2 (25 mg, 0.03 mmol), HL3 (18 mg, 0.06 mmol) with DCM (1 mL) and MeOH 
(0.8 mL). An orange solid was obtained (12 mg, 60 %); 1H NMR (700 MHz, Chloroform-d) δ 
9.28 (dd, J = 7.8, 0.9 Hz, 1H, H6triz), 8.58 (d, J = 8.1 Hz, 1H, H2’), 8.48 (d, J = 8.1 Hz, 2H, Hb’), 
8.38 (d, J = 8.6 Hz, 1H, H5’), 8.23 (ddd, J = 7.8, 1.4, 0.8 Hz, 1H, H8), 8.11 (d, J = 5.6 Hz, 1H, H5), 
7.96 (td, J = 7.8, 1.4 Hz, 1H, H7), 7.93 – 7.90 (m, 2H, H4’ and H4), 7.73 (d, J = 8.1 Hz,  2H, Hc’), 
7.69 (d, J = 7.6 Hz, 1H, H3triz), 7.64 – 7.58 (m, 2H, H3’ and H3), 7.41 (ddd, J = 7.7, 7.1, 1.3 Hz, 
1H, H5triz/4triz), 7.26 (td, J = 8.6, 1.4 Hz, 1H, H5triz/4triz), 7.15 (ddd, J = 7.2, 5.6, 1.4 Hz, 1H, H6); 
13C NMR (176 MHz, Chloroform-d) δ 168.7 (C1’), 164.8 (C9), 162.4 (Ce), 150.6 (C5), 146.4 (C2), 
145.9 (C2triz), 143.0 (Cb), 139.3 (C7), 139.2 (C5’), 136.3 (Ca’), 135.3 (C6triz), 130.4 (C4triz/5triz), 
130.3 (C3’), 129.7 (Cd’), 128.5 (C4/4’), 127.9 (C10), 127.2 (C3/3’), 126.4 (Cb’), 125.9 (C2’), 125.4 
(Cc’), 125.3 (Ca’), 125.0 (C3triz), 124.5 (C4triz//5triz), 123.1 (C6), 120.5 (C8), 117.3 (C4/4’); 19F NMR 
(376 MHz, Chloroform-d) δ -62.65; MS (ES+) m/z = 690.0 [M+H]+; HRMS (ES+) m/z = 
688.1210 [M+H]+; calculated for [C29H19N5F3194Pt]+ 688.1219. 
7.3.3.2 Cationic complexes  
General procedures 
Pt(N^N)Cl2 starting materials 
K2PtCl4 (1 eq) and 2,2’-bipyridine or 1,10-phenanthroline reagents (10 eq) were added to a 
round bottom flask with H2O and stirred. 2M HCl was added dropwise to this solution which 
was then refluxed for 1 hr. On cooling to RT, the suspension was filtered and washed with 
water. The resulting solid was then dried in vacuo and used without further purification.  
Pt(bpy)Cl2 
 
K2PtCl4 (200 mg, 0.48 mmol) and 2,2’-bipyridine (752 mg, 4.81 mmol) with H2O (120 mL) 
and 2M HCl (4 mL). A yellow solid resulted and was dried under vacuum (200 mg, 99 %). 
The experimental data obtained were in good agreement with the literature.198  
Pt(phen)Cl2 
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K2PtCl4 (116 mg, 0.28 mmol) and 1,10-phenanthroline (500 mg, 2.77 mmol) with H2O         
(60 mL) and 2M HCl (2 mL). A yellow solid resulted and was dried in vacuo (116 mg, 93 %). 
The experimental data obtained were in good agreement with the literature.199  
Pt(N^N)(triazole) complexes  
Pt(N^N)Cl2 (1 eq) and AgOTf (2 eq) were added to a Schlenk with DCM. This was degassed 
via 3 x FPT and then stirred at RT for 1 hr under argon. HLn (1 eq) was then added under 
argon and the mixture was heated at reflux overnight. After cooling to RT, the product was 
then extracted into MeOH. Following this, an ion exchange with PF6— was performed by 
dissolving in the minimum amount of DMSO and then precipitating out with saturated 
aqueous KPF6 solution. This was washed with H2O (3 x 5 mL) and dried in vacuo. 
Bipyridyl complexes 
[Pt(bpy)L1]PF6 
 
Pt(bpy)Cl2 (32 mg, 0.08 mmol) and AgOTf (39 mg, 0.15 mmol) were added to a Schlenk with 
DCM (2 mL) and HL1 (21 mg, 0.08 mmol). A yellow solid was obtained (36 mg, 76 %); 1H 
NMR (700 MHz, DMSO-d6) δ 10.36 (d, J = 5.7 Hz, 1H, H6), 8.76 (d, J = 5.7 Hz, 1H, H6bpy), 8.61 
(d, J = 5.7 Hz, 1H, H6triz), 8.47-8.42 (m, 2H, H3bpy and H3’), 8.35 (t, J = 7.7 Hz, 1H, H4bpy), 8.28 (t, 
J = 7.7 Hz, 1H, H4’), 8.16 (t, J = 7.5 Hz, 1H, H4triz), 7.83-7.79 (m, 2H, H5’ and H3triz), 7.76 – 7.75 
(m, 3H, H5bpy and Hb’), 7.55 (t, J = 6.4 Hz, 1H, H5triz), 7.37 (d, J = 8.1 Hz, 2H, Hc’), 1.34 (s, 9H, 
HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 163.2 (Ca’), 161.2 (Ce), 156.4 (C2bpy), 156.1 (C2’), 152.0 
(C6’), 151.9 (Cd’), 151.2 (C6bpy), 151.0 (C6triz), 148.8 (Cb), 143.0 (C4triz), 142.2 (C4’), 142.2 (C4bpy), 
128.8 (C5bpy), 128.7 (C3triz), 128.3 (C2triz), 126.0 (C5triz), 125.8 (Cb’), 125.7 (Cc’), 124.9 (C3bpy), 
124.5 (C3’), 121.3 (C5’), 34.9 (CtBu1), 31.6 (CtBu2); MS (ES+) m/z = 628.6 [M]+; HRMS (ES+) m/z = 
627.1767 [M]+; calculated for [C27H25N6194Pt]+ 627.1767. 
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[Pt(bpy)L2]PF6 
 
Pt(bpy)Cl2 (50 mg, 0.12 mmol), HL2 (30 mg, 0.12 mmol), AgOTf (61 mg, 0.24 mmol) and 
DCM (3 mL). A yellow solid was obtained (19 mg, 27 %); 1H NMR (600 MHz, DMSO-d6) δ 
10.39 (d, J = 5.7 Hz, 1H, H6’), 8.78 (d, J = 5.6 Hz, 1H, H6bpy), 8.65 (d, J = 5.7 Hz, 1H, H6triz), 8.52-
8.49 (m, 2H, H3bpy and H3’), 8.39 (t, J = 7.7 Hz, 1H, H4bpy), 8.33 (t, J = 7.8 Hz, 1H, H4’), 8.21 (t, J 
= 7.7 Hz, 1H, H4triz), 7.85-7.79 (m, 5H, H5’, H3triz, Hb’ and H5bpy), 7.59 (t, J = 6.8 Hz, 1H, H5triz), 
6.93 (d, J = 8.3 Hz, 2H, Hc’), 3.83 (s, 3H, HOMe); 13C NMR (151 MHz, DMSO-d6) δ 163.1 (C6triz), 
161.1 (Ce), 160.3 (Cd’), 156.5 (C2bpy), 156.1 (C2’), 152.1 (C6’), 151.1 (C6bpy), 151.0 (C6triz), 148.9 
(Cb), 142.9 (C4triz), 142.2 (C4’), 142.1 (C4bpy), 128.8 (C5bpy), 128.3 (C5’), 127.5 (Cb’), 126.0 (C5triz), 
125.0 (C3bpy), 124.6 (C3’), 124.2 (Ca’), 121.3 (C3triz), 114.4 (Cc’), 55.7 (COMe); MS (ES+) m/z = 
602.5 [M]+; HRMS (ES+) m/z = 601.1231 [M]+; calculated for [C24H19N6O194Pt]+ 601.1247. 
 
[Pt(bpy)L3]PF6 
 
Pt(bpy)Cl2 (76 mg, 0.17 mmol), HL3 (72 mg, 0.17 mmol), AgOTf (81 mg, 0.34 mmol) and 
DCM (4 mL). A yellow solid was obtained (30 mg, 28 %); 1H NMR (400 MHz, DMSO-d6) δ 
10.10 (dd, J = 6.0, 1.3 Hz, 1H, H6’), 8.62 (d, J = 5.7 Hz, 1H, H6bpy), 8.51 (d, J = 5.8 Hz, 1H, H6triz), 
8.39 – 8.28 (m, 3H, H3bpy, H3’ and H4bpy), 8.22 (td, J = 7.8, 1.4 Hz, 1H, H4’), 8.12 (td, J = 7.7, 1.2 
Hz, 1H, H4triz), 7.91 (d, J = 8.0 Hz, 2H, Hb’), 7.76 – 7.66 (m, 3H, H5’, H5bpy and H3triz), 7.66 – 7.62 
(d, J = 8.0 Hz, 2H, Hc’), 7.50 (ddd, J = 7.5, 5.8, 1.6 Hz, 1H, H5triz); 19F NMR (376 MHz, DMSO-d6) 
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δ -60.97; MS (ES+) m/z = 639.2 [M]+; HRMS (ES+) m/z = 639.1028 [M]+; calculated for 
[C24H16N6F3194Pt]+ 639.1015. 
 
Phenanthroline complexes 
[Pt(phen)L1]PF6 
 
HL1 (500 mg, 0.18 mmol), Pt(phen)Cl2 (80 mg, 0.18 mmol) and AgOTf (93 mg, 0.36 mmol) 
with DCM (4 mL). A yellow solid was obtained (70 mg, 60 %); 1H NMR (700 MHz, DMSO-d6) 
δ 10.11 (s, 1H, H9), 8.78 (d, J = 4.8 Hz, 1H, H2), 8.68 (d, J = 7.8 Hz, 1H, H4), 8.52 (d, J = 7.8 Hz, 
1H, H7), 8.40 (d, J = 5.2 Hz, 1H, H6triz), 7.93 (t, J = 7.3 Hz, 1H, H4triz), 7.88 (d, J = 8.5 Hz, 1H, 
H5/6), 7.85-7.82 (m, 2H, H5/6 and H3), 7.73 (t, J = 6.2 Hz, 1H, H8), 7.45 (d, J = 7.5 Hz, 2H, Hb’), 
7.35 (d, J = 7.4 Hz, 1H, H3triz), 7.32 (d, J = 7.8 Hz, 2H, Hc’), 7.24 (t, J = 6.4 Hz, 1H, H5triz), 1.38 (s, 
9H, HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 162.3, 160.7 (Ce), 152.2 (C9), 151.9 (Cd’), 151.5 
(C2), 150.3 (C6triz), 147.9 (Ca’), 145.8 (C10), 142.7 (C4triz), 141.3 (C4), 140.9 (C7), 130.6 (C), 130.2 
(C11), 128.2 (C5/6), 128.1 (C5/6), 126.6 (C3), 126.2 (C8), 125.8 (C5triz), 125.7 (Cb’), 125.6 (Cc’), 
121.1 (C3triz), 35.0 (CtBu1), 31.6 (CtBu2); MS (ES+) m/z = 653.1 [M]+; HRMS (ES+) m/z = 651.1785 
[M]+; calculated for [C29H25N6194Pt]+ 651.1767. 
[Pt(phen)L2]PF6 
 
239 
 
HL2 (20 mg, 0.08mmol), AgOTf (41 mg, 0.16 mmol) and Pt(phen)Cl2 (35 mg, 0.08 mmol) 
were added to a Schlenk with DCM (4 mL). The solid was then recrystallized in DMF and 
ether and dried in vacuo (6 mg, 12 %); 1H NMR (400 MHz, Chloroform-d) δ 9.36 (dd, J = 7.9, 
1.1 Hz, 1H, H9), 8.62 (d, J = 8.8 Hz, 1H, H2), 8.40 (d, J = 8.7 Hz, 1H, H4), 8.33 (d, J = 8.8 Hz, 1H, 
Hb’), 8.25 (ddd, J = 7.9, 1.5, 0.9 Hz, 1H, H7), 8.12 (d, J = 5.6 Hz, 1H, H6triz), 7.99 – 7.88 (m, 3H, 
H4triz, H5 and H6), 7.71 (d, J = 8.1 Hz, 1H, H3), 7.69 – 7.59 (m, 2H, H8 and H3triz), 7.43 (td, J = 
7.4, 1.4 Hz, 1H, H5triz), 7.06 (d, J = 8.8 Hz, 1H, Hc’), 3.91 (s, 3H, HOMe); MS (ES+) m/z = 650.1 
[M]+; HRMS (ES+) m/z = 650.1453 [M]+; calculated for [C29H22N5O194Pt]+ 650.1451. 
 
[Pt(phen)L3]PF6 
 
HL3 (30 mg, 0.103 mmol), Pt(phen)Cl2 (46 mg, 0.103 mmol) and AgOTf (53 mg, 0.206 mmol) 
with DCM (4 mL). A yellow solid was obtained (40 mg, 58 %);  1H NMR (700 MHz, DMSO-d6) 
δ 9.83 (s, 1H, H9), 8.63 (s, 1H, H2), 8.58 (d, J = 7.7 Hz, 1H, H4), 8.42 (d, J = 7.6 Hz, 1H, H7), 8.29 
(s, 1H, H6triz), 7.84 (t, J = 7.1 Hz, 1H, H4triz), 7.79-7.73 (m, 2H, H5/6 and H3), 7.72 (t, J = 6.0 Hz, 
1H, H5/6), 7.66 (d, J = 6.9 Hz, 1H, H8), 7.49 (d, J = 7.3 Hz, 2H, Hb’), 7.41 (d, J = 7.5 Hz, 2H, Hc’), 
7.22-7.17 (m, 2H, H3triz and H5triz); 13C NMR (176 MHz, DMSO-d6) δ 162.6, 159.3, 152.3 (C9), 
151.4 (C2), 150.3 (C6triz),  145.3, 142.9 (C4triz), 141.4 (C4), 140.9 (C7), 128.1 (C3), 128.0 (C5/6), 
126.7 (C5/6), 126.2 (C8), 126.1 (C3triz), 125.9 (Cb’), 125.6 (Cc’), 121.3 (C5triz), 40.9 (CCF3); 19F NMR 
(376 MHz, Chloroform-d) δ -60.72; MS (ES+) m/z = 664.1 [M]+; HRMS (ES+) m/z = 663.1000 
[M]+; calculated for [C26H16N6F3194Pt]+ 663.1015. 
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7.3.4 Tetrazoles  
7.3.4.1 Precursors  
Compound P1 
 
As for the 1,2,4-triazole precursor P1.  
Compound P5 
 
5-bromopyridine-2-carbonitrile (171 mg, 0.94 mmol), 4-tert-butyl phenylboronic acid       
(200 mg, 1.21 mmol) and Na2CO3 (496 mg, 4.68 mmol) with Pd(PPh3)4 (135 mg, 0.12 mmol) 
in DME (3 mL) and H2O (3 mL). A white solid was obtained (118 mg, 53 %); 1H NMR            
(700 MHz, Chloroform-d) δ 8.93 (dd, J = 2.2, 0.9 Hz, 1H, H6), 7.98 (dd, J = 8.1, 2.3 Hz, 1H, H4), 
7.74 (dd, J = 8.0, 0.9 Hz, 1H, H3), 7.55-7.54 (m, 4H, H2’ and H3’), 1.36 (s, 9H, HtBu2’); 13C NMR 
(176 MHz, Chloroform-d) δ 152.9 (C4’), 149.5 (C6), 139.7 (C1’), 134.5 (C4), 132.9, 131.9 (C5), 
128.4 (C3), 127.0 (C2’), 126.4 (C3’), 117.4 (C2), 114.7 (CCN), 31.5 (CtBu1’), 31.2 (CtBu2’); MS (ES+) 
m/z = 237.5 [M+H]+; HRMS (ES+) m/z = 237.1385 [M+H]+; calculated for [C16H17N2]+ 
237.1392.  
7.3.4.2 HLn Tetrazole ligands 
General procedure 
The cyano precursor (1 eq), NaN3 (5 eq) and NH4Cl (5 eq) were added to a Schlenk and 
placed under argon. Dry DMF was then added and the mixture was degassed via 3 x FPT. 
This was set to heat to reflux at 125 °C for 24 h. On leaving to cool to RT, the mixture was 
filtered and to the filtrate 0.1 M HCl aq. solution was added to precipitate out a white solid. 
This was stirred at RT for 1 hour, refrigerated and then re-filtered. The solid was then dried 
in vacuo. 
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Compound HL11 
 
2-cyanopyridine (1.00 g, 9.6 mmol), NaN3 (1.56 g, 24.0 mmol) and NH4Cl (1.28 g, 24.0 mmol) 
in dry DMF (20 mL). A white powder was obtained (837 mg, 59 %); The experimental data 
obtained were in good agreement with the literature.200 
Compound HL12 
 
4-Trifluoromethyl-2-cyanopyridine (200 mg, 1.16 mmol), NaN3 (189 mg, 2.91 mmol) and 
NH4Cl (156 mg, 2.91 mmol) in dry DMF (6 mL). A white powder was obtained (125 mg,        
50 %); 1H NMR (400 MHz, DMSO-d6) δ 9.10 (d, J = 5.1 Hz, 1H, H6), 8.44 (s, 1H, H3), 8.06 (dd, J 
= 5.2, 1.7 Hz, 1H, H5); MS (ES+) m/z = 216.1 [M+H]+; HRMS (ES+) m/z = 216.1341[M+H]+; 
calculated for [C7H5F3N5]+ 216.1362. 
 
Compound HL13 
 
5-Trifluoromethyl-2-cyanopyridine (1.00 g, 5.81 mmol), NaN3 (943 mg, 14.5 mmol) and 
NH4Cl (769 mg, 14.5 mmol) in dry DMF (20 mL). A white powder was obtained (199 mg,       
16 %); 1H NMR (400 MHz, DMSO-d6) δ 9.22 (s, 1H, H6), 8.52 (dd, J = 8.3, 2.3 Hz, 1H, H4), 8.44 
(d, J = 8.3 Hz, 1H, H3);  MS (ES+) m/z = 216.1 [M+H]+; HRMS (ES+) m/z = 216.1231[M+H]+; 
calculated for [C7H5F3N5]+ 216.1200. 
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Compound HL14 
 
P1 (1.01 g, 4.23 mmol), NaN3 (688 mg, 10.59 mmol) and NH4Cl (566mg, 10.59 mmol) with 
dry DMF (20 mL). A white solid was obtained (1.01 g, 86 %); 1H NMR (600 MHz, DMSO-d6) δ 
8.79 (dd, J = 5.2, 1.5 Hz, 1H, H6), 8.42 (s, 1H, Hc), 7.93 (s, 1H, H3), 7.88 (dd, J = 5.0, 2.2 Hz, 1H, 
H5), 7.82 (dd, J = 8.3, 1.7 Hz, 2H, H3’), 7.60 – 7.54 (m, 2H, H2’), 1.31 (d, J = 1.7 Hz, 9H, HtBu2); 
13C NMR (151 MHz, DMSO-d6) δ 162.8 (C3), 156.0 (Cc), 153.0 (C1’), 151.0 (C6), 149.1 (C4), 
145.6 (C2), 133.9 (C4’), 127.2 (C3’), 126.7 (C2’), 123.2 (C5), 35.0 (CtBu1’), 31.4 (CtBu2’); MS (ES+) 
m/z =280.1 [M+H]+.  
Compound HL15 
 
P5 (100 mg, 0.43 mmol), NaN3 (69 mg, 1.06 mmol) and NH4Cl (57 mg, 1.06 mmol) with dry 
DMF (2 mL). A white solid was obtained (73 mg, 61%); 1H NMR (600 MHz, DMSO-d6) δ 9.06 
(d, J = 1.8 Hz, 1H, H6), 8.31 (dd, J = 8.2, 2.3 Hz, 1H, H4), 8.25 (dd, J = 8.2, 0.9 Hz, 1H, H3), 7.75 
(d, J = 8.5 Hz, 1H, H3’), 7.54 (d, J = 8.5 Hz, 1H, H2’), 1.31 (s, 9H, HtBu2’); 13C NMR (151 MHz, 
DMSO-d6) δ 151.9 (C4’), 148.3 (C6), 137.6 (C1’), 136.0 (C4), 133.6 (C5), 127.3 (C3’), 126.5 (C2’), 
123.0 (C3), 110.0 (C2), 34.9 (CtBu1’) and 31.5 (CtBu2’); MS (ES+) m/z =280.2 [M+H]+; HRMS (ES+) 
m/z = 280.1559 [M+H]+; calculated for [C16H18N5]+ 280.1562. 
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7.3.4.3 Homoleptic Pt complexes 
General procedure 
HL11-15 and K2PtCl4 were added to a Schlenk with H2O and EtOH (1:3). The mixture was 
degassed via 3 x FPT and then refluxed at 80 oC for 24 h. This was cooled to RT and the solid 
was isolated by centrifuge and washed with H2O (2 x 5 mL), MeOH (2 x 5 mL) and Et2O (2 x      
5 mL). The solid was then dried in vacuo.  
PtL112 
 
HL11 (50 mg, 0.34 mmol), K2PtCl4 (71 mg, 0.17 mmol) with H2O (1 mL) and EtOH (3 mL). A 
yellow powder that was insoluble in all common organic solvents was obtained (68 mg,      
82 %); MS (ASAP+) m/z =488.1 [M+H]+; HRMS (ASAP+) m/z = 485.0626  [M+H]+; calculated 
for [C12H9N10195Pt]+ 485.0622; Anal. Calcd for C12H8N10Pt C, 29.57; H, 1.65; N, 28.74. Found: 
C, 29.09; H, 1.71; N, 28.62.   
PtL122 
 
HL12 (330 mg, 1.53 mmol), K2PtCl4 (350 mg, 0.84 mmol) with H2O (1 mL) and EtOH (3 mL). 
An orange powder that was insoluble in all common organic solvents was obtained          
(306 mg, 58 %); MS (ASAP+) m/z =624.0 [M+H]+; HRMS (ASAP+) m/z = 624.0145  [M+H]+; 
calculated for [C14H7F6N10195Pt]+ 624.0139; Anal. Calcd for C14H6F6N10Pt: C, 26.98; H, 0.97; F, 
18.29; N, 22.47. Found: C, 28.01; H, 1.63; F, 17.93; N, 23.12.  
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PtL132 
 
HL13 (190 mg, 0.88 mmol), K2PtCl4 (202 mg, 0.49 mmol) with H2O (1 mL) and EtOH (3 mL). An 
orange powder that was insoluble in all common organic solvents was obtained (181 mg,     
59 %); MS (ASAP+) m/z =624.0 [M+H]+; HRMS (ASAP+) m/z = 624.1256  [M+H]+ ]+; calculated 
for [C14H7F6N10195Pt]+ 624.1286. 
 
PtL142 
 
HL14 (50 mg, 0.17 mmol), K2PtCl4 (39 mg, 0.10 mmol) in H2O (1 mL) and EtOH (3 mL). An 
orange solid was obtained (51 mg, 69 %); 1H NMR (600 MHz, Chloroform-d) δ 9.82 (d, J = 
6.1 Hz, 2H, H6), 8.26 (d, J = 2.1 Hz, 2H, H3), 7.75 (d, J = 8.5, 4H), 7.64-7.60 (m, 6H, H5 and H3), 
1.42 (s, 18H, HtBu2’); 13C NMR (151 MHz, Chloroform-d) δ 155.2 (C1’), 153.6 (C4’), 153.0 (C6), 
146.6 (Cb), 132.0 (C2), 127.3 (C2’), 126.8 (C3’/5), 123.4 (C3’/5), 119.2 (C3), 35.1 (CtBu1’), 31.2 
(CtBu2’); MS (ES+) m/z = 752.3 [M+H]+; HRMS (ES+) m/z = 749.2511 [M+H]+; calculated for 
[C32H33N10192Pt]+ 749.2500. 
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PtL152 
 
HL15 (30 mg, 0.11 mmol), K2PtCl4 (20 mg, 0.05 mmol), H2O (0.5 mL) and EtOH (1.5 mL). An 
orange solid was obtained (27 mg, 73 %); 1H NMR (600 MHz, Chloroform-d) δ 10.45 (s, 2H, 
H6), 8.32 (d, J = 8.0 Hz, 2H, H4), 8.17 (d, J = 8.1 Hz, 2H, H3), 7.74 (d, J = 8.4 Hz, 4H, H2’), 7.62 
(d, J = 8.4 Hz, 4H, H3’), 1.41 (s, 18H, HtBu2’); 13C NMR (151 MHz, Chloroform-d) δ 153.60 (C4’), 
151.92 (C6), 144.53 (C2), 139.98 (C5) 138.24 (C4), 130.96 (C1’), 126.86 (C3’), 126.82 (C2’), 
121.96 (C3), 34.89 (CtBu1’), 31.23 (CtBu2’); MS (ES+) m/z = 752.2 [M+H]+; HRMS (ES+) m/z = 
749.2511 [M+H]+; calculated for [C32H33N10192Pt]+ 749.2500. 
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7.4 Chapter 3 Synthesis  
7.4.1 Pt(dpyb) complexes 
dpybH 
 
Benzene-1,3-diboronic acid (150 mg, 0.91 mmol), 2-bromopyridine (286 mg, 1.81 mmol) 
and Na2CO3 (7.5 mL, 1 M) were added with DME (7.5 mL) to a Schlenk and degassed by 3 x 
FPT. Pd(PPh3)4 (52 mg, 0.044 mmol) was then added under a flow of argon and the mixture 
was heated at reflux overnight. Water (5 mL) was then added and the product was 
extracted into DCM (3 x 30 mL) before drying over potassium carbonate (K2CO3). The 
solution was filtered, and the solvent removed under reduced pressure before drying in 
vacuo, giving a yellow oil. The product was purified by column chromatography on silica 
(hexane / ethyl acetate gradient, 100:0 to 70:30) to give the product as a yellow oily solid 
(141 mg, 67%). The experimental data obtained were in good agreement with the 
literature.201 
Pt(dpyb)Cl  
 
Method 1 
dpybH (121 mg, 0.52 mmol), K2PtCl4 (239 mg, 0.58 mmol) and acetic acid (15 mL) were 
placed in a clean, dry Schlenk and degassed by 3 x FPT cycles. The mixture was then heated 
at reflux for 72 h under nitrogen before cooling to RT. The crude, solid product was 
removed from the solvent by separation on the centrifuge then washed with water (4 mL), 
methanol (4 mL) and diethyl ether (4 mL). The product was then extracted into DCM and 
the solvent removed under reduced pressure to give Pt(dpyb)Cl as a yellow solid (115 mg, 
48 %). 
Method 2 
dpybH (109 mg, 0.47 mmol), K2PtCl4 (200 mg, 0.48 mmol), acetic acid (1.2 mL) and water 
(0.3 mL) were placed in a sealed microwave vial and degassed by 3 x FPT cycles. The 
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mixture was heated at 160 °C for 30 min in the microwave and then left to cool to RT. The 
solid was isolated by centrifuge and washed with H2O (2 x 5 mL), MeOH (5 mL) and Et2O       
(5 mL) before extraction into DCM. The solvent was removed under reduced pressure and 
the complex dried in vacuo to give the pure product (217 mg, 68 %).  
The experimental data obtained for both methods were in good agreement with the 
literature.201 
 
Pt(dpyb)Cl3  
 
Pt(dpyb)Cl (83 mg, 0.18 mmol) was suspended in chloroform (CHCl3) (83 mL) and chlorine 
gas (generated in a separate flask by addition of concentrated HCl, 37 %, to KMnO4) was 
bubbled through the solution for 30 min. The solvent was removed in vacuo and the 
product was dried in vacuo to give a pale yellow solid (86 mg, 90 %); 1H NMR (400 MHz, 
DMSO-d6) δ 9.24 (dd, J = 6.0, 1.4 Hz, 2H, H2’), 8.51 (dd, J = 8.1, 1.5 Hz, 2H, H5’), 8.36 (td, J = 
7.8, 1.6 Hz, 2H, H4’), 8.18 (d, J = 7.7 Hz, 2H, H3), 7.81 (ddd, J = 7.5, 5.9, 1.6 Hz, 2H, H3’), 7.58 
(t, J = 7.7 Hz, 1H, H4); MS (ASAP+) m/z =497.0 [M-Cl]+; HRMS (ASAP+) m/z = 494.9922 [M-
Cl]+; calculated for [C16H11N2Cl2194Pt]+ 494.9926.  
 
[Pt(dpyb)L1Cl]PF6 
 
Pt(dpyb)Cl3 (20 mg, 0.04 mmol) was suspended in dry toluene (3 mL) with AgOTf (21 mg, 
0.08 mmol) and HL1 (13 mg, 0.05 mmol). The mixture was heated at reflux, under nitrogen, 
with the exclusion of light for 24 h. After cooling to RT, the precipitated solid was isolated 
on the centrifuge and washed with toluene (2 × 3 mL). The crude product was extracted 
into acetone (3 × 5 mL) and the solvent removed under reduced pressure. The product was 
then dissolved in the minimum volume of acetone and the PF6− salt was obtained by 
pipetting a saturated aqueous solution of KPF6 (5 mL) to precipitate the product. The solid 
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was isolated by centrifugation and then washed with H2O (5 × 3 mL). The solid was then 
recrystallized by slow evaporation from acetone to yield a yellow crystalline solid before 
drying in vacuo (2 mg, 7 %); MS (ASAP+) m/z = 737.5 [M]+; HRMS (ASAP+) m/z = 737.1677 
[M]+; calculated for [C33H28N6Cl194Pt]+ 737.1691. 
 
[Pt(dpyb)L16]PF6 
 
Pt(dpyb)Cl3 (20 mg, 0.04 mmol), H2L16 (18 mg, 0.038 mmol) and AgOTf (48 mg, 0.19 mmol) 
were added to a Schlenk and suspended in ethylene glycol (2 mL). The mixture degassed via 
3 x FPT and then set to reflux for 3 days. After cooling to RT, water (5 mL) was added and 
the precipitated solid was isolated via centrifuge. The crude product was dissolved in the 
minimum volume of MeOH and the PF6— salt was obtained by pipetting a saturated 
aqueous solution of KPF6 (5 mL) to precipitate the product. The solid was isolated by 
centrifugation and then washed with water (5 × 3 mL). The solid was then purified by 3 x 
DCM/Hexane recrystallizations to afford a yellow crystalline solid (7 mg, 20 %); 1H NMR 
(400 MHz, DMSO-d6) δ 9.19 – 9.10 (m, 1H, H4triz), 9.01 (d, J = 8.0 Hz, 2H, H6’), 8.39 (d, J = 8.5 
Hz, 4H, Hb’), 7.85 (d, J = 5.7 Hz, 2H, H3triz), 7.70 (d, J = 7.7 Hz, 4H, Hc’), 7.59 (t, J = 7.8 Hz, 2H, 
H5’), 6.99 – 6.83 (m, 2H, H4’), 6.72 – 6.52 (m, 2H, H3’), 6.36 (d, J = 7.8 Hz, 2H, H3dpyb), 5.68 (t, J 
= 7.7 Hz, 1H, H4dpyb), 1.10 (s, 18H); MS (ASAP+) m/z = 901.3 [M]+. 
 
7.4.2 Ir(dpyb) complexes  
7.4.2.1 Step 1 intermediate 
Compound I1h 
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To a solution of 2,6-pyridinedicarbonitrile (500 mg, 3.87 mmol) in ethanol (25 mL) was 
added hydrazine monohydrate (3.76 mL, 77.45 mmol). The reaction mixture was stirred at 
RT overnight, yielding a pale-yellow precipitate in a yellow solution. The precipitate was 
filtered off, washed with cold ethanol, and dried in vacuo. A pale-yellow solid was obtained 
(582 mg, 78 %). The experimental data obtained were in good agreement with the 
literature.91 
 
7.4.2.2 Step 2 intermediates  
General procedure   
An oven-dried, nitrogen-purged Schlenk tube was loaded with I1h (1 eq) and Na2CO3         
(2.2 eq), evacuated, gently heated, and refilled with nitrogen after being cooled to RT. Next, 
dry DMF was added and the suspension was cooled to 0 °C. In a separately prepared 
Schlenk tube, a solution of the acyl chloride (2 eq) in dry DMF was prepared the same way 
as above. This solution was then slowly added to the cooled suspension under vigorous 
stirring and the reaction mixture was allowed to warm to RT overnight. Then the reaction 
volume was doubled by the addition of water, yielding a suspension. This suspension was 
stirred strongly for another 1.5 h and then filtered and washed with water thoroughly. The 
solid was then dried in vacuo.  
Compound I2k 
 
 
 
I1h (500 mg, 2.59 mmol) and Na2CO3 (603 mg, 5.70 mmol) in 16 mL DMF and                            
4-tert-butylbenzoyl chloride (1.01 mL, 5.18 mmol) in 6 mL DMF were reacted according to 
the general procedure outlined above. A cream-coloured solid was obtained (151 mg, 46 
%); 1H NMR (400 MHz, DMSO-d6) δ 10.12 (s, 2H, Hc), 8.25 (d, J = 7.8 Hz, 2H, H3), 7.99 (t, J = 
6.5 Hz, 1H, H4), 7.82 (d, J = 8.2, 4H, Hb’), 7.53 (d, J = 8.2, 4H, Hc’), 7.28-7.19 (m, 4H, Ha and 
Hd), 1.33 (s, 18H, HtBu2); MS (ESI+) m/z = 514.3 [M+H]+; HRMS (ESI+) m/z = 514.2921 [M+H]+; 
calculated for [C29H36N7O2]+ 514.2930. 
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Compound I2l 
 
I1h (300 mg, 1.55 mmol) and Na2CO3 (362 mg, 3.42 mmol) in 10 mL DMF and                          
4-methoxybenzoyl chloride (530 mg, 3.11 mmol) in 4 mL DMF were reacted according to 
the general procedure outlined above. A cream-coloured solid was obtained (326 mg, 46 
%); 1H NMR (400 MHz, DMSO-d6) δ 10.11 (s, 2H, Hc), 8.24 (d, J = 7.9 Hz, 2H, H3), 7.96 (t, J = 
6.9 Hz, 1H, H4), 7.91 (d, J = 8.3 Hz, 4H, Hb’), 7.37-7.13 (m, 4H, Ha and Hd), 7.04 (d, J = 8.3 Hz, 
4H, Hc’), 3.84 (s, 6H, HOMe); MS (ESI+) m/z = 462.2 [M+H]+; HRMS (ESI+) m/z = 462.1880 
[M+H]+; calculated for [C23H24N7O4]+ 462.1890. 
 
Compound I2m 
 
I1h (700 mg, 3.60 mmol) and Na2CO3 (840 mg, 7.92 mmol) in 22 mL DMF and                          
4-trifluoromethylbenzoyl chloride (1.08 mL, 7.25 mmol) in 8 mL DMF were reacted 
according to the general procedure outlined above. A cream-coloured solid was obtained 
(1.7 g,       87 %); 1H NMR (400 MHz, DMSO-d6) δ 10.44 (s, 2H, Hc), 8.28 (d, J = 7.9 Hz, 2H, H3), 
8.12 (d, J = 8.3 Hz, 4H, Hb’), 8.00 (t, J = 6.6 Hz, 1H, H4), 7.89 (d, J = 8.3 Hz, 4H, Hc’), 7.41-7.23 
(m, 4H, Ha and Hd); 19F NMR (376 MHz, DMSO-d6) δ -61.21; MS (ESI+) m/z = 538.1 [M+H]+; 
HRMS (ESI+) m/z = 538.1418 [M+H]+; calculated for [C23H18N7O2F6]+ 538.1426. 
 
7.4.2.3 H2Ln Triazoles  
General procedure  
I2x was suspended in ethylene glycol in a 100 mg/mL ratio in an open round-bottom flask. 
This suspension was heated to 180 °C, eliminating water. Once the solution was clear, the 
reaction mixture was heated under reflux for another hour. After the reaction mixture was 
cooled to RT, the product was precipitated with water and stirred vigorously for a further 
hour. The solid was filtered through a Whatman membrane filter (0.2 µm, nylon), washed 
with water, and dried in vacuo.  
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Compound H2L16 
 
 
I2k (4 g, 7.79 mmol) was suspended in ethylene glycol (40 mL) and reacted according to the 
general procedure as outlined above. A white solid was obtained (2.9 g, 78 %); 1H NMR     
(400 MHz, DMSO-d6) δ 14.50 (s, 2H, Hc), 8.24-8.19 (m, 3H, H3 and H4), 8.07 (d, J = 8.5 Hz, 4H, 
Hb’), 7.56 (d, J = 8.5 Hz, 4H, Hc’), 1.34 (s, 18H, HtBu2); 13C NMR (176 MHz, DMSO-d6) δ 126.2 
(Cb’), 126.0 (Cc’), 121.8 (C3 and C4), 35.0 (CtBu1), 31.5 (CtBu2); MS (ESI+) m/z = 478.2 [M+H]+; 
HRMS (ESI+) m/z = 478.4569 [M+H]+; calculated for [C29H32N7]+ 478.4876. 
 
Compound H2L17 
 
 
 
I2l (320 mg, 0.69 mmol) was suspended in ethylene glycol (3.5 mL) and reacted according to 
the general procedure as outlined above. A white solid was obtained (261 mg, 89 %); 1H 
NMR (400 MHz, DMSO-d6) δ 8.25-8.16 (m, 3H, H3 and H4), 8.07 (d, J = 8.8 Hz, 4H, Hb’), 7.11 
(d, J = 8.8 Hz, 4H, Hc’), 3.85 (s, 6H, HOMe); MS (ESI+) m/z = 426.2 [M+H]+; HRMS (ESI+) m/z = 
426.1679 [M+H]+; calculated for [C23H19N7O2]+ 426.1678. 
 
Compound H2L18 
 
 
I2m (1.6 g, 2.99 mmol) was suspended in ethylene glycol (16 mL) and reacted according to 
the general procedure as outlined above. A white solid was obtained (1.2 g, 80 %); 1H NMR 
(400 MHz, DMSO-d6) δ 8.36 (d, J = 8.2 Hz, 4H, Hb’), 8.28 – 8.19 (m, 3H, H3 and H4), 7.91 (d, J 
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= 8.2 Hz, 4H, Hc’); 19F NMR (376 MHz, DMSO-d6) δ -61.10; MS (ESI+) m/z = 502.5 [M+H]+; 
HRMS (ESI+) m/z = 502.1207 [M+H]+; calculated for [C23H13N7F6]+ 502.1215. 
7.4.2.4 Ir(dpyb)(Ln) complexes 
General procedure 
All chloro-bridged Ir dimers, [Ir(dpybX)(µ-Cl)Cl]2, were synthesised according to literature 
procedure (Nonoyama route) by reaction of the ligand with IrCl3.H2O in ethoxyethanol/H2O 
reflux for 24 h.202 [Ir(dpybX)(µ-Cl)Cl]2 (1 eq) was added to a Schlenk with H2Ln (2 eq) and 
ethylene glycol. The mixture was degassed via 3 x FPT cycles and then set to reflux at 185 °C 
for 24 h. The mixture was then allowed to cool to RT. The suspension was filtered and 
washed with water. This was then columned over a slow gradient of DCM/MeOH from 
100:0 to 95:5 on alumina.  
Ir(dpybMe2)L16 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (32 mg, 0.03 mmol), H2L16 (29 mg, 0.06 mmol) and ethylene glycol      
(2 mL). A yellow powder was obtained (15 mg, 52 %); Rf = 0.45 (95:5 DCM/MeOH, alumina);  
1H NMR (700 MHz, DMSO-d6) δ 8.37 (t, J = 7.8 Hz, 1H, H4triz), 8.21 (d, J = 8.2 Hz, 2H, H6’), 8.19 
(d, J = 7.7 Hz, 2H, H3triz), 7.80 (t, J = 8.0 Hz, 2H, H5’)), 7.61 (d, J = 8.7 Hz, 4H, Hb’), 7.40 (d, J = 
5.8 Hz, 2H, H3’), 7.25 (d, J = 8.7 Hz, 4H, Hc’), 7.18 (s, 1H, H4), 7.04 (d, J = 6.8 Hz, 2H, H4’), 2.90 
(s, 6H, HMe), 1.18 (s, 18H, HtBu2); MS (ES+) m/z = 928.3 [M+H]+; HRMS (ES+) m/z = 926.3439 
[M+H]+; calculated for [C47H45N9191Ir]+ 926.3404.  
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Ir(dpybMe2)L17 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (24 mg, 0.02 mmol), H2L17 (20 mg, 0.05 mmol) and ethylene glycol      
(1 mL). A yellow powder was obtained (5 mg, 25 %); Rf = 0.27 (90:10 DCM/MeOH, alumina); 
MS (ES+) m/z = 876.2 [M+H]+; HRMS (ES+) m/z = 874.2365 [M+H]+; calculated for 
[C41H33N9O2191Ir]+ 874.2363. This compound was insoluble in all common organic solvents, 
so no NMR data was obtained; Anal. Calcd for C41H33N9O2Ir: C, 56.28; H, 3.69; N, 14.41; 
Found: C, 55.76; H, 3.09; N, 14.78.  
Ir(dpyb(Me)2)L18 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (50 mg, 0.05 mmol), H2L18 (48 mg, 0.10 mmol) and ethylene glycol      
(3 mL). A yellow powder was obtained (30 mg, 63 %); Rf = 0.32 (95:5 DCM/MeOH, alumina); 
1H NMR (700 MHz, DMSO-d6) δ 8.42 (t, J = 7.7 Hz, 1H, H4triz), 8.27 (d, J = 8.0 Hz, 2H, H3triz), 
8.22 (d, J = 8.5 Hz, 2H, H6’), 7.90 (d, J = 8.2 Hz, 4H, Hc’), 7.81 (t, J = 7.7 Hz, 2H, H5’), 7.60 (d, J = 
8.3 Hz, 4H, Hb’), 7.42 (d, J = 5.8 Hz, 2H, H3’), 7.18 (s, 1H, H4), 7.04 (t, J = 6.6 Hz, 2H, H4’), 2.90 
(s, 6H, HMe);  19F NMR (376 MHz, Chloroform-d) δ -62.47; MS (ES+) m/z = 951.8 [M+H]+; 
HRMS (ES+) m/z = 950.1907 [M+H]+; calculated for [C41H27N9F6191Ir]+ 950.1900. 
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Ir(dpybF2)L16 
 
[Ir(dpybF2)(µ-Cl)Cl]2 (100 mg, 0.09 mmol), H2L16 (90 mg, 0.19 mmol) and ethylene glycol       
(3 mL). A yellow powder was obtained (46 mg, 52 %); Rf 0.51 (95:5 DCM/MeOH, alumina); 
1H NMR (400 MHz, DMSO-d6) δ 8.44 (dd, J = 8.4, 7.5 Hz, 1H, H4triz), 8.26 (d, J = 7.9 Hz, 2H, 
H6’), 8.22 (d, J = 8.2 Hz, 2H, H3triz), 7.94 (dd, J = 7.9, 1.4 Hz, 2H, H5’), 7.67 (d, J = 8.6 Hz, 4H, 
Hb’), 7.54 – 7.46 (m, 3H, H4 and H4’), 7.30 (d, J = 8.6 Hz, 4H, Hc’), 7.17 (ddd, J = 7.4, 5.7, 1.4 
Hz, 2H, H3’), 1.22 (s, 18H, HtBu); 19F NMR (376 MHz, DMSO-d6) δ -107.48 (d, J = 14.2 Hz); MS 
(ES+) m/z =936.3 [M+H]+; HRMS (ES+) m/z = 934.2894 [M+H]+; calculated for 
[C45H39N9F2191Ir]+ 934.2903.  
Ir(dpybF2)L17 
 
[Ir(dpybF2)(µ-Cl)Cl]2 (125 mg, 0.12 mmol), H2L17 (100mg, 0.24 mmol) and ethylene glycol      
(2 mL). A yellow powder was obtained (24 mg, 23 %); Rf=0.4 (95:5 DCM/MeOH, alumina); 1H 
NMR (700 MHz, DMSO-d6) δ 8.40 (t, J = 8.0 Hz, 1H, H4triz), 8.20-8.17 (m, 4H, H3triz and H6’), 
7.90 (td, J = 7.9, 1.6 Hz, 2H, H5’), 7.64 (d, J = 8.9 Hz, 4H, Hb’), 7.47 (d, J = 5.6 Hz, 2H, H3’), 7.44 
(t, J = 11.6 Hz, 1H, H4), 7.14 (ddd, J = 7.4, 5.8, 1.4 Hz, 2H, H4’), 6.80 (d, J = 8.9 Hz, 4H, Hc’), 
3.68 (s, 6H, HOMe); 19F NMR (376 MHz, DMSO-d6) δ -107.49 (d, J = 12.0 Hz); MS (ES+) m/z 
=884.1 [M+H]+; HRMS (ES+) m/z =882.1857 [M+H]+; calculated for [C39H27N9O2F2191Ir]+; 
882.1862. 
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Ir(dpybF2)L18 
 
[Ir(dpybF2))(µ-Cl)Cl]2 (100 mg, 0.09 mmol), H2L18 (95 mg, 0.19 mmol) and ethylene glycol      
(2 mL). A yellow powder was obtained (35 mg, 39 %); 1H NMR (700 MHz, DMSO-d6) δ 8.47 
(t, J = 8.1 Hz, 1H, H4triz), 8.30 (d, J = 7.9 Hz, 2H, H3triz), 8.19 (d, J = 8.2 Hz, 2H, H6’), 7.93 (d, J = 
8.4 Hz, 4H, Hc’), 7.91 (d, J = 7.7 Hz, 2H, H5’), 7.61 (d, J = 8.4 Hz, 4H, Hb’), 7.51 (d, J = 6.0 Hz, 
2H, H3’), 7.46 (t, J = 11.6 Hz, 1H, H4), 7.14 (ddd, J = 7.4, 5.9, 1.4 Hz, 2H, H4’); 19F NMR (376 
MHz, DMSO-d6) δ -60.99, -107.30 (d, J = 13.1 Hz); MS (ES+) m/z = 960.0 [M+H]+; HRMS (ES+) 
m/z = 958.1384 [M+H]+; calculated for [C39H21N9F8191Ir]+ 958.1398. 
Ir(dpybOMe)L16 
 
[Ir(dpybOMe)(µ-Cl)Cl]2 (50 mg, 0.05mmol), H2L16 (46 mg, 0.10 mmol) and ethylene glycol      
(3 mL). A yellow/orange powder was obtained (33 mg, 74 %); MS (ES+) m/z = 930.2 [M+H]+; 
HRMS (ES+) m/z = 928.3202 [M+H]+; calculated for [C46H43N9O191Ir]+ 928.3197; Anal. Calcd 
for C46H42N9OIr: C, 59.47; H, 4.56; N, 13.57; Found: C, 59.23; H, 4.48; N, 12.93.  
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Ir(dpybOMe)L17 
 
[Ir(dpybOMe)(µ-Cl)Cl]2 (50 mg, 0.05mmol), H2L17 (41 mg, 0.10 mmol) and ethylene glycol         
(3 mL). A yellow/orange powder was obtained (25 mg, 59 %); Rf=0.2 (95:5 DCM/MeOH, 
alumina); 1H NMR (700 MHz, DMSO-d6) δ 8.36 – 8.33 (m, 3H, H4triz and H6’), 8.15 (d, J = 7.9 
Hz, 2H, H3triz), 7.96 (s, 2H, H3), 7.84 (ddd, J = 8.1, 7.4, 1.5 Hz, 2H, H5’), 7.61 (d, J = 9.0 Hz, 4H, 
Hb’), 7.38 (d, J = 5.9 Hz, 2H, H3’), 7.04 (ddd, J = 7.3, 5.8, 1.4 Hz, 2H H4’), 6.78 (d, J = 9.0 Hz, 4H, 
Hc’), 4.06 (s, 3H, HOMe(NCN)), 3.67 (s, 6H, HOMe(triz));  MS (ES+) m/z = 878.1 [M+H]+; HRMS (ES+) 
m/z = 876.2155 [M+H]+; calculated for [C40H30N9O3191Ir]+ 876.2156. 
Ir(dpybOMe)L18 
 
[Ir(dpybOMe)(µ-Cl)Cl]2 (50 mg, 0.05mmol), H2L18 (48 mg, 0.10 mmol) and ethylene glycol       
(3 mL). A yellow/orange powder was obtained (34 mg, 71 %); Rf=0.26 (95:5 DCM/MeOH); 1H 
NMR (700 MHz, DMSO-d6) δ 8.42 (t, J = 7.9 Hz, 1H, H4triz), 8.36 (d, J = 8.1 Hz, 2H, H6’), 8.27 (d, 
J = 7.9 Hz, 2H, H3triz), 7.98 (s, 2H, H3), 7.91 (d, J = 8.2 Hz, 4H, Hc’), 7.85 (t, J = 7.7 Hz, 2H, H5’), 
7.59 (d, J = 8.4 Hz, 4H, Hb’), 7.42 (d, J = 5.8 Hz, 2H, H3’), 7.05 (t, J = 6.5 Hz, 2H, H4’), 4.07 (s, 
3H, HOMe); 19F NMR (376 MHz, DMSO-d6) δ -60.96; MS (ES+) m/z = 953.9 [M+H]+; HRMS (ES+) 
m/z = 952.1714 [M+H]+; calculated for [C40H24N9O1F6191Ir]+ 952.1692. 
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7.4.2.5 Ir(dpybMe2)(L1-3)Cl complexes 
General procedure 
[Ir(dpybMe2)(µ-Cl)Cl]2 (1 eq) and HLn (2 eq) were added to a Schlenk with AgOTf (4.5 eq) 
and suspended in toluene (3 mL). The mixture was degassed via 3 x FPT cycles and set to 
heat at reflux for 24 h. The mixture was cooled to RT and the solvent was removed in 
vacuo. The solid was extracted into DCM and then recrystallized in MeOH/hexane. 
Ir(dpybMe2)L1Cl 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (50 mg, 0.05 mmol) and HL1 (27 mg, 0.10 mmol) with AgOTf (56 mg, 
0.22 mmol) and toluene (3 mL). A yellow powder was obtained (30 mg, 82 %); 1H NMR     
(400 MHz, Methanol-d4) δ 8.41 (d, J = 8.3 Hz, 2H, H2’), 8.27-8.20 (m, 3H, H6triz and Hb’), 7.89 
(d, J = 5.6 Hz, 2H, H3’), 7.83 – 7.70 (m, 3H, H5’ and H3triz), 7.47 (d, J = 8.2 Hz, 2H, Hc’), 7.23 (d, J 
= 5.8 Hz, 1H, H4triz), 7.15 (s, 1H, H4dpyb), 7.01 (td, J = 6.9, 1.67 Hz, 1H, H5triz), 6.98-6.90 (m, 2H, 
H4’), 2.91 (s, 6H, HMe), 1.37 (s, 9H, HtBu2); MS (ES+) m/z = 763.0 [M+H]+; HRMS (ES+) m/z = 
763.2071 [M+H]+; calculated for [C35H33N6Cl191Ir]+ 763.2061. 
Ir(dpybMe2)L2Cl 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (50 mg, 0.05 mmol) and HL2 (24 mg, 0.10 mmol) with AgOTf (56 mg, 
0.22 mmol) and toluene (3 mL). A yellow powder was obtained (5 mg, 14 %); 1H NMR      
(700 MHz, DMSO-d6) δ 9.55 (d, J = 5.4, 1H, H6triz), 8.63 (d, J = 7.9, 1H, H3triz), 8.30 (t, J = 7.9, 
258 
 
1H, H5triz), 8.14-7.99 (m, 3H, H4triz and H2’), 7.85 (t, J = 8.0 Hz, 2H, H3’), 7.55 (d, J = 5.2 Hz, 2H, 
H5’), 7.29 (d, J = 7.7 Hz, 2H, Hc’), 7.14 (t, J = 7.1, 2H, H4’), 6.40 (s, 1H, H4dpyb), 6.35 (d, J = 7.7 
Hz, 2H, Hb’), 3.68 (s, 6H, HOMe), 2.51 (s, 6H, HMe); MS (ES+) m/z = 737.1 [M+H]+; HRMS (ES+) 
m/z = 737.1580 [M+H]+; calculated for [C32H27N6OCl191Ir]+ 737.1541. 
Ir(dpybMe2)L3Cl 
 
[Ir(dpybMe2)(µ-Cl)Cl]2 (50 mg, 0.05 mmol) and HL3 (28 mg, 0.10 mmol) with AgOTf (56 mg, 
0.22 mmol) and toluene (3 mL). A yellow powder was obtained (7 mg, 18 %); 1H NMR       
(700 MHz, DMSO-d6) δ 9.57 (dt, J = 5.2, 1.3 Hz, 1H, H6triz), 8.48 (dt, J = 7.9, 1.2 Hz, 1H, H3triz), 
8.42 (td, J = 7.9, 1.6 Hz, 1H, H5triz), 8.05-8.00 (m, 3H, H4triz and H2’), 7.85 (ddd, J = 8.5, 7.4, 1.7 
Hz, 2H, H3’), 7.58 (d, J = 5.7 Hz, 2H, H5’), 7.22 (d, J = 7.8 Hz, 2H, Hc’), 7.14 (ddd, J = 7.2, 5.6, 
1.3 Hz, 2H, H4’), 6.46 (s, 1H, H4dpyb), 6.35 (d, J = 7.7 Hz, 2H, Hb’), 2.53 (s, 6H, HMe); 13C NMR 
(176 MHz, DMSO-d6) δ 169.1 (C6’), 163.3 (Cb/e), 162.8 (Cb/e), 161.9 (Ca’), 151.8 (C5’), 148.9 
(Cd’), 148.6 (C6triz), 140.5 (C5triz), 139.3 (C3’), 138.0 (C3dpyb), 137.0 (C2dpyb), 130.8 (C4dpyb), 129.1 
(Cb’), 127.1 (C4triz), 124.1 (Cc’), 123.4 (C2’), 123.2 (C4’), 121.9 (C3triz), 22.0 (CMe); 19F NMR (376 
MHz, DMSO-d6) δ -61.84; MS (ES+) m/z = 775.1 [M+H]+; HRMS (ES+) m/z = 775.1348 [M+H]+; 
calculated for [C32H24N6F3Cl191Ir]+ 775.1309. 
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7.5 Chapter 4 Synthesis   
7.5.1 Precursors 
 Compound P6 
 
Toluene (40 mL) was added to a mixture of p-anisidine (490 mg, 4 mmol),                            
2,6-dibromopyridine (2.37 g, 10 mmol), NaOtBu (960 mg, 10 mmol) and                               
1,1′-bis(diphenylphosphino)ferrocene (dppf) (89 mg, 0.16 mmol). The mixture was 
degassed by 3 x FPT cycles and then the catalyst bis(dibenzylideneacetone)palladium(0) 
(Pd(dba)2) (46 mg, 0.08 mmol) was added. The reaction mixture was refluxed for 48 h under 
argon. After cooling to RT, water (10 mL) was added to the reaction mixture. The organic 
phase was extracted with ethyl acetate (3 x 20 mL) and washed with water (3 x 20 mL). The 
organic layer was dried with MgSO4 and the solvent was removed in vacuo. The crude oil 
was purified with column chromatography on silica gel (hexane/ethyl acetate 100:0 to 
80:20) to obtain a white crystalline powder (520 mg, 30 %); Rf =0.57 (silica, 70:30, 
hexane/ethyl acetate); 1H NMR (400 MHz, Chloroform-d) δ 7.39 (t, J = 7.6 Hz, 2H, H4’), 7.16 
(d, J = 8.9 Hz, 2H H2), 7.09 (dd, J = 7.6, 0.7 Hz, 2H, H3’), 7.01 – 6.90 (m, 4H, H3 and H5’), 3.87 
(s, 3H, HOMe); 13C NMR (400 MHz; CDCl3) 157.5 (C1), 156.3 (C2’), 138.6 (C6’), 138.4 (C4’), 135.1 
(C4), 128.8 (C2), 120.7 (C3’), 114.3 (C3), 113.4 (C5’), 54.6 (COMe); MS (ES+) m/z = 433.94 [M+H]+; 
HRMS (AP+) m/z = 433.9509 [M+H]+; calculated for [C17H14Br2N3O]+ 433.9504; Mp. = 125 °C.  
 
Compound P7 
 
Dibromopyridine (2.00 g, 8.44 mmol), 4-fluoroaniline (426.43 mg, 3.83 mmol), dppf          
(106 mg, 0.19 mmol), NaOtBu (3.31 g, 34.47 mmol) and Pd(dba)2 (110 mg, 0.19 mmol) were 
added to a Schlenk with dry toluene (90 mL). This mixture was degassed via 3 x FPT cycles 
and set to reflux for 3 days. The crude oil was purified with column chromatography on 
silica gel (hexane/DCM 1:1) to obtain a yellow oil (1.19 g, 74 %); Rf= 0.60 (80:20 
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hexane:ethyl acetate); 1H NMR (400 MHz, Chloroform-d) δ 7.42 (d, J = 8.2 Hz, 2H, H3), 7.24 – 
7.18 (m, 2H, H4’), 7.17 – 7.10 (m, 4H, H3’ and H5’), 6.96 (dd, J = 8.1 Hz, 2H, H2); MS (ES+) m/z = 
424.1 [M+H]+; HRMS (ES+) m/z = 421.9324 [M+H]+; calculated for [C16H10Br2N3F]+ 421.9304.  
7.5.2 H2Ln tetradentate ligands  
Compound H2L19 
 
The ligand was prepared via the Suzuki cross-coupling methodology. P6 (325.70 mg,       
0.7523 mmol), phenylboronic acid (275 mg, 2.26 mmol) and Na2CO3 (797 mg, 7.52 mmol) 
with DME (6 mL) and H2O (6 mL). Pd(PPh3)4 (70 mg, 0.06 mmol) was added after 3 x FPT 
cycles. The compound was purified by column chromatography on silica (hexane/ethyl 
acetate 70:30). A white powder was obtained (322 mg, 49 %); Rf= 0.79 (silica, 70:30, 
hexane/ethyl acetate); 1H NMR (400 MHz, Chloroform-d) δ 7.91 (dd, J = 8.2, 1.4 Hz, 4H, H2’’), 
7.64 (t, J = 7.9 Hz, 2H, H4’), 7.43 – 7.35 (m, 8H, H3’’ and H5’ and H4’’), 7.31 (d, J = 8.9 Hz, 2H, 
H3), 7.07 (dd, J = 8.2, 0.7 Hz, 2H, H3’), 7.01 (d, J = 8.9 Hz, 2H, H2), 3.90 (s, 3H, HOMe); 13C NMR 
(400 MHz; CDCl3) 157.8 (C2’), 157.7 (C6’), 155.3 (C1’’), 139.4 (C4), 137.9 (C4’), 129.9 (C3), 128.8 
(C4’’), 128.7 (C3’’), 126.8 (C2’’), 114.9 (C2), 114.7 (C3’), 113.7 (C5’), 55.7 (CMe); MS (ES+) m/z = 
430.2 [M+H]+; HRMS (ES+) m/z = 430.1907 [M+H]+; calculated for [C29H24N3O]+ 430.1919; 
Mp. = 188 °C.  
 
Compound H2L20 
 
The ligand was prepared via the Suzuki cross-coupling methodology. P6 (305 mg,               
0.70 mmol), Na2CO3 (748 mg, 7.06 mmol) and 2,4-difluorophenylboronic acid (280 mg,    
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1.77 mmol) with DME (5 mL) and water (5 mL).  Pd(PPh3)4 (66 mg, 0.06mmol) was added 
after 3 x FPT cycles. The crude product was purified by column chromatography on silica 
(100:0 to 50:50 hexane/ethyl acetate). A white powder was obtained (85 mg, 24 %); 1H 
NMR (700 MHz, Chloroform-d) δ 7.78 (td, J = 9.0, 6.8 Hz, 2H, H4’’), 7.60 (t, J = 7.9 Hz, 2H, H4’), 
7.43 (dd, J = 7.6, 2.0 Hz, 2H, H5’), 7.24 (d, J = 9.1 Hz, 2H, H3), 7.00 (d, J = 8.2 Hz, 2H, H3’), 6.96 
(d, J = 9.1 Hz, 2H, H2), 6.87 – 6.79 (m, 4H, H2’’ and H5’’), 3.85 (s, 3H, HOMe); 13C NMR (176 
MHz, Chloroform-d) δ 161.5 (C1’’), 160.1 (C3’’), 157.8 (C1), 157.4 (C2’), 150.0 (C6’), 137.8 (C4’), 
132.0 (C4’’), 129.6 (C3), 123.3 (C6’’), 117.7 (C2’), 114.9 (C3’), 114.8 (C2), 111.6 (C5’’), 104.1 (C2’’), 
55.5 (COMe); 19F NMR (376 MHz, Chloroform-d) δ -109.90, -111.70 (dd, J = 21.6, 10.4 Hz); MS 
(ESI+) m/z= 502.7 [M+H]+; HRMS (ES+) m/z = 502.1530 [M+H]+ calculated for for 
[C29H20F4N3O]+ m/z = 502.1543; Mp. = 127 °C. 
 
Compound H2L21 
 
This ligand was prepared via the Stille cross-coupling methodology. P6 (207 mg, 0.48 mmol), 
2-tri-n-butylstannylthiophene (453 mg, 1.21 mmol) and LiCl (162 mg, 3.82 mmol) with 
toluene (10 mL). Pd(PPh3)2Cl2 (23 mg, 0.03 mmol) was added after 3 x FPT. The reaction was 
refluxed for 48 h. The crude product was purified by column chromatography on silica 
(70:30, hexane/ethyl acetate). A white powder was obtained (145mg, 69 %); Rf =0.8 (silica, 
80:20 hexane/ethyl acetate); 1H NMR (700 MHz, Chloroform-d) δ 7.56 (dd, J = 8.3, 7.5 Hz, 
2H, H4’), 7.49 (dd, J = 3.7, 1.1 Hz, 2H, H3’’), 7.31-7.27 (m, 4H, H3 and H5’), 7.26 (dd, J = 7.6, 0.7 
Hz, 2H, H5’’), 7.09 – 7.03 (m, 4H, H4’’ and H3’), 7.01 (d, J = 9.0 Hz, 2H, H2), 3.90 (s, 3H, HOMe); 
13C NMR (176 MHz, Chloroform-d) δ 158.1 (C1), 157.0 (C6’), 150.5 (C2’), 145.7 (C2’’), 137.7 
(C4’), 137.1 (C4), 130.5 (C5’’), 127.9 (C3’), 127.2 (C3), 124.2 (C3’’), 114.8 (C2), 114.1 (C4’’), 111.9 
(C5’), 55.6 (CMe); MS (ES+) m/z = 442.1 [M+H]+; HRMS (ES+) m/z = 442.1033 [M+H]+; 
calculated for [C25H20N3OS2]+ 442.1040; Mp. = 137 °C. 
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Compound H2L22 
 
This ligand was prepared via the Stille cross-coupling methodology. P6 (213 mg, 0.49 mmol) 
with LiCl (166 mg, 3.92 mmol) and 2-tri-n-butylstannyl benzothiophene (520 mg,              
1.29 mmol) and dry toluene (8 mL). Pd(PPh3)2Cl2 (28 mg, 0.04 mmol) was added after 3 x 
FPT cycles. The reaction was refluxed for 48 h. The crude product was columned on silica 
(90:10, hexane/ethyl acetate). A white powder was obtained (68 mg, 26 %); Rf =0.27; 1H 
NMR (700 MHz, Chloroform-d) δ 7.78 (d, J = 8.1 Hz, 2H, H5’’), 7.74 (d, J = 7.7 Hz, 2H, H8’’), 
7.72 (s, 2H, H3’’), 7.62 (dd, J = 8.3, 7.5 Hz, 2H,  H4’), 7.40 (dd, J = 7.5, 0.7 Hz, 2H, H3’), 7.32 – 
7.26 (m, 6H, H3, H6’’ and H7’’), 7.13 (dd, J = 8.2, 0.7 Hz, 2H, H5’), 7.04 (d, J = 8.9 Hz, 2H, H2), 
3.90 (s, 3H, HOMe); 13C NMR (176 MHz, Chloroform-d) δ 156.8 (C2’), 150.2 (C6’),  140.7 (C4’’),  
140.5 (C9’’),  137.5 (C4’),  130.4 (C3),  124.6 (C6’’),  124.2 (C7’’),  123.9 (C8’’),  122.4 (C5’’),  120.5 
(C3’’),  114.8 (C2),  114.7 (C3’),  112.8 (C5’),  55.5 (COMe); (ESI+) m/z = 542.2 [M+H] +; HRMS (ES+) 
m/z = 542.1359 [M+H]+; calculated for [C33H24N3OS2]+ 542.1361; Mp. = 201 °C. 
Compound H2L23 
 
P7 (500 mg, 1.18 mmol), indole (306 mg, 2.61 mmol) and NaOtBu (1.02 g, 10.62 mmol) were 
added to a Schlenk with dry toluene (70 mL). In a separate Schlenk,                                         
tri-tert-butylphosphonium tetrafluoroborate (HP(tBu)3+BF4-) (52 mg, 0.18 mmol) was added 
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to Pd(dba)2 (33.9 mg, 0.06 mmol) with toluene (20 mL). The Schlenk containing the catalyst 
was added to the other Schlenk dropwise via cannular under an argon atmosphere. This 
was stirred at reflux for 24 hours and left to cool to RT. Water was added and the product 
was extracted with ethyl acetate and then reduced in vacuo. The crude product was 
columned on silica (100:0 to 80:20, hexane/ethyl acetate) to obtain a white powder (403 
mg, 69 %); Rf =0.57 (80:20. hexane/ethyl acetate); 1H NMR (599 MHz, Chloroform-d) δ 7.80 
(dq, J = 8.4, 0.9 Hz, 2H, H5’’), 7.68 (t, J = 8.0 Hz, 2H, H4’), 7.61 (d, J = 3.5 Hz, 2H, H2’’), 7.58 (d, J 
= 7.9 Hz, 2H, H8’’), 7.44 – 7.37 (m, 2H, H2), 7.27 – 7.20 (m, 2H, H3), 7.13 (ddd, J = 7.9, 7.0, 1.0 
Hz, 2H, H7’’), 7.08 (dd, J = 8.0, 0.6 Hz, 2H, H3’), 7.05 – 6.99 (m, 4H, H6’’ and H5’), 6.64 (dd, J = 
3.5, 0.8 Hz, 2H, H3’’); 13C NMR (151 MHz, Chloroform-d) δ 162.1 (C1), 160.5 (C4), 156.5 (C2’), 
151.3 (C6’), 139.6 (d, J = 2.1 Hz) (C4’), 135.0 (C4’’), 130.9 (d, J = 8.4 Hz) (C2), 130.3 (C9’’), 125.3 
(d, J = 1.5 Hz) (C2’’), 122.8 (C6’’), 121.2 (C7’’), 120.7 (C8’’), 116.8 (d, J = 22.6 Hz) (C3), 114.3 (C5’’), 
111.2 (C5’), 106.6 (d, J = 1.5 Hz) (C3’), 105.8 (C3’’); 19F NMR (376 MHz, Chloroform-d) δ -
115.37; (ESI+) m/z = 496.3 [M+H] +; HRMS (ES+) m/z = 496.1916 [M+H]+; calculated for 
[C32H23FN5]+ 496.1937. 
7.5.3 Pt and Pd Complexes    
7.5.3.1. PtII Complexes    
H2Ln (0.66 mmol, 1eq), K2PtCl4 (0.72 mmol, 1.1 eq), and acetic acid (3 mL) were added to a 
Schlenk. The reaction mixture was degassed by 3 x FPT cycles and heated at refluxed for 48 
hours. Water (5 mL) was added to the reaction mixture and the precipitate was collected 
via centrifugation. The precipitate was then washed with H2O (1 x 5 mL) EtOH (1 x 5 mL) 
and Et2O (2 x 5 mL) before being dried in vacuo.  
PtL19 
 
H2L19(100 mg, 0.233 mmol), acetic acid (3 mL) and K2PtCl4 (106 mg, 0.26 mmol). A yellow 
solid was obtained (84 mg; 58 %); 1H NMR (700 MHz, Chloroform-d) δ 8.40 (d, J = (195Pt 
50.4), 7.6 Hz, 2H, H2’’), 7.79 (d, J = 7.5 Hz, 2H, H5’’), 7.71 (dd, J = 8.6, 7.6 Hz, 2H, H4’), 7.60 (d, J 
264 
 
= 7.6 Hz, 2H, H5’), 7.43 (t, J = 7.7 Hz, 2H, H3’’), 7.30 (d, J = 8.7 Hz, 2H, H3), 7.21 (t, J = 7.4 Hz, 
2H, H4’’), 7.18 (d, J = 8.7 Hz, 2H, H2), 6.52 (d, J = 8.7 Hz, 2H, H3’), 3.95 (s, 3H, HOMe); 13C NMR 
(176 MHz, Chloroform-d) δ 164.3 (C6’), 160.1 (C1), 149.0 (C2’), 148.6 (C1’’), 147.0 (C6’’), 142.8 
(C4), 136.7 (C4’), 136.0 (C2’’), 131.3 (C3), 129.4 (C3’’), 123.7 (C5’’), 123.2 (C4’’), 116.6 (C2), 113.7 
(C3’), 111.7 (C5’), 55.7 (COMe); (ESI+) m/z = 623.4 [M+H]+; HRMS (ES+) m/z = 622.1397 [M+H]+; 
calculated for [C29H22N3O194Pt]+ 622.1390. 
PtL20 
 
H2L20 (50 mg, 0.10 mmol), K2PtCl4 (46 mg, 0.11 mmol) and acetic acid (3 mL) set to refluxed 
for 3 nights at 118 oC. A yellow solid resulted (5 mg; 7 %); Isomers obtained in NMR and so 
all characterisation done on a crystal; (ES+) m/z = 695.1 [M+H]+; HRMS (ES+) m/z = 694.1003 
[M+H]+; calculated for [694.1013]+.  
PtL21 
 
H2L21 (100 mg, 0.23 mmol), K2PtCl4 (103 mg, 0.25 mmol) and acetic acid (3 mL). A pale green 
powder was obtained (128 mg, 89 %); 1H NMR (700 MHz, Chloroform-d) δ 7.76 (d, J = (195Pt 
20.4), 4.7 Hz, 2H, H4’’), 7.64 (dd, J = 8.7, 7.5 Hz, 2H, H4’), 7.58 (d, J = 4.7 Hz, 2H, H5’’), 7.31 – 
7.27 (m, 4H, H5’ and H2), 7.17 (d, J = 8.8 Hz, 2H, H3), 6.36 (dd, J = 8.7, 0.8 Hz, 2H, H3’), 3.95 (s, 
3H, HOMe); 13C NMR (176 MHz, Chloroform-d) δ 160.2 (C1), 158.9 (C2’), 152.1 (C3’’), 148.2 (C6’), 
142.5 (C2’’), 137.1 (C4’), 135.4 (C4’’), 135.3 (C4), 131.3 (C5’/2), 128.2 (C5’’), 116.4 (C3), 111.8 (C3’), 
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110.7 (C5’/2); MS (ASAP+) m/z = 635.1 [M+H]+; HRMS (AP+) m/z = 634.0526 [M+H]+; 
calculated for [C25H18N3OPtS2]+ 634.0534.  
PtL23 
 
H2L23 (50 mg, 0.101 mmol), K2PtCl4 (46 mg, 0.111 mmol) and MeCN/H2O (6 mL, 2:1). A 
yellow powder was obtained which was recrystallized in hot DMF to afford the pure 
product (5 mg, 7 %); 1H NMR (599 MHz, DMSO-d6) δ 7.99 (d, J = 8.1 Hz, 2H, H5’’), 7.93 (t, J = 
8.6 Hz, 2H, H4’), 7.83 (d, J = 7.9 Hz, 2H, H5’), 7.74 (dd, J = 8.8, 4.9 Hz, 2H, H2), 7.62 (t, J = 8.7 
Hz, 2H, H3), 7.50 (d, J = 7.7 Hz, 2H, H8’’), 7.12 (td, J = 7.4, 0.8 Hz, 2H, H7’’), 7.07 (ddd, J = 8.3, 
7.1, 1.4 Hz, 2H, H6’’), 6.76 (d, s, 2H, H3’’), 6.09 (d, J = 8.6 Hz, 2H,H3’); 19F NMR (376 MHz, 
DMSO-d6) δ -110.81.  
7.5.3.2 PdII Complexes    
H2Ln (0.20 mmol, 1eq), Pd(OAc)2 (0.22 mmol, 1.1 eq), and acetic acid (3 mL) were added to a 
Schlenk. The reaction mixture was degassed by 3 x FPT cycles and heated at 90 °C for 48 h. 
The reaction was quenched with water (5 mL) and the precipitate was collected via 
centrifugation. The precipitate was then washed with H2O (1 x 5 mL) EtOH (1 x 5 mL) and 
Et2O (2 x 5 mL) before being dried in vacuo.  
 
PdL19 
 
H2L19 (40 mg, 0.093 mmol) and Pd(OAc)2 (23 mg, 0.10 mmol) in acetic acid (3 mL). A yellow 
solid was obtained (22 mg, 42 %); 1H NMR (400 MHz, DMSO-d6) δ 8.06 (d, J = 7.6 Hz, 2H, 
H2’’), 7.96 – 7.83 (m, 6H), 7.54 (d, J = 8.3 Hz, 2H, H5’’), 7.31 (t, J = 6.6 Hz, 4H), 7.18 (t, J = 7.5 
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Hz, 2H, H), 6.53 – 6.41 (m, 2H, H3’), 3.92 (s, 3H, HOMe);  MS (ESI+) m/z = 532.1 [M+H]+; HRMS 
(ES+) m/z = 532.0803 [M+H]+; calculated for [C29H21N3OPd]+ 532.0803. 
PdL20 
 
H2L20 (70 mg, 0.14 mmol) and Pd(OAc)2 (35 mg, 0.15 mmol) in acetic acid (4 mL). A green 
powder was obtained which was then recrystallized to obtain a yellow crystalline solid       
(67 mg, 79 %); 1H NMR (400 MHz, Chloroform-d) δ 7.90 (dt, J = 8.1, 1.0 Hz, 2H, H5’), 7.64 (t, J 
= 8.3 Hz, 2H, H4’), 7.58 (dd, J = 8.3, 2.4 Hz, 2H, H2’’), 7.27 (d, J = 8.8 Hz, 2H, H3), 7.19 (d, J = 
8.8 Hz, 2H, H2), 6.66 (ddd, J = 12.8, 8.8, 2.3 Hz, 2H, H4’’), 6.44 (d, J = 8.7 Hz, 2H, H3), 3.97 (s, 
3H, HOMe); 19F NMR (376 MHz, Chloroform-d) δ -108.44 (dd, J = 18.4, 8.9 Hz), -109.10 – -
109.42 (m); MS (ASAP+) m/z = 603.1 [M+H]+; HRMS (ASAP+) m/z = 603.0366 [M+H]+; 
calculated for [C29H21N3OPd]+ 603.0348. 
 
PdL21 
 
H2L21 (300 mg, 0.68 mmol) and Pd(OAc)2 (168 mg, 0.75 mmol) in acetic acid (6 mL). A green 
powder was obtained (300 mg, 81 %); 1H NMR (400 MHz, DMSO-d6) δ 7.83 (dd, J = 8.8, 7.6 
Hz, 2H), 7.70 (d, J = 4.7 Hz, 2H), 7.61 (d, J = 4.8 Hz, 2H), 7.57 – 7.49 (m, 2H), 7.40 (dd, J = 7.6, 
0.8 Hz, 2H), 7.33 – 7.24 (m, 2H), 6.30 (dd, J = 8.8, 0.7 Hz, 2H), 3.92 (s, 3H); MS (ASAP+) m/z = 
546.0 [M+H]+; HRMS (ASAP+) m/z = 546.001 [M+H]+; calculated for [C25H18N3OPdS2]+ 
546.004.  
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PdL22 
 
H2L22 (60 mg, 0.1108 mmol), Pd(OAc)2 (27 mg, 0.12 mmol) and acetic acid (3 mL). A green 
solid was obtained (25 mg, 35 %); 1H NMR (700 MHz, DMSO-d6) δ 8.00 (d, J = 8.0 Hz, 2H, 
H5’’), 7.95 (dd, J = 8.8, 7.6 Hz, 2H, H4’), 7.79 (d, J = 8.0 Hz, 2H, H8’’), 7.59 – 7.50 (m, 4H, H2 and 
H5’), 7.36 – 7.27 (m, 4H, H3 and H6’), 7.08 (ddd, J = 8.2, 7.1, 1.1 Hz, 2H, H7’’), 6.42 (dd, J = 8.8, 
0.8 Hz, 2H, H3’), 3.92 (s, 3H, HOMe); MS (ASAP+) m/z = 646.0 [M+H]+; HRMS (ASAP+) m/z = 
644.0214 [M+H]+; calculated for [C33H22N3OS2104Pd]+ 644.0245. 
7.5.3.3 PtIV Complexes 
PtL21Cl2   
 
PtL21 (46 mg, 0.07 mmol) was added to a solution of PhICl2 (20 mg, 0.07 mmol) in DCM        
(4 mL) and left to stir at room temperature for 24 h with the exclusion of light. The reaction 
solution was isolated from a precipitated orange solid by centrifuge. This solid was then 
washed with DCM (2 x 5 mL). The DCM washings were combined with the reaction solution 
and then evaporated to dryness to leave behind an orange solid. This was recrystallized 
with DCM and washed with hexane to obtain an orange solid powder (10 mg, 16 %); 1H 
NMR (700 MHz, DMSO-d6) δ 7.95 – 7.91 (m, 4H, H4’ and H4’’), 7.70 (d, J = 5.0 Hz, 2H, H5’), 
7.67 (d, J = 7.5 Hz, 2H, H5’’), 7.48 (d, J = 8.8 Hz, 2H, H2), 7.30 (d, J = 8.8 Hz, 2H, H3), 6.56 (d, J = 
8.7 Hz, 2H, H3’), 3.89 (s, 3H, HOMe); 13C NMR (176 MHz, DMSO-d6) δ 160.4 (C1), 155.9 (C2’’), 
149.5 (C2’), 141.9 (C4’), 137.9 (C3’’), 134.9 (C4), 133.3 (C6’), 131.7 (C2), 131.2 (C5’), 130.5 (C4’’), 
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117.4 (C3), 113.7 (C5’’), 113.4 (C3’), 56.1 (COMe); MS (ES+) m/z = 670.0 [M-Cl]+; HRMS (ES+) m/z 
= 669.0256 [M-Cl]-; calculated for [C25H17N3O194PtS2Cl]+ 669.0128. 
 
PtL19I2 
 
PtL19 (10 mg, 0.016 mmol) was added to 1.5 mL of H2O. To this yellow suspension was 
added a solution of I2 (4 mg, 0.016 mmol) in acetone (1.5 mL) dropwise. On addition, the 
yellow suspension turned orange, over further addition, a brown suspension resulted. This 
was stirred for 3 hours at RT. The orange solid was isolated by centrifugation and then dried 
in vacuo (10 mg; 71%); 1H NMR (700 MHz, DMSO-d6) δ 8.14 – 8.07 (m, 6H, H5’, H3’’ and H2’’), 
7.94 (dd, J = 8.6, 7.7 Hz, 2H, H4’), 7.58 (d, J = 8.9 Hz, 2H, H2), 7.47 (td, J = 7.6, 7.1, 1.5 Hz, 2H, 
H4’’), 7.29 (d, J = 8.9 Hz, 2H, H3), 7.13 (d, J = 7.4 Hz, 2H, H5’’), 6.78 (d, J = 8.9 Hz, 2H, H3’), 3.87 
(s, 3H, HOMe); 13C NMR (176 MHz; DMSO) 161.9 (C6’), 160.2 (C4), 150.8 (C2’), 144.7 (C1’’), 
141.1 (C4’), 136.2 (C1), 134.7 (C3’’), 132.1 (C2), 130.9 (C4’’), 125.9 (C6’’), 125.5 (C5’’), 125.4 (C2’’), 
117.3 (C3), 115.3 (C3’ and C5’), 56.1 (COMe); (ESI+) m/z = 749.3 [M-I]+; HRMS (ES+) m/z = 
748.0372 [M-I]+; calculated for [C29H21N3O194Pt127I]+ 748.0356. 
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7.6 Chapter 5 Synthesis  
7.6.1 Class 1 compounds 
7.6.1.1. General  
Miyaura borylation190 
The aryl halide (1 eq), B2pin2 (2 eq), KOAc (6 eq) and Pd(dppf)Cl2 (0.1 eq) were added to a 
Schlenk which was evacuated and heated, before adding dry dioxane under argon. This 
mixture was set to reflux for 18 h before cooling to RT. The solvent was then removed in 
vacuo the product was extracted into DCM, dried over MgSO4 and the solvent removed in 
vacuo. The resulting residue was purified by column chromatography on silica.  
7.6.1.2 Compound synthesis  
dypbBr 
 
Tribromobenzene (1.86 g, 9.10 mmol), 2-tri-n-butylstannyl pyridine (7.12 μL, 20.06 mmol), 
Pd(PPh3)2Cl2 (382 mg, 0.54 mmol) and LiCl (3.12 g, 73.4 mmol) reacted in refluxing dry 
toluene (30 mL) according to the outlined Stille procedure for 48 h. A yellow oil was 
obtained (220 mg, 58 %). The experimental data obtained were in good agreement with the 
literature.203 
dpybB(OH)2 
 
dypbBr (400 mg, 1.29 mmol) was added to a Schlenk, heated and evacuated before being 
filled with argon. Dry THF (10 mL) was added to the Schlenk and the mixture was cooled to   
-78 °C, nBuLi (2.5M in hexanes, 0.8 mL, 1.55 mmol) was added and the mixture was stirred 
at -78 °C under argon for 30 mins. In a separately prepared Schlenk, B(OMe)3 (173 μL,       
1.55 mmol) was added to 5 mL of dry THF and this was added to the other Schlenk. This 
was mixture was allowed to warm to RT and stirred for a further 18h at RT. H2O (10 mL) was 
then added and the organic layer was extracted with ethyl acetate and dried over MgSO4. 
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The crude product (350 mg) was used for the next step. The experimental data obtained 
were in good agreement with the literature.186 
Compound H2L24 
 
dpybH-B(OH)2 (300mg, 1.08 mmol), 4,5-dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene 
(261 mg, 0.543 mmol), Na2CO3 (576 mg, 5.43 mmol) and Pd(PPh3)4 (62 mg, 0.054 mmol) 
were reacted in refluxing DME/H2O (10 mL) according to the previously outlined Suzuki 
procedure. A white solid was obtained after column on silica (100 % ethyl acetate) which 
was still a crude product (54 mg) and which was used without further purification for the 
next step. The experimental data obtained were in good agreement with the literature.186 
L24(PtCl)2 
 
H2L24 (54 mg, crude) and K2PtCl4 (143 mg, 0.0345 mmol) were added to a Schlenk with 
acetic acid/H2O (4 mL, 3:1) and degassed via 3 x FPT cycles. This mixture was set to reflux 
under argon for 48 h. On cooling to RT, water (5 mL) was added and the resulting 
suspension was filtered and washed with H2O, MeOH and Et2O. The resulting yellow/brown 
solid was recrystallized in DCM/Hexane and a yellow solid resulted (5 mg). The 
experimental data obtained were in good agreement with the literature.186 
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B2pin2-bromobenzene 
 
 
Tribromobenzene (2 g, 6.35 mmol), B2pin2 (3.55 g, 13.98 mmol), KOAc (3.74 g, 38.1 mmol) 
and Pd(dppf)Cl2 (464 mg, 0.635 mmol) were reacted in refluxing dry dioxane (40 mL) 
according to the previously outlined Miyaura borylation procedure. A yellow oil was 
obtained (1.49g, 57 %). 1H NMR (400 MHz, Chloroform-d) δ 8.38 (s, 1H, H4’), 8.02 (d, J = 1.1 
Hz, 2H, H2’), 1.35 (s, 24H, HMe).  
 
(CF3)2dypbBr 
 
Bpin2-bromobenzene (1 g, 2.45 mmol), 4-trifluoromethyl-2-bromo pyridine (0.67 mL,        
5.39 mmol), Na2CO3 (1.3 g, 12.25 mmol) and Pd(PPh3)4 (141 mg, 0.1225 mmol) were added 
to a Schlenk containing DME/H2O (30 mL) and reacted according to the previously outlined 
Suzuki procedure. A white solid was obtained after column on silica (100:0 to 90:10 
hexane/ethyl acetate) (310 mg, 28 %); Rf = 0.5 (90:10 hexane/ethyl acetate, silica); 1H NMR 
(599 MHz, Chloroform-d) δ 8.90 (d, J = 5.0 Hz, 2H, H6), 8.62 (s,  1H, H4’), 8.27 (d, J = 1.6 Hz, 
2H, H2’), 8.00 (s, 2H, H3), 7.52 (d, J = 5.0, 2H, H5); 13C NMR (151 MHz, Chloroform-d) δ 156.6 
(C3’), 150.8 (C6), 140.4 (C2), 139.4 (d, J = 34.1 Hz) (CCF3), 131.2 (C2’), 124.2 (C4’), 123.9 (C1’), 
123.7 (C4) 118.4 (t, J = 3.5 Hz) (C5), 116.2 (d, J = 3.6 Hz) (C3); 19F NMR (376 MHz,     
Chloroform-d) δ -64.74; MS (ASAP+) m/z = 446.8 [M+H]+; HRMS (ES+) m/z = 446.9937 
[M+H]+; calculated for [C18H10N2BrF6N2]+ 446.9932. 
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(CF3)2dypbBpin 
 
(CF3)2dypbBr (300 mg, 0.67 mmol), B2pin2 (376 mg, 1.48 mmol), KOAc (395 mg, 4.02 mmol) 
and Pd(dppf)Cl2 (49 mg, 0.067 mmol) were reacted in refluxing dry dioxane (15 mL) 
according to the previously outlined Miyaura borylation procedure. A white crystalline solid 
was obtained after column on silica (100:0 to 70:30 hexane/ethyl acetate) (381 mg, 91 %); 
Rf = 0.78 (70:30 hexane/ethyl acetate, silica); 1H NMR (400 MHz, Chloroform-d) δ 8.92 – 
8.86 (m, 3H, H6 and H4’), 8.51 (d, J = 1.9 Hz, 2H, H2’), 8.08 (dt, J = 1.7, 0.9 Hz, 2H, H3), 7.47 
(ddd, J = 5.0, 1.6, 0.8 Hz, 2H, H5), 1.40 (s, 12H, HMe); MS (ASAP+) m/z = 495.2 [M+H]+; HRMS 
(ES+) m/z = 494.1737 [M+H]+; calculated for [C24H22N2O2F610B]+ 494.1715.  
Compound H2L25 
 
(CF3)2dypbBpin (300 mg, 0.61 mmol), 4,5-dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene 
(133 mg, 0.28 mmol), Na2CO3 (170 mg, 1.60 mmol) and Pd(PPh3)4 (20 mg, 0.017 mmol) 
were reacted in refluxing DME/H2O according to the previously outlined Suzuki procedure. 
A white solid was obtained after column on silica (100:0 to 70:30 hexane/ethyl acetate) 
(153 mg, 52 %); Rf= 0.83 (70:30 hexane/ethyl acetate, silica); 1H NMR (599 MHz, 
Chloroform-d) δ 8.68 (dd, J = 5.0, 0.8 Hz, 4H, H6), 8.22 (t, J = 1.7 Hz, 2H, H4’), 7.97 (d, J = 1.7 
Hz, 4H, H2’), 7.66 (s, 4H, H3), 7.53 (d, J = 2.4 Hz, 2H, Hf), 7.22 (d, J = 2.3 Hz, 2H, Hd), 7.11 (dd, J 
= 5.0, 1.5 Hz, 4H, H5), 1.85 (s, 6H, HMe), 1.38 (s, 18H, HtBu2); 13C NMR (151 MHz, Chloroform-
d) δ 157.3 (C2), 150.2 (C6), 145.6 (Ca), 144.7 (Ce), 139.6 (Cc), 138.6 (CCF3), 137.1 (C3’), 129.3 
(C2’), 128.2 (C1’), 125.9 (Cd), 123.6 (C4’), 123.0 (Cf), 121.9 (C4), 117.1 (C5), 115.4 (C3), 34.8 (Cg), 
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34.6 (CtBu1), 33.4 (CMe), 31.6 (CtBu2); 19F NMR (376 MHz, Chloroform-d) δ -64.83; MS (ASAP+) 
m/z = 1055.4  [M+H]+; HRMS (ES+) m/z = 1055.3558 [M+H]+; calculated for [C59H47N4OF12]+ 
1055.3575. 
L25(PtCl)2 
 
 
H2L25 (22 mg, 0.021 mmol) and K2PtCl4 (44 mg, 0.104 mmol) were added to a Schlenk with 
acetic acid (4 mL) and degassed via 3 x FPT cycles. This mixture was then set to reflux under 
argon for 48 h. Water (5 mL) was added and the resulting suspension was filtered and the 
solid washed with H2O, MeOH and Et2O. A grey-green solid resulted and the product was 
extracted into DCM from washings of this solid. An orange solid was obtained after removal 
of the solvent in vacuo (18 mg, 67 %); 1H NMR (700 MHz, Chloroform-d) δ 9.53 (d, J = (195Pt 
31.8),  5.8 Hz, 4H, H6), 7.54 (d, J = 2.4 Hz, 2H, Hd/f), 7.48 (s, 4H, H2’), 7.41 (s, 4H, H3), 7.38 (dd, 
J = 5.8, 1.9 Hz, 4H, H5), 7.23 (d, J = 2.3 Hz, 2H, Hd/f), 1.83 (s, 6H, HMe), 1.41 (s, 18H, HtBu2); 13C 
NMR (176 MHz, Chloroform-d) δ 167.8 (C2), 161.8 (C4’), 153.9 (C6), 146.1 (Ce), 144.1 (Cb), 
139.3 (C1’), 129.4 (Cc), 128.1 (Ca), 126.8 (C2’), 125.8 (Cd/f), 123.3 (Cd/f), 119.6 (C5), 115.0 (C3), 
34.7 (Cg), 34.6 (CtBu1), 33.7 (CMe), 31.6 (CtBu2); 19F NMR (376 MHz, Chloroform-d) δ -65.54; MS 
(ASAP+) m/z = 1478.2 [M-Cl]+; HRMS (ASAP+) m/z = 1478.2312 [M-Cl]+; calculated for 
[C59H44ClN4O1F12194Pt2]+ 1478.2314.  
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7.6.2 Class 2 compounds  
7.6.2.1 Precursors  
2,7-di-tert-butyl-4,5-diiodo-9,9-dimethylxanthene  
 
At -20 °C n-BuLi (2.5 M in hexanes, 1.66 mL, 4.14 mmol) was added dropwise to a stirred 
solution of 4,5-dibromo-2,7-di-t-butyl-9,9-dimethylxanthene (0.9 g, 1.87 mmol) in 20 ml of 
dry THF. The resulting beige suspension was stirred for 2 h. Next a solution of I2 (0.6 g,        
4.7 mmol) in 10 mL of dry THF was added and the reaction mixture was slowly warmed to 
RT overnight. The reaction mixture was poured out in a saturated sodium thiosulfate 
solution and extracted with DCM. The organic layer was washed with brine and dried over 
MgSO4. The solvents were removed in vacuo and the residue was recrystallised from DCM. 
A white powder was obtained (350 mg, 33 %). The experimental data obtained were in 
good agreement with the literature.204  
 
2,7-di-tert-butyl-4,5-bis((trimethylsilyl)ethynyl)-9,9-dimethylxanthene  
 
Pd(dppf)2Cl2 (74 mg, 0.10 mmol) and copper(I) iodide (32 mg, 0.17 mmol) were added 
successively to a solution of 2,7-di-tert-butyl-4,5-diiodo-9,9-dimethylxanthene (300 mg, 
0.52 mmol) and trimethysilylacetylene (0.24 mL, 1.58 mmol) in dry NEt3 (3 mL) under argon 
at RT. The reaction mixture was stirred at 60 °C for 24 h and the NEt3 was then removed in 
vacuo. The residue was diluted with H2O (5 mL) and DCM (5 mL). The product was extracted 
into DCM (3 x 10 mL), and the combined organic phases were dried over MgSO4 and 
evaporated. The crude produced was purified by flash column chromatography on silica gel 
(30:1, hexane/ethyl acetate) and a white solid was obtained (300 mg, 93 %). The 
experimental data obtained were in good agreement with the literature.189 
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2,7-di-tert-butyl-4,5-diethynyl-9,9-dimethylxanthene = H2L26 
 
A solution of K2CO3 (150 mg, 1.09 mmol) in MeOH (3 mL) was added to a solution of           
2,7-di-tert-butyl-4,5-bis((trimethylsilyl)ethynyl)-9,9-dimethylxanthene (100 mg,             
0.174 mmol) in DCM (3 mL). After stirring at RT for 12 h, the solvent was removed in vacuo. 
The residue was diluted with H2O (20 mL) and DCM (20 mL). The product was extracted into 
DCM (3 x 10 mL), and the combined organic phases were dried over MgSO4 and 
evaporated. The crude produced was purified by flash column chromatography on silica gel 
(30:1, hexane/ethyl acetate) and a white solid was obtained (69 mg, 93 %). The 
experimental data obtained were in good agreement with the literature.189 
7.6.2.2 Complexes 
General procedure for complexation of H2L26 with Pt(dpybX)Cl 
Starting complexes Pt(dpybX)Cl, where X= A, B, C, D and E as represented in each case, 
were synthesised by either Rebecca Salthouse or Chris Harris (MChem students in our 
group). H2L26 (1 eq) was suspended in MeOH and added to this was a solution of 0.5 M 
NaOMe in MeOH (2.1 eq). This mixture was stirred for 30 mins at RT. Following this, 
Pt(dpybX)Cl (2 eq) dissolved in DCM was added to the mixture and this was set to stir at     
60 °C for 48 h. On cooling to RT, the solvent was removed in vacuo and the resulting solid 
was then washed with H2O, MeOH and Et2O. Recrystallization in DCM/Hexane gave the 
pure product.  
L26(Pt(dpybA))2 
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H2L26 (7.5 mg, 0.02 mmol) and 0.5 M NaOMe solution (1 mL, 0.05 mmol) were stirred in 
MeOH (15 mL) at RT and Pt(dpybA)Cl (18 mg, 0.04 mmol) in DCM (15 mL) was then added. 
The mixture was reacted according to the general procedure given above. An orange solid 
was obtained (10 mg, 41 %); 1H NMR (700 MHz, Chloroform-d) δ 9.51 (d, J = (195Pt 38.8), 5.5 
Hz, 4H, H6), 7.47 – 7.44 (m, 6H, Hd/f and H4), 7.24 (d, J = 2.4 Hz, 2H, Hd/f), 7.08 (dd, J = 7.8, 1.3 
Hz, 4H, H3), 6.97 – 6.93 (m, 8H, H3’ and H5), 6.85 (t, J = 7.5 Hz, 2H, H4’), 1.70 (s, 6H, HMe), 1.33 
(s, 18H, HtBu2); 13C NMR (176 MHz, Chloroform-d) δ 168.8 (C2), 156.8 (C6), 143.9 (Ce), 142.3 
(C2’), 136.7 (Cd/f), 128.9 (Cc), 128.1 (C4), 122.8 (C3’), 122.7 (C5), 121.5 (C4’), 119.4 (Cd/f), 118.1 
(C3), 34.7 (Cg), 34.4 (CtBu1), 32.6 (CMe), 31.6 (CtBu2); MS (ASAP+) m/z = 1221.3 [M+H]+; HRMS 
(ASAP+) m/z = 1221.3357 [M+H]+; calculated for [C59H51N4O1194Pt2]+ 1221.3331. 
 
L26(Pt(dpybB))2 
 
H2L26 (7.5 mg, 0.02 mmol) and 0.5 M NaOMe solution (1 mL, 0.05 mmol) were stirred in 
MeOH (15 mL) at RT and Pt(dpybB)Cl (24 mg, 0.04 mmol) in DCM (15 mL) was then added. 
The mixture was reacted according to the general procedure given previously. A dark red 
solid was obtained (5 mg, 17 %); 1H NMR (400 MHz, Chloroform-d) δ 9.69 (d, J = (195Pt 38.6), 
5.8 Hz, 4H, H6), 7.45 (d, J = 2.3 Hz, 2H, Hf/d), 7.34 (d, J = 2.4 Hz, 2H, Hf/d), 7.31 (d, J = 2.0 Hz, 
4H, H3), 7.25 (dd, J = 5.9, 2.0 Hz, 4H, H5), 7.14 – 7.10 (m, 4H, H3’), 7.03 (dd, J = 8.3, 6.8 Hz, 
2H, H4’), 1.77 (s, 6H, HMe), 1.39 (s, 17H, HtBu2); 19F NMR (376 MHz, Chloroform-d) δ -65.13; 
MS (ASAP+) m/z = 1493.3 [M+H]+; HRMS (ASAP+) m/z = 1493.2853 [M+H]+; calculated for 
[C63H47N4O1F12194Pt2]+ 1493.2933. 
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L26(Pt(dpybC))2 
 
H2L26 (7.5 mg, 0.02 mmol) and 0.5 M NaOMe solution (1 mL, 0.05 mmol) were stirred in 
MeOH (15 mL) at RT and Pt(dpybC)Cl (28 mg, 0.04 mmol) in DCM (15 mL) was then added. 
The mixture was reacted according to the procedure given above. A dark red solid was 
obtained (24 mg, 73 %); 1H NMR (700 MHz, Chloroform-d) δ 9.60 (d, J = (195Pt 41.0), 5.8 Hz, 
4H, H6), 7.39 (d, J = 2.3 Hz, 2H, Hd/f), 7.30 (d, J = 2.3 Hz, 2H, Hd/f), 7.25 (s, 4H, H3), 7.18 (d, J = 
5.2 Hz, 4H, H5), 7.11 (s, 4H, H3’), 1.74 (s, 6H, HMe), 1.40 (s, 18H, HtBu2’), 1.35 (s, 18H, HtBu2); 13C 
NMR (176 MHz, Chloroform-d) δ 178.62 (C1’), 169.90 (C2’), 157.86 (C6), 150.25 (Cb), 
145.50(C4’), 144.47 (Ce), 140.70 (C2), 129.35 (Cg), 127.13 (Cd/f), 121.88 (C4), 121.43 (C3’), 
119.74 (Cd/f), 119.01 (C5), 115.98 (Calk1), 114.27 (C3), 35.17 (CtBu1’), 34.47 (CtBu1), 31.93 (CMe), 
31.65 (C tBu2’), 31.58 (C tBu2); 19F NMR (376 MHz, Chloroform-d) δ -65.01; MS (ASAP+) m/z = 
1605.4 [M+H]+; HRMS (ASAP+) m/z =1605.4097 [M+H]+; calculated for [C71H63N4O1F12194Pt2]+ 
1605.4105. 
 
L26(Pt(dpybD))2 
 
 
278 
 
H2L26 (7.5 mg, 0.02 mmol) and 0.5 M NaOMe solution (1 mL, 0.05 mmol) were stirred in 
MeOH (15 mL) at RT and Pt(dpybD)Cl (27 mg, 0.04 mmol) in DCM (15 mL) was then added. 
The mixture was reacted according to the procedure given above. A dark red solid was 
obtained (5 mg, 16 %); 1H NMR (400 MHz, Chloroform-d) δ 9.87 (d, J = (195Pt 45.9), 5.8 Hz, 
4H, H6), 7.47 (s, 4H, H3), 7.45 (d, J = 2.3 Hz, 2H, Hd/f), 7.34 (d, J = 2.4 Hz, 2H, Hd/f), 7.22 (d, J = 
6.0 Hz, 4H, H5), 6.60 (s, 2H, H4’), 2.39 (s, 12H, HMe2), 1.76 (s, 6H, HMe1), 1.38 (s, 18H, HtBu2); 19F 
NMR (376 MHz, Chloroform-d) δ -65.15; MS (ASAP+) m/z = 1549.4 [M+H]+; HRMS (ASAP+) 
m/z = 1549.3479 [M+H]+; calculated for [C67H55N4O1F12194Pt2]+ 1549.3547.  
 
L26(Pt(dpybE))2 
 
H2L26 (7.5 mg, 0.02 mmol) and 0.5 M NaOMe solution (1 mL, 0.05 mmol) were stirred in 
MeOH (15 mL) at RT and Pt(dpybE)Cl (22 mg, 0.04 mmol) in DCM (15 mL) was then added. 
The mixture was reacted according to the procedure given above. A dark red solid was 
obtained (10 mg, 35 %); 1H NMR (700 MHz, Chloroform-d) δ 9.67 (d, J = (195Pt 36.0), 6.2 Hz, 
4H, H8), 8.34 (d, J = 8.5 Hz, 4H, H6), 7.68 (d, J = 7.8 Hz, 4H, H3’), 7.54 (d, J = 2.3 Hz, 2H, Hd/f), 
7.40 (d, J = 7.9 Hz, 4H, H3), 7.35 (ddd, J = 7.9, 6.6, 1.0 Hz, 4H, H4), 7.30 (d, J = 2.4 Hz, 2H, 
Hd/f), 7.28 (ddd, J = 8.1, 6.6, 1.4 Hz, 4H, H5), 7.14 (d, J = 6.2 Hz, 4H, H7), 7.00 (t, J = 7.7 Hz, 2H, 
H4’), 1.77 (s, 6H, HMe), 1.37 (s, 18H HtBu2); 13C NMR (176 MHz, Chloroform-d) δ 186.7 (C1’),  
167.6 (C2), 148.8 (C8),  144.0 (C2’), 143.9 (Ce), 136.4 (C9), 129.9 (C4), 129.0 (Cg), 128.2 (Cf/d),  
127.8 (C3’), 127.2 (C3), 127.0 (C5), 126.1 (C10), 125.1 (C6), 121.2 (C4’), 121.1 (C7), 119.6 (Cd/f), 
34.4 (CtBu1), 32.7 (CMe), 31.6 (CtBu2).  
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9. Appendix 
9.1 Publications arising from this work 
The luminescence properties of multinuclear platinum complexes. 
Emma V. Puttock, Melissa T. Walden, J. A. Gareth Williams. 
Coordination Chemistry Reviews, 367, (2018), 127–162. 
9.2 Luminescence data for chapter 3 
 
Figure A1: Degassed emission in DCM of Pt(dpyb)Cl and Pt(dpybMe2)Cl. 
9.3 DFT data for chapter 4 
Complex HOMO-3 Complex HOMO-5 
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Figure A2: Orbital diagrams of the HOMO-3 for ML21 and the HOMO-5 for ML22. 
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9.4 Crystal structure information 
Crystal data and structure refinement for HL1 
Identification code  16srv384 
Empirical formula  C17H18N4 
Formula weight  278.35 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  5.9123(6) 
b/Å  13.2287(13) 
c/Å  18.6718(19) 
α/°  90 
β/°  98.757(4) 
γ/°  90 
Volume/Å3  1443.3(3) 
Z  4 
ρcalcg/cm3  1.281 
μ/mm-1  0.079 
F(000)  592.0 
Crystal size/mm3  0.21 × 0.09 × 0.08 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.414 to 55.992 
Index ranges  -7 ≤ h ≤ 7, -17 ≤ k ≤ 17, -24 ≤ l ≤ 24 
Reflections collected  27498 
Independent reflections  3480 [Rint = 0.0696, Rsigma = 0.0465] 
Data/restraints/parameters  3480/0/262 
Goodness-of-fit on F2  1.031 
Final R indexes [I>=2σ (I)]  R1 = 0.0467, wR2 = 0.0942 
Final R indexes [all data]  R1 = 0.0790, wR2 = 0.1057 
Largest diff. peak/hole / e Å-3  0.21/-0.27 
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Crystal data and structure refinement for HL2 
Identification code  16srv386 
Empirical formula  C14H12N4O 
Formula weight  252.28 
Temperature/K  100.0 
Crystal system  orthorhombic 
Space group  Pbca 
a/Å  6.9306(16) 
b/Å  10.920(3) 
c/Å  31.555(7) 
α/°  90 
β/°  90 
γ/°  90 
Volume/Å3  2388.1(10) 
Z  8 
ρcalcg/cm3  1.403 
μ/mm-1  0.088 
F(000)  1056.0 
Crystal size/mm3  0.03 × 0.005 × 0.005 
Radiation  synchrotron (λ = 0.6889) 
2Θ range for data collection/°  2.502 to 57.996 
Index ranges  -9 ≤ h ≤ 9, -15 ≤ k ≤ 15, -44 ≤ l ≤ 44 
Reflections collected  29429 
Independent reflections  3316 [Rint = 0.0822, Rsigma = 0.0524] 
Data/restraints/parameters  3316/0/177 
Goodness-of-fit on F2  1.046 
Final R indexes [I>=2σ (I)]  R1 = 0.0675, wR2 = 0.1856 
Final R indexes [all data]  R1 = 0.0768, wR2 = 0.1949 
Largest diff. peak/hole / e Å-3  0.42/-0.46 
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Crystal data and structure refinement for HL6 
Identification code MW401 
Empirical formula C22H22N4O 
Formula weight 358.43 
Temperature/K 120.0 
Crystal system monoclinic 
Space group C2/c 
a/Å 19.417(2) 
b/Å 6.9032(7) 
c/Å 27.468(3) 
α/° 90 
β/° 94.997(4) 
γ/° 90 
Volume/Å3 3667.7(6) 
Z 8 
ρcalcg/cm3 1.298 
μ/mm-1 0.082 
F(000) 1520.0 
Crystal size/mm3 0.63 × 0.19 × 0.044 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.212 to 62.226 
Index ranges -28 ≤ h ≤ 28, -10 ≤ k ≤ 10, -39 ≤ l ≤ 39 
Reflections collected 39689 
Independent reflections 5863 [Rint = 0.1350, Rsigma = 0.1019] 
Data/restraints/parameters 5863/0/248 
Goodness-of-fit on F2 1.041 
Final R indexes [I>=2σ (I)] R1 = 0.0674, wR2 = 0.1288 
Final R indexes [all data] R1 = 0.1358, wR2 = 0.1518 
Largest diff. peak/hole / e Å-3 0.28/-0.29 
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Crystal data and structure refinement for PtL12 
Identification code  16srv190 
Empirical formula  C34H38N8Pt 
Formula weight  753.81 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  11.6673(5) 
b/Å  5.5870(3) 
c/Å  21.8713(10) 
α/°  90 
β/°  101.0279(15) 
γ/°  90 
Volume/Å3  1399.36(12) 
Z  2 
ρcalcg/cm3  1.789 
μ/mm-1  5.055 
F(000)  752.0 
Crystal size/mm3  0.18 × 0.15 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.678 to 59.998 
Index ranges  -16 ≤ h ≤ 16, -7 ≤ k ≤ 7, -30 ≤ l ≤ 30 
Reflections collected  21893 
Independent reflections  4081 [Rint = 0.0489, Rsigma = 0.0399] 
Data/restraints/parameters  4081/0/199 
Goodness-of-fit on F2  1.177 
Final R indexes [I>=2σ (I)]  R1 = 0.0382, wR2 = 0.0799 
Final R indexes [all data]  R1 = 0.0630, wR2 = 0.0859 
Largest diff. peak/hole / e Å-3  3.45/-1.15 
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Crystal data and structure refinement for PtL22 
Identification code  16srv162 
Empirical formula  C28H22N8O2Pt x 2 C3H7NO 
Formula weight  843.82 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  14.3162(17) 
b/Å  5.8624(7) 
c/Å  19.762(2) 
α/°  90 
β/°  102.596(4) 
γ/°  90 
Volume/Å3  1618.7(3) 
Z  2 
ρcalcg/cm3  1.731 
μ/mm-1  4.391 
F(000)  840.0 
Crystal size/mm3  0.21 × 0.05 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.832 to 55.994 
Index ranges  -18 ≤ h ≤ 18, -7 ≤ k ≤ 7, -26 ≤ l ≤ 26 
Reflections collected  29088 
Independent reflections  3913 [Rint = 0.0949, Rsigma = 0.0665] 
Data/restraints/parameters  3913/0/226 
Goodness-of-fit on F2  1.023 
Final R indexes [I>=2σ (I)]  R1 = 0.0320, wR2 = 0.0550 
Final R indexes [all data]  R1 = 0.0750, wR2 = 0.0628 
Largest diff. peak/hole / e Å-3  1.25/-1.00 
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Crystal data and structure refinement for PtL42 
Identification code  18srv220 
Empirical formula  C34H34N8O2Pt x 6 C2HF3O2 
Formula weight  1465.95 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  14.6085(9) 
b/Å  14.8858(9) 
c/Å  15.4429(9) 
α/°  117.828(2) 
β/°  107.634(2) 
γ/°  97.622(2) 
Volume/Å3  2676.5(3) 
Z  2 
ρcalcg/cm3  1.819 
μ/mm-1  2.757 
F(000)  1448.0 
Crystal size/mm3  0.16 × 0.11 × 0.05 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.202 to 58.998 
Index ranges  -20 ≤ h ≤ 20, -20 ≤ k ≤ 20, -21 ≤ l ≤ 21 
Reflections collected  57254 
Independent reflections  14922 [Rint = 0.0480, Rsigma = 0.0559] 
Data/restraints/parameters  14922/66/780 
Goodness-of-fit on F2  1.059 
Final R indexes [I>=2σ (I)]  R1 = 0.0380, wR2 = 0.0895 
Final R indexes [all data]  R1 = 0.0536, wR2 = 0.0940 
Largest diff. peak/hole / e Å-3  1.75/-1.50 
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Crystal data and structure refinement for PtL72  
Identification code  18srv161 
Empirical formula  C54H58N8Pt 
Formula weight  1014.17 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  6.5952(3) 
b/Å  10.7367(5) 
c/Å  16.1585(8) 
α/°  88.6300(17) 
β/°  83.5014(17) 
γ/°  85.8827(17) 
Volume/Å3  1133.76(9) 
Z  1 
ρcalcg/cm3  1.485 
μ/mm-1  3.141 
F(000)  516.0 
Crystal size/mm3  0.13 × 0.07 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.538 to 55.996 
Index ranges  -8 ≤ h ≤ 8, -13 ≤ k ≤ 14, -21 ≤ l ≤ 21 
Reflections collected  22013 
Independent reflections  5458 [Rint = 0.0470, Rsigma = 0.0512] 
Data/restraints/parameters  5458/15/292 
Goodness-of-fit on F2  1.067 
Final R indexes [I>=2σ (I)]  R1 = 0.0343, wR2 = 0.0720 
Final R indexes [all data]  R1 = 0.0360, wR2 = 0.0729 
Largest diff. peak/hole / e Å-3  1.86/-1.32 
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Crystal data and structure refinement for Pt(pquin)L3 
Identification code  MW351 
Empirical formula  C59H38Cl2F6N10Pt2 
Formula weight  1462.07 
Temperature/K  120.0 
Crystal system  orthorhombic 
Space group  Pbca 
a/Å  22.121(2) 
b/Å  15.0778(17) 
c/Å  29.960(3) 
α/°  90 
β/°  90 
γ/°  90 
Volume/Å3  9992.5(19) 
Z  8 
ρcalcg/cm3  1.944 
μ/mm-1  5.777 
F(000)  5648.0 
Crystal size/mm3  0.034 x 0.062 x 0.402  
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  3.682 to 49.998 
Index ranges  -31 ≤ h ≤ 31, -21 ≤ k ≤ 21, -42 ≤ l ≤ 42 
Reflections collected  166359 
Independent reflections  8787 [Rint = 0.1849, Rsigma = 0.1049] 
Data/restraints/parameters  8787/54/709 
Goodness-of-fit on F2  1.095 
Final R indexes [I>=2σ (I)]  R1 = 0.0424, wR2 = 0.0886 
Final R indexes [all data]  R1 = 0.0659, wR2 = 0.1023 
Largest diff. peak/hole / e Å-3  2.00/-1.23 
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Crystal data and structure refinement for [Pt(bpy)L2]PF6 
Identification code  16srv263 
Empirical formula  C24H19N6OPt x PF6 x C2H6OS 
Formula weight  825.64 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  7.72184(18) 
b/Å  17.6396(4) 
c/Å  20.8547(5) 
α/°  90 
β/°  100.251(2) 
γ/°  90 
Volume/Å3  2795.29(12) 
Z  4 
ρcalcg/cm3  1.962 
μ/mm-1  5.230 
F(000)  1608.0 
Crystal size/mm3  0.09 × 0.07 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.592 to 57 
Index ranges  -10 ≤ h ≤ 10, -23 ≤ k ≤ 23, -27 ≤ l ≤ 27 
Reflections collected  45256 
Independent reflections  7094 [Rint = 0.1190, Rsigma = 0.0860] 
Data/restraints/parameters  7094/0/391 
Goodness-of-fit on F2  1.018 
Final R indexes [I>=2σ (I)]  R1 = 0.0495, wR2 = 0.0996 
Final R indexes [all data]  R1 = 0.0846, wR2 = 0.1136 
Largest diff. peak/hole / e Å-3  4.83/-1.15 
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Crystal data and structure refinement for [Pt(dpyb)L1Cl]PF6 
Identification code  18srv166 
Empirical formula  C36H34ClF6N6OPPt 
Formula weight  942.20 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  13.1978(5) 
b/Å  13.9099(6) 
c/Å  20.8134(8) 
α/°  106.4901(13) 
β/°  90.4623(14) 
γ/°  102.0568(13) 
Volume/Å3  3573.7(2) 
Z  4 
ρcalcg/cm3  1.751 
μ/mm-1  4.117 
F(000)  1856.0 
Crystal size/mm3  0.16 × 0.12 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.102 to 58 
Index ranges  -18 ≤ h ≤ 18, -18 ≤ k ≤ 18, -28 ≤ l ≤ 28 
Reflections collected  74522 
Independent reflections  18950 [Rint = 0.0410, Rsigma = 0.0433] 
Data/restraints/parameters  18950/7/942 
Goodness-of-fit on F2  1.014 
Final R indexes [I>=2σ (I)]  R1 = 0.0285, wR2 = 0.0588 
Final R indexes [all data]  R1 = 0.0486, wR2 = 0.0643 
Largest diff. peak/hole / e Å-3  1.01/-1.00 
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Crystal data and structure refinement for Ir(dpybMe2)(L16) 
Identification code  18srv184 
Empirical formula  C47H46IrN9 
Formula weight  929.13 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  16.4690(10) 
b/Å  12.1118(8) 
c/Å  22.6956(14) 
α/°  90 
β/°  103.379(2) 
γ/°  90 
Volume/Å3  4404.2(5) 
Z  4 
ρcalcg/cm3  1.401 
μ/mm-1  3.074 
F(000)  1872.0 
Crystal size/mm3  0.22 × 0.17 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.832 to 55.998 
Index ranges  -21 ≤ h ≤ 21, -16 ≤ k ≤ 16, -29 ≤ l ≤ 29 
Reflections collected  62748 
Independent reflections  10610 [Rint = 0.1340, Rsigma = 0.1205] 
Data/restraints/parameters  10610/21/516 
Goodness-of-fit on F2  1.006 
Final R indexes [I>=2σ (I)]  R1 = 0.0521, wR2 = 0.1041 
Final R indexes [all data]  R1 = 0.1088, wR2 = 0.1200 
Largest diff. peak/hole / e Å-3  2.45/-1.50 
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Crystal data and structure refinement for Ir(dpybF2)(L16) 
Identification code  MW387.res 
Empirical formula  C53H63F2IrN13O4 
Formula weight  1176.39 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  11.4994(7) 
b/Å  15.4525(10) 
c/Å  16.3649(10) 
α/°  117.046(2) 
β/°  91.454(2) 
γ/°  96.054(2) 
Volume/Å3  2566.7(3) 
Z  2 
ρcalcg/cm3  1.5221 
μ/mm-1  2.668 
F(000)  1195.9 
Crystal size/mm3  0.025 x 0.096 x 0.347 
Radiation  Mo Kα (λ = 0.71073) 
2Θ range for data collection/°  4.36 to 60 
Index ranges  -16 ≤ h ≤ 16, -22 ≤ k ≤ 22, -23 ≤ l ≤ 22 
Reflections collected  57856 
Independent reflections  14936 [Rint = 0.0736, Rsigma = 0.0936] 
Data/restraints/parameters  14936/14/669 
Goodness-of-fit on F2  1.033 
Final R indexes [I>=2σ (I)]  R1 = 0.0472, wR2 = 0.0865 
Final R indexes [all data]  R1 = 0.0709, wR2 = 0.0933 
Largest diff. peak/hole / e Å-3  2.38/-2.04 
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Crystal data and structure refinement for PtL20 
Identification code  15srv227 
Empirical formula  C29H17F4N3OPt 
Formula weight  694.55 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  9.5160(4) 
b/Å  11.7283(5) 
c/Å  12.0991(5) 
α/°  118.4489(12) 
β/°  95.4022(14) 
γ/°  104.4798(14) 
Volume/Å3  1112.91(8) 
Z  2 
ρcalcg/cm3  2.073 
μ/mm-1  6.369 
F(000)  668.0 
Crystal size/mm3  0.28 × 0.19 × 0.18 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.2 to 60 
Index ranges  -13 ≤ h ≤ 13, -16 ≤ k ≤ 16, -17 ≤ l ≤ 16 
Reflections collected  24536 
Independent reflections  6491 [Rint = 0.0462, Rsigma = 0.0364] 
Data/restraints/parameters  6491/0/344 
Goodness-of-fit on F2  1.043 
Final R indexes [I>=2σ (I)]  R1 = 0.0193, wR2 = 0.0404 
Final R indexes [all data]  R1 = 0.0221, wR2 = 0.0413 
Largest diff. peak/hole / e Å-3  1.35/-1.80 
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Crystal data and structure refinement for PdL22 
Identification code  15srv193 
Empirical formula  C33H21N3OPdS2 x C3H7NO 
Formula weight  719.14 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  11.2231(4) 
b/Å  11.5339(4) 
c/Å  13.0267(5) 
α/°  81.2260(10) 
β/°  68.9980(10) 
γ/°  72.4640(10) 
Volume/Å3  1499.20(9) 
Z  2 
ρcalcg/cm3  1.593 
μ/mm-1  0.800 
F(000)  732.0 
Crystal size/mm3  0.22 × 0.18 × 0.12 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  3.36 to 58 
Index ranges  -15 ≤ h ≤ 15, -15 ≤ k ≤ 15, -17 ≤ l ≤ 17 
Reflections collected  24903 
Independent reflections  7983 [Rint = 0.0269, Rsigma = 0.0278] 
Data/restraints/parameters  7983/0/409 
Goodness-of-fit on F2  1.048 
Final R indexes [I>=2σ (I)]  R1 = 0.0327, wR2 = 0.0821 
Final R indexes [all data]  R1 = 0.0388, wR2 = 0.0864 
Largest diff. peak/hole / e Å-3  1.27/-0.80 
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Crystal data and structure refinement for PtL23 
Identification code  17srv378 
Empirical formula  C32H20FN5Pt 
Formula weight  688.62 
Temperature/K  100.0 
Crystal system  monoclinic 
Space group  C2/c 
a/Å  15.8393(11) 
b/Å  20.9252(14) 
c/Å  7.2775(5) 
α/°  90 
β/°  105.968(4) 
γ/°  90 
Volume/Å3  2319.0(3) 
Z  4 
ρcalcg/cm3  1.972 
μ/mm-1  5.611 
F(000)  1336.0 
Crystal size/mm3  0.085 × 0.034 × 0.012 
Radiation  synchrotron (λ = 0.6889) 
2Θ range for data collection/°  6.228 to 54.99 
Index ranges  -19 ≤ h ≤ 21, -28 ≤ k ≤ 24, -9 ≤ l ≤ 9 
Reflections collected  8305 
Independent reflections  2756 [Rint = 0.0812, Rsigma = 0.1075] 
Data/restraints/parameters  2756/0/179 
Goodness-of-fit on F2  1.037 
Final R indexes [I>=2σ (I)]  R1 = 0.0520, wR2 = 0.1136 
Final R indexes [all data]  R1 = 0.0816, wR2 = 0.1238 
Largest diff. peak/hole / e Å-3  3.09/-2.93 
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Crystal data and structure refinement for L26(Pt(dpybA)Cl)2 
Identification code  18srv333 
Empirical formula  C60H51Cl3N4OPt2 
Formula weight  1340.57 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  11.1103(8) 
b/Å  26.454(2) 
c/Å  36.437(3) 
α/°  90 
β/°  96.037(3) 
γ/°  90 
Volume/Å3  10649.9(14) 
Z  8 
ρcalcg/cm3  1.672 
μ/mm-1  5.444 
F(000)  5232.0 
Crystal size/mm3  0.22 × 0.18 × 0.09 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  3.996 to 57.998 
Index ranges  -14 ≤ h ≤ 15, -36 ≤ k ≤ 36, -49 ≤ l ≤ 49 
Reflections collected  151553 
Independent reflections  28121 [Rint = 0.0752, Rsigma = 0.0932] 
Data/restraints/parameters  28121/48/1277 
Goodness-of-fit on F2  1.131 
Final R indexes [I>=2σ (I)]  R1 = 0.0840, wR2 = 0.1647 
Final R indexes [all data]  R1 = 0.1280, wR2 = 0.1788 
Largest diff. peak/hole / e Å-3  4.69/-3.50 
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Crystal data and structure refinement for L26(Pt(dpybD)Cl)2 
Identification code  18srv276 
Empirical formula  C67H54F12N4OPt2 x 2.5 CHCl3 
Formula weight  1847.74 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  13.3456(8) 
b/Å  15.5621(10) 
c/Å  18.5662(11) 
α/°  94.442(2) 
β/°  103.675(2) 
γ/°  113.8416(19) 
Volume/Å3  3361.4(4) 
Z  2 
ρcalcg/cm3  1.826 
μ/mm-1  4.537 
F(000)  1802.0 
Crystal size/mm3  0.12 × 0.11 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.384 to 57.998 
Index ranges  -18 ≤ h ≤ 18, -21 ≤ k ≤ 21, -25 ≤ l ≤ 25 
Reflections collected  69733 
Independent reflections  17856 [Rint = 0.0616, Rsigma = 0.0741] 
Data/restraints/parameters  17856/111/835 
Goodness-of-fit on F2  1.036 
Final R indexes [I>=2σ (I)]  R1 = 0.0535, wR2 = 0.1284 
Final R indexes [all data]  R1 = 0.0948, wR2 = 0.1457 
Largest diff. peak/hole / e Å-3  5.40/-2.95 
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Crystal data and structure refinement for L26(Pt(dpybE)Cl)2 
Identification code  18srv388 
Empirical formula  C75H58N4OPt2 
Formula weight  1421.43 
Temperature/K  100.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  12.3705(16) 
b/Å  14.832(2) 
c/Å  17.645(2) 
α/°  65.796(3) 
β/°  87.028(3) 
γ/°  73.841(3) 
Volume/Å3  2829.0(7) 
Z  2 
ρcalcg/cm3  1.669 
μ/mm-1  4.596 
F(000)  1400.0 
Crystal size/mm3  0.025 × 0.015 × 0.005 
Radiation  synchrotron (λ = 0.6889) 
2Θ range for data collection/°  3.022 to 53.998 
Index ranges  -16 ≤ h ≤ 16, -19 ≤ k ≤ 19, -23 ≤ l ≤ 23 
Reflections collected  38279 
Independent reflections  13486 [Rint = 0.0885, Rsigma = 0.1630] 
Data/restraints/parameters  13486/15/741 
Goodness-of-fit on F2  0.981 
Final R indexes [I>=2σ (I)]  R1 = 0.0864, wR2 = 0.2375 
Final R indexes [all data]  R1 = 0.1245, wR2 = 0.2684 
Largest diff. peak/hole / e Å-3  5.25/-0.89 
 
 
 
 
